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2Abstract
Magnetic resonance imaging of myocardial perfusion during the first-pass of
a contrast agent has been proved valuable for the detection of coronary artery
disease. During contrast enhancement, transient dark rim artifacts are some-
times visible in the subendocardium, mimicking real perfusion defects and com-
plicating diagnosis.
This thesis studied several different mechanisms behind dark rim artifacts
with the aim of exploring possible solutions to minimise them and potentially
improve the accuracy of perfusion methods.
An in-depth review of current myocardial perfusion imaging techniques is
presented. This is followed by a comprehensive study of dark rim artifacts, with
realistic phantom and numerical simulations, and in vivo measurements. Sim-
ulations for the most common perfusion sequences are made, showing that
Gibbs, myocardial radial-motion, and frequency-offsets are capable of creating
endocardial signal-loss, although dependent on many sequence parameters.
Frequency-offsets during first-pass of contrast agent were measured in vivo; re-
sults show negligible intra-voxel signal dephasing, although careful frequency
adjustments need to be considered for the b-SSFP and h-EPI sequences.
The investigations on dark rim artifacts lead to the development of an ultra-
fast but robust sequence suitable for first-pass myocardial perfusion imaging,
and the assessment of its in vivo performance. The sequence was a multi-slice
single-shot spin-echo EPI sequence accelerated by a reduced phase-encode
FOV (zonal excitation), and parallel imaging R=2. When tested in clinical volun-
teers with CA at rest, the sequence yielded a reasonable CNR with a very short
acquisition time, although spatial resolution needs to be improved.
3Acknowledgements
Firstly, my thanks to my supervisors, Dr Peter Gatehouse and Prof David Firmin
for their constant support and making my work enjoyable throughout. I would
like to thank the entire CMR unit at the Royal Brompton Hospital for their help
and support, in particular DCR(R) Ricardo Wage and Dr Chiara Bucciarelli-
Ducci for their help with the in vivo studies. I would also like to thank Dr Peter
Kellman for his insight and useful advice.
I am also deeply indebted to the British Heart Foundation for funding my
work, and making it possible.
I would finally like to thank Carla.
4
Contents
1 Introduction 51
1.1 The heart and the heart cycle. . . . . . . . . . . . . . . . . . . . . . . 51
1.1.1 Electrical activity: heartbeat . . . . . . . . . . . . . . . . . . 53
1.2 Cardiac output . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
1.3 Coronary artery disease and myocardial perfusion . . . . . . . . . 58
1.4 Assessing Coronary Artery Disease . . . . . . . . . . . . . . . . . . . 62
1.4.1 Coronary angiography . . . . . . . . . . . . . . . . . . . . . . 63
1.4.2 Myocardial perfusion imaging . . . . . . . . . . . . . . . . . 67
1.4.2.1 Myocardial perfusion defects are not always cor-
related with coronary artery disease . . . . . . . . . 71
1.4.3 Myocardial viability . . . . . . . . . . . . . . . . . . . . . . . 71
1.5 Myocardial perfusion defects due to diseases other than CAD . . . 73
1.5.0.1 Hypertrophic Cardiomyopathy . . . . . . . . . . . 74
1.5.0.2 Syndrome X . . . . . . . . . . . . . . . . . . . . . . . 75
2 Myocardial perfusion imaging with MR - review 77
2.1 Myocardial perfusion imaging protocol . . . . . . . . . . . . . . . . 77
2.2 Perfusion analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
2.2.1 Myocardial segments . . . . . . . . . . . . . . . . . . . . . . . 88
2.3 Sequences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
2.3.1 Magnetisation preparation for T1-weighting . . . . . . . . . 90
5
6 CONTENTS
2.3.2 Gradient recalled echo . . . . . . . . . . . . . . . . . . . . . . 92
2.3.2.1 Gradient Recalled Echo . . . . . . . . . . . . . . . . 94
2.3.3 Balanced-Steady State Free Precession . . . . . . . . . . . . 97
2.3.4 Echo planar imaging . . . . . . . . . . . . . . . . . . . . . . . 104
2.3.4.1 Multishot techniques . . . . . . . . . . . . . . . . . 108
2.3.5 CNR sequence comparison in perfusion . . . . . . . . . . . 110
2.4 First-pass MR perfusion and circulation . . . . . . . . . . . . . . . . 115
2.4.1 Gd-DTPA in first-pass perfusion . . . . . . . . . . . . . . . . 115
2.4.2 Transmural distribution of myocardial perfusion and the
effects of adenosine . . . . . . . . . . . . . . . . . . . . . . . 118
2.5 Relevant cardiac MRI artifacts . . . . . . . . . . . . . . . . . . . . . 121
2.5.1 Motion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
2.5.1.1 Intra-view motion . . . . . . . . . . . . . . . . . . . 122
2.5.1.2 Inter-view motion . . . . . . . . . . . . . . . . . . . 123
2.5.2 Magnetic susceptibility . . . . . . . . . . . . . . . . . . . . . 127
2.5.3 Gibbs ringing . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
2.5.3.1 Window function and PSF . . . . . . . . . . . . . . 132
2.6 Dark rim artifacts in first-pass cardiac perfusion MRI . . . . . . . . 133
2.7 Assessment of dark rim artifacts in patients . . . . . . . . . . . . . 138
2.7.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
2.7.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
2.7.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
2.8 Other MRI approaches to perfusion imaging . . . . . . . . . . . . . 148
2.8.1 Contrast-agent free techniques . . . . . . . . . . . . . . . . . 148
2.8.1.1 Arterial spin labelling . . . . . . . . . . . . . . . . . 148
2.8.1.2 Blood Oxygen Level-Dependent . . . . . . . . . . . 149
2.8.2 Alternative contrast agents . . . . . . . . . . . . . . . . . . . 150
2.9 Review of methods for accelerating perfusion imaging . . . . . . . 153
2.9.1 Reduced phase field of view . . . . . . . . . . . . . . . . . . . 153
2.9.1.1 Oblique pulses . . . . . . . . . . . . . . . . . . . . . 153
2.9.1.2 2D RF pulse . . . . . . . . . . . . . . . . . . . . . . . 154
2.9.2 Parallel imaging . . . . . . . . . . . . . . . . . . . . . . . . . . 158
2.9.2.1 SENSE vs. GRAPPA . . . . . . . . . . . . . . . . . . . 158
CONTENTS 7
3 Dark rim artifacts and simulations of Gibbs and motion artifacts 161
3.1 Endocardial border phantom . . . . . . . . . . . . . . . . . . . . . . 163
3.1.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
3.1.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
3.1.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 172
3.2 Variability of myocardial perfusion dark rim Gibbs artifacts due to
sub-pixel shifts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
3.2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
3.2.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
3.2.2.1 Phantom imaging . . . . . . . . . . . . . . . . . . . 181
3.2.2.2 Numerically simulated data . . . . . . . . . . . . . 182
3.2.2.3 Patient images . . . . . . . . . . . . . . . . . . . . . 183
3.2.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
3.2.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190
3.2.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . 196
3.3 Simulations of the dark rim artifact for perfusion protocols . . . . 197
3.3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
3.3.2 Materials and methods . . . . . . . . . . . . . . . . . . . . . 197
3.3.2.1 Gibbs artifacts . . . . . . . . . . . . . . . . . . . . . 203
3.3.2.2 Motion artifacts . . . . . . . . . . . . . . . . . . . . . 205
3.3.2.3 T1/T2* filtering . . . . . . . . . . . . . . . . . . . . . 208
3.3.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210
3.3.3.1 Gibbs artifacts . . . . . . . . . . . . . . . . . . . . . 210
3.3.3.2 Motion artifacts . . . . . . . . . . . . . . . . . . . . . 226
3.3.3.3 T1/T2* filtering . . . . . . . . . . . . . . . . . . . . . 259
3.3.4 Overall discussion of simulation results . . . . . . . . . . . . 264
3.3.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 269
4 Measurement of myocardial frequency offsets during first pass of a gadolinium-
based contrast agent in perfusion studies 271
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271
4.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273
4.2.1 In vivo studies . . . . . . . . . . . . . . . . . . . . . . . . . . . 273
8 CONTENTS
4.2.2 Phantom work . . . . . . . . . . . . . . . . . . . . . . . . . . . 275
4.2.3 Numerical Simulations . . . . . . . . . . . . . . . . . . . . . 277
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 279
4.3.1 in vivo studies . . . . . . . . . . . . . . . . . . . . . . . . . . . 279
4.3.2 Phantom work . . . . . . . . . . . . . . . . . . . . . . . . . . . 281
4.3.3 Numerical Simulations . . . . . . . . . . . . . . . . . . . . . 287
4.4 Discussion and Conclusions . . . . . . . . . . . . . . . . . . . . . . 291
Appendix 4.A Field distortion in a cylinder . . . . . . . . . . . . . . . . 296
5 Zonal single-shot spin-echo EPI sequence with TSENSE 299
5.1 Aim . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 299
5.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 300
5.2.1 Sequence structure . . . . . . . . . . . . . . . . . . . . . . . . 300
5.2.1.1 Crusher gradients and spoilers . . . . . . . . . . . . 302
5.2.1.2 2D spatial excitation . . . . . . . . . . . . . . . . . . 303
5.2.1.3 Ramp Sampling . . . . . . . . . . . . . . . . . . . . . 316
5.2.1.4 Saturation pulse: BIR-4 . . . . . . . . . . . . . . . . 318
5.2.1.5 Fat suppression . . . . . . . . . . . . . . . . . . . . . 318
5.2.1.6 Phase correction . . . . . . . . . . . . . . . . . . . . 319
5.2.1.7 GRAPPA vs SENSE . . . . . . . . . . . . . . . . . . . 323
5.2.1.8 Dark blood preparation . . . . . . . . . . . . . . . . 325
5.2.1.9 Protocol parameters dialog box . . . . . . . . . . . 333
5.2.2 Sequence protocol . . . . . . . . . . . . . . . . . . . . . . . . 334
5.2.3 Volunteer scans . . . . . . . . . . . . . . . . . . . . . . . . . . 337
5.2.3.1 Preliminary scans in healthy volunteers without
contrast agent . . . . . . . . . . . . . . . . . . . . . . 338
5.2.3.2 Clinical volunteers scans with contrast agent . . . 339
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 343
5.3.1 Preliminary scans in volunteers without contrast agent . . 343
5.3.2 Scans in clinical volunteers . . . . . . . . . . . . . . . . . . . 355
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 371
5.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 376
6 Conclusions and future work 377
CONTENTS 9
Appendices 381
A Adiabatic RF pulses: BIR-4 381
B Parallel Imaging 385
B.1 SENSE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 387
B.2 SMASH, g-SMASH & GRAPPA . . . . . . . . . . . . . . . . . . . . . . 390
B.3 Temporal filtering: UNFOLD . . . . . . . . . . . . . . . . . . . . . . 393
B.4 k-t BLAST & k-t SENSE . . . . . . . . . . . . . . . . . . . . . . . . . . 395
C Blood susceptibility 399
Bibliography 403
D Publications 431
Myocardial first-pass perfusion cardiovascular magnetic resonance: his-
tory, theory, and current state of the art . . . . . . . . . . . . . . . . 432
Measurement of Myocardial Frequency Offsets During First Pass of a
Gadolinium-Based Contrast Agent in Perfusion Studies . . . . . . 450
Variability of myocardial perfusion dark rim Gibbs artifacts due to sub-
pixel shifts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 461
10 CONTENTS
List of Figures
1.1 The heart and blood circulation. A,B-Vena cava; C-Pulmonary
artery; D-Aorta; E-Pulmonary veins; F-tricuspid valve; G-Pulmonary
valve; H-bicuspid valve; I-aortic valve. . . . . . . . . . . . . . . . . 52
1.2 The cardiac conducting system. A-sinoatrial node; B-atrioventricular
node; C-atrioventricular bundle; D-Purkinje fibres . . . . . . . . . 53
1.3 Electrocardiogram recorded events of the pacemaker cells in the
heart. Depolarisation happens when the heart muscle starts to
contract, and repolarisation triggers relaxation. . . . . . . . . . . . 54
1.4 A sketch of the left ventricular pressure, volume, and ECG. . . . . 56
1.5 Coronary Arteries. The main coronary arteries are displayed in
red, light red indicates the posterior coronaries, i.e. behind the
heart in this image orientation. . . . . . . . . . . . . . . . . . . . . . 58
1.6 Microscopic images of myocardial tissue. The top left corner con-
tains infarcted myocardium cells, while the bottom right corner
contains mostly viable myocardial tissue. Image kindly provided
by Dr. Mary Sheppard, department of Histopathology, Royal Bromp-
ton Hospital, Royal Brompton & Harefield NHS Trust. . . . . . . . 60
1.7 Patient MRA of the coronary arteries. The RCA (right coronary
artery), and LAD (left anterior descending artery) are labelled. . . 66
1.8 Short-axis late-enhancement image, with a visible infarction of
the inferior and infero-lateral walls. . . . . . . . . . . . . . . . . . . 73
11
12 LIST OF FIGURES
1.9 Cine imaging during end diastole shows myocardial thickening
in the anteroseptal and inferoseptal walls for a patient with di-
agnosed HCM. These myocardial segments correspond to the ar-
eas with perfusion defects during first pass at stress with adeno-
sine and with bright signal during late-GD enhancement imaging.
Note that during late-enhancement the subendocardial region is
not bright (no fibrosis). . . . . . . . . . . . . . . . . . . . . . . . . . . 74
1.10 Multi-slice short axis MR images of Gd first-pass during stress and
rest for a patient with a diagnostic concordant with syndrome X. . 76
2.1 Image plane positioning towards a short-axis image of the LV, in
red is shown the next image plane. Image A represents a simple
transverse slice through the chest, a perpendicular slice along the
LV gives us image plane B. Image C is perpendicular to image B
positioned through the mitral valve and apex of the LV. The last
perpendicular plane gives us the short axis plane, image D. . . . . 80
2.2 Frames depicting the first-pass of Gd-DTPA. The black arrows point
into regions with visible perfusion defects. . . . . . . . . . . . . . . 82
2.3 A sketch of the SI as a function of time for: the LV, a normal myo-
cardium, and for an ischaemic myocardium. . . . . . . . . . . . . . 84
2.4 SI curve parameters. (see text in pages 85-86) . . . . . . . . . . . . 84
2.5 Real SI curve measured for a patient with a real perfusion defect
in some myocardial segments. . . . . . . . . . . . . . . . . . . . . . 85
2.6 Standardised myocardial segmentation. . . . . . . . . . . . . . . . 89
2.7 T1-weighted magnetisation preparation with a saturation recov-
ery RF pulse per slice. The two lines (red and blue) represent dif-
ferent T1-recovery signal curves. The blue line has a shorter T1
recovery caused by a higher concentration of gadolinium. . . . . . 92
2.8 A basic GRE with a phase rewinder gradient. . . . . . . . . . . . . . 93
2.9 Steady-state signal in a GRE sequence as a function of the flip an-
gle in the myocardium before contrast and at peak contrast con-
centration. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
LIST OF FIGURES 13
2.10 Approach to steady state equilibrium of a GRE sequence with an
SR preparation for two different flip angles, at peak concentration
of Gd-DTPA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
2.11 Balanced-SSFP sequence. The sum integral of the gradients areas
is zero during each TR for each axis. . . . . . . . . . . . . . . . . . . 97
2.12 Balanced-SSFP magnetisation oscillation in its approach to equi-
librium around the z-axis. (no saturation recovery; 100 RF pulses
simulated). The plot shows the magnetisation trajectory in 3D
(rotating frame). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
2.13 Top: Transverse magnetisation magnitude values as the sequence
approaches the steady-state. Bottom: The phase as a function of
the RF pulse number. . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
2.14 Balanced-SSFP magnetisation oscillation in its approach to equi-
librium around the z-axis, with an off-resonance of 100 Hz. The
plot shows the magnetisation trajectory in 3D (rotating frame). . . 100
2.15 Top: Transverse magnetisation magnitude values as the sequence
approaches the steady-state. Bottom: Phase values as a function
of the RF pulse number. . . . . . . . . . . . . . . . . . . . . . . . . . 100
2.16 Steady-state signal as a function of the off-resonance frequency
for different RF angles. . . . . . . . . . . . . . . . . . . . . . . . . . . 101
2.17 Approach to steady state equilibrium of a bSSFP sequence with an
SR preparation (initial pulse was α/2). The signal was simulated
for the myocardium before contrast arrival and at peak concen-
tration of Gd-DTPA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
2.18 Comparison between the classical approach (left) and the Hennig
et al. approach (right). . . . . . . . . . . . . . . . . . . . . . . . . . . 103
2.19 Diagram representing the basic gradient setup of two types of EPI
sequences. Top: Gradient recalled echo EPI sequence. Bottom:
Spin echo EPI sequence. In both sequences, the readout train
uses a blipped phase-encode (Cartesian k-space sampling trajec-
tory). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
14 LIST OF FIGURES
2.20 Diagram representing the signal decay for the two types of EPI
sequences. Top: Gradient recalled echo EPI sequence with the T∗2
decay (blue). Bottom: Spin echo EPI sequence with the spin echo
modulated by the T∗2 decay (blue)(T2 decay in red). . . . . . . . . . 105
2.21 Left: Mosaic multishot technique with a k-space tiling in four quad-
rants. Centre: Interleaved multishot technique with a phase-encode
step of three k-space lines. Right: Centric-interleaved phase en-
coding scheme where the central lines are acquired with the first
echo. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
2.22 Echo time shifting diagram: the k-space is represented by a se-
ries of rectangles, where each one represents a different phase-
encode line for an h-epi sequence with an echo-train length of 3
and 4 interleaves. The gray-scale represents the phase error. In
the k-space data with no echo time shifting (left) there are big dis-
continuities in the ky centre, where greater signal energy occurs.
These discontinuities are shifted from the centre to the outer re-
gions of k-space in the data with echo time shifting (right). . . . . 112
2.23 T1 and T2 relaxation values of the myocardium and LV blood pool
as the concentration of Gd-DTPA increases. Myocardial Gd con-
centration: [0,1] mmol L−1, LV Gd concentration: [0,10] mmol L−1. 116
2.24 Recovered transverse magnetisation following a saturation pulse
with a TI of 80 ms as a function of the concentration of Gd. My-
ocardial Gd concentration: [0,1] mmol L−1, LV Gd concentration:
[0,10] mmol L−1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
2.25 Numerical simulation of the effects of motion in the frequency
and phase-encode direction of an octagon (phase-encode direc-
tion horizontal). The top row shows from left to right the octagon
with no motion, moving in the frequency-encode direction, and
moving in the phase-encode direction. The line profiles on the
second line are for the motion in the frequency-encode direction,
from left to right showing line profiles in the phase, frequency and
diagonal directions. The bottom row displays the corresponding
line profiles for the motion in the phase-encode direction. . . . . 126
LIST OF FIGURES 15
2.26 A step function and the same function but truncated to a 128 pixel
resolution. The Gibbs ringing is shown at a resolution of 1 mm. . . 131
2.27 A truncated step function and the same function but filtered with
a Hamming filter, the loss of resolution on the edge is apparent.
The resolution of both line profiles is at one pixel, i.e. 400/128 =
3.1 mm/px. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
2.28 Comparison between a dark rim artifact (top) and a real perfu-
sion defect (bottom), both are pointed by white arrows. From left
to right it is shown the contrast agent arrival to the left ventricle,
the myocardium, and finally recirculation. A DRA artifact usually
correlates with the LV bright blood which typically lasts for only a
few heartbeats, while a moderate or severe real defect persists for
longer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
2.29 Myocardial segment numbering. The same numbers were used
for each short-axis slice. . . . . . . . . . . . . . . . . . . . . . . . . . 141
2.30 Mid-slice short-axis image of the same subject during first-pass
with the three perfusion sequences. From left to right: h-EPI,
bSSFP, and GRE. The alignment of slices between the three ap-
pointments for each patient was not always so exact, although
this was the aim. Only the h-EPI had fat suppression, evident
from the dark layer of fat below the ventricles compared to the
bSSFP and GRE. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
2.31 Average RR interval as a function of the number of artifacts de-
tected from left to right: apical, mid, basal. There is no strong
correlation between the two parameters. . . . . . . . . . . . . . . . 144
2.32 DRAs visual appearance (arrows): on the left the DRAs (in the sep-
tal inferior segments) are thinner and located in the sub-endocardium.
The image in the middle has both a thin artifact (septal segment)
and a wider artifact located mid-wall (inferior segment). The im-
age on the right shows a wide DRA in the lateral segment mid-
wall, and a thinner sub-endocardial DRA in the infero-septal re-
gion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
16 LIST OF FIGURES
2.33 Oblique 90◦ and 180◦ pulse. The purple region, where both pulse
excitation planes coincide, is the excited plane. This purple plane
can be divided into a rectangular area and two triangular ones.
The minimum FOV in the phase direction is the rectangular area
plus half the triangular one from each side, in order to prevent the
triangular area from wrapping around into the myocardial tissue
(i.e. the ROI). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
2.34 Example of a 2DRF pulse with an echo planar trajectory. This par-
ticular 2DRF pulse was designed to excite a volume with 170 mm
× 18 mm (phase FOV × slice thickness). . . . . . . . . . . . . . . . . 157
3.1 T1 and T2 curve fitting for the gelatin phantom. . . . . . . . . . . . 164
3.2 Field map of the gelatin immersed in water. The gelatin block is
delineated by the dashed square. The field plot greyscale has a
range of 210 Hz (3.3 ppm at 1.5 T). There is a maximum difference
of 50 Hz in the gelatin border. . . . . . . . . . . . . . . . . . . . . . . 165
3.3 Gelatin phantom dimensions and photos. . . . . . . . . . . . . . . 165
3.4 Container with gelatin layer (dark) below a bright solution of Gd-
DTPA. This apparatus was scanned (GRE sequence with inversion
time of 100 ms) every 20 minutes overnight. During the first 13.4
hours there was an approximately 7 mm penetration of the Gd-
DTPA solution into the gelatin. . . . . . . . . . . . . . . . . . . . . . 166
3.5 Short-axis images of the phantom at the three resolutions; re-
peated with all three sequences: h-EPI, bSSFP, and GRE sequence
(from left to right). Each sequence is shown twice: with SR (left)
and without SR (right). The phase-encode direction is vertical. . . 168
3.6 Line profiles for the phantom images with SR in the frequency-
encode direction. The line profiles begin and end at the “epicar-
dial border” of the phantom. . . . . . . . . . . . . . . . . . . . . . . 170
3.7 Gibbs ringing for a sharp edge (left), and for a less sharper edge
(right). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
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3.8 Line profile of the bSSFP without zero-filling (left) and with zero-
filling (right). The first undershoot of the Gibbs ringing on the
left of the non-interpolated image (arrow) is hidden by the pixel
position. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
3.9 h-EPI scans of the phantom with no SR. Left: phase-encode di-
rection vertical. Right: phase-encode direction horizontal. . . . . 174
3.10 h-EPI scans of the phantom with two different frequency adjust-
ment boxes. The larger volume adjustment box was slightly big-
ger than the whole phantom, while the smaller box was predomi-
nantly LV blood pool signal. Both adjustment boxes were approx-
imately centred in the phantom centre. . . . . . . . . . . . . . . . . 175
3.11 Perfusion study with an h-EPI sequence (EPI-factor of 4, centric
phase-acquisition order), showing three frames during the first-
pass of CA. The phase-encode direction is vertical. Reliable per-
formance of this method will depend on the expertise of the oper-
ator more than most of the conventional sequences used clinically. 175
3.12 Perfusion patient scanned with an h-EPI sequence with an EPI-
factor of 4. The two images correspond to the same frame but the
raw-data of the image on the right was modified to change the
amount of off-resonance accumulated phase in each echo. Left:
original adjustment. Right: 130Hz frequency offset when com-
pared to the image on the left. The phase-encode direction is hor-
izontal. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 177
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3.13 A simulated short axis signal profile across the myocardium and
LV (red). The sharp edge in the profile represents the signal con-
trast between the myocardium and the LV. The signal around these
edges is going to be corrupted with Gibbs artifacts (blue line). Dif-
ferent pixel positions would measure the oscillating signal differ-
ently, since each pixel has a finite size, integrating the signal in-
side its corresponding position. Orange and green represent dif-
ferent pixel positions and the respective signal profile measured.
Gibbs ringing is much more visible in the orange pixel position
than on the green pixel position. This Figure does not consider
any image interpolation effects. . . . . . . . . . . . . . . . . . . . . 180
3.14 A phantom with a near horizontal flat edge between undiluted
gelatin and a solution of Gd-DTPA, corresponding to a signal ra-
tio of 1/3 in the edge boundary. a) Phantom image uninterpo-
lated. b) Image a interpolated in the image space with a bicu-
bic interpolation. The solid arrows point into the regions where
Gibbs artifacts are visible, while the dashed arrows point into the
in-between regions with no artifact. c) Image a but with zero-
filling pre FFT interpolation. Image a shows the measured peak
artifact signal loss in the bottom right corner. . . . . . . . . . . . . 185
3.15 Top: a) numerically simulated short axis image. b) Image a shifted
horizontally half a pixel by phase-shifting the raw-data. c) Image
a shifted vertically half a pixel using the same method. d) Image
a with lower LV / myocardium signal ratio. Images e-h are images
a-d interpolated in the image space respectively. Images i-l are
images a-d zero-filled pre-FFT respectively. Both figure 3 a, and
d also show, in the top right corner, the corresponding measured
peak artifact signal loss. . . . . . . . . . . . . . . . . . . . . . . . . . 187
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3.16 a) The original image retrieved from the perfusion scan, with a
mild artifact in the septal region as pointed by the white arrow. b)
The same magnitude image but with a shift of 0.375 pixel length
in the horizontal direction, corresponding to the shift with the
most prominent artifact in the same region. c) A shift of half a
pixel compared to image b in the horizontal direction, showing a
reduction of the DRA. Images d-f, and g-i show images a-c inter-
polated in the image space, and zero-filled pre-FFT respectively.
The measured peak artifact % signal loss in the region pointed by
the arrows is shown at the bottom of Images a-c. . . . . . . . . . . 188
3.17 a) Original perfusion image with a DRA located in the anterior re-
gion of the subendocardium. b) Image a shifted 0.875 pixel length
in the vertical direction. c) Image a shifted 0.375 pixel length in
the vertical direction (half-pixel difference from b). Image b cor-
responds to the shift with the most prominent artifact, and image
c the shift with the biggest DRA reduction. Images d-f, and g-i
show the post-FFT and pre-FFT interpolations of images a-c. The
measured peak artifact % signal loss in the region pointed by the
arrows is shown at the bottom of Images a-c. . . . . . . . . . . . . . 189
3.18 a) The original perfusion frame with an artifact in the septal re-
gion, which is an example where the original boundary was ex-
actly at a location with the most prominent DRA. b) Corresponds
to image a shifted in the horizontal direction by half a pixel length,
showing a reduction of the artifact. Figures c-d and e-f are the re-
spective post-FFT and pre-FFT interpolations of figures a-b. The
measured peak artifact signal loss in the regions pointed by the
arrows is shown at the lower edges of Figures a, b. . . . . . . . . . . 191
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3.19 Figure 3.19 a-d shows 4 consecutive frames of the basal slice dur-
ing the beginning of myocardial perfusion for one patient. The
top panel (Images a-l) correspond to the shift where the artifacts
were most prominent, whereas the lower panel (Images m-x) are
the shift that minimises the DRAs. There are two DRAs visible in
the 4 frames, one in the anterior and another in the inferior sub-
endocardial region (white arrows). Figure 3.19 e-h, and 3.19 i-l
are the post-FFT and pre-FFT interpolated images of 3.19 a-d, re-
spectively. Figure 3.19 m-x has an identical layout to Figure 3.19
a-l, but shows the frames with the shift that minimised the same
artifacts; the shift is of half a pixel in the vertical direction, when
compared to Figure 3.19 a-l. Figure 3.19 a-d and m-p show the
measured peak artifact signal loss for the anterior (top) and infe-
rior (bottom) segments as pointed by the arrows (there is an an-
imated GIF in the attached CD, that cycles between the original
data and the shifted one for an easier comparison (sub pixel shift
gibbs anim.gif)). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 192
3.20 a) numerically simulated short-axis image. b) simulated short
axis image with the added perfusion defect. (Cropped images
from typical FOV, which is described later). Both magnitude im-
ages are inherently corrupted with Gibbs ringing. . . . . . . . . . . 198
3.21 SI curves for the LV and myocardium for each of the three se-
quences. The first three rows show the SI curves for each of the
four patients separately and for each sequence. The bottom row
shows the average SI curves used in the simulations for the three
sequences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200
3.22 The two parameters measured in the signal line profile in the sub-
endocardial edge: the depth and width of the artifact. The solid
line is a signal line profile corrupted by ringing, while the dashed
line represents the theoretical artifact-free image used as an input
in the simulations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202
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3.23 a) Tukey filter r = 0.25, b) Tukey filter r = 0.50, c) Tukey filter
r = 0.75, d) Tukey filter r = 1.0 (also known as Hann filter), e)
Hamming filter. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203
3.24 Radial velocities of the endocardial border at rest measured by
Jung et al. [2006], temporally aligned to a 800 ms RR interval. . . . 205
3.25 a) The radial velocity of the endocardial border during the heart
cycle at stress. It is also shown the three R-kc times used in the
motion simulations. These times correspond to the time between
the R-wave and the acquisition of the k-space central line (R-kc).
b) Myocardial wall thickness and corresponding radius for the ep-
icardium and subendocardium borders. Please note that 800 ms
does not represent the end of the cardiac cycle, but only the end
of our velocity data. For these simulations this is not important
since we are only interested up to the peak-filling period. . . . . . 207
3.26 a)-c) numerically simulated short axis images with resolutions:
128x128 pixels, 160x160 pixels, and 192x192 pixels respectively.
All images have in the bottom the corresponding line profile across
the centre of the LV. (The number of pixels in the line profile is the
number of pixels after zero filling the raw-data into a 2048x2048
matrix. As explained in Methods, all of the simulated images were
reconstructed in this way.) . . . . . . . . . . . . . . . . . . . . . . . . 212
3.27 Gibbs SL% (a) and Gibbs + added-defect SL% (b) for the 128x128,
160x160, and 192x192 matrices as a function of filter type, in the
h-EPI sequence; the same for the bSSFP sequence (c-d) respec-
tively; and for the GRE sequence (e-f ) respectively. . . . . . . . . . 214
3.28 a) 128x128 unfiltered, b) 128x128 Hamming filtered, c) 128x128
with added defect, unfiltered, d) 128x128 with the added defect,
Hamming filtered. e)-h) similar to a)-d) but for the 160x160 ma-
trix. i)-l) similar to a)-d) but for the 192x192 matrix. . . . . . . . . . 215
3.29 Gibbs/defect depth ratio for the 128x128, 160x160, and 192x192
matrices as a function of filter type, in the h-EPI (a), bSSFP (b),
and GRE (c) sequence. (The erratic 192x192 no filter point is as
previously discussed.) . . . . . . . . . . . . . . . . . . . . . . . . . . 218
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3.30 SL% as a function of the resolution for 4 different defect widths
for the bSSFP sequence. a) Without filtering, b) Hamming filtered.
The plots include lower-phase-encode resolutions in a square FOV.
These measurements of signal loss and width were done along the
phase encode direction. . . . . . . . . . . . . . . . . . . . . . . . . . 220
3.31 a), d), and g) show the magnitude images with Gibbs ringing and
a real perfusion defect with a 40 % myocardial thickness at a 50
SL%. Images b), e), and h) show the same magnitude images as in
a), d), and g) respectively, but with simulated realistic noise levels.
Finally images c), f), and i) show images b), e), and h) after being
Hamming filtered. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223
3.32 Noise measured in A.U. for the three sequences with and without
Hamming filtering. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
3.33 Motion simulations for the h-EPI sequence: a)-c) 128x128 matrix
with R-kc times: 120, 310, and 410 ms. d)-f) the same as a)-c) but
for a 160x160 matrix. g)-i) the same as a)-c) but for a 192x192 matrix.227
3.34 Motion simulations for the bSSFP sequence: a)-c) 128x128 matrix
with R-kc times: 120, 310, and 410 ms. d)-f) the same as a)-c) but
for a 160x160 matrix. g)-i) the same as a)-c) but for a 192x192 matrix.228
3.35 Motion simulations for the GRE sequence: a)-c) 128x128 matrix
with R-kc times: 120, 310, and 410 ms. d)-f) the same as a)-c) but
for a 160x160 matrix. g)-i) the same as a)-c) but for a 192x192 matrix.229
3.36 Short-axis magnitude image indicating the direction of the fre-
quency and phase-encode bulk motion. The coloured rectangles
indicate the edges that are going to be analysed in the following
results (red for the bulk motion along the frequency-encode di-
rection, and green for a bulk motion along the phase-encode di-
rection). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231
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3.37 Figure showing from left to right, the zoomed Gibbs PSF, the zoomed
short-axis magnitude image convolved with the PSF, the corre-
sponding unzoomed images, and the line profiles across the cen-
tre of the short-axis along the frequency and phase-encode direc-
tion respectively. The red rectangle in the unzoomed images rep-
resent the zoom region. . . . . . . . . . . . . . . . . . . . . . . . . . 232
3.38 Figure showing from left to right: the phase-encode motion PSF
(magnitude and phase respectively) for the h-EPI acquisition or-
der and the convolution of the PSF with the short-axis image with
an arrow indicating the bulk motion direction. The PSF images on
the bottom show the zoomed central region demarcated by the
blue dashed rectangle. The phase PSF image is also thresholded
to the magnitude image, i.e. the phase values were nulled (grey)
for the corresponding magnitude points with < 10% of the peak
magnitude. The coloured green rectangle shows the relevant bor-
ders to the motion analysis. (Phase-encode direction horizontal). 234
3.39 Figure showing from left to right: the phase-encode motion PSF
(magnitude and phase respectively) for the ECE acquisition order
and the convolution of the PSF with the short-axis image with an
arrow indicating the bulk motion direction. The PSF images on
the bottom show the zoomed central region demarcated by the
blue dashed rectangle. The phase PSF image is also thresholded
to the magnitude image, i.e. the phase values were nulled (grey)
for the corresponding magnitude points with < 10% of the peak
magnitude. The coloured green rectangle shows the relevant bor-
ders to the motion analysis. (Phase-encode direction horizontal). 235
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3.40 Figure showing from left to right: the frequency-encode motion
PSF (magnitude and phase respectively) for the h-EPI acquisition
order and the convolution of the PSF with the short-axis image
with an arrow indicating the bulk motion direction. The PSF im-
ages on the bottom show the zoomed central region demarcated
by the blue dashed rectangle. The phase PSF image is also thresh-
olded to the magnitude image, i.e. the phase values were nulled
(grey) for the corresponding magnitude points with < 10% of the
peak magnitude. The coloured red rectangle shows the relevant
borders to the motion analysis. (Phase-encode direction horizon-
tal). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 237
3.41 Figure showing from left to right: the frequency-encode motion
PSF (magnitude and phase respectively) for the ECE acquisition
order and the convolution of the PSF with the short-axis image
with an arrow indicating the bulk motion direction. The PSF im-
ages show the zoomed central region demarcated by the blue dashed
rectangle. The phase PSF image is also thresholded to the magni-
tude image, i.e. the phase values were nulled (grey) for the corre-
sponding magnitude points with < 10% of the peak magnitude.
The coloured red rectangle shows the relevant borders to the mo-
tion analysis. (Phase-encode direction horizontal). . . . . . . . . . 238
3.42 Line profiles of the short-axis convoluted with the motion PSFs
for the h-EPI acquisition order. Left: line profile along the phase-
encode direction for a bulk motion along the same direction. Right:
line profile along the frequency-encode direction for a bulk mo-
tion along the same direction. The arrows on top indicate the di-
rection of the motion. . . . . . . . . . . . . . . . . . . . . . . . . . . 239
3.43 Line profiles of the short-axis convoluted with the motion PSFs
for the ECE acquisition order. Left: line profile along the phase-
encode direction for a bulk motion along the same direction. Right:
line profile along the frequency-encode direction for a bulk mo-
tion along the same direction. The arrows on top indicate the di-
rection of the motion. . . . . . . . . . . . . . . . . . . . . . . . . . . 240
LIST OF FIGURES 25
3.44 h-EPI acquisition order. From left to right; Top row: Numerical
simulated short-axis image with motion and Gibbs artifacts, ana-
lytical analysis short-axis image with motion in the phase-encode
direction and Gibbs, analytical analysis short-axis image with mo-
tion in the frequency-encode direction and Gibbs. Middle row:
Line profiles along the phase-encode direction for the correspon-
dent images on the top row. Bottom row: Line profiles along the
frequency-encode direction for the correspondent images on the
top row. The coloured lines show the direction of the line profiles. 242
3.45 ECE acquisition order. From left to right; Top row: Numerical
simulated short-axis image with motion and Gibbs artifacts, ana-
lytical analysis short-axis image with motion in the phase-encode
direction and Gibbs, analytical analysis short-axis image with mo-
tion in the frequency-encode direction and Gibbs. Middle row:
Line profiles along the phase-encode direction for the correspon-
dent images on the top row. Bottom row: Line profiles along the
frequency-encode direction for the correspondent images on the
top row. The coloured lines show the direction of the line profiles. 243
3.46 Motion simulation results for the h-EPI sequence: a)-b) the per-
centage of signal loss and the width of the DRAs respectively in
a line profile along the phase-encode direction with R-kc times:
120, 310, and 410 ms. c)-d) similar to a)-b) but for line profiles
along the frequency-encode direction. . . . . . . . . . . . . . . . . 245
3.47 Motion simulation results for the bSSFP sequence: a)-b) the per-
centage of signal loss and the width of the DRAs respectively in
a line profile along the phase-encode direction with R-kc times:
120, 310, and 410 ms. c)-d) similar to a)-b) but for line profiles
along the frequency-encode direction. . . . . . . . . . . . . . . . . 246
3.48 Motion simulation results for the GRE sequence: a)-b) the per-
centage of signal loss and the width of the DRAs respectively in
a line profile along the phase-encode direction with R-kc times:
120, 310, and 410 ms. c)-d) similar to a)-b) but for line profiles
along the frequency-encode direction. . . . . . . . . . . . . . . . . 247
26 LIST OF FIGURES
3.49 Motion simulation results for the bSSFP sequence and h-EPI se-
quence at rest and stress during diastolic filling: a)-b) the percent-
age of signal loss and the width of the DRAs respectively in a line
profile along the phase-encode direction. c)-d) similar to a)-b)
but for line profiles along the frequency-encode direction. e)-f)
bSSFP at stress and rest respectively. g)-h) h-EPI at stress and
rest respectively. All magnitude images shown at image matrix
size of 192x192. Note that for the h-EPI some signal loss values
were close to zero and therefore the width measured was non-
significant (for example the peak seen at stress for the width at a
resolution of 192x160 along the frequency-encode direction). . . . 251
3.50 Motion simulation images for the bSSFP sequence at a resolution
of 192x192. a)-c) edge-centre-edge trajectory with R-kc times: 120,
310, and 410 ms. d)-f) edge-centre trajectory with R-kc times: 226,
416, and 526 ms. g)-i) centre-edge trajectory with R-kc times: 14,
204, and 314 ms. j)-l) h-EPI trajectory with R-kc times: 120, 310,
and 410 ms. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 253
3.51 h-EPI: a)magnitude image for the motion simulations at R-kc 120
ms for the 128x128 matrix size. b) image a Hamming filtered. c)
the same magnitude image as a but with an added perfusion de-
fect. d) image c Hamming filtered. Images e)-h) similar to a-d but
for the 310 ms R-kc time. Images i)-l) similar to a-d but for the 410
ms R-kc time. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 254
3.52 bSSFP: a)magnitude image for the motion simulations at R-kc 120
ms for the 128x128 matrix size. b) image a Hamming filtered. c)
the same magnitude image as a but with an added perfusion de-
fect. d) image c Hamming filtered. Images e)-h) similar to a-d but
for the 310 ms R-kc time. Images i)-l) similar to a-d but for the 410
ms R-kc time. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 255
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3.53 GRE: a)magnitude image for the motion simulations at R-kc 120
ms for the 128x128 matrix size. b) image a Hamming filtered. c)
the same magnitude image as a but with an added perfusion de-
fect. d) image c Hamming filtered. Images e)-h) similar to a-d but
for the 310 ms R-kc time. Images i)-l) similar to a-d but for the 410
ms R-kc time. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 256
3.54 Motion simulation results for the h-EPI sequence with the Ham-
ming filter (no defect): a) the signal loss as a percentage of the
average myocardial signal as a function of matrix size along the
phase-encode direction. b) the signal loss as a percentage of the
average myocardial signal as a function of matrix size along the
frequency-encode direction. All plots show the measurements for
the three R-kc times: 120, 310, and 410 ms. . . . . . . . . . . . . . . 257
3.55 Motion simulation results for the bSSFP sequence with the Ham-
ming filter (no defect): a) the signal loss as a percentage of the
average myocardial signal as a function of matrix size along the
phase-encode direction. b) the width of the DRAs in a line profile
along the phase-encode direction as a function of the image ma-
trix. c) the signal loss as a percentage of the average myocardial
signal as a function of matrix size along the frequency-encode di-
rection. All plots show the measurements for the three R-kc times:
120, 310, and 410 ms. . . . . . . . . . . . . . . . . . . . . . . . . . . . 257
3.56 Motion simulation results for the GRE sequence with the Ham-
ming filter (no defect): a) the signal loss as a percentage of the
average myocardial signal as a function of matrix size along the
phase-encode direction. b) the width of the DRAs in a line profile
along the phase-encode direction as a function of the image ma-
trix. c) the signal loss as a percentage of the average myocardial
signal as a function of matrix size along the frequency-encode di-
rection. All plots show the measurements for the three R-kc times:
120, 310, and 410 ms. . . . . . . . . . . . . . . . . . . . . . . . . . . . 258
3.57 Frequency-encode signal modulation for the myocardium (a), and
the LV (b). The initial magnetisation was normalised to M0 = 1. . . 259
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3.58 FWHM as a function of Gd concentration for the kx-modulation
for the myocardium (a), and the LV (b). . . . . . . . . . . . . . . . . 260
3.59 Left: kx-modulation as a function of frequency-encode line in the
LV for the bSSFP sequence with a T1 ≈ 8×TR and a T2 ≈ 6×TR
(values used in the bSSFP sequence). Right: Similar to image on
the left but for a T1 ≈ 400×TR and a T2 ≈ 300×TR. As T1 and T2
increase in relation to TR, the kx-modulation for the bSSFP be-
comes less T2* weighted with a complete refocus at TE, assuming
TE = TR/2. In this simulation TE = 1.0ms < TR/2 = 1.1 ms, thus
the centre of the echo (#64) is slightly off the peak of the curve in
the plot shown on the right. . . . . . . . . . . . . . . . . . . . . . . . 261
3.60 a) Transverse magnetisation signal in the myocardium as a func-
tion of the phase encode line number for the three sequences. b)
similar to a) but for the left ventricle. The simulated curves are
for an image with 128 phase-encode lines, with only 64 phase-
encodes shown because of parallel imaging with R = 2. The phase-
encode acquisition order of the h-EPI sequence is not sequential
but an interleaved-centric. . . . . . . . . . . . . . . . . . . . . . . . 262
3.61 The FWHM values as a function of the concentration of Gd-DTPA
(from one tenth to 1.5 the expected [Gd] at the peak of the first-
pass bolus for the myocardium (a) and LV (b) respectively. . . . . . 263
3.62 PSF in the image space (Phase and magnitude superimposed in
the same plot) for the ky-modulation in the LV. . . . . . . . . . . . . 265
4.1 a) The four ROIs used (Anterior: 1; Inferior: 2; Septal: 3; Lateral:
4). The in plane component of B0 is shown. b) Mean frequency
offset measured for each ROI for each heart cycle for a typical pa-
tient. The arrows represent the time of peak i.e. first pass of CA in
the LV. c) Line profiles for the cardiac cycle pointed by the arrow
in b). The ends of each line profile are in the epicardium. The line
profiles are also colour coded and represented in a. . . . . . . . . . 275
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4.2 Three stages of frequency offset for the first pass of Gd-DTPA in
the heart for one volunteer (a, b, c) showing phase difference and
magnitude images. From a) to c) we have the end of first-pass
of contrast agent in the RV, the first-pass in the LV, and during
myocardial perfusion. d) frequency offsets for a septal ROI, and
SI curves for the RV and LV in the magnitude images with a grey
shade marking the timing of the images on the top for the frames
a, b, and c. During the first pass in the LV all patients showed an
increase of B0 in the inferior and anterior myocardial segments
(brighter regions) and a decreasing of B0 in the septal and lat-
eral segments (darker regions) (An example of a magnitude and
phase image throughout first-pass is shown in the attached CD).
The arrow represents the direction of the in-plane component of
the main magnetic field. . . . . . . . . . . . . . . . . . . . . . . . . . 280
4.3 Peak frequency offsets for each patient in the basal slice plotted
against the angle between B0 and the LV long-axis. The error bars
are the temporal standard deviation of the signal in each ROI: a)
positive (inferior, anterior). b) negative (septal, lateral). . . . . . . 282
4.4 Peak frequency offsets for each patient in the mid slice plotted
against the angle between B0 and the LV long-axis. The error bars
are the temporal standard deviation of the signal in each ROI: c)
positive (inferior, anterior). d) negative (septal, lateral). . . . . . . 283
4.5 Peak frequency offsets for each patient in the apical slice plotted
against the angle between B0 and the LV long-axis. The error bars
are the temporal standard deviation of the signal in each ROI: e)
positive (inferior, anterior). f) negative (septal, lateral). . . . . . . . 284
4.6 Peak frequency offsets measured in the LV cavity versus the angle
between B0 and the long axis of the LV for each patient in the mid
slice. The error bars are the temporal standard deviation of the
signal in the ROI. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 285
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4.7 Phantom and numerical simulation images at a range of angles:
phantom/simulation: a/f) 10◦; b/g) 25◦; c/h) 50◦; d/i) 70◦; e/j)
90◦. Line profiles for the respective images are given on the right:
across the field a’/f’, b’/g’, c’/h’, d’/i’, e’/j’; along the field a”/f”,
b”/g”, c”/h”, d”/i”, e”/j”. All images are at 1.5 % Gd-DTPA concen-
tration in the LV cavity and 0 % in the myocardium, and with the
same frequency range of±420 Hz. The orientation of the in-plane
component of the main field is vertical for all images. The arrow
represents the direction of the in-plane component of the main
magnetic field. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 286
4.8 Line profiles taken diametrically across the short-axis, crossing
the LV cavity and subendocardium: inferior-anterior (a,c,e) and
septal-lateral (b,d,f ); for a typical patient (3-pixel average) (a,b),
a phantom (c,d) and a numerical simulation (e,f ). Phantom and
numerical simulation data at 80◦, and patient at 76◦ between the
long axis and the B0 field. The frequency difference in the phan-
tom data is normalised to the LV cavity. . . . . . . . . . . . . . . . . 289
4.9 Numerical simulation line profiles (along (a, c, e) and across (b,
d, f ) the field) at an 80◦ orientation for three different CA doses,
0.05 (a, b), 0.10 (c, d), and 0.15 mmol / Kg−1 (e, f ), assuming a Gd-
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CHAPTER 1
Introduction
In this chapter, a short introduction to some relevant heart physiology topics is
given followed by a brief overview of Coronary Artery Disease (CAD) and my-
ocardial perfusion imaging.
1.1 The heart and the heart cycle.
The heart (Figure 1.1) is a muscular organ, and its muscle tissue is known as
myocardium, from the Greek (myos = muscle) + (kardio = heart). The heart is
divided into three layers:
Pericardium It encloses the heart and it contains an outer fibrous sac, and an
inner layer of mesothelial* cells that provide both lubrication and con-
nective tissue containing fat, arteries, veins, and nerves. The pericardium
prevents the heart from expanding excessively due to overfilling with blood.
Myocardium The muscle layer.
*Mesothelium: A membrane layer that lines many cavities and organs such as the heart.
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Figure 1.1: The heart and blood circulation. A,B-Vena cava; C-Pulmonary
artery; D-Aorta; E-Pulmonary veins; F-tricuspid valve; G-Pulmonary valve;
H-bicuspid valve; I-aortic valve.
Endocardium The inner layer of the heart in between the muscle and the heart
cavities. It contains connective tissue and an inner layer made of en-
dothelial* cells.
The myocardium presents unique features very different from the skeletal
muscle:
• The myocardial cells, called cardiac myocytes are much smaller than the
skeletal muscle’s myocytes, measuring around 50−110µm long and 10−
20µm in diameter.
• Cardiac myocytes are mononuclear with a centralised nucleus, contrast-
ing from the multi-nucleus skeletal muscle cells.
• The existence of intercalated discs. They are responsible for the connec-
tion and communication between different myocytes, therefore vital for
the coordination of the heartbeat.
*Endothelium: Thin layer of cells normally found in the interior of blood vessels, between
the Lumen and the vessel wall.
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Figure 1.2: The cardiac conducting system. A-sinoatrial node; B-
atrioventricular node; C-atrioventricular bundle; D-Purkinje fibres
• The myocardium is myogenic, meaning that its contraction originates in
the myocytes itself, i.e. is independent of any neuronal stimulation, al-
though the heart receives stimulus from the autonomic nervous system
to secure homoeostasis.
1.1.1 Electrical activity: heartbeat
Embedded in the myocardium there is a specialised conducting tissue capable
of generating a coordinated heartbeat. The electrical impulse is initiated by a
group of pacemaker cells, located in the sinoatrial node in the right atrium, Fig-
ure 1.2. These cells are capable of generating spontaneous electrical impulses,
at around 100 beats per minute, although nervous input controls and lowers
this value at rest, [Pocock and Richards, 2006]. The signal is then conducted
through the atria causing these to contract.
The contraction impulse subsequently reaches the atrioventricular node.
The signal is conducted to the ventricles by the atrioventricular bundle and the
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Purkinje fibres. The atrioventricular node is located in the junction between the
atria and the ventricles. The electrical conduction through the atrioventricular
node is slow, preventing the ventricles from contracting at the same time as the
atria.
An atrial contraction is thus followed by a ventricular one and it happens
around 70− 80 times per minute in a healthy human at rest. This electrical
activity can be recorded on an Electrocardiogram (ECG), Figure 1.3.
Figure 1.3: Electrocardiogram recorded events of the pacemaker cells in the
heart. Depolarisation happens when the heart muscle starts to contract, and
repolarisation triggers relaxation.
The P wave comes from the depolarisation of the atria, pushing the blood
into the ventricles through the AV valves.
During the QRS complex the atria relax while the ventricles’ contraction is
triggered, forcing the blood into the arteries through the semilunar valves. The
QRS complex corresponds to the depolarisation of the ventricles and masks an
inverted P wave that would represent the atria repolarisation. The magnitude of
the QRS complex is much larger than the P wave due to a much more abundant
muscle tissue in the ventricles compared to the atria.
Finally, the T wave represents the repolarisation of the ventricles. It is easy
to notice that depolarisation means contraction while repolarisation triggers
relaxation. It might seem strange at first that the recorded R and T wave on
the ECG have the same polarity, since they represent a depolarisation and re-
polarisation respectively, but both events happen in opposite directions, with
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repolarisation starting in the apex of the heart towards the base.
The alternating polarisation and depolarisation of the heart is known as
the heart cycle making the heart act as a blood pump. The heart cycle can be
divided into atrial and ventricular contraction and relaxation, also known as
atrial/ventricular systole and diastole respectively. At rest the normal adult hu-
man heart will undergo a systole and enter its diastolic phase within 500 ms
after the R wave.
1.2 Cardiac output
The blood flow in the circulatory system is mainly controlled by the heart, more
specifically by pressure differences generated by myocardial contraction, work-
ing together with the heart valves. The pressure in the heart’s chambers rises
during systole, and decreases during diastole. Blood will only move to another
chamber if the pressure in that chamber is lower, and if pressure difference
enables the opening of the valve (the valves have a passive action by being
pressure-operated). During ventricular diastole, the atrioventricular valves are
open and the aortic and pulmonary valves are closed. During ventricular sys-
tole the situation is reversed, the aortic and pulmonary valves are open, while
the atrioventricular valves are closed. This co-ordination between pressure and
valves prevents the blood from flowing the wrong way in the circulation. A di-
agram of the Left Ventricle (LV) pressure, volume and ECG is shown in Figure
1.4.
Cardiodynamics is usually described by the use of several terms described
below:
End Diastolic Volume (EDV) : The volume of blood in each ventricle at the
end of ventricular diastole.
End Systolic Volume (ESV) : The volume of blood in each ventricle at the end
of ventricular systole.
Stroke Volume (SV) : The volume of blood pumped in each beat: SV = EDV−
ESV. A related definition is the Cardiac Output (CO), known as the amount
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Figure 1.4: A sketch of the left ventricular pressure, volume, and ECG.
of blood pumped by each ventricle during one minute: CO = HR× SV,
where HR is the heart rate given in beats per minute.
Ejection Fraction (EF) : is defined as the ratio EF= SV/EDV
The cardiac output can be affected by either a change in the heart rate and/or
a change in the stroke volume. Heart rate and stroke volume are intimately
connected; an increase in the heart rate is usually followed by an increase in
the stroke volume up to a certain level, levelling off when cardiac output ap-
proaches 50 percent of its maximum value [Pocock and Richards, 2006] and
further increase in CO is entirely due to further increases in heart rate.
The heart rate receives input from the autonomic nervous system, where
a sympathetic and parasympathetic* stimulation increases and decreases the
heart rate respectively. The autonomic nervous system changes the ionic per-
*The sympathetic and parasympathetic nervous system are a part of the autonomous ner-
vous system. In very general terms, the sympathetic nervous system functions in situations
that require a quick response, "fight or flight", while in contrast the parasympathetic nervous
system is preponderant in action that do not require an immediate reaction, "rest and digest".
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meabilities of mainly the SA node, changing the rate of depolarisation and re-
polarisation thus changing the heart rate.
The venous return, i.e. the blood coming back to the heart also has an in-
fluence on the heart rate in two ways: increasing the venous return stretches
the right atrium, which triggers an increase of the heart rate in a process called
atrial reflex; it also stretches the conducting cells of the SA node leading to a
faster depolarisation.
Stroke volume is regulated by two mechanisms: intrinsically the SV is regu-
lated by the degree of stretch in the myocardial fibers at the end of diastole; and
extrinsically by the autonomic nervous system and hormonal input.
Increasing venous flow stretches the heart muscle, increasing the EDV. This
not only increases heart rate, as mentioned earlier, but is also associated with
an increase in the contractile force which increases the SV; this "more in equals
more out" phenomenon is known as the Frank-Starling principle. An increase
in contractility is usually followed by a decrease in the ESV as well. The Frank-
Starling principle ensures equilibrium between the outputs from both ventri-
cles.
Nervous sympathetic stimulation can also increase contractility by stimu-
lating the alpha and beta-receptors* in the myocytes’ membranes. Recipro-
cally, the inverse effect of reducing contractility is caused by a stimulation of
the parasympathetic nervous system. Hormones secreted from the adrenal
medulla, such as epinephrine, and norepinephrine also affect the CO by stimu-
lating mainly beta-receptors resulting in an increase in contractility. Dopamine
and dobutamine are drugs that mimic hormones, which increase contractility,
while others such as beta-blockers depress the sympathetic stimulation.
It follows from recent paragraphs that heart rate and stroke volume changes
are intimately connected with each other.
During exercise, the heart increases its rate, all the phases of the heart are
shortened in time, but the biggest acceleration happens during diastole. When
the heart rate climbs from 75 bpm to 200 bpm, the time spent in systole drops
*Alpha and beta receptors are located in many cells which when stimulated by the sympa-
thetic nervous system activate enzymes inside the cell membranes (alpha) and triggers changes
in the metabolic activity (beta).
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40%, but the time spent in diastole decreases 75 %, [Martini, 2006]. The SV
of an adult at rest is approximately 75 mL, with an ESV of 50 mL [Pocock and
Richards, 2006]. A healthy adult has a CO of around 6 L/min at rest, and is able
to increase it to 18-30 L/min, [Martini, 2006].
1.3 Coronary artery disease and myocardial perfusion
Myocardial Perfusion is the process of delivering the nutrients contained in the
arterial blood to the capillary bed of the heart muscle; this is done through the
coronary circulation, Figure 1.5. The left and right coronary arteries emerge
in the aortic sinuses in the base of the ascending aorta. When the LV relaxes
and the semilunar valves close, blood flows from the aorta through the aortic
sinuses in a process called elastic rebound. Hence, the fact that blood flow into
the coronary arteries happens mainly during diastole. The epicardial arteries
Figure 1.5: Coronary Arteries. The main coronary arteries are displayed in
red, light red indicates the posterior coronaries, i.e. behind the heart in this
image orientation.
branch into smaller penetrating arteries perfusing from the epicardium trans-
murally into the endocardium.
CAD is the leading cause of death in the Western world. It is mainly caused
by atherosclerosis of the coronary arteries. It affects mainly the LV due to its size
and demand. Atherosclerosis involves the formation of a lipid plaque within
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the walls of a vessel. As the plaque (lesion) increases in size at first the arte-
rial wall remodels preserving the arterial lumen cross-section by a circumfer-
ential expansion of the non affected area (Glagov effect); however with gradual
increase of the atherosclerotic plaque luminal occlusion increases, reducing
blood flow and increasing the chances of a thrombus (blood clot) formation.
CAD culminates in a blockage of coronary arteries leading to a reduced supply
of blood and nutrients, and also oxygen with the most serious consequences.
This process is known as ischaemia. As CAD develops and coronary artery
stenosis gradually worsens, a progressively worsening sequence of events un-
fold, known as ischaemic cascade:
1. Hypoperfusion in the subendocardial layer of the myocardium.
2. Transmural perfusion deficits.
3. Diastolic wall motion abnormalities.
4. Abnormal systolic wall motion.
5. ECG changes.
6. Angina Pectoris.
Ischaemia causes hypoxia of the myocytes, leading to their damage and po-
tential necrosis. Figure 1.6 shows a microscopic image of myocardial tissue.
Infarcted myocardium can be seen in the top left (necrotic myocytes). The out-
come from ischaemia varies from a stunned myocardium to necrosis:
Stunned myocardium : After a short interval of ischaemia the affected area
goes through a stage of contractile dysfunction but gradually comes back
to normal function.
Hibernated Myocardium : It also manifests as a deficient function, but after
revascularisation it can be, at least partially, recovered. The recovery pe-
riod can vary from a few days to months.
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Figure 1.6: Microscopic images of myocardial tissue. The top left corner
contains infarcted myocardium cells, while the bottom right corner contains
mostly viable myocardial tissue. Image kindly provided by Dr. Mary Sheppard,
department of Histopathology, Royal Brompton Hospital, Royal Brompton &
Harefield NHS Trust.
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Necrosis : Severe and prolonged (more than 30 minutes) ischaemia is most
likely to end up in death of the affected cells, starting in the subendocar-
dium and travelling to the subepicardium (first and second stages in the
progression of ischaemia). This results in tissue death with no possible
regeneration. The dead tissue will then be gradually transformed into an
akinetic fibrotic scar tissue by immune cells.
Ischaemia can be controlled by a combination of changes in lifestyle, such
as avoiding stressful activities or strenuous exercise, stopping smoking and low-
ering dietary fat consumption; and the use of medication such as vasodilators
or sympathetic stimulation blockers. All of these methods control ischaemia
either by preventing the coronary blockage from increasing or by reducing the
chances that the blood flow to the heart is insufficient when compared to the
demand.
Surgical intervention can also be used to treat ischaemia. A catheter can be
inserted into a blocked coronary artery through a peripheral artery with the aim
of destroying and removing the plaque with the use of a laser or other surgical
tools, although this method is seldom used.
Balloon angioplasty is often used to widen the stenosis. This plaque is pre-
vented from redeveloping by using stents that hold the cleared vessel open.
An alternative to angioplasty, or for treatment of total occlusions, is coronary
artery bypass graft, where a small section of an artery or vein is removed (it is
common to use the internal thoracic artery or the great saphenous vein of the
leg), and used to create another route around the blocked section of the coro-
nary artery.
Even in severe stenosis, a perfusion defect may occur only while the pa-
tient is hyperaemic, i.e. increased blood flow. This is because in the presence
of mild to severe stenosis, the blood circulation autoregulatory system makes
the coronary arteries dilate to their maximum extent, keeping the blood flow
normal at rest. During hyperaemia, the already dilated stenotic arteries can-
not dilate any more, creating a detectable difference in the blood flow between
normal and stenotic arteries. Hyperaemia commonly called “stress” is usually
induced pharmacologically in Magnetic Resonance Imaging (MRI) studies by
dipyridamole or adenosine, which dilate most vascular beds.
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One often cited indicator of CAD is the Myocardial Perfusion Reserve (MPR):
MPR= myocardial blood flow at stress
myocardial blood flow at rest
(1.1)
Kern et al. [1991] with ultrasound imaging techniques reported, for normal in-
dividuals, an MPR value of approximately 3. Uren et al. [1994] with Positron
Emission Tomography (PET) measured the MPR for healthy volunteers and pa-
tients with different levels of single vessel stenosis; a stenosis degree* of 40 %
or less did not change the MPR, but as the stenosis increased, the MPR de-
creased reaching unity at around a degree of 80 % stenosis. A more recent
study by Cullen et al. [1999] with first-pass perfusion MRI obtained an MPR
of 4.21±0.7 for normal volunteers, 2.80±0.77 for patients with < 40% stenosis,
and 1.93±0.38 for patients with stenosis between [40%,60%].
An ECG exercise test is regularly prescribed to patients with angina. An ex-
ercise ECG with an ST depression can suggest myocardial ischaemia. After a
myocardial infarction, there is a time line of changes in the ECG including [Sut-
ton, 2008]:
• Within hours there is an ST elevation, and T wave becomes longer and
higher.
• Within a day the T wave inverts.
• Finally within days there is an abnormal large Q wave, the T wave usually
persists inverted, and ST segment becomes normal.
1.4 Assessing Coronary Artery Disease
Assessment of CAD can be done either directly by imaging the coronaries, known
as angiography or indirectly by assessing myocardial perfusion. Coronary an-
giography shows which vessel has the stenosis but it does not provide infor-
mation on perfusion and on how flow limiting it is. With myocardial perfusion
*The degree of stenosis was measured as the percentage reduction of the internal luminal
diameter in relation to the estimated diameter interpolated from the diameter at the proximal
and distal boundaries of the stenosis.
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imaging, the assessment of the flow-limitation is better, i.e. it has the advantage
of assessing the direct functional effects of a possible stenosis. The myocardial
segment where the perfusion defect is observed can indicate which coronary
artery needs attention [Cerqueira et al., 2002], although the relation between
myocardial segments and specific coronary arteries varies.
Each method can also be done with a multitude of different imaging modal-
ities, namely:
• Angiography:
– X-Ray Coronary Angiography (XCA)
– Computed Tomography (CT) (electron-beam or multi-detector X-
ray) (calcium score)
– MRI (Magnetic Resonance Angiography (MRA))
• Myocardial perfusion:
– Nuclear Medicine (Single Photon Emission Computed Tomography
(SPECT) and PET)
– CT (electron-beam or multi-detector X-ray)
– Ultrasound (US)
– MRI
1.4.1 Coronary angiography
The current angiography gold standard is XCA where the whole vascular ana-
tomy is visualised in good detail making it possible to detect possible lumi-
nal narrowing. An x-ray opaque Contrast Agent (CA) is injected directly into
the required main coronary artery by using a catheter, while an x-ray movie is
recorded showing the circulation of the blood with CA in the coronaries, en-
abling a direct visualisation of the arteries’ lumen. This technique also allows
for percutaneous intervention in the same session if needed.
There are however a few drawbacks with XCA such as the risks associated
with its invasive nature (direct injection of contrast), the high costs of multiple
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staff members required during the procedure, the risks associated with using
ionising radiation, and the fact that it is a 2D projection technique.
Alternatively, CT modalities can also be used to image the coronary arteries
with a contrast agent in a non-invasive way. Two different CT modalities have
been used: electron-beam CT and multi-slice CT.
Electron-beam CT provides a good temporal resolution and a lower dose
when compared to XCA. A typical XCA study has a radiation exposure of 2 to
3 mSv, while a typical electron-beam angiography study dose is 1.5 to 2.0 mSv
[Lee and Panting, 2006]. This modality has been primarily used for screening of
coronary calcifications, but it can be used for the visualisation of the coronar-
ies with the use of an intravenous iodinated CA. Several studies report a high
specificity and sensitivity in the detection of high-grade stenosis or complete
occlusions when compared to XCA: Achenbach et al. [1998] 94 % and 92 %;
Ropers et al. [2002] 66 % and 90 %; Nikolaou et al. [2002] 77 % and 85 % respec-
tively. The first referenced study, [Achenbach et al., 1998], reported an excellent
specificity and sensitivity, but this study excluded patients with more than mild
calcifications, which reduces the number of false negative and false positive re-
sults. All these studies were also limited to the proximal and middle segments
of the major coronary arteries, and to the assessment of high-grade or complete
occlusions, where the requirements on spatial-resolution are more relaxed.
Disadvantages of electron-beam CT are poor image quality, with studies
commonly excluding around 25 % of the results, poor spatial resolution, and
high image noise, which only allows the assessment of major coronary arteries.
The diameters of small branches of the coronaries are too small to be imaged
reliably.
Coronary angiography CT was initially popular with electron-beam CT due
to its higher temporal resolution when compared to multi-detector CT. How-
ever with the development of a greater number of CT slice detectors, the tem-
poral resolution of multi-slice CT increased. This increase, coupled with a higher
spatial-resolution, made multi-slice CT angiography popular. Studies with 64
slice CT report an excellent correlation with XCA with specificity and sensitivity
of: Raff et al. [2005] 95 % and 86 %; Mollet et al. [2005] 95 % and 99 % respec-
tively.
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modality temporal resolution spatial resolution
XCA 5-20 mm 0.2 mm
electron-beam CT 33-100 mm 0.6 mm
64 slice CT 80-90 mm 0.4 mm
MRA 20 mm 0.7 mm
Table 1.1: Temporal and spatial resolutions for different angiography
modalities, from Lee and Panting [2006].
Noteworthy is the fact that both 64-slice studies mentioned above analysed
all available coronary segments and not just the proximal and middle segments
of the coronaries as the electron-beam CT studies mentioned previously. This
is due to the better image quality, although as a downside, multi-slice CT has a
much higher dose so far when compared to both XCA and electron-beam CT.
Mollet et al. [2005] estimated a radiation exposure of 15 to 21 mSv, i.e. 10 times
higher than electron-beam CT.
MRI of the coronaries, known as coronary MRA, has the obvious advantage
of not using ionising radiation or iodinated CAs. The main disadvantages are
the long time of acquisition, with whole heart imaging being longer than 10
minutes, and limited by poor image quality and spatial resolution. The com-
mon protocol uses a ECG-triggered segmented 3D acquisition, with free-breathing
[Greenwood et al., 2009, Weber et al., 2003]. A navigator echo measures the po-
sition of the diaphragm and it accepts or rejects the last acquired data based
on its position. Sakuma et al. [2005] compared MRA with XCA obtaining a sen-
sitivity and specificity of 82 % and 91 % respectively, although evaluating the
degree of stenoses became tricky due to limited spatial resolution available in
MRA. Figure 1.7 shows a typical MRA of the coronary arteries, with some of the
main arteries labelled.
Temporal and spatial resolutions for the modalities mentioned above are
shown in Table 1.1.
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Figure 1.7: Patient MRA of the coronary arteries. The RCA (right coronary
artery), and LAD (left anterior descending artery) are labelled.
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1.4.2 Myocardial perfusion imaging
Currently myocardial perfusion imaging is mainly done using Nuclear Medi-
cine imaging modalities: SPECT, and PET where available. Despite its wide
acceptance, Nuclear Medicine suffers from attenuation artifacts, radiation bur-
den and lack of resolution. In SPECT, the patient is injected intravenously with
a radionuclide, normally 99m Technetium - sestamibi. The perfusion of the ra-
dionuclide is then captured by gamma cameras. Hendel et al. [1999] obtained
a sensitivity of 78 % for the detection of a 50 % or more coronary stenosis when
comparing SPECT with XCA.
In PET 82Rb and 13N-ammonia* are radionuclides commonly used in per-
fusion imaging. Schwitter et al. [2001] obtained a sensitivity and a specificity of
87% and 85% respectively when comparing PET with XCA. PET does not require
a collimator in front of the detector, increasing sensitivity and or reducing data
acquisition time when compared with SPECT. It also has a better attenuation
correction, and generally spatial resolution of PET is better than SPECT. PET
images are therefore of better quality allowing accurate quantifications of blood
flow in the myocardium. Recently hybrid-imaging systems such as PET-CT or
SPECT-CT have been considered, although an optimal protocol still needs to be
established [Carli et al., 2007]. CT can be used to improve the tissue attenuation
correction, and also provide a coronary angiogram to complement the study.
Ultrasound has also been used for myocardial perfusion imaging. It con-
tains, together with MRI, the advantage of no ionising radiation. It is read-
ily available in any clinical environment due to its low cost and portability,
although it presents some difficulties when imaging the heart because both
the lungs and the rib cage do not allow the passage of the ultrasound waves.
An ultrasound imaging technique known as Harmonic Power Doppler Imaging
(HPDI) with an intravenous CA containing microspheres has been used to as-
sess myocardial perfusion. Conventional Doppler imaging cannot be used to
measure perfusion due to the low velocity of blood flow in the myocardial cap-
illaries. HPDI measures the amount of back-scatter, and not the frequency shift
*82Rb does not need an in situ cyclotron since it can be generated from its parent radionu-
clide 82Sr which has a half-life of 26 days, while 13N-ammonia has a half-life of 10 minutes
needing a cyclotron facility nearby.
68 Assessing Coronary Artery Disease
as conventional Doppler imaging. HPDI transmits ultrasound pulses that result
in the destruction of the microspheres present in the contrast agent. This de-
struction results in a reduction of the backscatter intensity [Heinle et al., 2000].
The information in the ultrasound machine is not displayed as velocity but as
power, and it is related to the number of scatterers that have been destroyed
[Senior et al., 2000]. A reduction of backscatter will therefore be present only
in regions of the myocardium where CA managed to perfuse, although wall
motion artifacts might present a problem. A problem in using US is the non-
homogeneity of the field, with far and side tissues having less microsphere de-
struction, which can be interpreted as a false perfusion defect [Senior et al.,
2000].
Heinle et al. [2000] compared HPDI with SPECT in the assessment of my-
ocardial perfusion abnormalities at both stress and rest. There was concor-
dance of 81% between the two modalities for normal vs abnormal perfusion.
When considering each main artery separately the concordance is still above
70%, although fixed defects vs reversible defect (see section 1.4.3) were not so
concordant, especially in the right coronary artery and left circumflex with a
concordance of 64%. It must be pointed out that stress/rest studies are needed
and were carried out on separate occasions.
Both electron-beam and multi-slice CT can also be used to assess myocar-
dial perfusion. CT, just like MR, can combine angiographic studies with my-
ocardial perfusion imaging in the same scan.
Bell et al. [1999] assessed quantitative myocardial perfusion in seven dogs
and in fourteen human volunteers with electron-beam CT during the first-pass
of an intravenous iodinated CA. Myocardial perfusion quantification was com-
pared with radioactive microsphere measurements in the animal experiments.
It was shown that this imaging modality can quantify myocardial accurately
(correlation coefficient of 0.87 with microspheres) when an estimate of the vas-
cular volume in the myocardium is included. Intra-myocardial vascular vol-
ume was estimated by measuring the mean concentration of iodine in the my-
ocardium and in the LV cavity and assuming that a priori iodine remains ma-
inly intravascular. A vascular volume of 7% and 15-18% were found at rest
and adenosine-stress respectively. The human studies were performed with
Assessing Coronary Artery Disease 69
no complications although a 30-40 second breath-hold was required. Blood
flow estimates were similar to the ones obtained with PET, with an estimated
myocardial perfusion reserve of ≈ 2.8.
Multi-slice CT can also be used to assess myocardial perfusion during the
first-pass of an iodinated CA. George et al. [2006] examined 8 dogs, prepared
with an LAD stenosis. The CT images were analysed semi-quantitatively by
measuring the signal in the myocardium normalised to the signal in the LV cav-
ity; the MPR obtained correlated well with absolute myocardial blood flow de-
rived from microspheres. Tachycardia and arrhythmias were found to degrade
image quality and therefore beta-blockers were administered. In the follow-
ing year, George et al. [2007] assessed the ability of multi-slice CT for a fully
quantitative analysis. In a similar fashion to the previous study, six dogs with
an induced LAD stenosis were imaged with multi-slice CT. The quantitative
measurements were compared with a semi-quantitative analysis (myocardial
upslope), and to microsphere myocardial blood flow measurements. A good
correlation was found between the results. Noteworthy is the linear relation
between iodinated CA concentration and signal for the concentrations used in
these experiments, a well known limitation of fully-quantitative MRI first-pass
perfusion (see Section 2.2). Disadvantages of multi-slice CT are the limited LV
coverage, 32 mm in the axial plane with 64 detectors, high doses of radiation,
and limited temporal resolution when compared with electron-beam CT.
Deficient perfusion in the myocardium is the first step of ischaemia, thus
making myocardial perfusion imaging a very important factor in the preven-
tion of myocardial infarction. The higher resolution of MRI (when compared to
Nuclear medicine modalities) enables the visualisation of the subendocardial
layer and the detection of ischaemia in its first stage. Several studies suggest
that perfusion MR can be a viable alternative for SPECT or PET studies. An-
other advantage of MRI is the possibility of imaging the coronary arteries in the
same exam, which gives a valuable spatial distribution of the major coronary
arteries linking each coronary to the corresponding myocardial segments.
The spatial resolutions for the myocardial perfusion imaging modalities men-
tioned above are shown in Table 1.1.
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modality spatial resolution
SPECT 10-14 mm [Bateman et al., 2006]
PET 6-10 mm [Bateman et al., 2006]
HPDI 1 mm [Heinle et al., 2000]
electron-beam CT 0.6 mm [Lerman et al., 1999]
multi-slice CT 0.5 mm [George et al., 2006]
MRI <3.0 mm [Kellman and Arai, 2007]
Table 1.2: Spatial resolutions for different myocardial perfusion imaging
modalities.
Al-Saadi et al. [2000] assessed the diagnostic accuracy of first-pass perfu-
sion MR in diagnosing CAD by measuring the MPR and comparing it to XCA.
A sensitivity and specificity of 90% and 83% was obtained respectively. 34 CAD
patients were analysed, with stress induced by dipyridamole. MPR was indexed
approximately by a linear fit of the upslope of the SI-time curves during first-
pass of Gd-DTPA (the contrast agent). Gd-DTPA was injected through a central
vein catheter. A cutoff value of 1.5 in the MPR was used to separate normal from
stenotic regions. This study used a single-slice MR protocol, but only patients
with a high degree of stenosis were analysed, and therefore that might explain
the high sensitivity obtained with one slice only.
A similar method was used by Schwitter et al. [2001], who assessed the de-
tection of CAD by MRI as defined by PET with a sensitivity/specificity of 91%/94%.
The same analysis was made with CAD defined by XCA with an MRI sensitiv-
ity/specificity of 87%/85%. In this study, 48 patients and 18 normals were in-
cluded. Stress was induced by dipyridamole, and a pixel-wise upslope map was
calculated. No rest-study was performed, therefore MPR index was not calcu-
lated. A pixel-wise up-slope map is highly sensitive to breathing motion.
Later a similar study comparison between MRI and XCA was done by Nagel
et al. [2003] with a sensitivity and specificity of 88% and 90% respectively; adeno-
sine was used as the stress agent and the upslopes at rest and stress were scaled
with the upslope of the LV blood pool. 84 patients were included in the study.
In all the previous three studies, a careful manual segmentation of the my-
ocardial Region of Interest (ROI) must be made. This task is complicated by
diaphragmatic motion, and therefore user dependency must be accounted.
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Ishida et al. [2003] assessed perfusion MR against SPECT, in a comparison
to XCA as the gold-standard. A similar sensitivity and specificity of 90% and
85% respectively in detecting a significant stenosis was measured for MRI while
SPECT had a sensitivity and specificity of 82% and 71% respectively. MRI had
a better diagnostic accuracy then SPECT for the detection of stenosis. Dipyri-
damole was the stress agent used, and the MRI images were analysed visually
only. This qualitative analysis also introduces user dependency in the results.
Perfusion MRI protocols are described and reviewed in greater detail in sec-
tion 2.1.
1.4.2.1 Myocardial perfusion defects are not always correlated with coro-
nary artery disease
Some patients that had a successful thrombolysis* or angioplasty after an acute
Myocardial Infarction (MI) still exhibit perfusion defects, showing a lower re-
covery in global and regional contractile function than patients with normal
re-flow. This phenomenon is known as no-reflow and has been associated with
necrosis and microcirculatory damage by the infarction, preventing the re-flow
and the improvement in regional function [Ito et al., 1992].
Patients may also suffer from a stenotic artery but perfusion may appear
normal due to collateral blood flow. Sabia et al. [1992] assessed myocardial per-
fusion using US in patients with recent acute MI before and after angioplasty.
It was found that in most patients there was a significant amount of collateral
blood flow in the regions affected by the stenotic artery. Collateral blood flow
helps in regional function preservation after an acute MI. Different degrees of
collateral blood flow can also explain the variability of infarct size in patients
with similar coronary occlusions, [Cohen and Rentrop, 1986].
1.4.3 Myocardial viability
Another very useful feature of MRI is the possibility to assess myocardial via-
bility after a myocardial infarction, i.e. assess if myocytes “survived”. Ischaemic
*The intravenous injection of a drug that enables the solubility of a blood clot.
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events are, in principle, reversible if the myocytes survived hypoxia. It is there-
fore crucial to assess which areas are potentially salvageable with angioplasty
or bypass grafting, and separate them from necrotic ones. Viability imaging is
usually carried out by Nuclear Medicine, but with limitations: its low resolution
cannot resolve the transmural extent of viability, coupled with attenuation arti-
facts, and the fact that viability is assessed indirectly by imaging the contractile
reserve or perfusion, while MRI provides a direct visualisation of the infarcted
areas. The MRI technique is known as delayed or late enhancement, and relies
on the fact that 10 to 15 minutes after a Gadolinium-based CA injection there
is an accumulation of the CA in the infarcted areas of the myocardium. During
this period, high-spatial resolution images of the heart in the short and long
axis planes are acquired with a segmented inversion-recovery gradient-echo
sequence. Each image requires a breath-hold of less than 10 seconds. The in-
farcted areas will have an accumulation of Gd, and therefore a shorter T1 when
compared to normal myocardial regions. Choosing a suitable time of inver-
sion* it is possible to null the signal in the normal myocardium, while making
the signal in the infarcted regions bright. The regions with bright signal in the
myocardium are therefore infarcted and non salvageable - “bright is dead” [Si-
monetti et al., 2001] (Figure 1.8).
In an acute infarct, a viability assessment can be done to distinguish stunned
from infarcted tissue [Choi et al., 2001]. It takes about 15 minutes after occlu-
sion for necrosis wavefront to start in the subendocardium spreading into the
epicardium. The reason why Gadolinium (Gd) concentrates in the infarcted
areas is thought to be that necrosis is related to a rupture in the myocyte mem-
brane, allowing the diffusion of the Gd into the intracellular space, increas-
ing the concentration and therefore hyperenhancing that area [Edelman et al.,
2006].
On the other hand, a chronic infarction also produces hyperenhancement
in areas where the tissue was dead, although in this case we do not have a
necrotic tissue but collagenous scar tissue. Viability in this case is used to dis-
tinguish between hibernated and scar tissue [Wu et al., 2001]. The reason be-
*The duration of time between the inversion recovery pulse, and the acquisition of the
centre of k-space.
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hind the hyperenhancement is less certain in this case, but a theory points
out that in a dense matrix of collagenous scars the interstitial space is bigger
than within areas with normal “living” myocytes. The CA fills this area creat-
ing a region with a higher concentration. On the contrary, reversible, i.e. non-
infarcted, areas will not be hyperenhanced, allowing the prediction of which
areas in the region of risk can improve their function [Edelman et al., 2006].
Delayed enhancement is often used after contrast first pass imaging of my-
ocardial perfusion, to complement the latter, making MRI an invaluable tool to
assess not only the risk of myocardial infarction for patients with typical symp-
toms (e.g an angina pectoris), but also to assess baseline ECG abnormalities,
previous revascularisations, and myocardial viability (Figure 1.8).
Figure 1.8: Short-axis late-enhancement image, with a visible infarction of
the inferior and infero-lateral walls.
1.5 Myocardial perfusion defects due to diseases other than
CAD
Perfusion defects can also occur due to myocardial fibrosis* caused by Hyper-
trophic Cardiomyopathy (HCM), or by microvascular dysfunction in Syndrome
X [Moon et al., 2003, O’Hanlon et al., 2008, Panting et al., 2002, Slobodny, 2008].
*Abnormal formation of fibrous connective tissue.
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1.5.0.1 Hypertrophic Cardiomyopathy
HCM is characterised by a myocardial thickening, i.e. myocyte hypertrophy,
disarray and myocardial fibrosis. It is a genetic disorder, and extreme HCM is
linked to high risk of sudden death [Spirito et al., 2000]. First-pass perfusion
MRI coupled with cine MRI can be used to assess hypertrophy [O’Hanlon et al.,
2008, Sipola et al., 2003]. HCM is related to a global decrease in the MPR. A local
assessment of MPR for each segment can also be used to localise the hypertro-
phied LV regions.
Moon et al. [2003] showed that MR imaging with a late-enhancement tech-
nique could also be useful in the assessment of HCM. Late-enhancement can
occur in regions where HCM fibrosis is present, which can have different char-
acteristics from a myocardial infarction fibrosis. HCM fibrosis can spare the
subendocardium, which never happens with infarction (first step in the ischaemia
cascade).
Figure 1.9 illustrates the relationship between cine, perfusion, and late-Gd
images in a patient with HCM.
Figure 1.9: Cine imaging during end diastole shows myocardial thickening
in the anteroseptal and inferoseptal walls for a patient with diagnosed HCM.
These myocardial segments correspond to the areas with perfusion defects
during first pass at stress with adenosine and with bright signal during late-
GD enhancement imaging. Note that during late-enhancement the subendo-
cardial region is not bright (no fibrosis).
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1.5.0.2 Syndrome X
Syndrome X is by definition a diagnosis by exclusion. It is defined as an ab-
sence of CAD or cardiomyopathies coupled with typical angina pectoris and
abnormal ST (ECG) segment during exercise. Most patients are menopausal
women. Several theories exist for the pathophysiology of Syndrome X such as
ischaemia from microvascular dysfunction, or endothelial dysfunction of the
coronary microcirculation with an absence of vasodilation during exercise [Slo-
bodny, 2008].
Recently first-pass myocardial perfusion MRI has been used in Syndrome X
patients showing a low MPR (normalised to the heart rate) in the subendocar-
dial layer while showing a normal MPR in the subepicardial layer [Panting et al.,
2002]. These symptoms can easily be mistaken for CAD; syndrome X patients
are often referred to a XCA study which will result negative.
Figure 1.10 shows a patient diagnosed with a perfusion pattern typical of
the microvascular dysfunction of syndrome X, who had chest pain on exertion
or at rest, with a normal heart function and no infarcted tissue. Nevertheless, a
circumferential ischaemia is noticeable during stress.
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Figure 1.10: Multi-slice short axis MR images of Gd first-pass during stress
and rest for a patient with a diagnostic concordant with syndrome X.
CHAPTER 2
Myocardial perfusion imaging with MR - review
This chapter assumes that the reader knows basic cardiac MRI and is familiar
with MRI terms. The majority of this review concerns conventional first-pass
myocardial perfusion imaging for assessing perfusion into the myocardial tis-
sue using a gadolinium based CA. Other MRI perfusion techniques are men-
tioned in section 2.8.
2.1 Myocardial perfusion imaging protocol
The first-pass clinical protocol and perfusion imaging methods vary between
centres. In this section, a typical clinical myocardial perfusion protocol is de-
scribed only as an introduction to the procedure:
1. Assess if the patient refrained from caffeine and/or theophylline in the
24 hours prior to the examination, since these substances can counteract
the stress agent (adenosine).
2. Scout imaging of the heart: The orientation of the heart varies between
individuals. For example, tall people have, in general, a more vertical
heart. Myocardial perfusion images are usually assessed using short-axis
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planes, which are perpendicular to the line that crosses the apex and mi-
tral valve (long-axis). A series of end-expiratory low-resolution images
are acquired first (scout images), usually during late diastole, in order to
ensure the image plane is placed correctly in the short axis, as described
in the caption of Figure 2.1.
3. Cine* images of the long-axis views B and C are used to position typi-
cally a 3 slice short axis perfusion sequence ensuring that the 3 slices are
a reasonable coverage of basal, mid and apical slices (16 of the 17 seg-
ments standardized by the Cardiac Imaging Committee of the Council on
Clinical Cardiology of the American Heart Association [Cerqueira et al.,
2002].) at all phases of the cardiac cycle. Particular attention is given to
the basal slice, using the long-axis cines to allow for the systolic motion
of the basal plane. It should be remembered that stress changes cardiac
motion somewhat and the slice positioning of the perfusion slices might
change slightly from the one defined in the cines.
The perfusion sequence is run as a test (e.g. only a few cardiac cycles,
without contrast agent, sometimes with saturation pulses turned off for a
better view of the myocardium but with all sequence timings unchanged
by turning off saturation.) The saturation pulse saturates the magnetisa-
tion with a non-selective Radio-Frequency (RF) pulse prior to imaging,
increasing the T1-weighting of the perfusion images. More details on sat-
uration pulses and T1-weighting contrast is given in Section 2.3.1.
ECG gating is used in order to synchronise imaging with the cardiac cycle;
each R wave of the ECG triggers the start of a new measurement in all
slices. ECG gating can be checked during this test, as the fast switching of
the magnet gradients are capable of disrupting it.
Perfusion images are checked for reasonable basal-mid-apical coverage.
Phase-encode wraparound† must not cross the LV, and in-plane rotation
is preferably used to control this, bearing in mind that minimal phase-
*Movie of the heart throughout the cardiac cycle.
†A type of image artifacts where signal from outside the FOV along the phase-encode di-
rection is aliased into the FOV.
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encode FOV minimizes image time and therefore motion blurring. This
optimization is highly dependent on patient size and shape as well as car-
diac orientation.
4. Stress perfusion imaging is done during the first-pass of a gadolinium
based contrast agent; for example: at a dose of 0.1 mmol / Kg of body
weight at an injection rate of 3 mL / sec followed by a 15 mL saline flush
at 5 mL/s facilitating a compact bolus. For a compact bolus at the LV, the
injection is administered in the antecubital vein. Stress is induced phar-
macologically, by an infusion of adenosine in the other arm at a rate of
140 µg / kg / min. Infusion starts at least 3-4 minutes prior to injection of
CA.
Gadolinium based contrast-agents modify the relaxation of water pro-
tons reducing both T1 and T2. The T1-weighted perfusion images show a
strong signal for the water protons that interacted with the Gadolinium.
More details on Gd-based CA can be found in Section 2.4.1.
5. During the first pass of the CA the heart is imaged in typically 3 short-axis
planes per cardiac cycle, with the patient in breath-hold. End-expiration
is used in order to avoid large inspiratory movements, although it is more
difficult to hold for long, followed by gentle breathing if possible (adeno-
sine stress agent makes this difficult as well). Three sequences commonly
used for Myocardial Perfusion Imaging (MPI) are Gradient Recalled Echo
(GRE), balanced Steady State Free Precession (bSSFP), or hybrid-Echo
Planar Imaging (EPI). A typical protocol for each sequence is displayed
in table 2.1.
6. Late enhancement imaging can be performed after first-pass to assess
the viability of infarcted tissue.
7. 20 minutes after contrast injection, the first-pass of a second Gd-DTPA
injection is imaged with the patient at rest. This step can be skipped if
the stress first-pass images were normal.
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Figure 2.1: Image plane positioning towards a short-axis image of the LV,
in red is shown the next image plane. Image A represents a simple trans-
verse slice through the chest, a perpendicular slice along the LV gives us image
plane B. Image C is perpendicular to image B positioned through the mitral
valve and apex of the LV. The last perpendicular plane gives us the short axis
plane, image D.
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parameter GRE bSSFP h-EPI
TR (ms) 2.2 2.3 6.1
TE (ms) 1.3 1.1 1.1
read FOV (mm) 340-400 340-400 340-400
phase FOV (mm) 250-300 250-300 250-300
flip angle (deg) 12 50 25
TD (ms) 41 39 54
TI (ms) 85 85 85
TA (ms) 130 132 117
bandwidth (Hz/pixel) 780 1400 1630
matrix(readout) 128 128 128
matrix(phase) 96 96 96
echo-train length 1 1 4
Table 2.1: These sequence protocols were published by Kellman and Arai
[2007] in a perfusion review article and are based on recent literature. TD - is
the time delay between the saturation recovery pulse and the first RF pulse. TI
- is the time of inversion defined as the time between the saturation recovery
preparation and the acquisition of the k-space centre line. TA - is the total
time of one image acquisition, including the saturation recovery preparation.
All sequences have parallel imaging with an acceleration factor of 2.
82 Perfusion analysis
Figure 2.2: Frames depicting the first-pass of Gd-DTPA. The black arrows
point into regions with visible perfusion defects.
2.2 Perfusion analysis
The patient is asked to breath-hold during the image acquisition in order to
“freeze” the imaging planes. The arrival of the CA increases the signal intensity
and it takes around 5 to 10 heartbeats to go from the initial stage of contrast
arrival in the heart to peak signal intensity in the myocardium. The data ex-
tracted during the first-pass is then analysed to detect possible hypoperfused
segments in the myocardium. This analysis is performed qualitatively or quan-
titatively, examining the various time frames on each plane. Factors used in this
assessment are (Figure 2.2): darkness and persistence of the defect, correlation
with LV bright blood timings, expectancy of defects in any distal territories of
the same coronary artery, absence of defect on rest perfusion scan (subject to
sufficient Gd washout time if performed second). A visual assessment has been
used previously in several publications and is widely used clinically. The ac-
curacy of visual assessment has been established in comparison with nuclear
medicine [Ishida et al., 2003] and X-ray angiography [Ishida et al., 2003, Klem
et al., 2006, Wolff et al., 2004]. Ishida et al. [2003] acquired MR first-pass per-
fusion images in 104 patients. These images were analysed visually and com-
pared to XCA. MR perfusion had a sensitivity of 90% for detecting at least one
coronary artery with significant stenosis. Specificity could not be obtained re-
liably due to the low number of patients without significant CAD. Similar com-
parisons were published by Wolff et al. [2004] (N = 99 with a sensitivity and
specificity of 93% and 75% respectively) and by Klem et al. [2006] (N = 92 with
a sensitivity and specificity of 84% and 58% respectively).
In general the accuracy of visual analysis is potentially limited: dependence
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on observer experience and CA bolus compactness, follow-up of a patient where
the CA bolus may have very different timings and concentrations, and 3-vessel
disease (global perfusion reduction). Also the comparison with XCA depend
on angiographic cutoff values that separate significant disease from nonsignif-
icant.
A more time consuming approach, but in principle with less inter-observer
variability, is semi-quantitative or fully-quantitative analysis (described more
fully below). The Signal Intensity (SI) in various segmental ROI located in the
myocardium can be plotted as a function of time. The necessary fifty measure-
ments take longer than the time most patients can hold their breath, making
the registration of each segment for each heartbeat the most time consuming
aspect of a semi/fully quantitative analysis.
Motion correction methods which improve ROI’s positioning and accuracy
do exist; Adluru et al. [2006], Bidaut and Vallée [2001] published automated
methods where images are motion-corrected in post-processing (in-plane only).
Also early work on prospective navigator-guided slice-followed perfusion has
been recently published by Pedersen et al. [2009]. The quality of the navigator
was shown to need improvement, but it was also shown that through plane mo-
tion does introduce errors in myocardial perfusion measurement and this was
corrected prospectively.
The SI plots are known as SI-curves and can be used to semi-quantify or
quantify the CA uptake. Figure 2.3 and 2.4 show a sketch of a SI curve and some
of the curve parameters commonly used. Figure 2.5 shows a real SI curve of
a patient with a perfusion defect. The ROI positioning remains a significant
source of observer variability and some approaches to analysis are therefore
now “pixel-based” [Panting et al., 2001, Ruan et al., 2006]. Correction of varying
surface coil response for SIs from different cardiac regions at varying distances
from the receiver coil is sometimes necessary, although in theory this cancels
out in an MPR assessment.
For semi-quantitative analysis, the SI-curves in the myocardium are usu-
ally normalised to a ROI located in the LV. The latter is also used to measure the
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Figure 2.3: A sketch of the SI as
a function of time for: the LV, a
normal myocardium, and for an
ischaemic myocardium.
Figure 2.4: SI curve parame-
ters. (see text in pages 85-86)
Arterial Input Function (AIF) in quantitative analyses. An important problem
arises from the measurement of the AIF. When the CA concentration is high
enough to produce a good CNR in the myocardium, the linear relationship be-
tween the signal and the concentration is lost in the LV blood pool, where the
Gd concentration is higher. Linearity in the LV requires a lower concentration
of CA and/or a shorter TI value from the saturation preparation. This would
then produce a very low SNR of signal enhancement in the myocardium. Sig-
nal linearity and CA concentration relationship is discussed in more depth in
Section 2.4.1.
To overcome the signal linearity problem some authors suggest the use of
a dual-bolus injection method in order to measure the AIF separately with a
much lower concentration of Gd-DTPA: 0.005 or even less, 0.0025 mmol / Kg,
[Christian et al., 2004, Hsu et al., 2006]. Other authors suggested a dual-sequence
with a separate low resolution imaging sequence optimized to measure the AIF,
[Gatehouse et al., 2004, Kim and Axel, 2006]. A dual-sequence would avoid
some of the difficulties associated with a dual-bolus technique, such as differ-
ences in cardiac timings and breath-holding, and residual CA from the previous
injection.
More recently, Kholmovski and DiBella [2007] described a similar method to
obtain the AIF using a single bolus and single sequence with a radial sampled
k-space, where perfusion images could be acquired at different TIs by using
different k-space subsets, and the shortest TI image gave the AIF. This method
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Figure 2.5: Real SI curve measured for a patient with a real perfusion defect
in some myocardial segments.
does not require any additional time, although typical streaking artifacts from
radial acquisitions may become problematic.
Linearity is not the only problem in measuring the AIF reliably. Kellman
et al. [2006] measured the reduction of signal due to T2∗ effects for different
Time of Echo (TE)s, concluding that only for short TEs of ≤ 1ms there are no
significant losses. Note that the AIF is irrelevant for visual analysis; this explains
why many publications use sequences and doses likely to cause significant AIF
distortion.
Many parameters can be used from the SI-curve to semi-quantify the first-
pass myocardial perfusion, [Jerosch-Herold et al., 2004] :
• The most frequently used parameter is the up-slope of the curve, when
CA arrives at the myocardium, Figure 2.4, [Christian et al., 2004, Hsu et al.,
2006, Ishida et al., 2003, Schwitter et al., 2001].
• Contrast enhancement ratio:
SIpeak−SIbaseline
SIbaseline
[Christian et al., 2004, Hsu et al.,
2006].
• The time it takes the CA to reach the peak SI (time-to-peak).
• Area under the SI curve, between two defined points; usually the foot and
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the peak points; it is known as upslope-integral or upslope-area, [Chris-
tian et al., 2004].
The upslope is directly related to the perfusion capability of that particular ROI,
but it is also related to the hemodynamic changes induced by vasodilation,
therefore the up-slope in the myocardium is usually normalised with the up-
slope in the LV pool. Regions with a perfusion deficit exhibit a lower upslope.
The peak signal is also lower than normal perfused myocardium although this
method does not take into account the temporal characteristics of the SI curve.
A full quantitative analysis is the most difficult to achieve, but at the same
time is the most accurate, especially in patients with triple vessel CAD, where
MPR is reduced globally, making semi-quantitative analysis based on regional
differences insufficient. Measuring blood flow in the myocardium is better at
assessing perfusion than solely measuring the signal enhancement.
A popular quantitative model is the central volume principle introduced by
Zierler [1962], Zierler et al. [1965] used to measure blood flow, [Jerosch-Herold
et al., 1998, Larsson et al., 1994]. If there is a linear and stationary transport
through a tissue ROI, the output contrast concentration, i.e. the concentration
of contrast that flows through the organ, Cout(t ), is given by the convolution of
the input contrast concentration, i.e. the concentration of the injected bolus,
Cin(t ), with a tissue impulse response, R(t ):
Cout(t )=
∫ t
0
Cin(t −τ) ·R(τ)dτ (2.1)
Equation (2.1) can be written as:
Mout(t )= LV (t )∗R(t ) (2.2)
where Mout is the myocardial output response, ∗ is the convolution operator,
and LV is the arterial input.
The tissue impulse response initial amplitude, R(t = 0), is equal to the My-
ocardial Blood Flow (MBF), assuming that the input of the contrast is a Dirac
delta function, and that Cin(t < 0) = 0 and Cout(t = 0) = 0. This property is in-
dependent of the distribution of the CA inside the ROI, therefore, measuring
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the blood flow does not require any parameter related to the distribution in the
vascular and compartmental structure of the CA.
This model is valid in MR assuming a linear relationship between the MR
signal intensity and the Gd-DTPA concentration. It is also assumed that this
relationship is the same in both the LV and myocardium. There is also an as-
sumption that the first-pass extraction fraction of Gd-DTPA out of blood into
the extracellular space is a constant, but this may become approximate under
stress [Larsson et al., 1996].
To find R(t ) we therefore need a deconvolution of equation (2.2), constrained
due to its high sensitivity to noise, excluding abrupt changes. A Fermi function
is used as an empirical model of R(t ), since its shape is similar to the impulse
response:
R(t )= A
1+e ω−tτ
(2.3)
A, ω, and τ are model parameters of the Fermi function. A is the magnitude of
the function, ω is the temporal delay length, and 1/τ is the decay rate; the last
two parameters refer to the contrast wash-out. This model works only for the
first pass, when the SI curve is related mainly to blood flow and not redistribu-
tion of the CA into the vasculature.
Christian et al. [2004] concluded that semi-quantitative analysis does not
reliably reflect the myocardial blood flow for values higher than 1 mL / min /
g, underestimating the stress myocardial blood flow. Similar conclusions were
obtained by Hsu et al. [2006] when comparing the Central Volume Principle
(CVP) model to two semiquantitative methods (the contrast enhancement ra-
tio and the upslope index). The results showed an underestimation of both
the MBF and the MPR for both semiquantitative methods, affecting mostly the
stress values, especially with the contrast enhanced ratio method. With semi-
quantitative methods, it was impossible to completely separate the MBF at rest
from stress. The values given by the CVP method for a group of healthy volun-
teers were MBF= 1.02±0.22 mL/min/g at rest, and MBF= 3.39±0.59 mL/min/g
at stress.
More recently, Utz et al. [2008] concluded that there is no significant dif-
ference in a dual/single-bolus method for the measurement of global MPRs,
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although it was found that a dual-bolus approach reduces the variability be-
tween myocardial segments MPR with the disadvantage of an increase in anal-
yses complexity.
Very recently, Ishida et al. [2009] published an article suggesting an injec-
tion rate of 4 mL/sec with a dose ≤ 0.1 mmol/kg with a time of inversion of 180
ms, for an accurate quantification of myocardial blood flow. It was also found
that a maximum dose of 0.01 mmol/kg shold be used for an accurate AIF mea-
surement. The study estimated the MR CA concentration in the LV at different
injection rates by imaging myocardial first-pass perfusion in 50 patients with
X-ray CT and an iodinated CA at different injection rates. Blood samples with
the Gd-DTPA concentrations estimated previously in the LV were then imaged
with MR.
Schwitter et al. [2008] also concluded that a fast injection of 0.1 mmol/kg
dose is required for best visual analysis. This study involved multiple centres
with random multiple injection dose protocols. The dose of 0.1 mmol/kg yielded
the best performance for perfusion MR.
However all such conclusions about optimal dose and injection-rate are
somewhat sequence-dependent, as will be discussed in the sections below.
2.2.1 Myocardial segments
Cerqueira et al. [2002] (Cardiac Imaging Committee, AHA) standardised my-
ocardial segmentations and nomenclatures for cardiac imaging. The myocar-
dium is divided into several regions, using anatomic features in order to select
the slice positioning and the circumferential location. Three slices in the short
axis view are typically acquired: basal, mid-cavity, and apical, as depicted on
the left of Figure 2.6. Table 2.2 shows the anatomical landmarks used to localise
the imaging-slices. Circumferential location in the short axis view is also im-
portant and it follows the four main directions: anterior, lateral, inferior, and
septal, as shown in the centre of Figure 2.6.
The standard segmentation divides the basal and mid-cavity short-axis slices
into 6 segments, 4 segments in the apical slice, and one segment, the 17th , for
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Figure 2.6: Standardised myocardial segmentation.
Myocardial Slice Anatomical boundaries
Basal slice mitral annulus↔ papillary muscle at end diastole
Mid-cavity slice The entire length of the papillary muscle
Apical slice papillary muscles↔ end of cavity
Table 2.2: The three short-axis slices, and the corresponding anatomical
landmarks that define their regions. A typical slice thickness of 8 mm is com-
monly used.
the apical cap. All the regions can be displayed into a simplified bull’s eye di-
agram, as depicted on the right of Figure 2.6. Each segment is associated with
a main coronary artery by default. This assignment is important to determine
which artery is stenosed, but it must be kept in mind that the coronary terri-
tories vary greatly between subjects, especially towards the apex. Typical coro-
nary artery territories are described in table 2.3.
Coronary artery Supplied segments
Left anterior descending 1, 2, 7, 8, 13, 14, 17
Right 3, 4, 9, 10, 15
Left circumflex 5, 6, 11, 12, 16
Table 2.3: Main coronary arteries and the myocardial segments typically
supplied by them.
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2.3 Sequences
There is no standard imaging protocol for cardiac perfusion MRI but some re-
quirements, sometimes contradictory to each other, have to be fulfilled:
Temporal resolution is necessary to trace the first-pass of the CA in every slice
for every heartbeat, especially in a fully quantitative analysis where trac-
ing the dynamic signal intensity changes is crucial to quantify blood flow
[Thiele et al., 2003]. A fast readout (ideally < 100 ms) is also important to
avoid motion artifacts during each image.
Spatial resolution to resolve the subendocardium and transmural changes in
perfusion. This requires the resolution to be lower than 3mm, preferably
towards 2mm.
Spatial coverage of the LV in order to detect localised perfusion deficits. At
least three short axis slices are required, and a long-axis view is some-
times added for apical coverage. Increasing the number of slices might
not be possible especially during stress.
Linearity of the LV blood signal intensity in order to quantify the blood flow.
This requirement limits the dose of Gd-DTPA limiting the achievable Con-
trast to Noise Ratio (CNR) as discussed above.
Artifacts have to be avoided if possible, therefore long acquisition times per
image, and sequences more sensitive to frequency offsets such as balanced-
Steady State Free Precession (SSFP) have to be used with care.
2.3.1 Magnetisation preparation for T1-weighting
Myocardial perfusion sequences contain a magnetisation preparation pulse in
order to achieve a T1-weighted image. For semi or fully quantitative work, a
desirable image property is that the signal intensity must have a linear relation
with the concentration of Gd-DTPA, as mentioned before. Several approaches
have been used for T1-weighting such as Inversion Recovery (IR) in early studies
[Larsson et al., 1994, 1996]. Fritz-Hansen et al. [1998] proposed an IR pulse with
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a GRE sequence for a myocardial perfusion quantitative approach, where two
slices were acquired, the first with a short Time of Inversion (TI)* for measuring
the signal in the LV blood pool and a second slice with a longer TI for measur-
ing the signal in the myocardial tissue (both slices had high spatial resolution).
With IR preparation pulses, it is possible to use a TI that nulls the blood signal
with no CA, maximising contrast, although it results in a long TI which limits
multi-slice imaging. The IR approach also becomes complicated by variable
R-R intervals creating signal variations, and becomes unusable in arrhythmia.
Imaging more than one slice per heartbeat is more practicable (especially at
stress) with a Saturation Recovery (SR) approach, accepting reduced CNR com-
pared to IR imaging, but with the advantage of signal magnitude now being im-
mune to RR-interval variability. Shortening the SR for more slices for improved
myocardial coverage inevitably reduces the myocardial CNR, whereas an ade-
quate SI curve in the myocardium is crucial for a reliable detection of perfusion
defects [Bertschinger et al., 2001]. Two different approaches have been used
with SR preparations, a single SR pulse per cardiac cycle [Nagel et al., 2003,
Plein et al., 2002], or an SR pulse per slice imaged. A single SR pulse per cy-
cle has the obvious advantage of decreasing the imaging time when compared
to using an SR pulse before each slice, although analysis is potentially compli-
cated by the variable recovery times of the slices. For quantitative work, the first
slice can be used for the AIF data.
Despite the increased "dead time" waiting for magnetisation recovery for
each slice, an SR pulse per slice is more commonly used in MPI, Figure 2.7.
Slavin et al. [2001] introduced notched preparation technique where a SR
pulse with an inverse slice-selective profile was described. The TI can this way
be extended because it includes the time for imaging the previously saturated
slice and the SR pulse for the next slice. This technique enables a good CNR
without sacrificing heart coverage, although the signal of the moving blood
is non-uniform, and through-plane motion of the myocardial tissue is a big-
ger problem than in conventional techniques; it does not appear to have been
*Time duration from preparation pulse to centre of k-space acquisition. This definition is
commonly used for both inversion recovery and saturation recovery preparation pulses.
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Figure 2.7: T1-weighted magnetisation preparation with a saturation recov-
ery RF pulse per slice. The two lines (red and blue) represent different T1-
recovery signal curves. The blue line has a shorter T1 recovery caused by a
higher concentration of gadolinium.
widely adopted.
Whichever magnetisation preparation is employed, its uniformity over the
heart is important, and for quantification, it is essential. BIR (B1 Independent
Rotation) pulses are a class of adiabatic pulses that produce an uniform excita-
tion, refocusing or inversion [Ugurbil and Garwood, 1987]. The most popular
pulse from this class is the BIR-4 pulse [Staewen et al., 1990] (see Appendix A).
Kim et al. [2005] showed that a BIR-4 pulse could be used to produce a homo-
geneous saturation of the magnetisation, yielding better results than conven-
tional pulses.
The following subsections will describe the basics behind the sequences
normally used in MPI along with some relevant properties.
2.3.2 Gradient recalled echo
GRE sequences are very popular for cardiac perfusion imaging due to their fast
acquisition times, reliability, and simplicity. Instead of relying on a 180◦ refo-
cusing pulse technique used in spin echo, the signal is rephased using a gradi-
ent reversal alone, Figure 2.8.
GRE can use fast TRs (around 2-3 ms) because the flip angle is usually much
smaller than 90◦, reducing the need for T1 recovery. A small angle is very effi-
cient because it reduces only slightly the longitudinal magnetisation (Mz) while
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Figure 2.8: A basic GRE with a phase rewinder gradient.
creating an appreciable amount of transverse magnetisation (M⊥). A downside
of GRE sequences is the lack of a 180◦ RF pulse; local magnetic field inhomo-
geneities will not be refocused making this type of sequences sensitive to mag-
netic susceptibility. The contrast is also influenced by T2∗ instead of T2:
T2∗ =
(
1
T2
+γ∆B
)−1
(2.4)
where ∆B is the field inhomogeneity inside each voxel. However, the TE is also
very short, limiting the effect of susceptibility distortions.
When this sequence uses a fast repetition of RF pulses, the Mz relaxation
will be continuously perturbed, leading to a steady-state equilibrium (this equi-
librium must be perceived as a dynamic one), assuming the same tissue re-
mains within the image slice. The equilibrium magnetisation is smaller than
the value given by thermal equilibrium, and the time taken to reach the steady-
state equilibrium is a function of RF pulse angle, and T1.
There are two common approaches when using GRE sequences. M⊥ can
be “spoiled” before each new RF pulse, or it can be reused. The first approach
is known as spoiled-GRE or incoherent-GRE, and the second as SSFP-GRE or
steady-state coherent-GRE. SSFP-GRE is used mostly with balanced gradients,
therefore, the SSFP-GRE sequence is mentioned throughout this thesis as Balanced-
SSFP or bSSFP. To simplify notations spoiled-GRE is named solely as GRE. Both
bSSFP and GRE are also known by their commercial names [Bernstein et al.,
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vendor GRE bSSFP
Siemens FLASH True-FISP
Philips CE-FFE-T1 Balanced FFE
General Electric SPGR FIESTA
Table 2.4: GRE and bSSFP sequences commercial names.
2004], table 2.4.
It is important to consider the approach to steady-state since image acquisi-
tion in MPI happens in this stage, marked by signal variations, T1/T2 relaxation
during saturation recovery, and the possibility of image artifacts. Equilibrium
approaches will be plotted and analysed for relevant sequence parameters.
Please note, the following subsections include signal simulations. These
simulations were performed on MATLAB (Mathworks, Natick, USA-MA) with
the Sekihara method [Sekihara, 1987].
2.3.2.1 Gradient Recalled Echo
GRE was the first sequence established in myocardial perfusion imaging, [Jerosch-
Herold et al., 1998, Larsson et al., 1994, Wilke et al., 1997]. Spoiling the trans-
verse magnetisation is accomplished by RF and gradient spoiling. RF spoiling
consists of creating a predefined phase cycle for the RF excitations, equation
(2.5), cancelling different magnetisations that evolved through different trajec-
tories.
φn =φn−1+nφ0 n = 1,2,3, . . . (2.5)
The starting value φ0 is usually 117◦, because no small integer multiple of 117◦
is divisible by 360◦ [Zur et al., 1991].
To prevent the RF spoiling from being spatially dependent some versions of
GRE have a phase-encode rewinder [Bernstein et al., 2004]. Because the M⊥ is
spoiled, the sequence Signal to Noise Ratio (SNR) is lower when compared to
bSSFP.
The longitudinal magnetisation in the steady state of a GRE sequence, Mzeq ,
Sequences 95
can be described mathematically by equation (2.6):
Mzeq
M0
= 1−E1
1−E1 cosα
(2.6)
where E1 ≡ e−TR/T1 , and α is the flip angle.
The signal, when at the steady-state equilibrium, can easily be obtained us-
ing equation (2.6):
Sspoil =
1−E1
1−E1 cosα
M0 sinαe
−TE/T∗2 (2.7)
The first and second derivative of equation (2.7) yields the angle with the max-
imum signal, the Ernst angle (although this neglects imperfect slice profile):
αE = arccosE1 (2.8)
The steady state signal was simulated as a function of the flip angle in the my-
ocardium before arrival of CA and at peak concentration of Gd-DTPA, Figure
2.9. Peak concentration in the myocardium was assumed to be [Gd-DTPA] =
1.5 mmol / L*. The parameters given in table 2.5 were used in the simulations.
A constant flip angle was used in the simulations.
When TR ¿ T1, the peak signal can be shown to be M⊥(αE) ≈ 12 M0αE (an-
gle in radians); for the values used in the simulations this yields αE = 11◦ and
M⊥(αE)≈ 0.093 at peak concentration, andαE = 4◦ and M⊥(αE)≈ 0.036 without
CA. It can also be shown that at low angles (α < αE) the signal is proportional
to M0 and α alone reducing the T1 contrast, this property can be seen in Figure
2.9 with the two curves having identical values for angles ¿αE. For angles ap-
proaching and higher than αE, T1-weighted contrast comes into play [Haacke
et al., 1999].
Figure 2.10 shows the approach to the steady state equilibrium for a GRE
sequence throughout the readout with an SR preparation, and using the values
from table 2.5 for two different RF pulse angles: α = αE = 7◦ and α = 12◦. The
*This concentration is close to the maximum CA concentration, Hsu et al. [2008] measured
in the myocardium (1.32 mmol/L) during hyperemia with an injection dose of 0.1 mmol/kg.
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signals were simulated for the myocardium at peak concentration. Although
the Ernst angle gives us the maximum signal, the time to reach equilibrium is
greater than for bigger angles. It is clear that in perfusion imaging there is usu-
ally no time to wait approximately 100× TR for full development of the steady
state; in fact this may not be desirable anyway as it may suppress the contrast
between normal and defect myocardium. Perfusion imaging occurs during this
buildup to equilibrium and the effects of this are considered further in section
3.3.
TR 2.2 ms
TE 1.3
T1 127/870 ms
T2∗ 8/60 ms
M0 1
TD 41 ms
Table 2.5: Simulation parameters for the GRE sequence. TR and TE are taken
from table 2.1. The T1 and T2∗ values are the ones assumed in the myocar-
dium before CA, and at peak concentration of Gd-DTPA. TD - is the time delay
between the saturation recovery and the first RF pulse.
Figure 2.9: Steady-state signal
in a GRE sequence as a function
of the flip angle in the myocar-
dium before contrast and at peak
contrast concentration.
Figure 2.10: Approach to
steady state equilibrium of a GRE
sequence with an SR preparation
for two different flip angles, at
peak concentration of Gd-DTPA.
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2.3.3 Balanced-Steady State Free Precession
Another option to reach steady-state equilibrium is not to spoil the transverse
magnetisation but reuse it, using additional gradients. Because this type of se-
quences share properties with both gradient recalled echo and spin-echo se-
quences it is described in a new section and not inside the scope of the GRE
section.
bSSFP has also been used in myocardial perfusion imaging [Schreiber et al.,
2002]. This technique enables a better SNR and CNR than GRE. Fenchel et al.
[2004] compared the two sequences using clinical patients and healthy volun-
teers at rest only, obtaining a CNR increase of more than 100% with bSSFP when
compared to GRE, enabling a higher sensitivity for the detection of perfusion
abnormalities.
One property of bSSFP sequences is that the gradient dephasing for each TR
interval must be zero; this means that the sum integral of the gradient areas for
each axis is zero (balanced gradients) in each TR interval, Figure 2.11. The ba-
lanced gradients also make the bSSFP sequence less sensitive to motion, since
slice-select and frequency-encode velocity-related phase shifts are cancelled at
the time of the next RF pulse, more exactly if the waveforms are symmetrical
around the echo as is usual.
Figure 2.11: Balanced-SSFP sequence. The sum integral of the gradients
areas is zero during each TR for each axis.
bSSFP sequences are usually used with an initial preparation to catalyse the
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approach to the steady state. The most simple method is to use an initial prepa-
ration α/2 RF pulse, followed by a train of (−α,+α,−α,+α...) pulses. The time
separation between the preparation pulse and the first pulse is TR/2. The rea-
son behind the preparation pulse is to shift the magnetisation into the steady
state position smoothing the M⊥ decay. The following RF pulses will oscillate
the magnetisation back and forward around the z axis, with a damping effect
caused by spin relaxation, converging into the steady state equilibrium [Schef-
fler and Hennig, 2003]. This magnetisation oscillation was simulated, using
typical bSSFP sequence parameters (table 2.6) and it is shown in Figure 2.12
and Figure 2.13.
TR 2.3 ms
TE 1.1 ms
α 50◦
T1 127 ms
T2 41 ms
M0 1
TD 39 ms
Table 2.6: Sequence parameters used on the bSSFP simulations. TR and TE
are taken from table 2.1. The T1 and T2 values correspond to the myocar-
dium at peak concentration of Gd-DTPA (1.5 mmol /L). TD - is the time delay
between the saturation recovery and the first RF pulse.
Although bSSFP sequences provide a better SNR than GRE, they are much
more sensitive to field distortions ∆B0. In bSSFP sequences, a non perfect
shimming will cause a dephasing, θ, given by:
θ = 2piνTR (2.9)
where the frequency offset ν= γ∆B0 and in general varies with position.
Reeder et al. [1998] measured a frequency offset of up to 100 Hz on the my-
ocardium at 1.5 T. This frequency offset translates into a phase offset of 1.44
radians for a TR of 2.3 ms, which changes the approach to equilibrium. The
bSSFP sequence approach to the steady-state was again simulated with an 100
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Hz offset. It can be seen in Figure 2.14 that the oscillation is no longer in a
plane, but it has components in the three orthogonal components of the mag-
netisation. Figure 2.15 shows the magnitude and phase angle as a function of
RF pulse number for this offset, it is clear these are rapid signal variations in
conjunction with phase oscillations.
Field distortions not only change the approach to equilibrium but also change
the steady state signal; Figure 2.16 shows the steady-state signal as a function
of the dephasing angle for several flip angles, using a (−α,+α,−α,+α...) train
of pulses. Magnetic field inhomogeneities will therefore introduce signal vari-
ations, degrading real tissue uniformity. The signal breaks down for dephasing
angles around ±pi (Figure 2.16) creating dark bands in the image, therefore one
should use the shortest TR possible to minimise θ in equation (2.9); also a min-
imal ∆B0 is essential. Noteworthy is the fact that for small flip angles there are
two peaks in the signal for values close to±pi, while large flip angles have a more
stable signal across a bigger range of dephasing angles.
An engaging property of the dephasing mechanism is that whatever the de-
phasing angle, at the centre of the echo, the magnetisation vector is close to the
0◦ dephasing angle position, going from±θ/2 to∓θ/2*. bSSFP sequences share,
therefore, some attributes of spin echo sequences as mentioned above [Schef-
fler and Lehnhardt, 2003]. In addition it is not beneficial to reduce TE, as it is
done in GRE sequences to reduce T∗2 sensitivity. Nevertheless, it is beneficial to
reduce TR.
In the steady state equilibrium and with no frequency offsets, the bSSFP
signal can be approximated to (provided that TE=TR/2) [Haacke et al., 1999]:
SbSSFP =M0
sinα (1−E1)
1− (E1−E2)cosα−E1E2
e−TE/T2 (2.10)
where E1 = e−T R/T 1, and E2 = e−T R/T 2. Note the e−TE/T2, instead of e−TE/T2∗ .
*Considering a T E = T R/2 and a T 1,T 2 À T R. This can be seen only when simulating a
distribution of dephasing angles and not an isochromat at the same frequency-offset as shown
in the previous simulations. This topic is further explored in section 3.3.2.3.
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Figure 2.12: Balanced-SSFP
magnetisation oscillation in its
approach to equilibrium around
the z-axis. (no saturation recov-
ery; 100 RF pulses simulated).
The plot shows the magnetisa-
tion trajectory in 3D (rotating
frame).
Figure 2.13: Top: Transverse
magnetisation magnitude values
as the sequence approaches the
steady-state. Bottom: The phase
as a function of the RF pulse
number.
Figure 2.14: Balanced-SSFP
magnetisation oscillation in its
approach to equilibrium around
the z-axis, with an off-resonance
of 100 Hz. The plot shows the
magnetisation trajectory in 3D
(rotating frame).
Figure 2.15: Top: Transverse
magnetisation magnitude values
as the sequence approaches the
steady-state. Bottom: Phase val-
ues as a function of the RF pulse
number.
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Figure 2.16: Steady-state signal as a function of the off-resonance frequency
for different RF angles.
Figure 2.17: Approach to steady state equilibrium of a bSSFP sequence with
an SR preparation (initial pulse was α/2). The signal was simulated for the
myocardium before contrast arrival and at peak concentration of Gd-DTPA.
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The first and second derivative of equation (2.10) yields the angle with the
maximum signal, αmax :
αmax ≈ arccos
T1
T2
−1
T1
T2
+1
⇒ SbSSFP(αmax)≈
1
2
M0
√
T2
T1
(2.11)
Equation (2.11) tells us that the signal at equilibrium is given by a T2T1 ratio when
using an RF pulse angle αmax . The signal for a high T2/T1 ratio is uniquely
high in the realm of fast sequences. At peak Gd concentration (T1 = 127 ms,
T2 = 41 ms) the ratio is T2/T1 ≈ 0.32. When motion is considered, equation
(2.11) is approximate because the approach to equilibrium of the moving tissue
is “distorted”.
Using the values from table 2.6 and equation 2.10, we obtain a signal at equi-
librium of:
SbSSFP = 0.279 forT1 = 127,T2 = 41ms (peak [Gd])
SbSSFP = 0.112 forT1 = 870,T2 = 60ms (no [Gd])
(2.12)
The approach to the steady state was simulated for these two configura-
tions confirming these equilibrium values, Figure 2.17. A higher signal is ob-
tained at peak concentration than before CA first-pass. The signal without CA is
smoothly increasing to the equilibrium value, while the signal with CA slightly
oscillates in the first 20 RF pulses in its approach to equilibrium.
Alternative approaches to equilibrium have also been introduced. Instead
of the classical RF pulse sequence (α/2,−α,+α,−α...), Hennig et al. [2002] sug-
gested an algorithm to make the magnetisation a monotonic linear transition
to the steady state value, improving off-resonance approach behaviour when
compared to the classical transition. It is known as continuous Transition Into
Driven Equilibrium (c-TIDE):
• The first flip angle is α(0)=−α(1)/2.
• α(1) is played after T R/2.
• The flip angle decrement ∆α is given by α(1)−α(N )N , where N is the number
of steps to the SSFP equilibrium.
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Figure 2.18: Comparison between the classical approach (left) and the Hen-
nig et al. approach (right).
• The following flip angles are given by the algorithm below:
◦ α(n)=α(1)− 2n−32 ∆α for 2≤ n ≤N +1.
◦ α(n)=α(N +1)=α for n >N +1.
The initial RF pulse angles are large, converting most of the magnetisation avail-
able into signal, but this approach does not avoid residual artifacts such as
eddy currents when compared with low initial RF pulse angles. What it avoids
is some of the signal variations on the approach, possibly evading image ar-
tifacts and speeding the transition time. A simulation on MATLAB compares
the two approaches for a 100HZ off resonance using the same protocol given
in table 2.6, and it is shown in Figure 2.18. The Hennig et al. [2002] approach
simulated uses 10 steps, when using more steps, the transition to SSFP is even
smoother. There is a big initial slope for the Hennig approach when at the ini-
tial pulses, but it approaches the equilibrium signal faster than the classical
approach. The Hennig approach has a much lower phase oscillation than the
classical approach as well.
During these first steps, there is a big signal fall-off, making it impractical for
data acquisition during this stage, but the next RF pulses have less signal and
phase fluctuations than the classical approach. Therefore using a small number
of introductory steps makes this approach practicable. The time required for
the signal to stabilise depends on the relaxation times. Long relaxation times
imply a longer stabilisation time.
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Another approach to equilibrium was proposed by Hargreaves et al. [2001].
It consists of two magnetisation stages. The first stage uses a pair of RF pulses
in order to scale the longitudinal magnetisation into the respective equilibrium
value. A subsequent crusher gradient spoils the transverse magnetisation. The
second “catalysing” stage uses the fact that the magnetisation decays without
any oscillation (purely exponentially decay) if the magnetisation vector is in the
direction of an eigenvector of the matrix A in the following equation:
Mi+1 =AMi +B (2.13)
where Mi is the magnetisation vector at i th period. Both A and B are matrices
dependent on T1, T2, and off-resonance precession and flip-angle rotation an-
gles. Taking this into account, the second step rotates the magnetisation with
another RF pulse in order for the pulse to be directed along the same direction
as the eigenvectors of A. Ideally it is logical to just put the magnetisation in the
steady-state position, but the two steps comes as a trade-off between accuracy,
pulse duration, and practicality.
The catalysing method proposed by Hargreaves et al. [2001] is not as prac-
ticable as the one proposed by Hennig et al. [2002], since it requires a-priori
calculations and selective-pulse careful design. As a final note, neither method
is very robust for in vivo imaging due to motion, ∆B0, and∆B1, and this cannot
be ignored, especially when imaging in the chest. bSSFP sequences at the time
of writing in the Siemens scanners use the α/2 preparation method.
One drawback of bSSFP sequences is therefore the approach to equilibrium.
If an oscillatory approach is not suitable for imaging then the time required to
wait until equilibrium might be bigger than the time of scan, therefore bSSFP
is commonly used for MPI during the approach to equilibrium and this is con-
sidered in section 3.3.
2.3.4 Echo planar imaging
EPI is one of the fastest imaging sequences available, as it can generate an im-
age in less than 100 ms. The basic principle behind it is the use of an oscillat-
ing readout gradient to produce multiple echoes after a single excitation, shar-
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Figure 2.19: Diagram repre-
senting the basic gradient setup
of two types of EPI sequences.
Top: Gradient recalled echo EPI
sequence. Bottom: Spin echo
EPI sequence. In both se-
quences, the readout train uses
a blipped phase-encode (Carte-
sian k-space sampling trajec-
tory).
Figure 2.20: Diagram repre-
senting the signal decay for the
two types of EPI sequences. Top:
Gradient recalled echo EPI se-
quence with the T∗2 decay (blue).
Bottom: Spin echo EPI sequence
with the spin echo modulated by
the T∗2 decay (blue)(T2 decay in
red).
ing the basic principle of generating signal with GRE sequences. In its extreme
form, all the image data is acquired in one echo-train, known as single-shot EPI.
Single-shot EPI has been used in MPI [Edelman et al., 1994, Panting et al., 2001].
The following discussion of artifacts leads into the requirement to reduce
the echo-train length, leading to multi-shot (segmented or interleaved) EPI meth-
ods in the next section.
In a gradient-recalled-echo EPI (GRE-EPI) sequence, top of Figure 2.19, the
signal echoes in the readout train are modulated by the intrinsic T∗2 decay, given
by e−t/T
∗
2 . The signal modulation on a spin-echo EPI sequence (SE-EPI) is sym-
metric around the spin echo time, but following the same exponential decay.
These two decays are depicted in Figure 2.20, with the T∗2 decay represented in
blue, and the T2 decay in red.
One disadvantage of EPI sequences is the longer durations of the readout
period, making these types of sequences very sensitive to magnetic field inho-
mogeneities [Farzaneh et al., 1990], leading to image distortions and signal loss
106 Sequences
due to dephasing. The length of the readout train is limited by a T 2∗ decay,
given by equation 2.4.
One effect of the T 2∗ decay is the widening of the voxel along the phase-
encode direction causing blurring in that direction. The Full Width Half Maxi-
mum (FWHM) of the voxel is given by [Bernstein et al., 2004]:
FWHM=
p
3
pi
(
Ta/T
∗
2
)
∆y GRE−EPI
FWHM= 1
pi
(
Ta/T
∗
2
)
∆y SE−EPI
(2.14)
where Ta is the time of acquisition, and ∆y is the voxel width along the phase-
encode direction. It can be seen in equation (2.14) that the blurring effect is
smaller by a factor of
p
3 for the SE-EPI, when compared to the GRE-EPI.
Another pronounced artifact in EPI sequences is the chemical shift. This
is a problem mainly in the phase-encode direction due to the low frequency
per pixel in this direction. The chemical shift, ∆yfat, is directly proportional to
the phase-encode Field of View (FOV), and to the echo-spacing tesp (interval
between two adjacent echoes), and is given by the following equation:
∆yfat =
tesp
Nshots
∆ f FOVphase (2.15)
where ∆ f is the difference in resonance frequency (210 Hz between water and
lipids), and Nshots = phase-encode matrix/ETL is the number of excitation pulses
used to acquire one image (1 if using a single-shot EPI, > 1 for multishot tech-
niques mentioned below); ETL is the echo train length: number of gradient
echoes after an RF pulse. In a typical EPI perfusion protocol (FOV of 370 mm,
matrix 128x128, an tesp = 0.8 ms, Nshots = 32), the chemical shift between wa-
ter and lipids is approximately 1.94 mm, i.e. less than one pixel for the spatial-
resolution used, although the same protocol for a single-shot EPI would result
in a chemical shift of 62.1 mm.
One type of artifact limited only to sequences that use alternating sampling
gradients is the Nyquist ghost N/2 artifact. This artifact displays itself in the
image as phase-encode ghosting. N/2 artifacts come from imperfect gradi-
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ents [Bruder et al., 1992], eddy currents, concomitant fields [Zhou et al., 1998],
receiver filter asymmetry [Delakis et al., 2005] or susceptibility; these factors
cause mismatches between odd and even echoes, creating phase errors. Due
to the nature of the sequence, these artifacts propagate along the readout, cre-
ating an oscillating error over k-space. In the spatial domain, this results in sig-
nal intensity displaced halfway across the image in the phase-encode direction.
A technique often used to reduce this ghosting is known as phase correction,
usually applied prior to the EPI readout train. It consists of a short collection
of echoes using the same readout gradients as the EPI readout train, but non
phase-encoded.
The correction requires the acquisition of at least two echoes (with opposite
gradient polarity) with no phase encoding gradients. After a Fourier transform
in the frequency-encode direction, it is possible to measure the difference be-
tween them, which in its simplest form is only a timing difference between the
echoes. Mathematically this can be described by the following [Bruder et al.,
1992, Reeder et al., 1999]:
Let s′i (kx) be the i
th calibration scan signal, and si (kx) the same signal with
no gradient mismatch. If performing a 1D FT in the readout direction, their
relation can be described by*:
1DFT
[
s′i (kx)
]= S′i (x)= Si (x) exp(iφi (x)) (2.16)
where φi (x) is the phase difference between odd and even echoes, and x ∈
[−FOV/2,FOV/2].
Using two consecutive calibration echoes, it is possible to obtain the phase
difference. After performing the time reversal and 1D FT in the frequency-
encode direction, we have:
φi (x)= arg
[
S′i (x),S
∗′
i+1(x)
]
(2.17)
where S∗′i+1(x) is the complex conjugate of S
′
i+1(x).
The distorted phase-encoded echoes of the EPI readout, spe′i (kx,k y) can
*This is true if the magnitude of the system response is even symmetric.
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therefore be corrected by applying the opposite of the phase difference, i.e.:
1DFT
[
spei (kx ,k y)
]= Spei (x,k y)= Spe′i (x,k y) exp(−iφi (x)) (2.18)
where Spei (x,k y) is the i
th corrected phase encoded echo in the hybrid space
(x,k y). The final corrected image is obtained by performing 1D FTs in the
phase-encode direction for each x: 1DFT
[
Spei (x,k y)
]= Spei (x, y).
Two consecutive calibration echoes can be used to correct all lines of the
EPI readout, by using the corresponding odd and even calibration echo. Al-
ternatively, phase correction can be performed by using the same number of
calibration echoes as the number of phase-encode lines in the EPI readout,
with each calibration echo used to correct the corresponding phase encoded
line only. The last method is in principle more reliable because it replicates the
imperfect gradients, eddy currents, and susceptibility of the EPI readout, but it
also takes longer to acquire.
Note that this correction method is only approximate as it measures the
phase of φi (x) complex sum down each phase-encode column of signal. Vari-
ations in the correct value of φ along the phase-encode direction, for example
due to spatially dependent residual eddy current effects, are therefore averaged.
The function φi (x) is sometimes also fitted to a linear or higher-order slope.
The intercept of this slope φi (0) represents a frequency offset.
There are also other sources for Nyquist ghosting that are not corrected by
the standard phase correction mentioned above. One such type of ghosting
originates from oblique planes and gradient anisotropies [Aldefeld and Börn-
ert, 1998], and it is very relevant for cardiac imaging.
2.3.4.1 Multishot techniques
Single-shot EPI is severely affected by artifacts, mainly caused by B0-distortion
and cardiac motion. It is also limited by hardware and/or safety issues. Both of
these limitations can be improved by using a multishot approach, where each
shot acquires a limited amount of echoes; the number of echoes per RF excita-
tion is known as the echo-train length or EPI-factor.
This type of sequence is also called hybrid-EPI (h-EPI) although it must not
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be confused with another approach also called hybrid developed by Haacke
and Patrick [1986], which used an oscillating phase-encode gradient, with a
static readout gradient.
h-EPI sequences are commonly used in MPI [Kim and Axel, 2006, Nagel
et al., 2003, Schwitter et al., 2001].
Several different multishot techniques are known:
Mosaic This approach divides the k-space in different “tiles”. Each tile is ac-
quired in a different shot (top left of Figure 2.21). The division of the tiles
can be made in the frequency and/or phase-encode direction. If divided
in the phase-encode direction, susceptibility and motion artifacts are still
a problem because k-space is traversed in the phase-encode direction at
the same speed as the single-shot technique. The joins between shots
in k-space may also be problematic. Another technique described in the
next paragraph is more robust than mosaic and therefore this technique
was never widely used.
Interleaved This technique increases the rate at which the phase-encode di-
rection is sampled in each shot. The bigger the phase-encode step, the
more shots are needed to cover the entire k-space (top right of Figure
2.21). Two conditions must be kept: first, a similar signal for each RF exci-
tation. In amplitude, this is not possible for all tissues in the image simul-
taneously, due to T1 differences, creating ghosting and blurring; ampli-
tude variations across ky are surprisingly well tolerated. If the shots have
different phases for any reason, phase-encoding is disrupted and artifacts
are more severe; fortunately on modern hardware such phase variabil-
ity seems small. A second condition is on the distribution of the echoes
from each shot; as the signal decays during each echo-train, and more
seriously, each echo of the train may have a slightly different phase. With
interleaved ky-coverage, the joins between echoes along ky can generate
artifacts. A technique often used to reduce these artifacts is echo time-
shifting [Feinberg and Oshio, 1994] in order to introduce a smooth phase
transition between different segments along ky (Figure 2.22). It consists
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of introducing a time increment ∆t before each readout-train:
∆t = TGR
Nshots
(2.19)
where TGR is the time of one read gradient, and Nshots is the number of
shots (for conventional interleave coverage). However echo time shifting
is approximate for off-resonance signals [Mugler and Brookeman, 1996].
A hybrid sequence was tailored for dynamic contrast-enhanced cardiac imag-
ing [Fischer et al., 1996] and later modified by Ding et al. [1998] (bottom of Fig-
ure 2.21). This sequence uses a centric-interleaved phase encoding scheme,
where the central lines are acquired with the first echo, minimising susceptibil-
ity and flow signal-loss effects.
Although in conventional EPI a frequency offset causes simply a phase-
encode image shift (distortion if the offset is spatially variying), it is more diffi-
cult in centre-out multishot techniques where separate regions of rawdata may
contain opposite phase-slopes due to off-resonance.
2.3.5 CNR sequence comparison in perfusion
Myocardial CNR is clearly one factor in defect visibility, and this section reviews
CNR comparisons of the three sequences. Discussion of artifacts may occur in
these same references, but its review is deferred until section 2.6.
Several articles have been published where comparisons between different
sequences were made in the context of MPI. In comparing the sequences for
the purpose of detecting stress-induced perfusion defects, comparison of nor-
mal myocardial CNR may be misleading. The aim is the reliable detection of
stress-induced defects. Comparing the visibility of defects between sequences
is highly subjective, unless quantitative analysis is used, and the diagnostic re-
liability is affected by dark-rim-artifacts and motion blurring of defects just as
much as by the normal myocardial SNR. Comparisons performed with stress
imaging and in patients with CAD could therefore be regarded as more valid.
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Figure 2.21: Left: Mosaic multishot technique with a k-space tiling in
four quadrants. Centre: Interleaved multishot technique with a phase-
encode step of three k-space lines. Right: Centric-interleaved phase encoding
scheme where the central lines are acquired with the first echo.
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Figure 2.22: Echo time shifting diagram: the k-space is represented by a
series of rectangles, where each one represents a different phase-encode line
for an h-epi sequence with an echo-train length of 3 and 4 interleaves. The
gray-scale represents the phase error. In the k-space data with no echo time
shifting (left) there are big discontinuities in the ky centre, where greater sig-
nal energy occurs. These discontinuities are shifted from the centre to the
outer regions of k-space in the data with echo time shifting (right).
Having said this, the CNR measurements in the literature are never made be-
tween stress-induced defects and remote myocardium, it is rather difficult.
Fenchel et al. [2004] compared the CNR between a bSSFP and a GRE se-
quence in CAD patients with fixed defects due to infarcted tissue at rest only,
obtaining a higher CNR for the bSSFP sequence, Table 2.7, although the CNR
error values make the CNR comparison inconclusive!
CNR
bSSFP 7.9±10.7
GRE 2.7±5.8
Table 2.7: CNR comparison between bSSFP and GRE by Fenchel et al. [2004].
The CNR was measured between normal and infarcted myocardium.
Hunold et al. [2004] also compared a bSSFP with a GRE sequence in CAD
patients at rest with myocardial infarcts. An increase of 24% in the CNR was
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measured for the bSSFP sequence. The CNR was measured, just like in the pre-
vious mentioned study, between scar and normal tissue.
Elkington et al. [2005b] compared an h-EPI protocol with a similar GRE
protocol, in a stress perfusion setup with CAD patients. The h-EPI sequence
yielded a superior CNR when applied with a superior either temporal or spatial
resolution (Table 2.8).
h-EPI GRE
matched spatial resolution 32 22 (p < .001)
matched temporal resolution 35 23 (p < .001)
Table 2.8: CNR comparison between h-EPI and GRE by Elkington et al.
[2005b]. The CNR was measured between the baseline signal and at peak con-
trast signal.
Wang et al. [2005] compared a bSSFP sequence with a GRE and with an h-
EPI sequence in healthy volunteers at rest. The bSSFP sequence time of ac-
quisition was matched to the sequence to which was being compared. bSSFP’s
CNR compared favourably to any of the other two sequences, Table 2.9.
bSSFP/compared sequence
bSSFP/GRE 153.1±10.3/124.3±11.7
bSSFP/h-EPI 158.6±10.6/107.2±7.5
Table 2.9: CNR comparison between bSSFP and GRE or h-EPI by Wang et al.
[2005]. The CNR was measured between the baseline signal and at peak con-
trast signal.
More recently Lyne et al. [2007] compared at stress a GRE, a bSSFP, and
an h-EPI sequence with parallel imaging (bSSFP and h-EPI with TSENSE R=2,
and GRE with GRAPPA R=1.6). All sequences had identical time per slice. The
scanned population were clinical patients referred to coronary angiography.
The bSSFP had the higher CNR of the three sequences, Table 2.10.
A similar comparison in healthy volunteers at rest was made by Weber et al.
[2007], with the same sequences with and without TSENSE R=2. Similar results
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bSSFP GRE h-EPI
13.16 10.85 7.85 (p < .001)
Table 2.10: CNR comparison between bSSFP, GRE, and h-EPI by Lyne et al.
[2007]. The CNR was measured between myocardial pre-contrast signal and
peak enhancement post contrast.
bSSFP GRE h-EPI
without TSENSE 21.2 (17.5-24.9) 12.4 (8.8-20.2) 10.7 (6.6-16.3)
with TSENSE 12.3 (10.5-14.5) 6.5 (5.1-9.6) 8.8 (5.9-12.7)
Table 2.11: CNR comparison between bSSFP, GRE, and h-EPI with/without
TSENSE R=2 by Weber et al. [2007]. The CNR was measured between the base-
line signal and at peak contrast signal.
with a higher CNR for the bSSFP sequence were obtained, Table 2.11.
In conclusion the myocardial CNR is higher for the bSSFP with GRE and h-
EPI sequences having lower values, but as later sections will show, this is not
the only factor when comparing these sequences for MPI.
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2.4 First-pass MR perfusion and circulation
2.4.1 Gd-DTPA in first-pass perfusion
The CA used in myocardial perfusion is gadolinium-based. Gd is a rare earth
metal that modifies the relaxation of the water protons reducing both the T1
and T2. However, it must be chelated* because it is poisonous by itself. Gd-
DTPA (diethylene-triamine-pentaacetic acid) was the first MRI CA to be ap-
proved.
The change of the T1 or T2 relaxation time can be defined mathematically
by the following equation:
1
Ti
= 1
T 0i
+ ri C i = 1,2 (2.20)
where Ti is the relaxation time with the CA, T 0i is the relaxation prior to the
CA, ri is the relaxivity, and C is the concentration of the CA (Figure 2.23). From
equation (2.20) we can see that the relaxivity constant describes the slope at
which 1/Ti varies with the CA concentration. At 20◦C and B0 = 1.5 T, Gd-DTPA
has relaxivity values of r1 = 4.5±0.2mmol−1Ls−1, and r2 ≈ 5.1mmol−1Ls−1. A
noteworthy remark is the study of Stanisz and Henkelman [2000], who found
that Gd-DTPA relaxivity also changes with macromolecular concentration, be-
sides temperature and field strength. They predicted an increase in relaxivity
in muscle tissue, when compared to a saline solution of Gd-DTPA. This may
lead to an overestimation of Gd-DTPA concentration in the myocardial tissue
in quantitative perfusion work, assuming the relaxivity in blood is similar to
saline.
When using a saturation recovery preparation, the magnetisation recovers
following the following equation before the imaging sequence:
M = 1−e− T IT1 (2.21)
*The combination of the Gd ion with a chemical compound forming a ring which blocks
its chemical activity.
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Figure 2.23: T1 and T2 relaxation values of the myocardium and LV blood
pool as the concentration of Gd-DTPA increases. Myocardial Gd concentra-
tion: [0,1] mmol L−1, LV Gd concentration: [0,10] mmol L−1.
where T1 is given by equation (2.20). This equation is valid for a perfect 90◦
saturation pulse. A spatial homogeneous saturation pulse, such as the BIR-4
(see appendix A), is important to keep the magnetisation recovery curve the
same in the whole FOV.
Using equations (2.20) and (2.21) it is easy to prove that only for a small
T I /T 1 ratio is the signal approximately linear to the concentration of the CA*.
This is shown in Figure 2.24 for a TI of 80 ms, the signal in the myocardium
is linear for the range of Gd concentrations considered, but the LV blood pool
loses its linearity as the concentration increases. For a typical perfusion proto-
col with a dose of Gd-DTPA of 0.1 mmol / kg at an injection rate of 3 mL s−1,
the estimated peak concentration at stress found in the LV blood pool is of 12.5
mmol / L [Elkington et al., 2005a] and 1.5 mmol / L in the myocardium.
An important idea to have in mind is that the contrast agent is not imaged
directly in MRI; instead, what is really measured is its effect on the proton re-
laxation. Due to its low molecular weight, Gd-DTPA rapidly diffuses into the
extravascular space but does not cross into cells [Gerber et al., 2002]. Most pro-
tons are on water molecules, so it is crucial to know how much water exchange
there is between different compartments (intravascular, interstitial, and intra-
cellular). The work done by Judd et al. [1999], concluded that water exchange is
an important factor for myocardial CA signal enhancement in fully quantitative
*This is without considering the saturation caused by the perfusion imaging itself.
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Figure 2.24: Recovered transverse magnetisation following a saturation
pulse with a TI of 80 ms as a function of the concentration of Gd. Myocardial
Gd concentration: [0,1] mmol L−1, LV Gd concentration: [0,10] mmol L−1.
models. The results yielded a fast water exchange between interstitial-cellular
compartments. It was also verified that the effect of a single Gd ion in the sig-
nal is greater if it is located in the extracellular compared to the intravascular
space. The reason pointed out is that the water exchange is fast between the in-
terstitial and intra-cellular spaces, the Gd ion will therefore statistically interact
with more water protons since the intravascular compartment comprises only
approximately 10% of the myocardial tissue volume.
Jerosch-Herold et al. [1999] made a direct comparison between the extracel-
lular CA Gd-DTPA and the intravascular Gadomer-17, with a bigger molecular
weight that limits its flow into extravascular space, using an SR preparation and
a GRE sequence in swine models. The results however show no significant dif-
ference between the two in the peak contrast enhancement, both at rest and
during stress. This could be because of the higher relaxivity of Gadomer-17
compensating for its reduced exchange with extracellular volume. After the
first-pass peak, more signal is seen with Gd-DTPA as it remains in the inter-
stitial space in the myocardium. Gadomer-17 does simplify blood volume and
blood flow estimation due to its negligible extravasation, simplifying capillaries
permeability to zero.
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Rest Stress
without stenosis 1.1 1.4
with stenosis 1.2 1.0
Table 2.12: Endo/epi-cardial ratio of blood perfusion during rest and stress
for patients with and without coronary stenosis, [Fukuda et al., 2002].
2.4.2 Transmural distribution of myocardial perfusion and the effects of
adenosine
The human body contains a feedback system capable of maintaining a suit-
able coronary blood flow when there is a reduction of perfusion pressure. The
mechanics behind it are a variable vascular resistance to blood flow by vasodi-
lation. Vasodilation is mediated by the release of adenosine from the myocar-
dial cells [Ely and Berne, 1992]. The dilation of resistance vessels maintains
the coronary flow when pressure is reduced due to an upstream stenotic artery.
This response is not uniform within the myocardium; the subendocardium is
more vulnerable to ischaemia than the subepicardium, due to a more limited
vasodilatory reserve. This higher vasodilatory limitation is due to a higher tis-
sue pressure in the subendocardium when compared to the subepicardium.
A study done by Fukuda et al. [2002] measured a endo/epicardial blood flow
ratio at rest of 1.1. This ratio increased to 1.4 at stress induced by dipyridamole.
They also measured a smaller ratio during hyperaemia for patients with steno-
sis when compared with normal subjects, the results are shown in table 2.12.
These values confirm the higher vulnerability of the subendocardium to is-
chaemia (first step in the ischaemic cascade, section 1.3).
Kern et al. [1991] injected a continuous infusion of adenosine at 150 µg kg−1
min−1, measuring an increase in mean coronary blood flow of 198±59%, and
109± 86% for a group of subjects without CAD, and another group with CAD
respectively. The MPR was measured respectively as 2.94±1.50, and 2.16±0.81.
The endo/epi ratio was once again smaller for patients with stenosis at stress.
Similar results were obtained by Bache et al. [1992], although in this study
the endo/epi-cardium blood flow ratio was reduced even further to values of
a minimum around 0.2 in the ischemic regions, where in normal regions the
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same ratio was approximately 1.30. The values obtained were attributed to
the use of serotonin as the hyperaemia inducer and subsequent studies with
adenosine support this by producing a lesser decrease in the endo/epi-cardium
flow ratio.
Vasodilator response is also not constant throughout the range of coronary
blood vessel’s diameter. The work done by Chilian and Layne [1990], using
mongrel dogs, shows that for a small reduction in the perfusion pressure to 80
mm Hg, only the small arterioles increase their diameter. As the perfusion pres-
sure is reduced even more, the coronary arteriolar response (i.e. increase in di-
ameter) becomes more equally distributed throughout all the myocardial sup-
ply vasculature. In general, the magnitude of dilation (diameter) is bigger for
small arterioles (10%) than for bigger vessels (5%). The same study obtained the
same coronary response when using adenosine, but the diameter of the small
arterioles increased up to 30% while small arteries responded with a magni-
tude similar to the study with no adenosine. Similar heterogeneous adenosine
effects on microvasculature diameter were measured by Kanatsuka et al. [1989].
There is some controversy over which stress agent to use during perfusion
studies. It is now common practice to use adenosine for perfusion studies al-
though some literature referenced in this chapter used dipyridamole as the va-
sodilator. It has been shown that adenosine has a greater vasodilator effect, and
it is faster to reach peak vasodilation than dipyridamole [Redberg et al., 1995,
Rossen et al., 1991, Wilson et al., 1990]. Adenosine also has a shorter in vivo
half-life (4 to 10 seconds) and better reproducibility, since it does not depend
on the patient’s metabolic rate when compared to dipyridamole [Barkhausen
et al., 2004, Panting et al., 2002].
Adenosine relaxes the resistive arterioles, which normally autoregulate my-
ocardial perfusion. This results in a vasodilation with an increase in myocar-
dial perfusion in non-ischaemic areas. Adenosine is reported to give up to a
fourfold increase in the myocardial blood flow, [Chilian and Layne, 1990, Wilke
et al., 1997]. Uren et al. [1994] found an increase from an average heart rate
of 64 to 86 beats per minute during injection of adenosine. This increase was
found to be similar in patients with single-vessel CAD and healthy volunteers. A
similar heart rate increase was measured by Redberg et al. [1995] coupled with
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a slight decrease in blood pressure.
As mentioned in Chapter 1, it is thought that the visibility of perfusion de-
fects during hyperaemia is due to a greater increase in the coronary blood flow
in the normal myocardial bed when compared to the bed supplied by the steno-
sis. It is commonly believed that the coronaries distal to the stenosis are already
close to maximal vasodilation at rest, and are therefore unable to increase blood
flow during hyperaemia.
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2.5 Relevant cardiac MRI artifacts
The following subsections present a literature review of the three sources of
imaging artifacts, which are most likely to affect first-pass MPI. Their most im-
portant consequence is mainly the Dark Rim Artifact (DRA), reviewed in sec-
tion 2.6, which mimics a real perfusion defect and complicates diagnosis and
quantification.
2.5.1 Motion
Cardiac imaging is prone to both blurring and ghosting, due to various sorts of
motion: blood flow, breathing motion, cardiac motion and bulk motion. Car-
diac ECG gating is normally used not only to synchronise imaging with the car-
diac cycle, but it can also minimise cardiac motion by imaging in diastole when
the heart is relatively still. Respiratory gating is another technique that allows
the removal of gross motion artifacts by restricting data acquisition to the ex-
piratory portion [Runge et al., 1984]. An alternative approach is breath-hold
although it is common for patients having adenosine to fail to breath-hold dur-
ing the series of images required for first-pass acquisition. Motion can also be
corrected by using diaphragm navigator echoes, [Ehman and Felmlee, 1989].
These echoes can be used to track translation and rotation by cross correlating
them with a reference echo. This motion information can then be used a poste-
riori to correct the raw data affected by the motion. It can also be used to make
the image slice follow the motion, as generally used in coronary artery imaging
[Oshinski et al., 1998], and recently in first-pass imaging [Pedersen et al., 2009].
However, such slice-following requires some assumptions or measurements of
the relationship between the navigator-detected motion and the heart’s mo-
tion. The use of ultra fast sequences such as single-shot EPI or parallel imaging
also reduces the duration of each image acquisition reducing the extent of mo-
tion artifacts.
Cardiac motion cannot be avoided easily in first-pass imaging, especially
for multislice imaging done at stress. Some of the image data is likely to be
acquired during motion, and any attempt to setup the image times to avoid this
[Schwitter, 2006] is somewhat patient-specific, especially at stress. The fastest
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cardiac motion is the ventricular filling, i.e. during the peak of cardiac radial
motion [Jung et al., 2006]. This topic is discussed later in section 3.3.
Motion of an object in-between images results in the change of both the
phase and magnitude of the k-space components corresponding to the shifted
object. In the case of a translation, we have:
Sm(k)= Soriginal(k)e i 2pik·T (2.22)
where Soriginal(k) is the original raw data with no motion of the patient and T is
the displacement vector. The result is a phase shift linearly proportional to the
displacement, and this applies to the components of S forming the heart while
other regions move differently or not at all.
In the case of a rotation:
Sm(k,θ)= Sor i g i nal (k,θ−α)e i 2pik(x0 cosθ+y0 sinθ) (2.23)
where α is the rotation angle and (x0, y0) is a possible translation. When ro-
tation is involved, there is a phase shift but also the magnitude of the data is
changed.
The motion artifacts during each image acquisition may be divided into two
types. There are “inter-view” motion artifacts, i.e. the motion causes inconsis-
tency between different phase-encode lines (“views”) of the rawdata. The sec-
ond type of motion artifacts are “intra-view”, i.e. caused by motion within the
acquisition of one phase-encode line.
2.5.1.1 Intra-view motion
In this type of motion artifacts, the spins experience an extra phase accumula-
tion, given by the changing position of the spins during the imaging gradients
after each RF pulse; mathematically this is described by:
φ= γ
∫ T R
0
r(t ) ·G(t )dt (2.24)
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where t = 0 is the time of RF excitation, G(t ) is the gradient amplitude and r(t ) is
the position of the spin. Considering a simple case of constant velocity during
signal sampling from time [0, t ]:
x(t )= x0+ vx · t (2.25)
We have that equation (2.24) becomes:
φ= γx0
∫ t
0
Gx(tˆ )dtˆ +γvx
∫ t
0
tˆGx(tˆ )dtˆ (2.26)
The second term in equation (2.26) is the phase shift introduced by the object’s
motion, while the first term is the normal frequency encoding.
For conventional perfusion sequences (GRE, bSSFP), the duration of the
sampling after each RF pulse is short enough that intra-view motion at typi-
cal myocardial speeds can probably be ignored. However, for single-shot EPI,
the accumulating velocity-related phase shifts during the long series of echoes
after each RF pulse can lead to signal loss, ghosting and phase-encode distor-
tion effects [Duerk and Simonetti, 1991]; these effects from fast-moving blood
are a strong reason for keeping the EPI readout short as in h-EPI and also as
investigated in chapter 5.
2.5.1.2 Inter-view motion
Inter-view motion artifacts result mainly in a spatial ringing of the signal visible
as banding artifacts next to sharp edges. This makes this type of artifacts very
relevant for first-pass MPI, since they can produce DRAs near the bright LV-
myocardium border [Storey et al., 2002].
The effects of motion are dependent on many parameters such as FOV, ve-
locity and direction of the motion, imaging protocol, k-space trajectory, etc. In
some simple translations, it is possible to solve analytically equation (2.22). For
a simple translation at constant velocity during a Cartesian sequential phase-
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encode ordering, we can write equation (2.22) as:
Sm(k)= Sm(k)original ·exp
(
i2piTR vy j 2
FOVy
)
·exp
(
i2piTR vx j k
FOVx
)
(2.27)
where TR is the time of repetition, vy and vx are the velocities in the phase-
encode direction and frequency-encode direction respectively, j is the phase-
encode line index ranging from [−N /2, N /2−1] (where N is the number of
complex data points in the phase-encode direction), FOVy and FOVx are the
field of view in the phase-encode direction and frequency-encode direction re-
spectively and k is the frequency-encode complex data point number index
ranging from [−M/2, M/2−1] (where M is the number of complex data points
in the frequency-encode direction).
For a uniform speed along the phase-encode direction only, v= vy we have
a one-dimensional problem. The work done by Storey et al. [2002], shows that
the effect of equation (2.27) is the same as a convolution of the moving object
in the image by the following function:
ψ(y j )≈ e
−ipi/4
N
√
FOVy
2 v TR
exp
(
ipiy2j
2FOVy vy TR
)
(2.28)
where y j is the position in the phase-encode direction in image-space. This
convolution will result in ringing of the pixel value next to signal discontinuities
(i.e. sharp edges) in the phase-encode direction.
The same author defined the length scale of the resulting ringing as:
λ=
√
2FOVphase v TR (2.29)
The length scale gives us the first lobe width of the ringing and it is dependent
on TR, v , and the FOV. However, the amplitude of the ringing can be shown to
depend only on the signal difference across the boundary, with a higher con-
trast at a given edge causing a stronger oscillation.
If the uniform displacement is in the frequency-encode direction, the con-
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voluting function becomes [Storey et al., 2002]:
ψ(xk , y j )=
2FOVy FOVx
N 2λ2
exp
(
i 4pixk y j
λ2
)
(2.30)
where xk is the position in the frequency-encode direction in image-space. It
should be noted that this does not refer to the intra-view quadratic phase slope
but to the phase “twist” across the rawdata in the phase-encode direction, aris-
ing from the changing frequency-encode position of the moving object from
one view to the next.
It can be shown that the ringing has the same length scale as the one with
motion in the phase-encode direction, but it is localised near edges with a di-
agonal orientation, i.e. edges that have a component in both x and y. This effect
is shown in Figure 2.25, where motion in the frequency-encode direction only
produces ringing at the sides of an octagon that have components in both the
frequency and phase-encode direction, while motion in the phase-encode di-
rection shows ringing for all sides with a phase-encode direction component.
In conclusion, the scale of this artifact is equal for motions in the phase and
frequency-encode directions, although its orientation varies with the direction
of the translation.
One immediate technique to reduce these artifacts is to use parallel imag-
ing, which reduces the FOV [Storey et al., 2002]. The reduction factor is given by
the dependence of the length scale in the square root of the acceleration factor,
i.e. λ∝pR. This technique reduces the length scale of the ringing but it is does
not affect the brightness of the ringing.
Phase-encode order is also an important factor when considering motion
artifacts. Storey et al. [2002] compared sequential ordering with a centric order-
ing. Sequential phase-encode ordering is preferable, since it produces ringing
with lower amplitude and a smaller λ. Previously Nguyen et al. [2001] anal-
ysed one-dimensional translation artifacts with different phase-encode orders
and concluded that in general an “edge-centre-edge” (i.e. a sequential order)
trajectory is better than a centre-out order. In the same article, it was also sug-
gested to make the readout direction perpendicular to the motion direction in
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Figure 2.25: Numerical simulation of the effects of motion in the frequency
and phase-encode direction of an octagon (phase-encode direction horizon-
tal). The top row shows from left to right the octagon with no motion, moving
in the frequency-encode direction, and moving in the phase-encode direc-
tion. The line profiles on the second line are for the motion in the frequency-
encode direction, from left to right showing line profiles in the phase, fre-
quency and diagonal directions. The bottom row displays the corresponding
line profiles for the motion in the phase-encode direction.
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order to reduce the blurring. This can be useful when considering breathing
motion, but the complexity of cardiac motion cannot be modelled with a one-
dimensional motion.
Two dimensional radial cardiac motion artifacts in the context of myocar-
dial perfusion by first-pass of Gd-DTPA with a standard perfusion protocol are
modelled in section 3.3.
2.5.2 Magnetic susceptibility
The degree of magnetisation M of an object when exposed to a magnetic field
H is given by its magnetic susceptibility χ, equation (2.31); only a tiny fraction
is the nuclear magnetisation used in MRI.
M=χH (2.31)
Materials with a positive susceptibility are known as paramagnetic, while
negative susceptibility materials are known as diamagnetic. Most organic tis-
sues are diamagnetic*. The electrons in an atom tend to pair up†; in diamag-
netic materials most of the electrons are paired which minimise interactions
with external magnetic fields. In addition, the electrons oppose the applied
magnetic field due to the Lenz’s law. On the other hand, materials like gadolin-
ium are paramagnetic due to the presence of unpaired electrons that align their
dipoles to the applied field resulting in a positive susceptibility, overwhelming
the Lenz’s diamagnetism.
The Larmor Frequency is given by the magnetic flux density B field, which
can be expressed using the magnetic susceptibility:
B=µ0(1+χ)H (2.32)
where µ0 is the permeability of free space. The susceptibility of a material also
distorts the B around it. The field lines are slightly repelled in the presence of a
diamagnetic material and slightly attracted where the material is paramagnetic.
*Although e.g. thalassaemia patients contain an abnormal amount of iron in some organs
of the body thus changing their susceptibility.
†Spin up with spin down.
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This distortion will change the Larmor frequency of nearby tissue as well as
the material itself, and several artifacts may arise from this:
• Dephasing in individual voxels caused by the inhomogeneities in the mag-
netic field. This effect is stronger on gradient echo sequences.
• Misregistration due to the alteration in the Larmor frequency, causing an
erroneous frequency encoding.
• bSFFP sequences are quite sensitive to frequency offsets, which can pro-
duce black bands in regions with certain frequency offsets. Single-shot
EPI sequences are also sensitive to frequency offsets, which can create
signal loss, and image geometric distortion.
Reeder et al. [1998] measured the field inhomogeneities in the heart, with
no CA, for five normal volunteers in a 1.5 T field. The average peak-to-peak
variation was found to be 71 Hz. The field inhomogeneity across most of the
heart was smooth (requiring only low-order shims for correction), although lo-
cal field inhomogeneities were seen in the heart close to the posterior vein of
the LV. The frequency offsets in this region were approximately 70-100 Hz. One
reason pointed out as a possible explanation for the distortion in these regions
is the increased magnetic susceptibility from deoxygenated blood in large epi-
cardial veins.
Atalay et al. [2001] suggest the interface of the myocardium with the lungs
to be responsible for the generation of susceptibility artifacts in some regions of
the myocardium. The distortion is probably due to a mixture of the very small
diamagnetism of the lungs compared to tissues. This work was carried out in a
3T scanner with three farm pigs. The authors mention anatomical differences
between humans and porcine lungs; although the authors speculate, similar
susceptibility effects are likely to happen in humans. The same authors dismiss
the large cardiac veins as a source of local susceptibility artifacts.
From the appendix C the arterial blood is slightly diamagnetic when com-
pared to water, nevertheless this difference is very small corresponding to -
0.1 ppm in resonant frequency. Mulkern et al. [2005] measured the increase
of water magnetic susceptibility with Gd concentration, obtaining a value of
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0.30 · 10−6 mmol−1 L. Considering a similar effect of Gd in blood, a concen-
tration of 30 mmol L−1 of Gd-DTPA is needed to cancel the arterial blood’s
diamagnetism. This concentration is much higher than the ones found in the
heart during first pass, therefore the heart remains diamagnetic throughout the
first-pass, with only approximately half of the diamagnetism of the LV chamber
being cancelled by the peak bolus (approximately 15 mmol L−1) of Gd.
Susceptibility artifacts in first-pass MPI are discussed further in chapter 4,
where a measurement of frequency offsets during the first-pass of contrast agent
is made.
2.5.3 Gibbs ringing
The Gibbs ringing artifact (also known as truncation or Gibbs phenomenon)
is present at discontinuities like the object’s sharp edges and it manifests as a
series of lines parallel to the edge, i.e. intensity oscillations superimposed in the
object’s structure. As a rule of thumb truncation artifacts become a problem
when the discontinuity is so sharp that its width is equal or smaller than the
pixel size.
When the real object, I is not smooth, i.e. contains sharp discontinuities,
the reconstructed image, Iˆ , will not converge to I as the number of samples, N ,
increases. Simplifying to one dimension, and assuming a discontinuity at x0,
with I
(
x+0
) > I (x−0 ), the maximum overshoot location (x˜+N ) approaches x+0 as
N →∞:
lim
N→∞
[
Iˆ
(
x˜+N
)− I (x+0 )]≈ 0.09[I (x+0 )− I (x−0 )] (2.33)
lim
N→∞
[
Iˆ
(
x˜−N
)− I (x−0 )]≈−0.09[I (x+0 )− I (x−0 )] (2.34)
where x+0 and x
−
0 are the positions “just” before and “just” after the signal dis-
continuity respectively*; and x˜+N and x˜
−
N are the maximum overshoot and min-
imum undershoot location respectively.
As the resolution N increases, the above equations imply that the oscilla-
tions do not tend to zero amplitude. If N is large the first lobe of the oscillation
*Mathematically:
x±0 = lim
²→0+
x0±²
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will have a maximum of 9% of the intensity discontinuity (undershoot and over-
shoot). This amplitude of the undershoot and overshoot is independent of the
number of samples used in the reconstruction for large N. The mathematical
derivation of equations (2.33) and (2.34) are described by [Haacke et al., 1999]
(Page 272).
The effects of Gibbs can also be derived by considering the effect of a trun-
cating function on the sampled data. Analysing the problem in one dimension,
we have that the raw-data is multiplied by a rect function and a sampling func-
tion, [Haacke et al., 1999]:
sˆ(k)= rect
(
k+ 12∆k
W
)
∆k s(k)
∞∑
p=−∞
δ
(
k−p∆k) (2.35)
where ∆k is the step size in k-space, W is the width of k-space covered from
−n∆k to (n−1)∆k, δ is the Kronecker’s delta, and s(k) is the original theoretical
k-space signal. The inverse Fourier transform of sˆ(k) give us the final image
including the effects of finite sampling by MRI:
ρˆ(x)=∆k
n−1∑
p=−n
s(p∆k)e i 2pip∆kx (2.36)
The Point Spread Function (PSF) of the truncation function can be obtained by
considering a point source in equation (2.35). The truncated image can then be
obtained by the convolution of the non-truncated image ρ(x) with the PSF:
ρˆ(x)= ρ(x)∗PSF(x) (2.37)
The PSF can be shown to be, [Haacke et al., 1999]:
PSF (x)= W sinc(piW x)
sinc(pi∆k x)
(2.38)
Figure 2.26 shows the effects of the PSF for an edge function when N=128,
where N=W /∆k.
One important property of Gibbs artifact has to be emphasized since it is
a source of confusion in many publications. As N increases the first peak gets
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Figure 2.26: A step function
and the same function but trun-
cated to a 128 pixel resolution.
The Gibbs ringing is shown at a
resolution of 1 mm.
Figure 2.27: A truncated step
function and the same function
but filtered with a Hamming fil-
ter, the loss of resolution on the
edge is apparent. The resolu-
tion of both line profiles is at one
pixel, i.e. 400/128= 3.1 mm/px.
closer to the edge, as mentioned before, but the oscillation overshoot and un-
dershoot stays at 9% of the signal jump. The Gibbs effect is mainly given by the
factor sinc(piW x) in equation 2.38. x can be defined as ∆x · p, where p is the
pixel number. If N doubles, W doubles as well, but ∆x halves. Therefore the
factor sinc(piW ∆x p) depends only on the pixel number. So increasing the res-
olution of the image will not change the 9% overshoot and undershoot ampli-
tudes of the ringing, it will only make the spatial frequency of the ringing scale
with pixel size. This property is true only as long as the edge maintains its infi-
nite sharpness, although in real life, edges are usually not as sharp as the edge
function; therefore, increasing the resolution can decompose an edge into in-
termediate steps, reducing the amplitude of Gibbs overshoot and undershoot.
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2.5.3.1 Window function and PSF
The effective width* Wh of the PSF, given in equation (2.38), can be shown to be:
Wh =
1
N∆k
(2.39)
One solution to decrease Gibbs ringing is to filter the k-space data with a
window function attenuating the high spatial frequencies. A common window
function used is the Hamming filter, defined as:
HHamming(k)= 0.54+0.46cos(2pik/N ) −N /2≤ k ≤N /2 (2.40)
where N is the number of samples.
This type of filter averages a pixel with its neighbours in the image domain,
averaging and reducing the ringing. However, filtering k-space to reduce Gibbs
ringing introduces blurring and reduces image resolution, Figure 2.27.
Methods that are more complex have been published with the objective of
minimising the loss of resolution [Amartur and Haacke, 1991, Amartur et al.,
1991, Archibald and Gelb, 2002]. One of those methods uses an edge-preserving
filter after zero filling and converting the raw data. These methods have the dis-
advantage that the filter sometimes cannot distinguish between true and false
ramp structures. In these cases, it will fail in removing ringing and it will even
distort edges.
*The effective width is the width of a rectangular pulse with height PSF(0) and the same
area as the main lobe of the PSF.
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Figure 2.28: Comparison between a dark rim artifact (top) and a real perfu-
sion defect (bottom), both are pointed by white arrows. From left to right it
is shown the contrast agent arrival to the left ventricle, the myocardium, and
finally recirculation. A DRA artifact usually correlates with the LV bright blood
which typically lasts for only a few heartbeats, while a moderate or severe real
defect persists for longer.
2.6 Dark rim artifacts in first-pass cardiac perfusion MRI
The most important artifact in myocardial perfusion images is the Dark Rim Ar-
tifact (DRA), which appears in the subendocardium during the first left-ventricular
pass of the Contrast Agent (CA) mimicking an under-perfused region. An expe-
rienced observer can detect a DRA due to its transient behaviour, typically cor-
relating with the blood brightness lasting normally only for a few heartbeats,
while a real perfusion defect is visible for longer, Figure 2.28. Mild perfusion
defects, which fill in quickly, are sometimes less easy to separate from DRA. An-
other property of the artifact is that quite often the signal drop is usually below
the baseline signal, i.e. below the signal before the contrast arrival [Edelman
et al., 2006], but this signal is often very small and therefore noisy.
In view of the three DRA mechanisms reviewed in section 2.5, the correla-
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tion of DRA with LV blood brightness is a property of all three of them.
From section 2.3.5 the sequences CNR comparisons are strongly in favour of
bSSFP for perfusion imaging, although this section will later show that there is
no clear winner when additionally considering diagnostic confidence and DRA
scores.
As mentioned above (section 2.5.1), the work done by Storey et al. [2002],
hypothesised inter-view motion artifacts as a possible DRA mechanism and
showed with a mathematical analytical model that bulk motion of an object
causes banding artifacts at the tissue boundary. If DRAs are created by motion,
they would be located in the phase-encode or diagonal directions depending
on the direction of the motion. The model simulates the intensity profile of a
tissue boundary modelled as a step function, resulting in ringing at the bound-
ary.
In Storey et al. [2002], the analytical model was then validated in a rectan-
gular phantom. Preliminary tests were carried out in healthy volunteers with a
GRE sequence and no CA. A DRA was visible with characteristics predicted by
the analytical model, although the in vivo results were somewhat affected by
poor SNR and the heart’s complex motion with through-plane components.
Salerno et al. [2007] numerically simulated a moving short-axis endocar-
dial border with a sequential phase-encode order. The motion velocities were
fitted to a cycle of a cosinusoidal wave. A volunteer was also scanned with a
T2-prep GRE pulse sequence. A T2 preparation enables a 3:1 contrast between
the myocardium and the LV signal without using a CA. Images were obtained
throughout the cardiac cycle. The numerical results showed dark bands in the
myocardium in the phase and diagonal directions caused by motion. These
bands are closer to the endocardium and darker at 300 ms from the R-wave,
when the motion is, although slower, changing direction. When using parallel
imaging the data acquisition time is reduced and so are the motion artifacts
(135 ms acquisition time with parallel-imaging). The in vivo data also showed
DRAs and their behaviour seems to correlate well with the numerical data.
Di Bella et al. [2005] mention the possibility of the DRAs being produced by
Gibbs truncation. Three ex-vivo canine hearts were filled with saline and Gd
at a concentration of approximately 5 mmol/L, creating a reproducible model
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of a first-pass perfusion (before Gd perfusion into the myocardium) with no
motion artifacts. The LV filled with contrast agent provided a realistic signal
contrast between the LV and the myocardium in a typical perfusion protocol.
The hearts were imaged with a GRE/bSSFP sequence, and the results showed
that Gibbs artifacts in the myocardium-LV border alone could explain DRAs.
Gibbs and motion have in common the property that the artifact would
only be visible during the bright first-pass of the contrast agent in the LV which
agrees with the transient behaviour of the DRAs. Both motion and Gibbs de-
pend on a sharp boundary with a high signal discontinuity, which happens only
during first-pass of CA with the LV being very bright with a high concentration
of Gd-DTPA while the myocardium is still dark. During myocardial perfusion
and after the LV peak bolus has passed, the signal discontinuity is reduced and
so will be possible motion and Gibbs artifacts.
A similar reasoning can be applied to susceptibility artifacts during first-
pass, only we have a big difference in CA concentrations between the LV blood
pool and the myocardial wall. Subsequent perfusion into the myocardium re-
duces this concentration gradient, and coincides with the drop in lower LV con-
centration if the bolus is compact, therefore also reducing possible susceptibil-
ity artifacts as the LV blood becomes less bright.
Another possible origin for the DRA is the non-uniform k-space weighting,
mentioned by Kellman and Arai [2007]. Their calculation was based on the con-
tinuing saturation recovery during the image acquisition, modified by the par-
tially saturating image excitations. The effect of this is to vary the signal ampli-
tude as a function of phase-encode line. This leads to a distortion in the point
spread function (PSF) due to data acquisition prior to reaching the steady state.
This is dependent on many protocol parameters. Because the LV blood pool
and the myocardium have different k-space weighting there is the possibility of
a DRA at the tissue boundary.
Hazel et al. [2008] analysed perfusion data from two studies. Both studies
were performed in healthy volunteers. In the first study, 14 volunteers were
imaged at rest and stress with a SR-bSSFP sequence. In the second study, vol-
unteers were imaged with three pulse sequences in a random order: SR-GRE,
SR-bSSFP, and SR-h-EPI. All studies were performed with a Gd-based contrast
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agent. Results showed that DRAs were found at both rest and stress, but a
higher count was made at rest (heart rate: rest 61.4 bpm; stress 85.7 bpm). The
mean signal loss in the DRAs was approximately 32% (rest: 26-90%; stress 22-
84%). The most severe DRA signal loss coincided with the highest concentra-
tion of Gd in the LV blood pool. DRAs had also a higher count in the bSFFP
sequence, followed by the GRE sequence; both sequences had a similar signal
loss and DRA duration (approximately 11 frames). The h-EPI sequence did not
have any visible DRAs.
Many other articles on myocardial perfusion imaging mention DRAs. Al-
though, a study into the possible origin of the DRA is out of the scope of these
articles, nevertheless, possible explanations for its origin are often speculated
about and often an in-depth investigation of the possible DRA mechanisms is
mentioned as needed.
• Arai [2000], in a review of MPI with MR, believed the DRAs are related
to susceptibility associated with the high concentration of Gd in the LV
during the first pass of the bolus.
• Schreiber et al. [2002] performed MPI in six healthy volunteers during
the first-pass of Gd-DTPA with a dose of approximately 0.015 mmol/Kg
of body weight. The sequence used was a SR-bSSFP sequence on a 1.5 T
scanner. This sequence was compared to a SR-GRE in the same volun-
teers. Artifacts were visible with the SR-bSSFP sequence, during the peak
Gd concentration in the LV blood pool. The signal in the artifacts region
was lower than the baseline signal. An experiment was made in one vol-
unteer with a much higher dose of CA (≈ 0.1 mmol / Kg). During the CA
first-pass a frequency offset of 234 Hz was measured in the artifact region,
compared to no major changes in another artifact-free myocardial ROI.
This led to the conclusion that the DRA was caused by susceptibility*.
• Fenchel et al. [2004] compared MPI between a SR-bSSFP and a SR-GRE
*The B0 phase measurements were made with the bSSFP sequence (with T E ≈ T R/2)
which is unexpected and questionable, since bSSFP shares some properties with spin-echo se-
quences. One of these properties is that off-resonant spins approximately rephase at TE=TR/2,
therefore ∆B cannot be measured from the phase shift at TE, which would be close to 0 inde-
pendently of the off-resonance frequency.
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sequence in a 1.5 T scanner. The comparison was carried out in seven
healthy volunteers at rest with a Gd based CA at a dose of 0.025 mmol/kg
of body weight. DRAs were scored in healthy volunteers, which elimi-
nates confusion with real perfusion defects. DRAs in the subendocardial
border were visible in both sequences but more often and for longer (av-
erage of 3.9 frames for SR-bSSFP, and 2.8 frames for SR-GRE) in the SR-
bSSFP sequence during CA first-pass in the LV. The authors described the
DRAs as susceptibility artifacts.
• Weber et al. [2007] published a comparison between the three most com-
mon MPI sequences: SR-GRE, SR-bSSFP, and SR-h-EPI; in a 1.5 T scan-
ner. 24 Healthy volunteers were examined at rest with an injection of Gd-
DTPA at a dose of 0.015 mmol/kg of body weight. All sequences were
accelerated with parallel imaging (TSENSE). As in previous studies, DRA
score was higher for the SR-bSSFP sequence, followed by the SR-GRE, and
finally with the least DRA count was the SR-h-EPI sequence. The authors
state that several mechanisms have been considered previously in liter-
ature as possible sources of DRA: susceptibility, motion, and Gibbs. The
authors further speculate that the DRA seen in this study is likely to be a
susceptibility artifact based on two observations: variability in DRA vis-
ibility at the same spatial resolution, and no correlation between DRA
visibility and acquisition window time.
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2.7 Assessment of dark rim artifacts in patients
No consistent factor in the appearance of DRAs has been reported, except for
their association with the brightness of the LV blood pool. We therefore looked
for common factors in DRAs using retrospective analysis of data obtained dur-
ing a bSSFP/GRE/h-EPI comparison in 13 patients [Lyne et al., 2007], a total of
39 stress perfusion studies. This work seemed to confirm the general view, that
there are no common factors in DRAs. As it was a preliminary survey of the
DRA it is mentioned in this chapter and does not form part of the experimental
chapters of this PhD.
2.7.1 Methods
A single observer assessed DRAs in 13 patients that had a myocardial perfusion
study with three different sequences (h-EPI with an EPI factor 4, bSSFP, and a
GRE) at the Royal Brompton Hospital, i.e. a total of 39 stress perfusion studies.
These patients were part of a study where the three myocardial perfusion se-
quences were compared to each other by Lyne et al. [2007]. The average age of
the patients was 58 (SD 13) years.
The sequence protocols are shown in table 2.13. The GRE and bSFFP se-
quences had a cartesian k-space sampling trajectory, while the h-EPI sequence
had a centre-out trajectory described by Ding et al. [1998] (bottom of figure
2.21).
The CA used was Gd-DTPA (0.5 mol/l) (Magnevist; Schering , Berlin, Ger-
many) at a dose of 0.1 mmol kg−1 of body weight, with an injection rate of 7 mL
s−1 followed by 15 mL of a saline solution at the same rate. Stress was induced
by adenosine at 140 µgkg−1min−1. Adenosine was induced for 3 minutes prior
to CA injection. There was an interval of at least 20 minutes after the stress
study before the second CA injection for the rest study.
The first-pass was imaged during breath-hold for as long as comfortably
possible at end expiration. Three short-axis slices were acquired per R-R inter-
val. The slice order was basal→mid→ apical.
The objective of this assessment was to obtain possible correlations of the
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parameter h-EPI bSSFP GRE
TR (ms) 5.8 2.2 2.4
TE (ms) 1.22 1.0 1.2
read FOV (mm) 340-400 340-400 340-400
phase FOV (mm) 250-300 250-300 250-300
flip angle (deg) 30 50 12
TD (ms) 74 33 6
TI (ms) 108 91 80
TA (ms) 146 147 152
bandwidth (Hz/pixel) 1860 1400 550
matrix(readout) 128 128 128
echotrain-length 4 1 1
parallel imaging R=2 (TSENSE) R=2(TSENSE) R=1.6(GRAPPA)
Table 2.13: These sequence protocols were used by Lyne et al. [2007] in a
sequence comparison in MPI. TD - is the time delay between the saturation
recovery and the first RF pulse. TI - is the time of inversion defined as the
time between the saturation recovery preparation and the acquisition of the
k-space centre line. TA - is the time of acquisition of the whole sequence
including the saturation recovery preparation. All sequences have parallel
imaging with an acceleration factor of 2 or 1.6.
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DRA with acquisition parameters. These include the following:
• Differences in artifact count between sequences.
• Correlation between heart rate and artifact count.
• Position of the artifacts in different myocardial segments and in relation
to the phase/frequency-encode directions.
• Visual appearance of the artifact (distance from border, and width in my-
ocardium.
• Visibility at rest and stress.
• Average signal loss in the DRA.
• Orientation of the LV long-axis with the main field (field distortions in the
myocardium are dependent on the angle between the long axis and the
main field orientation (See Chapter 4)).
An apparent perfusion defect was considered a DRA when it was transient last-
ing only through a few frames during first-pass, correlated with bright LV blood.
A more persistent signal loss was considered a real perfusion defect.
The myocardial wall was divided into 6 segments for each slice in a similar
way to the work of Cerqueira et al. [2002], although in order to simplify the re-
sults each slice had the same 1-6 numbering, since the phase-encode direction
did not change between the three slices of the study, Figure 2.29.
A statistical analysis of these observations was performed using Microsoft
Excel (Microsoft corporation, USA).
2.7.2 Results
Assessment results:
• A two-way ANOVA analysis indicated a significant difference (p < 0.05) in
the artifact count for both the sequence type and the segments where it
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Figure 2.29: Myocardial segment numbering. The same numbers were used
for each short-axis slice.
Figure 2.30: Mid-slice short-axis image of the same subject during first-
pass with the three perfusion sequences. From left to right: h-EPI, bSSFP,
and GRE. The alignment of slices between the three appointments for each
patient was not always so exact, although this was the aim. Only the h-EPI
had fat suppression, evident from the dark layer of fat below the ventricles
compared to the bSSFP and GRE.
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occurred. The results are summarised in table 2.14. The bSSFP sequence
had the highest number of artifacts, followed by GRE, and last the h-EPI.
There was also a higher number of artifacts in the septal region (segments
2, 3) (p < 0.05) when compared to other segments.
• A paired t-test suggests a difference between the artifacts count in the
phase and frequency-encode direction. There was a higher count of DRAs
in the phase-encode direction, table 2.14.
• The artifacts average signal loss for each sequence is shown in table 2.15.
This signal loss is given as a percentage of the mean myocardial signal.
• The artifacts were visible at both stress and rest with no statistical differ-
ence.
• Regression analysis strongly suggests no relation between heart rate (mea-
sured at stress) and artifacts visibility (p À 0.05). This can easily be seen
in Figure 2.31.
• The patients’ LV long-axis orientation to the main magnetic field was be-
tween 63◦ to 88◦. No correlation was found between the heart’s orienta-
tion and the artifact count.
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sequence average signal loss
bSSFP 34 % (±14%)
GRE 31 % (±12%)
h-EPI 25 % (±10%)
Table 2.15: Average signal and standard deviation for the DRAs for each se-
quence.
parameter number of artifacts
bSSFP 85
GRE 65
h-EPI 34
segment 1 14
segment 2 50
segment 3 52
segment 4 30
segment 5 24
segment 6 14
phase-encode direction 65.5
frequency-encode direction 44.5
Table 2.14: The artifact count when considered each parameter individually
and summing all other variables.
It was also noted that the DRAs had two different appearances which might
give a clue about their origin. Some artifacts were thinner and located in the
sub-endocardium, while others were slightly wider and located more into mid-
wall, Figure 2.32. The width of the artifacts is difficult to measure accurately
due to the low spatial-resolution.
2.7.3 Discussion
Visually it was very clear that the bSSFP sequence had a higher SNR and CNR
between myocardial signal pre/post CA perfusion, when compared to the other
two sequences. The CNR obtained by Lyne et al. [2007] was: bSSFP 13.16, GRE
10.85, and h-EPI 7.85. This may explain the higher number of DRAs observed
in the bSSFP sequence, since that sequence contains a higher artifact-to-noise
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Figure 2.31: Average RR interval as a function of the number of artifacts
detected from left to right: apical, mid, basal. There is no strong correlation
between the two parameters.
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Figure 2.32: DRAs visual appearance (arrows): on the left the DRAs (in the
septal inferior segments) are thinner and located in the sub-endocardium.
The image in the middle has both a thin artifact (septal segment) and a wider
artifact located mid-wall (inferior segment). The image on the right shows
a wide DRA in the lateral segment mid-wall, and a thinner sub-endocardial
DRA in the infero-septal region.
ratio (i.e. signal intensity of the artifacts compared to the intensity of noise)
, and this has been confirmed by several authors [Fenchel et al., 2004, Hazel
et al., 2008, Jerosch-Herold et al., 2004, Wang et al., 2005].
The artifact happens both at stress and rest. The Gd-DTPA tends to be less
concentrated in the LV at the first pass for the rest study, which would be ex-
pected to reduce the CNR slightly and therefore also the visibility of the DRAs;
probably this effect was insignificant since the LV blood signal is fully recov-
ered from the saturation pulse in both stress and rest peak. The heart rate is
normally lower at rest, and the incidence of motion artifacts may be reduced.
However, the results also found no correlation of DRAs with the heart rate. In
retrospect, an analysis of DRA incidence with the cardiac timing of each image
might have been more useful.
The artifact pattern, Figure 2.32 might suggest that the thinner ones are
caused by Gibbs truncation since Gibbs ringing would be the size of one pixel
located in the subendocardial border, while the wider ones (more than one
pixel wide) more into mid-wall are most likely to be motion artifacts. Motion
DRAs located mid wall and wider than one pixel have been described previ-
ously by Salerno et al. [2007], Storey et al. [2002].
The higher number of artifacts counted in the phase-encode direction is
most likely related to the higher count in the septal segments since, for most
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patients, the septal-lateral regions of the myocardium are perpendicular to the
phase-encode direction. Therefore we cannot conclude with certainty that there
were more artifacts in the phase-encode direction than the frequency-encode
direction, since this might incidentally be related to the higher count in the sep-
tal segments. If the effect was related to the phase-encode direction, a similar
count would be expected in the lateral segments across the LV from the septal
segments. One possible cause for the higher count in the septum is its location
in-between the bright RV and LV, which can create a superposition of ringing
from the two close borders. This is discussed further in chapter 3.
The spatial resolution of the three sequences was very similar over all the
patients in the group. Gibbs artifacts were thus of fairly consistent width in
all the images evaluated. The images had square true pixels, therefore Gibbs
truncation artifacts were also equally likely to happen in any direction.
Looking at the time spent during image acquisition we can easily see that
the GRE sequence was the one with the longest time of acquisition, while the
h-EPI was the fastest. The GRE sequence was therefore more prone to motion
artifacts than the bSSFP sequence for the protocols used since both shared the
same k-space sampling trajectory. The h-EPI being the fastest made it the least
prone to motion artifacts, although it cannot be compared directly with the
other two since the h-EPI k-space sampling trajectory was different.
Both Gibbs and motion cannot therefore explain the higher DRA count for
the bSSFP sequence. Two remaining mechanisms which may explain the higher
count, besides a higher artifact-to-noise ratio are the bSSFP inherent sensitiv-
ity to frequency offsets [Scheffler and Hennig, 2003], and broadening of the PSF
due to k-space modulation [Kellman and Arai, 2007].
Motion, Gibbs, and k-space modulation artifacts in typical perfusion proto-
cols are studied in chapter 3. Susceptibility artifacts in the heart due to arrival
of a Gd-based CA is studied in chapter 4.
In conclusion, the results obtained raised more questions than answers.
This might explain why no similar studies have been published, as other groups
may also have attempted this obvious idea, but with inconclusive findings were
perhaps more likely to remain unpublished. One exception is an abstract from
ISMRM 2008 where similar findings are found [Hazel et al., 2008]: Higher count
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for the bSSFP sequence, no correlation with heart rate, similar mean signal loss,
and DRA appearance correlated with brightness of the LV.
In this work it was found as in many other studies that the bSSFP sequence
was more prone to DRAs, although this could be attributed solely to the higher
SNR. This preliminary survey showed that further work was needed in order
to assess several parameters individually and obtain possible clues as to what
causes DRAs, which led to the experimental work in chapters 3 and 4.
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2.8 Other MRI approaches to perfusion imaging
2.8.1 Contrast-agent free techniques
Currently clinical MPI using MRI is done during the first-pass of a contrast
agent. Although this method yields a reasonable SNR, it is not easily repeat-
able due to the lengthy washout of the contrast agent limiting its repetition in a
single CMR examination. To obtain the MPR, a 20 minutes wait is necessary to
re-inject contrast agent in order to compare stress with rest. Additionally Gd-
DTPA may possibly be linked to renal failure in patients with advanced renal
disease impeding therefore its use*.
Currently a hot topic of MPI with MRI is the development of new MPI meth-
ods without the use of contrast agent. Two techniques are currently being in-
vestigated: Arterial Spin Labelling (ASL) where blood flow in the myocardium
is measured by using arterial water as a endogenous tracer; and Blood Oxy-
gen Level-Dependent (BOLD) where both MPR and myocardial oxygenation
are measured by the alteration of oxygen content in the capillaries and venous
vessels.
2.8.1.1 Arterial spin labelling
In ASL T1 is measured for two sets of images with an inversion recovery prepa-
ration; one set with a slice-selective inversion and another set with a non-selective
inversion. Each set acquires multiple images with different recovery times after
the inversion pulse, measuring the magnetisation recovery curve.
In the slice-selective inversion images, non-inverted water protons flow into
the image slice and reduce the effective T1 value when compared to the non-
selective inversion images. From the T1 value difference between the two sets
it is possible to measure the myocardial blood flow [Belle et al., 1998]:
MBF= λ
T1,blood
(
T1,GS
T1,SS
−1
)
(2.41)
where λ is the constant blood-tissue coefficient of water (0.92 mL/g for blood-
*The renal safety of Gadolinium based agents is still in debate and a good review is given
by Ledneva et al. [2009].
Other MRI approaches to perfusion imaging 149
perfused myocardial tissue [Bergmann et al., 1984]); T 1blood is the average T1
for the LV blood pool; T 1GS is the T1 of the myocardium after the non-selective
inversion; and finally T 1SS is the T1 of the myocardium after the slice-selective
inversion.
This method has been validated in rats by Waller et al. [2000] against my-
ocardial perfusion quantification using microspheres; it was shown that ASL
allows the quantitative measurement of perfusion. There are also some pre-
liminary positive results in patients with coronary artery disease. Wacker et al.
[2003] showed that differences in MPR (average 44%±18%) were detectable in
patients with single-vessel CAD.
Because this method depends on the difference between two sets of images,
it is highly sensitive to motion; therefore the accuracy of the results is highly de-
pendent on cardiac and respiratory motion. Further limitations also arise from
the imperfect inversion profiles of the RF pulses which would create incom-
plete tissue subtraction [Holm and Sidaros, 2006, Pell et al., 2004].
2.8.1.2 Blood Oxygen Level-Dependent
In BOLD, oxygen alterations are measured by the signal intensity change of T2
or T2* weighted images due to local field inhomogeneities caused by paramag-
netic deoxyhaemoglobin, known as the BOLD effect. T2* has a higher sensitivity
to changes in oxygen levels, although it is also more sensitive to susceptibility
artifacts, such as field inhomogeneity. T2-weighted techniques are more robust
to field inhomogeneities and can still measure changes in blood oxygenation
since T2 decay has a quadratic dependence on the oxygenation level [Boxer-
man et al., 1995].
BOLD imaging can therefore quantify the myocardial oxygen extraction frac-
tion using the T2 image maps [Zheng et al., 2004]. The study can also be com-
plemented by calculating the MPR from the same data. This can be done by
using Fick’s law:
MV O2 =MBF ×Ya ×OEF × [Hb] (2.42)
where MV O2 is the myocardial oxygen consumption, MBF is the myocardial
blood flow, Ya is the arterial oxygen saturation, OEF is the oxygen extraction
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fraction and [Hb] is the concentration of haemoglobin. Assuming that the
oxygen consumption MV O2 does not change at rest and when in hyperaemia
with adenosine or dipyridamole [Kanatsuka et al., 1989], and also assuming no
change in Ya or [Hb], a pharmacological increase in the MBF will be associated
with a decrease of the OEF . This results in a decrease of deoxyhaemoglobin and
an increase in the T2-weighted image. Assuming that there is no significant
change in the MV O2 in a non-critical stenosis (< 80% diameter narrowing),
a lower MBF will translate into a local maximum OEF , and therefore a local
T2 image intensity minimum when compared to normal myocardium [Zhang
et al., 2007]. Therefore the MPR can be calculated by:
MPR = OEFrest
OEFstress
(2.43)
A BOLD T2-weighted TSE (Turbo Spin Echo) sequence was used to quantify
both the oxygen extraction fraction and the MPR of a canine model by Zhang
et al. [2007]. The estimation of the MPR was compared to microspheres, but
the results were affected by a low SNR, especially in the stenotic regions which
led to a modest R = 0.6 correlation with microspheres.
The current main limitation of BOLD perfusion is its low sensitivity due to
low SNR. Nevertheless with an increase in the interest of cardiac at 3T, cou-
pled with T2 measurement improvements, this technique has the potential to
become a useful method to measure the MPR while also providing useful func-
tional information about the oxygenation of the myocardium.
2.8.2 Alternative contrast agents
First-pass imaging with Gd-DTPA suffers from time constraints on imaging due
to the contrast agent’s fast extravasation. First-pass has to be quickly imaged
and therefore spatial resolution and SNR are typically low, although higher than
for BOLD or ASL.
A molecular contrast agent may overcome these limitations. Very recently
Spuentrup et al. [2009] performed myocardial perfusion imaging with a molec-
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ular CA, EP-3600*, in 7 domestic swine with an induced coronary artery steno-
sis during stress induced by adenosine. All studies were performed on a 1.5 T
scanner.
EP-3600 binds reversibly to the myocardium “storing” the signal difference
between normal myocardium and ischaemic myocardium. This binding lasts
much longer than typical Gd-based CAs and therefore relaxes some of the imag-
ing constraints, allowing a much longer scan. A segmented GRE sequence was
used with a resolution of 1.05×1.05×10 mm.
Results show that the EP-3600 T1-weighted signal decreases continually over
time in the LV blood pool, while in the normal myocardium the signal remains
bright providing good contrast for up to 20 minutes after injection with the is-
chaemic myocardium. Preliminary results are good; nevertheless molecular
contrast agents for MPI are in early stages of development, and more investiga-
tion into its safety and its behaviour with different levels of stenosis need to be
assessed.
Another potential candidate to be used as a CA in MPI is hyperpolarised 13C
[Månsson et al., 2006]. Hyperpolarised 13C presents several advantages such as,
analogous to nuclear medicine, being the only visible signal due to the RF coils
and receivers being tuned to its unique frequency†. Hyperpolarised 13C also
offers the possibility of measuring flow directly when repeated RF depolarisa-
tion is used, this way subsequent signal reflects inflow only. This contrast agent
would also be imaged directly and not indirectly by its effect in the protons’
relaxation, such as Gd-based CAs.
Hyperpolarised 13C also has its challenges such as the depolarisation during
its course, which will complicate quantification, and the fact that tracers inves-
tigated are intravascular, and therefore may introduce SNR limitations depend-
ing on the tracer distribution of volumes in the tissue. It also has lower spatial
resolution due to the lower resonant frequency.
One advantage of using current extravascular Gd-based contrast agents when
compared to the CAs mentioned above is the possibility of doing a Gd late-
enhancement study after first-pass imaging. None of the CAs mentioned above
*Small peptide gadolinium hybrid.
†The gyromagnetic ratio γ of 13C is 10.705 MHz/T (1H = 42.576 MHz/T).
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is capable of doing so.
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2.9 Review of methods for accelerating perfusion imaging
2.9.1 Reduced phase field of view
The time taken to acquire an image is deeply important in cardiac imaging. One
method of reducing this parameter without compromising on image resolution
is by reducing the FOV in the phase-encode direction and disabling the excita-
tion of the wrapped tissue. This can be done by using oblique spin-echo pulses
or by using a two dimensional RF (2DRF) pulse, to spatially select the excitation
volume within only the phase-encode FOV.
2.9.1.1 Oblique pulses
A strip of refocussed excitation can be obtained when using a spin echo with
the 180◦ perpendicular to the 90◦, the intersection of the excitation and the
refocusing plane is the excited slab that will be imaged, a technique first de-
scribed as “inner volume” imaging [Feinberg et al., 1985]. Perpendicular planes
are usually incompatible with multislice imaging. An alternative method is to
use oblique planes [Weaver et al., 1991], enabling multislice imaging as long as
a predefined minimum distance between slices is respected; this is represented
by the gap length on Figure 2.33. The excited volume is given by the purple area
(blue + red), and the minimum FOV in the phase direction has to cover the rect-
angular region of the purple area plus half the triangular edge region in order
to prevent wrap around into myocardial tissue, [Gatehouse et al., 2000, Symms
et al., 2000]. Although this method enables multislice, it is not a robust method
for cardiac imaging due to misplacement of the planes of excitation by motion
and B0-field distortion, and errors due to realistic slice profiles. Another disad-
vantage is the requirement of a spin-echo.
However, multi-slice imaging with perpendicular spin-echo pulses does be-
come possible in perfusion imaging when a saturation pulse precedes each
slice, when combined with a single-shot EPI sequence, which enables the use of
a spin-echo for single-shot imaging. This topic is further discussed in chapter
5.
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Figure 2.33: Oblique 90◦ and 180◦ pulse. The purple region, where both
pulse excitation planes coincide, is the excited plane. This purple plane can
be divided into a rectangular area and two triangular ones. The minimum
FOV in the phase direction is the rectangular area plus half the triangular one
from each side, in order to prevent the triangular area from wrapping around
into the myocardial tissue (i.e. the ROI).
2.9.1.2 2D RF pulse
A 2DRF pulse is a spatially selective RF pulse that excites a predefined cylindri-
cal* shape inside the patient.
A 2DRF pulse design method was developed by Pauly et al. [1989], using the
k-space formalism. This method uses the approximation of the small-tip-angle,
where the longitudinal magnetisation is negligibly reduced by the RF-pulse, but
good results can be obtained with angles up to 90◦.
The transverse magnetisation obtained by the application of a RF magnetic
*By cylindrical it is intended to be the generalised cylinder and not just the particular case
where the cross section is circular.
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field B1, along with a time-varying gradient field G, can be defined as:
M⊥(r)= iγM0
∫ T
0
B1(t )e
i r·k(t )dt (2.44)
where [0,T ] is the interval of time of the RF excitation, r is the spatial coordi-
nates in space, and k(t ) is a spatial frequency variable defined as:
k(t )=−γ
∫ T
t
G(t ′)dt ′ (2.45)
We can define the excitation profile, p(k), using a spatial weighting func-
tion, W (k), and a correction function for variable sampling densities of k-space
known as sampling function, S(k):
p(k)=W (k) ·S(k) (2.46)
The excitation profile is the ratio of the M⊥ after the RF excitation and the orig-
inal Mz , [Rieseberg et al., 2002].
The spatial weighting function is defined by*:
W (k)= B1(t )|γG(t )| (2.47)
This function measures the speed at which the RF k-space is traversed, [Bern-
stein et al., 2004].
Pauly et al. [1989], demonstrated that equation (2.44) can be approximated
to:
M⊥(r)= iγM0
∫
k
W (k)S(k)e i r·kdk (2.48)
The transverse magnetisation can therefore be defined using the Fourier trans-
form of the product between the weighting function and the sampling function.
To design a 2D RF pulse we have to first:
• Specify the excitation profile, i.e. the cross-sectional shape of the excited
cylinder.
*This definition is only true for the case where the k-space trajectory of the k-space sam-
pling does not cross itself (e.g. EPI readout, spiral).
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• Choose the sampling k-space trajectory, designing the correct gradient
waveforms for the “excite” k-trajectory FOV and resolution required.
Making sure that the k-space is uniformly sampled (ignoring the blips by
turning off the RF power during these times), and with a sampling density suffi-
cient to avoid FOV aliasing, we can drop the sampling function S(k). According
to equation (2.46), the weighting function is then given by the excitation profile.
Finally, using equation (2.47) it is possible to obtain the desired RF waveform,
B1(t ).
The k-space 2D trajectory is usually an echo planar blipped trajectory, Fig-
ure 2.34 [Rieseberg et al., 2002]; or a spiral trajectory, [Pauly et al., 1989]. Both
approaches are very sensitive to timing errors between RF and gradient wave-
forms of the order of a few microseconds (normally such errors do not matter
because the gradient waveform is flat during conventional RF pulses). Timing
errors cause half phase-encode FOV N/2 ghost excitations analogous with EPI
readout, or rotation and distortion of the spiral 2DRF pulse profile. The 2DRF
pulse therefore requires a careful setup of the RF and the gradient synchronisa-
tion. An advantage of echo planar gradients is that we have independent con-
trol of the excitation-FOV and excitation “pixel size” in its frequency-encode
and phase-encode directions. On the other hand, for a square pixel and FOV,
spiral pulses tend to be shorter than the EPI version. ∆B0 distortions during ex-
citation mainly result in the shifting of the excited volume in the excite-phase-
encode FOV direction when using the EPI approach, and blurring of the spatial
profile with the spiral trajectory.
These effects limit the sensible longest duration of a 2DRF pulse. They
therefore only provide a limited detail in their profile because of the limited
k-space coverage feasible before detrimental off-resonance phase errors accu-
mulate. A typical profile “resolution” is about 8mm for abdominal FOV.
2DRF pulses are compatible with multislice imaging and have the advan-
tage of not requiring a spin echo.
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Figure 2.34: Example of a 2DRF pulse with an echo planar trajectory. This
particular 2DRF pulse was designed to excite a volume with 170 mm× 18 mm
(phase FOV × slice thickness).
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2.9.2 Parallel imaging
The array coils generally used in cardiac imaging make parallel imaging an
attractive image-acquisition acceleration technique. A shorter time spent on
image-acquisition will reduce motion artifacts and perhaps allow more slices
and/or more phase-encode spatial resolution per cardiac cycle. As a penalty,
imaging complexity increases while SNR decreases, which can be ill afforded in
MPI.
Parallel imaging uses the spatial variation in the coil sensitivities, i.e. the
coil response, to reconstruct the missing phase-encode lines. The coil response
can be obtained in many different ways: separately in a pre-scan; included in
the accelerated main scan by fully sampling the centre of k-space; or by taking
advantage of the dynamic imaging using spatio-temporal filtering techniques
(UNFOLD [Madore et al., 1999], k-t SENSE, k-t BLAST [Tsao et al., 2003]).
Parallel imaging noise amplification is generally not spatially uniform which
complicates the measurement of SNR, i.e. measuring the standard deviation in
a separate ROI in empty image is not an accurate technique due to the spatially
variable noise [Kellman and McVeigh, 2005].
Higher fields enable the use of higher acceleration factors* (although a real
advantage in using higher acceleration factors comes for fields B0 > 3T) and
also better coil separation functions [Ohliger et al., 2003, Wiesinger et al., 2004].
High-field scanners with parallel imaging can also relax some of the practi-
cal limitations including RF power deposition [Niendorf and Sodickson, 2008].
SNR loss is less of an issue at 3T cardiac imaging.
2.9.2.1 SENSE vs. GRAPPA
SENSE and GRAPPA are two common parallel imaging methods used in MPI.
SENSE [Pruessmann et al., 1999] does not tolerate phase-encode wraparound
artifacts well, since aliased tissue will create an erroneous coil sensitivity map
[Goldfarb, 2004]. This is important in short-axis perfusion since radiographers
commonly allow some benign wraparound to happen (acceptable as long as
*The acceleration factor is related to the amount of phase-encode lines skipped, e.g. an
acceleration factor of 2 means that only half the phase-encode lines are acquired.
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the heart is unaffected), in order to reduce the phase-encode FOV. It is therefore
less useful to speed-up imaging with parallel imaging if we have to slow it down
by extending the phase-encode FOV.
GRAPPA [Griswold et al., 2002] uses coil sensitivity information in k-space
and therefore is able to handle aliasing just like conventional imaging [Blaimer
et al., 2004]. Fitting in k-space uses global spatial information and is there-
fore less prone to localised inhomogeneities/low signal that might be present.
GRAPPA is therefore advantageous over SENSE in regions where SNR is weak,
and coil sensitivity obtained in the image space might be inaccurate.
A theoretical description of the imaging techniques relevant to this work is
included in appendix B.
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CHAPTER 3
Dark rim artifacts and simulations of Gibbs and
motion artifacts
This chapter is divided into three main sections. Since no consistent factors in
the DRA were identified in vivo (section 2.6), the majority of this chapter’s work
is based on phantom models and simulations.
In the first section, a simple phantom model of the endocardial border was
developed. This phantom had realistic first-pass peak perfusion T1 and T2 val-
ues, as well as field distortion properties similar to those of the heart during the
CA first-pass, and it was scanned with typical perfusion protocols in order to
start an investigation of some factors affecting the DRA appearance.
The preliminary results of the phantom simulations triggered the work of
the second section, which describes an interesting property of Gibbs artifacts
contributing to its variable appearance in perfusion studies. The contents of
this section were published in the Journal of Cardiovascular Magnetic Reso-
nance; Ferreira et al. [2009] (page 461).
The final section of this chapter presents a series of numerical simulations
of a range of realistic perfusion protocols, with the aim of finding optimum set-
tings, which would be difficult in vivo due to the need for repeated contrast
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agent and stress in the same patient. Because of the high number of parameters
analysed, this section is unavoidably large and unfortunately perhaps harder
to read than other sections. An overall discussion is shown in the end with the
purpose of cohesively providing a general overview of all the findings in this
section.
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3.1 Endocardial border phantom
3.1.1 Methods
A hollow cylindrical phantom was developed as a model of the border between
the myocardial wall and the LV, aiming for similar T1, T2, and susceptibility as
the LV and myocardium during the contrast agent first-pass (when filled with
appropriate fluid). Short-axis images of this phantom (i.e. perpendicular to the
cylinder axis) should therefore have similar blood/myocardium contrast and
susceptibility effects as the heart. The phantom had no dividing material on the
inside of the cylinder, representing the border between the endocardium and
blood. This phantom was used in these preliminary investigations and used
later (in Chapter 4) to study susceptibility artifacts.
The first phantom model to be considered was based on silicone, but this
approach was eventually dismissed due to chemical shift artifacts and unsuit-
able relaxation times. In the following work, the phantoms were made of gelatin
(Hartley’s strawberry jelly, Spalding, UK).
The relaxation times of the gelatin were measured with a spin-echo sequence.*
T1 was measured by repeating the sequence with an inversion recovery prepa-
ration at different inversion times (T R = 500 ms) (the TI values used are shown
on the left of Figure 3.1). T2 was measured by repeating the sequence with dif-
ferent echo times with no magnetisation preparation (T R = 740 ms). The signal
as a function of TI or TE was then fitted to the appropriate equation (3.1) in or-
der to estimate the T1 and T2 relaxation times respectively, Figure 3.1.
T1 curve: signal=M0
(
1−2e− T IT 1 +e− T RT 1
)
T2 curve: signal=M0
(
1−e− T RT 1
)
e−
T E
T 2
(3.1)
The relaxation times obtained were: T 1= 74 ms, T 2= 12 ms. The T1 value was
sufficiently close to that estimated to occur in the myocardium at 1.5 mmol
/ L (Tables: 2.5 and 2.6 (T1= 127 ms; T2= 41 ms)), to enable the use of this
*The results are included within this section because they were part of the experiment’s
design.
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Figure 3.1: T1 and T2 curve fitting for the gelatin phantom.
phantom model for this study. Diluting the gelatin would have given more re-
alistic relaxation times but would also accelerate its dissolution. As the gelatin
was intended to model the myocardium, the susceptibility of the gelatin was
tested using a field-mapping sequence (Figure 3.2), and found similar to water
which has been shown similar to the susceptibility of most tissues [Schenck,
1996]. The magnetostatic properties were sufficiently close to those expected
in vivo, to enable the use of this phantom model to study susceptibility artifacts
in Chapter 4.
The “left-ventricle” phantom consisted of a hollow cylinder made with undi-
luted gelatin, Figure 3.3. The cylindrical shape was obtained by filling a round
glass container (diameter 8 cm) with gelatin after melting the gelatin in a mi-
crowave oven. A plastic cylinder (diameter 4 cm) covered with a condom was
then inserted in the middle of the container. This apparatus was left overnight
in a refrigerator for the gelatin to set. The plastic cylinder and condom were
removed in the following day, leaving the glass vessel full of gelatin except for a
cylindrical hole modelling the LV chamber in the middle of the gelatin LV “my-
ocardium”.
Just before scan time, the phantom was removed from the fridge and the
hollow cylinder was filled with cold water doped with 12.5 mmol/L Gd-DTPA
to simulate the blood pool in the left ventricle during the peak first-pass of CA,
before sealing the phantom with a lid. The T1 and T2 were also measured for
the simulated blood pool: T1=18 ms, T2=17 ms.
Endocardial border phantom 165
Figure 3.2: Field map of the gelatin immersed in water. The gelatin block is
delineated by the dashed square. The field plot greyscale has a range of 210
Hz (3.3 ppm at 1.5 T). There is a maximum difference of 50 Hz in the gelatin
border.
Figure 3.3: Gelatin phantom dimensions and photos.
166 Endocardial border phantom
Figure 3.4: Container with gelatin layer (dark) below a bright solution of
Gd-DTPA. This apparatus was scanned (GRE sequence with inversion time of
100 ms) every 20 minutes overnight. During the first 13.4 hours there was an
approximately 7 mm penetration of the Gd-DTPA solution into the gelatin.
For this model to be useful, the gelatin should not begin to dissolve or per-
mit Gd-DTPA into the subendocardial layer during the experiments. Therefore,
early on in this work a time-series of T1-weighted images were made in a con-
tainer where a gelatin layer was in direct contact with a solution of Gd-DTPA
poured in above it (Figure 3.4). The images showed negligible dissolving of the
cold gelatin within 1 hour, which allowed each phantom to be used for a short
series of experiments before replacing it with a new one.
The phantom was imaged with typical perfusion protocols for the three
sequences: GRE, bSSFP, and h-EPI, Table 3.1; the imaging plane was perpen-
dicular to the longitudinal axis of the cylinder. The phantom was positioned
with the long axis of the cylinder aligned with the B0 field in order to minimise
susceptibility artifacts (further explained in Chapter 4), with anterior/posterior
phased array cardiac coils. The phantom was imaged at three different spatial
resolutions with square pixels of sizes: 2.4×2.4 mm, 1.7×1.7 mm, 1.4×1.4 mm
by changing the image matrix size. The bSFFP and GRE sequences used a linear
phase-acquisition order, while the h-EPI sequence used a centric interleaved
phase-acquisition order described by Ding et al. [1998].
The phantom was imaged with and without an SR preparation pulse in or-
der to study Gibbs artifacts, which were expected to be dependent on the image
contrast between the LV blood pool and the myocardial wall signal. Images with
minimal image contrast were required to exclude any unexpected DRAs caused
by the boundary in the phantom. When a saturation recovery was not used, the
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parameter h-EPI bSSFP GRE
TR (ms) 5.41/5.67/6.31 2.06/2.32/2.59 2.63/2.95/3.49
TE (ms) 0.97/1.06/1.22 1.03/1.16/1.30 1.56/1.69/1.99
flip angle (deg) 30 50 12
TI (ms) 100 100 100
bandwidth (Hz/pixel) 1447 1395 1395
slice thickness (mm) 8 8 8
echo-train length 4 1 1
TSENSE R=2 R=2 R=2
Table 3.1: Sequence protocols used in the phantom scans. In the h-EPI the
TE refers to the first echo. TR and TE are given for the resolutions 2.4, 1.7, 1.4
mm respectively. The other parameters were constant for all resolutions.
flip angle of all the sequences was reduced to 2◦ in order to further reduce the
border contrast, but coupled with averaging of 10 images to acquire sufficient
SNR for images to be evaluated.
The visibility of DRA is generally assumed to be linked to the myocardial
SNR and the LV/myocardium image contrast. Therefore, the myocardial SNR
and LV/myocardium signal ratio were measured using tools written in MAT-
LAB. ROIs were drawn to select the myocardium and LV pixels, without in-
cluding Gibbs ringing. The average myocardial and LV signals were obtained
by averaging all the pixels from 6 measurements*. To measure the myocardial
SNR, the first of these 6 frames was subtracted from the other frames. The re-
sulting pixel values in the myocardium give us the standard deviation, i.e. the
noise in the myocardial region. The standard-deviation quoted is the averaged
standard-deviation of all frames.
Line profiles (4 pixels wide) across the centre of the phantom were also mea-
sured in the frequency-encode direction, using ImageJ (National Institutes of
Health, USA). The reason for the line profiles to be in the frequency-encode di-
rection was to avoid off-resonance artifacts of the h-EPI sequence, which man-
ifest along the phase-encode direction (discussed later in this section). These
*Each scan had 8 measurements, since this is the minimum required by TENSE. From these
8 measurements, the first two were ignored since in some protocols there is no magnetisation
preparation for the first two measurements. The other six were then used to obtain the SNR
and the LV/myocardial signal ratio.
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Figure 3.5: Short-axis images of the phantom at the three resolutions; re-
peated with all three sequences: h-EPI, bSSFP, and GRE sequence (from left
to right). Each sequence is shown twice: with SR (left) and without SR (right).
The phase-encode direction is vertical.
line profiles were used to calculate the signal loss in the subendocardial border.
The undershoot signal loss was averaged from both sides of the line profile.
All scans were done with zero filling by a factor of two before FFT. Zero filling
the raw-data upsamples Gibbs ringing (see Section 3.2) which enables a better
estimate of the Gibbs artifacts signal loss.
3.1.2 Results
The phantom short-axis images at all 3 resolutions with and without SR prepa-
ration are shown in Figure 3.5. As expected the images with an SR preparation
had a high contrast between the bright LV blood pool filled with a solution of
Gd-DTPA at 12.5 mmol L−1 and the darker myocardial wall simulating the my-
ocardium with a concentration of approximately 2 mmol L−1 (T 1= 74 ms).
The myocardial SNR and LV/myocardium signal ratios are displayed in Ta-
ble 3.2. Note: The SNR was not simply related to the changing voxel size, but
also due to changing TR/TE. The highest SNR was measured for the bSSFP se-
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quence, and the lowest for the GRE sequence. The LV/myocardium signal ratio
was also higher for the bSSFP sequence at approximately 3.8. A similar signal
ratio was found for the h-EPI and GRE sequence at approximately 2.5.
SNR LV/myo signal
h-EPI
2.4 mm 111 2.3
1.7 mm 76 2.3
1.4 mm 49 2.5
bSSFP
2.4 mm 125 3.1
1.7 mm 91 3.9
1.4 mm 54 4.5
GRE
2.4 mm 79 2.4
1.7 mm 47 2.6
1.4 mm 24 2.7
Table 3.2: Myocardial SNR and LV/myocardium signal values of Figure 3.5.
Two different DRA mechanisms were seen in the phantom images of Fig-
ure 3.5. The images with an SR preparation, i.e. with a high contrast between
the bright LV cavity and the myocardium, contain Gibbs ringing close to the
subendocardial edge. The most visible effect of this ringing was an undershoot
signal in the first pixel of the subendocardium. The Gibbs artifacts were most
visible in the low resolution images with pixel size 2.4 mm. This loss of signal
can be seen in both the magnitude images in Figure 3.5 and, perhaps better, in
the line profiles in Figure 3.6. The Gibbs artifacts were most visible in the bSSFP
sequence followed by h-EPI, and least in the GRE sequence. It is useful to point
out here that a second DRA in the subendocardial region artifact is seen along
the phase-encode direction for the h-EPI images. This DRA mechanism is de-
scribed later but it should be emphasised here that it is not Gibbs, it is related
to the h-EPI frequency-offsets sensitivity.
The signal loss of the Gibbs artifacts as a percentage of the myocardium
signal and as a percentage of the contrast between the LV and myocardial signal
are shown in Table 3.3 for the images with SR. These results were obtained along
the frequency-encode direction, in order to avoid the h-EPI frequency-offsets
artifacts. The lower signal loss measured in the low-resolution (2.4 mm) h-EPI
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image when compared to the other two higher resolutions (1.7, 1.4 mm) is likely
to be related to blurring introduced by the h-EPI frequency-offsets artifacts.
The images with no SR had a lower contrast between the LV blood pool and
the myocardial wall, especially in the h-EPI and GRE sequence. This reduction
of contrast reduced the Gibbs artifacts visibility.
% myocardial signal % (LV - myo) contrast
h-EPI
2.4 mm 13% 10%
1.7 mm 20% 16%
1.4 mm 20% 13%
bSSFP
2.4 mm 26% 12%
1.7 mm 26% 9.1%
1.4 mm 26% 7.3%
GRE
2.4 mm 11% 7.4%
1.7 mm 11% 6.9%
1.4 mm 14% 8.4%
Table 3.3: Gibbs’ subendocardial signal loss as a percentage of the myocar-
dial signal and as a percentage of the contrast between the LV and myocardial
signal for the images with SR.
The second DRA mechanism, visible in the phase-encode direction of the
h-EPI images, consisted of a split of the phantom into two images a few pixels
apart along the phase-encode direction. These artifacts were visible with and
without SR (with a similar magnitude) and are discussed further in the next
section. Table 3.4 shows the DRAs’ signal loss in the phase-encode direction of
the h-EPI images with SR.
% myoc. signal % (LV - myo) cont. width
h-EPI
2.4 mm 28% 21% 5.75 mm (≈ 2.4 px)
1.7 mm 41% 31% 6.55 mm (≈ 3.8 px)
1.4 mm 23% 35% 4.38 mm (≈ 3.1 px)
Table 3.4: h-EPI’s frequency-offset artifacts signal loss as a percentage of
the myocardial signal and as a percentage of the contrast between the LV and
myocardial signal. The width of the DRA is also shown in mm and in pixels.
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3.1.3 Discussion
The images without saturation recovery served to show that most of the visible
DRAs are created by Gibbs artifacts and are not physical defects of the phan-
tom.
Gibbs artifacts are more visible in the bSSFP sequence because it provides
a better SNR in the normal myocardium, and because the ratio of blood sig-
nal to myocardial signal is larger which creates larger Gibbs signal losses. This
LV/myocardium signal ratio is similar for both the h-EPI and GRE sequence,
and smaller than in bSSFP, although the h-EPI sequence has a higher myocar-
dial SNR, and therefore a higher Gibbs artifacts visibility than GRE.
The sharp endocardial boundary will be inherently corrupted with Gibbs
ringing due to the finite image resolution. As described in section 2.5.3, a cir-
cumferential dark-rim in the subendocardium with a width of one pixel will
be darker than the myocardium by approximately 9% of the sharp boundary
signal difference. This theoretical value was reasonably similar to the results
shown in Table 3.3, where the signal loss as a percentage of the LV-myocardium
signal jump was close to 9%. The slightly higher value for the h-EPI is likely to
be due to the additional frequency offset artifacts.
Gibbs ringing is very dependent on the edge sharpness. A less sharp bound-
ary reduces the amplitude of the Gibbs ringing. A numerical simulation of this
effect is shown in Figure 3.7. The less sharp step on the right is divided across
two pixels with two small steps in brightness as would happen to a less sharp
edge in a finite resolution. Although each step would generate its own Gibbs
ringing, the two Gibbs artifacts are offset from each other and cancel each other
out, thus the overall visibility of Gibbs ringing is highly reduced.
The phantom data analysed in this section is all zero-filled. This interpola-
tion oversampled Gibbs ringing and therefore reduced its dependency on the
edge position inside the pixel. This phenomenon is shown in Figure 3.8 for a
line profile. When zero-filling is not used * Gibbs visibility is highly depend-
ent on the edge position inside the pixel. This observation triggered the study
*Myocardial perfusion studies do not generally use zero filling in the Royal Brompton Hos-
pital.
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Figure 3.7: Gibbs ringing for a sharp edge (left), and for a less sharper edge
(right).
Figure 3.8: Line profile of the bSSFP without zero-filling (left) and with zero-
filling (right). The first undershoot of the Gibbs ringing on the left of the non-
interpolated image (arrow) is hidden by the pixel position.
shown in the next Section 3.2, where this topic is discussed further.
The second DRA mechanism observed in the phantom was the splitting of
the image along the phase-encode direction due to localised frequency-offsets
with the h-EPI sequence. These artifacts were visible with SR on and off, and
occurred only along the phase-encode direction, Figure 3.9.
Optimising the main field uniformity using first and second order terms cal-
culated from a 3D field-mapping sequence (Siemens) was unable to correct the
field inhomogeneities in the phantom when the LV cavity was filled with the Gd
solution. The effects of frequency-offsets with the conventional linear ky order
interleaved-EPI sequence have been studied by Mugler and Brookeman [1996],
whose results showed that even with echo-time-shifting (see section 2.3.4), fre-
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Figure 3.9: h-EPI scans of the phantom with no SR. Left: phase-encode di-
rection vertical. Right: phase-encode direction horizontal.
quency offsets can result in a doublet of the PSF along the phase encode direc-
tion. These artifacts are worsened by the centric phase-acquisition order used
in the perfusion h-EPI sequence.
The artifact’s visibility is highly dependent on the scanner shim and fre-
quency adjustments. As an example, Figure 3.10 shows a scan of the phantom
with the h-EPI sequence with two different scanner frequency adjustment vol-
umes*. The larger adjustment box adjusted the resonance frequency closer to
the gelatin frequency generating conspicuous splitting of the bright LV blood
pool. The smaller adjustment box set this frequency closer to that of the LV
blood pool, reducing the LV splitting but instead created dark rim artifacts in
the subendocardial layer along the phase encode direction, and also increased
ghosting in the epicardial border.
This type of artifact has also been seen in vivo. An example is shown in Fig-
ure 3.11, this is a rare example of a perfusion study where these artifacts were
very severe. Ghosting of the myocardium along the phase-encode direction can
be easily seen. A DRA can also be seen in the inferior segment of the myocar-
dium in frame 23.
*A 3D box is defined by the user in the FOV using the scanner graphical user interface. The
volume inside the box is used by the scanner to calculate the resonance frequency. Note that
this is a single-echo non-imaging one-shot technique which gives an average frequency from
the whole volume.
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Figure 3.10: h-EPI scans of the phantom with two different frequency ad-
justment boxes. The larger volume adjustment box was slightly bigger than
the whole phantom, while the smaller box was predominantly LV blood pool
signal. Both adjustment boxes were approximately centred in the phantom
centre.
Figure 3.11: Perfusion study with an h-EPI sequence (EPI-factor of 4, centric
phase-acquisition order), showing three frames during the first-pass of CA.
The phase-encode direction is vertical. Reliable performance of this method
will depend on the expertise of the operator more than most of the conven-
tional sequences used clinically.
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Figure 3.12, shows another in vivo example. The original shimmed image
taken from the scanner is shown on the left. Although not easily visible from
this image alone, the lateral segment of the myocardium is blurred along the
phase-encode direction. The raw-data of this in vivo example was modified in
MATLAB considering the following:
The phase accumulated in each echo due to off-resonance is given by
φ(n)= 2pi
TE(n)∫
0
∆ f dt (3.2)
where n is the echo number, ∆ f is the frequency offset. φ(n) varies from echo
to echo and also between echo-trains of the h-EPI rawdata because of the echo-
time-shifting used in the sequence. By introducing an added frequency offset
∆ f2 to each phase-encode line and considering the TEs of each echo, the ac-
cumulated phase of each echo can be adjusted simulating the effects of a dif-
ferent resonance frequency. Several frequency adjustments were evaluated by
importing the raw-data into MATLAB before reconstructing the modified data
back on the scanner using the same image reconstruction algorithm as the orig-
inal image.
When the frequency offset was adjusted by 130 Hz (the image on the right of
Figure 3.12) the lateral segment became sharper compared to the original im-
age. It is perhaps easier to see the increase in sharpness in the lung vessels next
to the antero-lateral segment. It is also evident that the sharper endocardial
border of the lateral segment increased the Gibbs artifact in the lateral wall.
However, at the same time the septal segment became more blurred than in
the original image. Therefore in this example it appeared likely that there was a
slope in the resonance frequency in the septal-lateral direction across the heart
due to a main field shimming error (there is an animated GIF in the attached
CD (frequency offset anim.gif), that shows the magnitude image with several
different frequency offsets applied to the original raw-data going from the orig-
inal 0Hz offset to the maximum offset of 130 Hz).
Even though it may seem possible to modify the raw-data and correct the
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Figure 3.12: Perfusion patient scanned with an h-EPI sequence with an EPI-
factor of 4. The two images correspond to the same frame but the raw-data of
the image on the right was modified to change the amount of off-resonance
accumulated phase in each echo. Left: original adjustment. Right: 130Hz
frequency offset when compared to the image on the left. The phase-encode
direction is horizontal.
off-resonance phase accumulation of each echo, if the off-resonance frequency
varies across the image, as in the example shown in Figure 3.12, then the correc-
tion becomes local only, and therefore a global correction is much more com-
plex.
Returning to the discussion of the gelatin phantom results, motion mod-
elling with this phantom would obviously have been useful, however it was de-
cided that a realistic modelling taking into consideration T1/T2, B0-distortion,
and the complex movement of the twisted helical layers [Carreras et al., 2006]
of the cardiac fibres was too complex to model in a phantom. Section 3.3 will
describe numerical simulations of in-plane radial contraction of the heart in a
short-axis view.
In conclusion, this section of work showed that the Gibbs artifact will cor-
rupt the subendocardial layer of a perfusion scan during the first-pass of CA.
Gibbs ringing is more visible with the bSSFP sequence due to the higher con-
trast between the myocardium and LV, and the superior myocardial SNR. Frequency-
offsets in the h-EPI sequence can also create DRAs due to the phase-encode
splitting of the PSF. These artifacts are darker than the Gibbs artifacts, and can
potentially be localised anywhere in the myocardium along the phase-encode
direction and diagonal regions, and not only in the immediate subendocardial
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pixel like Gibbs artifacts. The h-EPI sequence yields moderate SNR coupled
with a fast acquisition time, making this sequence popular for MPI in many
centres including ours, although its sensitivity to frequency offsets is a disad-
vantage when compared to GRE or bSSFP.
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3.2 Variability of myocardial perfusion dark rim Gibbs arti-
facts due to sub-pixel shifts
3.2.1 Introduction
DRAs are commonly described as transient lasting a few heart beats [Arai, 2000,
Barkhausen et al., 2004]. Some of this transient behaviour can be explained by
the DRA becoming visible only when the LV is much brighter than the myo-
cardium, i.e. the DRA is a ringing artifact into the myocardium from the sharp
edge.
This section illustrates a source of DRA variability based on the sub-pixel
position of the endocardial border. The exact position of the endocardial bor-
der with respect to a pixel will determine the amount of Gibbs artifacts visible
near that border, i.e. by introducing a relative shift of the pixels by a distance
smaller than the pixel size (sub-pixel shifts) the amount of visible Gibbs ringing
can be affected. This is illustrated in Figure 3.13, on the left showing a simpli-
fied signal profile that could be found across a short axis of the heart, cross-
ing the centre of the LV blood pool and the myocardial wall on both sides (red
line). The sharp step of the line profile corresponds to the endocardial border
on each side. Because of the limited spatial resolution of a typical perfusion
image acquisition, the signal around these edges would actually be corrupted
with Gibbs artifacts (blue line). Figure 3.13 shows how different pixel posi-
tions would result in the oscillating signal being displayed very differently. This
occurs because each pixel displays the sum of the signal within its finite size
(orange and green represent different pixel positions and the respective pixel
values obtained). Gibbs ringing is much more prominent for the orange pixel
position than for the green pixel position. (This illustration is over-simplified,
neglecting any other contributions to the point-spread function, to make the
fundamental point).
The appearance of the magnitude image is commonly improved by increas-
ing the matrix size. Zero-filling (pre FFT (Fast Fourier Transform) interpolation)
is widely used, and it has been reported to reduce partial volume artifacts and
increase the resolution in the diagonal direction [Bernstein et al., 2001, Du et al.,
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1994]. Image display programs also usually interpolate data in the image space
(post FFT interpolation). This section will also demonstrate the effects on the
Gibbs artifacts caused by interpolating the original image; mainly the differ-
ence between pre and post FFT interpolation.
The objective of this section is to illustrate the effect on Gibbs artifacts of in-
troducing sub-pixel shifts in the context of myocardial perfusion imaging. This
has not been published before in the context of myocardial perfusion.
3.2.2 Methods
3.2.2.1 Phantom imaging
For a practical example of the effect, which will be examined in the context of
perfusion imaging, we made the following initial demonstration. Images were
acquired with a 8 mm slice perpendicular to a flat boundary between a solu-
tion of Gd-DTPA and a block of undiluted gelatin with a signal ratio of approxi-
mately 3/1 (which is similar to typical perfusion first-pass images when normal
myocardium begins to enhance after the LV bolus peak). The sequence used
was a bSSFP with a saturation-recovery pulse and the relevant protocol param-
eters are shown in table 3.5. The image plane was slightly rotated with respect
parameter value
TR (ms) 1.6
TE (ms) 1.0
flip angle (deg) 70
base resolution (pixels) 128x128
pixel size (mm) 3×3
bandwidth (Hz/pixel) 890
SR time (ms) 300
Table 3.5: Sequence protocols used in the phantom scans.
to the phantom’s edge so that the edge was misaligned in relation to the in-
plane imaging axes. This aimed to test the effect of varying border position in
relation to pixels in the vertical direction, as a function of position across the
image. The uninterpolated image was compared with the two approaches to
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interpolation described in section 3.2.1:
1. the phantom image was interpolated in MATLAB (Mathworks, Natick,
USA-MA) using a bicubic interpolation in the image space by a factor of
two in each direction.
2. the same raw data (i.e. of the uninterpolated image) was zero-filled by a
factor of two in each direction before FFT.
3.2.2.2 Numerically simulated data
A short-axis image of the heart with an epicardial diameter of 65 mm and an
endocardial diameter of 35 mm was simulated numerically using MATLAB. The
LV / myocardium signal ratio was 3/1. The magnitude image was reconstructed
from a finite 128×128 raw-data matrix, as would be obtained in practical MRI,
and therefore was inherently corrupted with Gibbs artifacts. Sub pixel shifts
were introduced by applying a linear phase slope across the simulated raw-
data, which corresponds to a translation of the object being imaged. Recon-
struction was repeated with appropriate phase slopes to introduce shifts of half
a pixel horizontally and then vertically, in order to simulate the effects of a small
sub-pixel shift of the heart. A magnitude image with a lower image contrast
with a ratio of 4/3 between the LV and the myocardium was also simulated,
representing the normal heart after the bolus transit. No filtering was applied
during any reconstruction.
All of the uninterpolated simulated magnitude images described above were
also compared against two methods of interpolation, in a similar fashion to the
phantom data:
1. image-based interpolation by a factor of 2 along each direction in the im-
age space using bicubic interpolation (MATLAB).
2. zero-filling of the raw-data by a factor of 2 along each direction before
FFT.
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3.2.2.3 Patient images
By retrospective processing of patient data, sub-pixel shifts were also intro-
duced into the raw-data of three patients who had clinical stress perfusion stud-
ies, where a DRA was visible. All the in vivo raw-data used was anonymised.
The perfusion sequence was a hybrid centre-out [Ding et al., 1998] echo
planar imaging (h-EPI) sequence with an EPI factor of 4 and with a protocol
that is shown in table 3.6. Perfusion was imaged for three slices (order: basal
parameter value
TR (ms) 5.1
TE (first echo) (ms) 1.02
flip angle (deg) 30
base resolution (pixels) 128x128
voxel size (mm) 2.8×2.8×8
bandwidth (Hz/pixel) 1860
parallel imaging TSENSE (R = 2)
TI (ms) 90
Table 3.6: Clinical stress perfusion studies protocol.
→ mid → apical) each heartbeat, at the first pass of Gadobutrol (1 mol/l) (Gd-
DO3A-butriol) (Gadovist-Bayer, Germany) at a dose of 0.1 mmol kg−1 of body
weight at an injection rate of 3 mL s−1. Images were acquired in the short-axis
plane for fifty R-R intervals, with the patient holding their breath for as long
as possible. Maximal hyperaemia was induced by a continuous intravenous
infusion of adenosine at a rate of 140µg kg−1 min−1 and stress perfusion images
were acquired after 4 minutes of adenosine infusion.
The in vivo sub-pixel shifts applied had a step of 1/8th of a pixel ranging
from 0.125 to 0.875 of the in-plane 2.8mm pixel size. A somewhat cumbersome
procedure was necessary to achieve this. The unprocessed raw-data was trans-
ferred from the scanner to a separate PC where an appropriate phase slope was
introduced using MATLAB before reconstructing the data back on the scanner
using the same image reconstruction settings as the original unshifted images.
These non-interpolated magnitude images were also interpolated in the image
space using MATLAB with a bicubic interpolation by a factor of two, making a
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second set of images. The scanner’s image reconstruction of the same raw-data
was also repeated with a zero-filling interpolation by a factor of two to make a
third image set. The effects of inplane shifts in the original, the image-based
interpolated and the zero-filled magnitude images were compared visually.
The myocardial segments pointed out as DRAs were not in territories where
a real perfusion defect was reported clinically. All the DRAs considered were
transient in nature lasting only a few heart beats during first-pass and corre-
lated with the LV bright blood signal.
The Gibbs artifact signal loss was measured as a percentage of the average
myocardial signal in all experiments. These values were measured with a 3 pixel
wide line profile perpendicular to the endocardial border in the myocardial seg-
ment being considered.
3.2.3 Results
Figure 3.14 a-c shows the phantom edge results: uninterpolated image, the im-
age interpolated in the image space, and the zero-filled interpolated image re-
spectively. It can be seen, in image a, and b that the near-horizontal edge gen-
erates Gibbs artifacts at some locations along the horizontal direction (solid ar-
rows) but not at others (dashed arrows). The artifact is seen in the single-pixel
layer immediately adjacent to the bright region (simulated LV blood), to which
layer all of the following descriptions will refer. The locations indicated by the
solid arrows correspond to the situation shown in orange in Figure 3.13, while
the locations of the dashed arrows correspond to the green case also shown in
Figure 3.13. The maximum measured signal loss on the uninterpolated image
in Figure 3.14 a was 14% of the average myocardial signal. On Figure 3.14 c, fol-
lowing zero filling interpolation, the artifact’s variability with the edge position
is less visible and this would be expected to be slightly further reduced if more
zero filling was used.
The simulated images are displayed in Figure 3.15. Image a shows Gibbs
artifacts in the subendocardial layer in the anterior, septal, inferior and lateral
regions. In Figure 3.15 b, the heart has been given a half-pixel shift in the hori-
zontal direction in relation to the original position given in a, and this results in
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Figure 3.14: A phantom with a near horizontal flat edge between undiluted
gelatin and a solution of Gd-DTPA, corresponding to a signal ratio of 1/3 in the
edge boundary. a) Phantom image uninterpolated. b) Image a interpolated in
the image space with a bicubic interpolation. The solid arrows point into the
regions where Gibbs artifacts are visible, while the dashed arrows point into
the in-between regions with no artifact. c) Image a but with zero-filling pre
FFT interpolation. Image a shows the measured peak artifact signal loss in
the bottom right corner.
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a reduction of the Gibbs artifacts for the septal, and lateral segments (arrows),
i.e. the regions with vertical edges. In Figure 3.15 c the heart has been given a
half-pixel shift in the vertical direction with a reduction of the Gibbs artifacts
for the inferior and anterior segments (arrows), i.e. the regions with horizontal
edges. However, note that at some nearby positions around the circumference,
towards the diagonal regions of the subendocardium in image b-c, there are
sometimes increases of the Gibbs artifacts with the shift; these positions can
be seen to have low-Gibbs offset before the shift. Figure 3.15 d is the same as
Figure 3.15 a except for a much lower contrast ratio between the LV blood pool
and the myocardium (LV/myocardium signal ratio is 4/3 instead of 3/1), and
this shows less prominent Gibbs artifact as expected. The image-based inter-
polation images (Figure 3.15 e-h) exhibit exactly the same shifting effects as the
non interpolated images, i.e. a similar reduction of the artifacts in the regions
pointed out by the arrows, but increased artifact at some other locations. In the
zero-filled images (Figure 3.15 i-l) the artifacts appear consistently regardless
of the small inplane shifts of the heart.
Results from the in vivo sub-pixel shifts are shown in Figures 3.16-3.19. Fig-
ure 3.16 a shows the original uninterpolated image retrieved from the perfusion
scan for one patient, with a mild artifact in the septal region. After testing sev-
eral sub-pixel shifts, Figures 3.16 b and c show the shifted image correspond-
ing to the shift with the most prominent artifact and the highest reduction of
the DRA respectively. The image-based interpolation images (Figure 3.16 d-f )
replicate the sub-pixel shifts’ effect, but the variability of Gibbs artifact is highly
reduced by zero-filling interpolation (Figures 3.16 g-i).
Figure 3.17 a shows another in vivo example where the DRA is located in
the anterior region of the subendocardium. The shifts (in the vertical direc-
tion) shown in Figure 3.17 b and c correspond to the shift with the most promi-
nent artifact, and the shift with the biggest DRA reduction respectively. Again
the post-FFT interpolation (Figures 3.17 d-f ) replicates the uninterpolated case
while the pre-FFT interpolation (Figures 3.17 g-i) greatly reduces the variability.
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Figure 3.16: a) The original image retrieved from the perfusion scan, with a
mild artifact in the septal region as pointed by the white arrow. b) The same
magnitude image but with a shift of 0.375 pixel length in the horizontal di-
rection, corresponding to the shift with the most prominent artifact in the
same region. c) A shift of half a pixel compared to image b in the horizontal
direction, showing a reduction of the DRA. Images d-f, and g-i show images
a-c interpolated in the image space, and zero-filled pre-FFT respectively. The
measured peak artifact % signal loss in the region pointed by the arrows is
shown at the bottom of Images a-c.
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Figure 3.17: a) Original perfusion image with a DRA located in the ante-
rior region of the subendocardium. b) Image a shifted 0.875 pixel length in
the vertical direction. c) Image a shifted 0.375 pixel length in the vertical di-
rection (half-pixel difference from b). Image b corresponds to the shift with
the most prominent artifact, and image c the shift with the biggest DRA re-
duction. Images d-f, and g-i show the post-FFT and pre-FFT interpolations of
images a-c. The measured peak artifact % signal loss in the region pointed by
the arrows is shown at the bottom of Images a-c.
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Figure 3.18 a shows a third example of a perfusion scan, this time with an
artifact in the septal segment, and is an example where the original mid-septal
endocardial boundary happened to be in the position with the most promi-
nent DRAs. Note that there is a real perfusion defect in the inferior segment of
the myocardium, but we are interested in the mid-septal segment as marked
in Figures 3.18 a and b. Consistent with previous results the image-based in-
terpolation (Figures 3.18 c-d) shows the same variability while the zero-filled
interpolated images (Figures 3.18 e-f ) highly reduces the variability.
The fourth patient example in Figure 3.19 again demonstrated how a partic-
ular in-plane shift could minimize the DRAs except for the pre-FFT interpolated
images. Figure a-d shows 4 consecutive frames of the basal slice during the be-
ginning of myocardial perfusion for one patient with DRAs in the anterior and
inferior subendocardial regions. The top panel (Images a-l) correspond to the
shift where the artifacts were most prominent, whereas the lower panel (Images
m-x) are the shift that minimises the DRAs. This Figure is more easily viewed as
a 2-frame movie with Images a-l on the first frame, and Images m-x on the sec-
ond frame (animated GIF in the attached CD (sub pixel shift gibbs anim.gif)).
To summarise the in vivo results, all the images interpolated in image space
exhibit similar Gibbs artifact dependency on the edge position as shown by the
non-interpolated images. This dependency is highly reduced for the images in-
terpolated by zero-filling pre-FFT, i.e. the DRAs seem identical before and after
shifting the raw-data.
3.2.4 Discussion
It should be noted that this section focussed on the Gibbs artifact’s contribution
to perfusion DRAs, so other factors that contribute to DRAs are not considered
here.
This work illustrates that the exact position of the endocardial border with
respect to the image pixels can explain some of the variability of the DRA in dif-
ferent myocardial segments, in different patients and from frame to frame dur-
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Figure 3.18: a) The original perfusion frame with an artifact in the septal
region, which is an example where the original boundary was exactly at a lo-
cation with the most prominent DRA. b) Corresponds to image a shifted in the
horizontal direction by half a pixel length, showing a reduction of the artifact.
Figures c-d and e-f are the respective post-FFT and pre-FFT interpolations of
figures a-b. The measured peak artifact signal loss in the regions pointed by
the arrows is shown at the lower edges of Figures a, b.
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Figure 3.19: Figure 3.19 a-d shows 4 consecutive frames of the basal slice
during the beginning of myocardial perfusion for one patient. The top panel
(Images a-l) correspond to the shift where the artifacts were most prominent,
whereas the lower panel (Images m-x) are the shift that minimises the DRAs.
There are two DRAs visible in the 4 frames, one in the anterior and another
in the inferior subendocardial region (white arrows). Figure 3.19 e-h, and 3.19
i-l are the post-FFT and pre-FFT interpolated images of 3.19 a-d, respectively.
Figure 3.19 m-x has an identical layout to Figure 3.19 a-l, but shows the frames
with the shift that minimised the same artifacts; the shift is of half a pixel in the
vertical direction, when compared to Figure 3.19 a-l. Figure 3.19 a-d and m-p
show the measured peak artifact signal loss for the anterior (top) and inferior
(bottom) segments as pointed by the arrows (there is an animated GIF in the
attached CD, that cycles between the original data and the shifted one for an
easier comparison (sub pixel shift gibbs anim.gif)).
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ing first-pass perfusion. This variability is linked to respiratory motion as well
as beat-to-beat cardiac motion variability. It should be understood that the rel-
evant sub-pixel shift is the sub-pixel remainder of any larger in-plane shift, e.g.
if the heart moves by a length of three and a half pixels then the sub-pixel shift
effects described here are the same as moving by half a pixel. Although it may
be possible to minimise the Gibbs ringing contribution to a DRA in a particular
myocardial segment by introducing a phase slope to the raw-data and repeat-
ing its reconstruction, this action may simultaneously strengthen Gibbs ringing
in DRAs in other subendocardial segments (i.e. where the subpixel remainder
of border location in relation to pixels differs). Furthermore, it may seem fea-
sible to identify DRAs due to Gibbs by repeating shifted reconstructions while
checking consistent appearance of DRA, however this idea would probably be
confounded by partial-volume effects obscuring true thin defects. For these
reasons, we doubt whether it is possible to devise a tool to evaluate the contri-
bution of Gibbs ringing artifacts by applying shifted image reconstructions.
The nature of the Gibbs artifact makes it very sensitive to sub-pixel shifts,
since each oscillation lobe covers the size of one pixel. Gibbs artifacts scale
with the pixel size, therefore the spatial frequency of the ringing increases ex-
actly with the resolution. Consequently, the sensitivity to sub-pixel shift ap-
plies at any resolution, although at higher resolution, the relative sharpness of
endocardial borders is likely to be reduced and this reduces the artifact. This
is in line with the work done by Plein et al. [2007], where a high-resolution k-t-
SENSE perfusion study was compared with a standard SENSE perfusion proto-
col, scoring less dark-rim artifacts.
Reducing the Gibbs artifact can be achieved by filtering the raw data, reduc-
ing the ringing drastically at the price of reducing the resolution as well, which
is a high cost when considering the typical low resolutions obtained clinically
by most perfusion studies. Section 3.3 contains further work on the effects of
filtering.
In theory each frame of each slice in a perfusion study will image the heart
in the same part of the cardiac cycle, nevertheless small differences in the po-
sition of the heart walls from frame to frame are likely, changing the position of
the edge inside an approximate 2.5×2.5 mm pixel. Sub-pixel shifts are there-
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fore a contributor to the variability of the Gibbs artifacts during a perfusion
run, in addition to the variable sharpness of the endocardial border between
the LV blood pool and the myocardium from frame to frame and also between
patients. This variability probably confuses some clinical users of perfusion
imaging.
The appearance of the Gibbs artifact is not only dependent on the LV blood
pool / myocardium signal ratio but also on the myocardial SNR, i.e. sequences
less affected by random noise, such as bSSFP, make Gibbs artifacts more visible
(mentioned previously in sections 2.3.5 and 3.1). It is also recognised that the
most sensitive time for DRA is shortly after the LV peak, when contrast agent
begins to perfuse normal myocardium but the LV blood is sometimes still ex-
tremely bright; however, this time is also likely to show the strongest motion
and susceptibility artifacts. A higher LV gadolinium concentration or the use
of a 3T field with its associated increase in SNR and CNR would increase the
overall visibility of Gibbs artifacts unless the higher SNR is utilised for greater
resolution.
Although a rest scan is sometimes used to determine DRAs [Gerber et al.,
2008, Klem et al., 2006, Kramer et al., 2008], it is often associated with a less
compact bolus due to the lower cardiac output, resulting in a smaller LV / my-
ocardium signal ratio, which in addition to the effect of possible sub pixel po-
sitional differences, makes the rest scan potentially unreliable in determining
Gibbs-related DRAs.
This work showed that the DRA variability is reduced by zero-filling the raw-
data before FFT and reconstructing a larger matrix image, since this technique
upsamples (i.e. places more interpolated pixels on each cycle of) the Gibbs sig-
nal oscillations and thereby reduces the variability of Gibbs appearance; a fac-
tor higher than 2 in the interpolation would make the zero-filled data even less
dependent on the edge position [Du et al., 1994, Haacke et al., 1999]. On the
other hand, if interpolation in the image space is used, the sub-pixel shift vari-
ability is the same as the original data. It is important to point out that zero-
filling does not reduce the artifacts in any way; it only reduces their variabil-
ity by reducing their dependency on the endocardial border position. Never-
theless, a less variable artifact may be preferable, especially if quantification
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methods are used. Zero-filling pre-FFT increases the need for reconstruction
memory and fast (larger) 2DFFT processing for the big series of perfusion im-
ages. This may have obstructed the use of zero-filling in older work on perfu-
sion imaging, but with modern hardware is less of a problem.
A phenomenon of Gibbs ringing interference between two close edges might
also be possible, such as in the septal segment of the myocardium in-between
the right and left ventricle, where the ringing from both edges interfere either
destructively or constructively, decreasing or increasing the Gibbs artifacts re-
spectively. This is mentioned in Section 2.7, as a possible explanation for the
higher count of DRAs in the septal segments when compared to other myocar-
dial segments. One example where this phenomenon is likely to have hap-
pened is in Figure 3.18 a (the septal DRA ringing is also visible in the pixel ad-
jacent to the RV although less visible due to the lower contrast between the
myocardium and the RV).
It was difficult to measure the in vivo average signal intensities accurately
due to the low resolution and low SNR of the perfusion frames. Nevertheless,
the average (over all 4 patients) of the in vivo signal loss caused at the artifact
regions in the images where the DRA was most visible was 31% of the respec-
tive average myocardial signal. Averaging the signal loss as a percentage of the
subendocardial signal discontinuity (over all 4 patients) resulted in 8.4%, which
is very close from the theoretical value of 9%.
Motion artifacts are more complicated than Gibbs artifacts, in that their sig-
nal ringing wavelength increases with distance from the sharp edge. Consider-
ing a simplification of a constant motion and a normal Cartesian k-space filling,
the signal oscillations will have a first lobe width of approximately 2 pixels for a
typical perfusion sequence protocol [Storey et al., 2002]. Motion artifacts alone
are therefore wider and probably less prone to be affected by sub-pixel shifts,
but motion artifacts may occur in combination with Gibbs artifacts, since the
latter are always present (assuming no image filtering). The effects of com-
bining motion and Gibbs artifacts is analysed in more detail in section 3.3. The
width of h-EPI frequency-offsets DRAs was measured in a phantom (see section
3.1) and it was found to be approximately 2.3 pixels for a resolution close to the
one used clinically. Therefore, these artifacts are also less sensitive to sub-pixel
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shifts, although their width is highly dependent on the frequency-offsets in the
heart.
3.2.5 Conclusions
It was shown that the contribution made by Gibbs artifacts to DRAs in perfusion
studies is very dependent on the position of the subendocardial wall inside the
pixel in the absence of zero-filled pre-FFT interpolation. Position variations
between patient studies and from frame to frame in a typical ECG-gated per-
fusion study can explain some of the variability often seen in DRAs. This work
also showed that image-based pixel interpolation does not reduce this source
of DRA variability. However, interpolation by zero-filling prior to FFT makes the
DRA appearance less variable, i.e. reduces the artifact’s ringing dependency on
the position of the subendocardial wall in relation to image pixels.
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3.3 Simulations of the dark rim artifact for perfusion proto-
cols
3.3.1 Introduction
Both Gibbs and motion artifacts have been shown, separately, as potential sources
for the DRA [Di Bella et al., 2005, Storey et al., 2002]. Although very different,
both have a similar effect of creating an undershoot of the signal near the sub-
endocardial border when there is a sharp edge between the LV blood pool and
myocardium, such as during the first pass of contrast agent. Main field distor-
tion by Gd is often mentioned as another source [Arai, 2000, Fenchel et al., 2004,
Schreiber et al., 2002, Weber et al., 2007] which will be addressed separately in
Chapter 4. One other possible DRA source speculated in the literature is T1 and
T2* k-space weighting with the potential for these to introduce blurring in the
final image, dependent on the protocol used [Kellman and Arai, 2007].
The relative importance of all these different possible sources through the
cardiac cycle for a range of typical perfusion protocols has not been fully exam-
ined.
A realistic numerical simulation using recent typical myocardial perfusion
MRI protocols, such as the ×2 acceleration commonly applied using parallel
imaging, has not been published to the best of our knowledge. In this section,
a comparison of the most usual perfusion sequences: GRE; bSSFP; and h-EPI is
shown. It includes analysis of three possible DRA sources: Gibbs, motion and
relaxation effects; and the effects of some possible solutions, leading to con-
clusions drawn on acceptable trade-offs between DRA, resolution and imaging
time. An overall discussion is shown in the end (section 3.3.4) providing a gen-
eral overview of all the findings.
3.3.2 Materials and methods
The numerical simulations were made using MATLAB. The k-space raw-data
of a short axis image of the left ventricle was simulated using jinc functions,
which represent the Fourier Transforms of circular discs. By summing two jinc
functions of different radii the raw-data of two concentric disks was created,
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Figure 3.20: a) numerically simulated short-axis image. b) simulated short
axis image with the added perfusion defect. (Cropped images from typical
FOV, which is described later). Both magnitude images are inherently cor-
rupted with Gibbs ringing.
representing the myocardial wall and the LV, Figure 3.20 a. Figure 3.20 b shows
the same short axis image with an added circumferential perfusion defect in the
subendocardium. The defect was simulated (using a third jinc function) with
a signal loss of 50% of the normal myocardium signal, and width of approxi-
mately 45% of the wall thickness (unless stated otherwise). The signal loss and
width of the defect was chosen after measuring and averaging these properties
in 10 clinical subjects with clinical reports indicating perfusion defects using
an h-EPI sequence*. The added defect was used in some of the simulations to
analyse the effects of the artifacts and image filtering in the presence of a real
perfusion defect.
For most simulations, the LV endocardial diameter was fixed at 31 mm and
the epicardial border at 62 mm. For motion simulations, all of these diameters
were modified as described in section 3.3.2.2.
The tissue pixel values used for the simulations were set up from in vivo
perfusion SI curves using the same patient data described in Section 2.7 from
the Lyne et al. [2007] study. The SI curves for each sequence were obtained by
averaging the corresponding mid-slice SI curves from 4 patients where no ar-
*Considering a signal loss of 50% of the normal myocardium signal for all sequences is
clearly a simplification since each sequence has a different CNR.
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tifact was visible. The SI curve for the myocardium was averaged from all the
different segments’ SI values, averaging the surface coil response with depth.
The arrival of the CA in the LV was temporally shifted to the same frame in each
patient before averaging. After the LV temporal alignment the myocardium up-
take time was well aligned as well, which allowed the myocardial SI curves to
be averaged for all 4 patients as well, Figure 3.21.
In the following work the signal used in the LV and myocardium corresponded
to the frames when DRAs are visible, i.e. at the beginning of CA perfusion into
the myocardium. Each sequence had, therefore its corresponding contrast ra-
tio between the LV and myocardium: h-EPI 5.0; bSSFP 6.4; GRE 6.4.
All the raw-data was zero filled in k-space to a matrix size of 2048x2048 pix-
els. This interpolation to a much bigger size not only upsamples the Gibbs ar-
tifacts, minimising its dependency on the sub-pixel position of the edge (sec-
tion 3.2), but also includes partial volume effects with sub-pixel shifts during
the motion simulations, and finally also enables better measurements of DRA
darkness and width from the line profiles. The frequency FOV was fixed at 370
mm in all simulations. Three base resolution matrices of 128, 160, and 192
frequency-encode points were simulated. The phase-encode resolution* was
the same as the frequency-encode resolution in most of the data presented.
For tests on the varying defect width and effect of filtering, the phase-encode
resolution was varied as follows: for each frequency-encode resolution a phase-
encode resolution of 70%, 85%, and 100% was simulated, resulting in matri-
ces from 128x90 to 192x192; these matrix sizes were then approximated to the
nearest matrix size required by the k-space sampling trajectory in the h-EPI se-
quence of multiples of 16. The h-EPI centric acquisition order requires steps of
8 phase encode lines in order to maintain its symmetry for an echo-train-length
of 4, when using parallel imaging with R = 2 the step size doubles to 16 (Table
3.7).
The time of image acquisition was calculated by using the protocols given
*Siemens protocol parameter, where the phase-encode resolution is given as a percentage
of the resolution used in the frequency-encode direction; for example a phase-encode resolu-
tion of 50% creates rectangular pixels with a phase-encode length twice the length specified in
the frequency-encode direction.
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Figure 3.21: SI curves for the LV and myocardium for each of the three
sequences. The first three rows show the SI curves for each of the four pa-
tients separately and for each sequence. The bottom row shows the average
SI curves used in the simulations for the three sequences.
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by Lyne et al. [2007] (Table 3.8).
matrix size (pixels) spatial resolution (mm)
image acquisition time (ms)
h-EPI bSSFP GRE
128×96 2.9×3.9 69.6 106 115
128×112 2.9×3.4 81.2 123 134
128×128 2.9×2.9 92.8 141 154
160×112 2.3×3.4 81.2 123 134
160×144 2.3×2.6 104 158 173
160×160 2.3×2.3 116 176 192
192×128 1.9×2.9 92.8 141 154
192×160 1.9×2.3 116 176 192
192×192 1.9×1.9 139 211 230
Table 3.7: Matrix sizes, spatial resolution and time of image acquisition used
in the simulations.
Line profiles across the myocardium and LV centre were obtained along the
frequency-encode and phase-encode axes throughout the simulations, and a
routine was written to measure two properties: the intensity depth and width
of the DRA first undershoot lobe when compared to the theoretical line profile
without artifacts which was known from the simulations input values (Figure
3.22). The theoretical line had the intensity value of the LV and myocardium set
in the simulations.
For Gibbs artifacts, the range of matrix sizes simulated is the relevant pa-
rameter, as Gibbs truncation is unchanged by parallel imaging. However, for
the motion simulations and T1 and T2 recovery simulations the shorter imag-
ing time of the simulations was important, therefore parallel imaging with an
acceleration factor R=2 was simulated by acquiring only alternate phase-encode
lines; resulting in an image with half the FOV in the phase-encode direction.
No parallel unwrapping algorithm was needed, since the simulated short-axis
heart was smaller than half the FOV. No partial-Fourier or partial-echo (i.e. par-
tial ky or kx) acquisitions were considered. Because the time of imaging is ef-
fectively halved with no extra reference lines, this is equivalent to TSENSE used
202 Simulations of the dark rim artifact for perfusion protocols
parameter h-EPI bSSFP GRE
TR (ms) 5.8 2.2 2.4
TE (ms) 1.22 1.0 1.2
read FOV (mm) 340-400 340-400 340-400
phase FOV (mm) 250-300 250-300 250-300
flip angle (deg) 30 50 12
TD (ms) 74 33 6
TI (ms) 108 91 80
TA (ms) 146 147 152
bandwidth (Hz/pixel) 1860 1400 550
matrix(readout) 128 128 128
echotrain-length 4 1 1
parallel imaging R=2 (TSENSE) R=2(TSENSE) R=1.6(GRAPPA)
Table 3.8: These sequence protocols were used by Lyne et al. [2007] in a
sequence comparison in MPI. TD - is the time delay between the saturation
recovery and the first RF pulse. TI - is the time of inversion defined as the
time between the saturation recovery preparation and the acquisition of the
k-space centre line. TA - is the time of acquisition of the whole sequence
including the saturation recovery preparation. All sequences have parallel
imaging with an acceleration factor of 2 (h-EPI and bSSFP) or 1.6 (GRE). The
GRE protocol used GRAPPA instead of TSENSE due to stimulated echo arti-
facts most apparent in the GRE-TSENSE.
Figure 3.22: The two parameters measured in the signal line profile in the
subendocardial edge: the depth and width of the artifact. The solid line is a
signal line profile corrupted by ringing, while the dashed line represents the
theoretical artifact-free image used as an input in the simulations.
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Figure 3.23: a) Tukey filter r = 0.25, b) Tukey filter r = 0.50, c) Tukey filter
r = 0.75, d) Tukey filter r = 1.0 (also known as Hann filter), e) Hamming filter.
in Lyne et al. [2007] work*.
Potential effects of these DRA mechanisms (e.g. the T1-related variation of
signal over ky) on the parallel reconstruction techniques themselves were be-
yond the time available for this PhD.
3.3.2.1 Gibbs artifacts
The simulated k-space raw-data was finite, therefore it inherently corrupted the
resulting magnitude images with Gibbs artifacts, as can be seen in Figure 3.20.
Several filters were tested on the simulated raw-data: Four different Tukey
filters with 0.25, 0.5, 0.75 and 1 ratio of taper to constant sections (a Tukey filter
with a ratio of 1 is also known as the Hann filter), and a Hamming filter. All the
2D filters are depicted in Figure 3.23 and defined in equations (3.3) and (3.4).
Tukey filter in 1D:
w(n)=
 1.0, 0≤ |n| ≤α
N
2
1
2
(
1+cos
(
pi
n−αN2
2(1−α) N2
))
, αN2 ≤ |n| ≤ N2
(3.3)
Hamming filter in 1D:
w(n)= 0.54−0.46cos
(
2pi
n
N
)
, 0≤ n ≤N (3.4)
where N+1 is the number of points, and α= 1−r where r is the ratio of taper to
constant sections.
*Note that the GRE sequence was changed to GRAPPA (R=1.6) due to stimulated echo arti-
facts with TSENSE in Lyne et al. [2007] work. In this work all sequences were simulated consid-
ering TSENSE R=2.
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sequence CNR
h-EPI 7.85
bSSFP 13.16
GRE 10.85
Table 3.9: CNR values considered in the 128x128 matrix simulations for the
three sequences [Lyne et al., 2007].
The effects of filtering were also tested for other myocardial defect widths
ranging from 20% to 80% of the myocardial wall thickness (31 mm): 6, 12, 19,
and 25 mm; and for realistic noise levels modelled as follows:
The noise was calculated taking into consideration the CNR measured by
Lyne et al. [2007] in his work (Table 3.9). The CNR was calculated from the
myocardial pre-contrast signal and at peak contrast concentration. Using the
myocardial SI values from this simulation, it is possible to calculate the my-
ocardial contrast enhancement and therefore the noise necessary to obtain the
same CNR as in Lyne’s work. This noise was considered to be the noise in the
image-space for the 128x128 image matrix. In the simulations the noise was in-
troduced in the original raw-data by considering that the noise in k-space σ2ks ,
is given by ([Liang and Lauterbur, 2000] page 246) :
σ2ks ∝σ2i s ·Nx ·Ny (3.5)
where σ2i s is the variance in the complex image-space, Nx and Ny are the data
points along the frequency and phase-encode directions.
The noise was considered white, i.e. evenly distributed over all frequen-
cies with a normal distribution (zero mean, standard deviation σ), and with
no structured noise coming from the parallel imaging.
For all other image matrices, the noise level to be added to the raw-data was
obtained by considering that the SNR is scaled according to the resolution:
SN R ∝ SN R128p
a×b
(3.6)
where SN R128 is the SNR for the 128x128 matrix size, and a and b are the ratio
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Figure 3.24: Radial velocities of the endocardial border at rest measured by
Jung et al. [2006], temporally aligned to a 800 ms RR interval.
between the number of data points in the frequency and phase-encode direc-
tions relative to the original size matrix of 128x128 respectively. It was assumed
that the sampling bandwidth (Hz/pixel or Hz/mm) did not change with matrix
size. We also neglected any changes in signal due to T1 or T2 effects.
3.3.2.2 Motion artifacts
Motion was simulated by changing the radius, in the k-space jinc functions, of
the endocardial and epicardial borders of the heart as a function of time during
the k-space acquisition. For the endocardial border, radial motion was simu-
lated based on measurements of myocardial radial velocity at rest by Jung et al.
[2006] in 12 healthy volunteers. The data used by Jung et al. [2006] was av-
eraged from all volunteers for each acquired slice. The data was temporally
normalised to end systole-time (due to variable inter-subject heart rates) with
velocities ranging from -40 to 30 mm/sec (positive velocities for contraction). A
resting heart rate of 75 bpm was considered in order to scale the velocity data
along one heart cycle (Figure 3.24).
To simulate the maximum effect of adenosine stress on myocardial wall ve-
locity, an estimate of the greatest likely increase in velocity was made as follows:
• Ogilby et al. [1992] measured the effects of adenosine with SPECT ven-
triculograms in 16 patients. Data showed an increase of approximately
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22% in the heart rate with adenosine stress when compared to the base-
line from subjects with and without CAD. This increase in the heart rate
is mainly due to a reduction of the late diastole period and therefore the
ECG R-T distance and subsequently the radial velocity were considered
approximately unchanged. The stroke volume did not change in aver-
age for the patients with no CAD, but increased 15% in the patients with
CAD. This change in stroke volume was mainly due to a decrease in the
end-systolic volume. In conclusion, this data suggests a small increase in
the radial velocities, mainly during systole, during adenosine stress.
• Saha et al. [2004] measured the myocardial longitudinal velocity during
rest and adenosine with ultrasound tissue Doppler imaging in 10 healthy
volunteers. An average increase of 18% in the myocardial systolic velocity
was found.
Therefore as a basic approximation of stress imaging, all the endocardial
radial velocities were increased by 20% while keeping the same cardiac timings.
Note that this “short-axis” simulation did not include any possible effects of
motion along the long-axis (through-plane motion) or in-plane circumferential
motion (torsion).
The epicardial velocity was roughly estimated from mid-ventricular cines
of 5 healthy patients at stress. The epicardial radial velocity is much lower than
the endocardial one and it was considered constant at a radial speed of 10 mm
s−1 during systole, at end systole the epicardial motion direction was inverted
maintaining the same speed. Although these considerations in the epicardial
velocity may be oversimplified, it is assumed that it has little impact on the
subendocardial DRA.
The radius of the endo/epicardium of the simulated left ventricle at the R
wave was 22/34mm; subsequent dimensions throughout the heart cycle were
calculated from the estimated radial velocity data for the endocardium and ep-
icardium as described above up to 800 ms. The estimated stress velocity and
myocardial border radii are shown in Figure 3.25.
The motion simulations acquired their central rawdata at three different
Simulations of the dark rim artifact for perfusion protocols 207
Figure 3.25: a) The radial velocity of the endocardial border during the heart
cycle at stress. It is also shown the three R-kc times used in the motion sim-
ulations. These times correspond to the time between the R-wave and the
acquisition of the k-space central line (R-kc). b) Myocardial wall thickness
and corresponding radius for the epicardium and subendocardium borders.
Please note that 800 ms does not represent the end of the cardiac cycle, but
only the end of our velocity data. For these simulations this is not important
since we are only interested up to the peak-filling period.
times in the heart cycle: approximately 120/310/410 ms after R-wave (arrows
Figure 3.25 a). These times correspond to the central rawdata coverage, for
the three sequences, coinciding with the fastest contraction, the end-systolic
pause (first zero velocity), and the fastest filling of the heart respectively. Late
diastole was not simulated because at stress this phase of the cardiac cycle is
very short; and in disease, frequently, the diastolic relaxation is less rapid. It
should be emphasised that the times 120/310/410 ms correspond to the time
between the R-wave and the acquisition of the central raw-data line (k-space
centre). Therefore, these times are named as R-kc and used throughout this
work. The image acquisition times are shown in Table 3.7.
GRE was simulated with the conventional sequential cartesian ky-space sam-
pling order (also called linear or top-down), in this work referred to as edge-
centre-edge (ECE). The h-EPI trajectory was a centric interleaved phase encod-
ing scheme, previously described by Ding et al. [1998] (Figure 2.21 (right)).
bSSFP was also simulated with the conventional ECE trajectory in most of
the work, although a comparison with different phase-encode acquisition or-
ders was made for this sequence. The additional simulated acquisition orders
were: centre-edge (CE), i.e. from the centre lines to the edges of k-space; edge-
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centre (EC) i.e. from the edges of k-space to the centre, and finally with the same
trajectory as the h-EPI. The two alternative k-space trajectories, CE and EC, do
not acquire their central raw data at the same time as the conventional ECE
trajectory; instead, the same imaging window of the heart cycle was used. The
alternative approach, of making the central raw-data acquisition at the same
time for the three different trajectories would make each image acquisition oc-
cupy a different phase of the cardiac cycle; therefore, the R-kc times for these
trajectories are different from the other acquisition orders, Table 3.10.
3.3.2.3 T1/T2* filtering
The “filtering” in the title of this section refers to the possible effects caused by
broadening of the point-spread-function due to relaxation/recovery changing
the weighting across the raw-data. T1 and T2* modulation of the k-space raw-
data was measured, in terms of PSF broadening of a point source. Phase shifts
in the PSF were also measured after the modulation of the raw-data.
As a model of peak stress perfusion, a concentration of Gd of 1.5 mmol L−1
and 12.5 mmol L−1 was considered in the myocardium and in the LV blood pool
respectively. The concentration values of the contrast agent in the LV and my-
ocardium were based on measurements made by Elkington et al. [2005a] in the
ascending aorta at rest, and Hsu et al. [2008] in the myocardium at stress with
a dose of 0.1 mmol/kg. Using a Gd T1 relaxivity of 4.5 L mmol−1 s−1 and 5.1
L mmol−1 s−1 for T2 relaxivity, a T1/T2 of 127/41 ms for the myocardium and
18/14 ms for the LV was estimated. Kellman et al. [2006] measured a T2* of 9
ms at rest in the LV cavity, at stress we estimate a higher concentration of con-
trast agent and therefore considered a value of T2* 5 ms. A T2* of 8 ms in the
myocardium was also estimated.
These T2* values consider a range of frequencies of approximately 100 Hz in
the myocardium and 131 Hz in the LV. This range of frequencies was considered
present inside each pixel (microscopic field variations) with an homogeneous
frequency distribution.
Modulation along the frequency-encode and phase-encode direction were
calculated by simulating the signal intensity using a method described by Sek-
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ECG matrix sequence ECE h-EPI CE EC
peak systole
128x128
h-EPI 120 120 74 166
bSSFP 120 120 50 190
GRE 120 120 43 197
160x160
h-EPI 120 120 62 178
bSSFP 120 120 32 208
GRE 120 120 24 216
192x192
h-EPI 120 120 50 190
bSSFP 120 120 14 226
GRE 120 120 5 235
end-systole
128x128
h-EPI 310 310 264 356
bSSFP 310 310 240 380
GRE 310 310 233 387
160x160
h-EPI 310 310 252 368
bSSFP 310 310 222 398
GRE 310 310 214 406
192x192
h-EPI 310 310 240 380
bSSFP 310 310 204 416
GRE 310 310 195 425
peak diastole
128x128
h-EPI 420 420 374 466
bSSFP 420 420 350 490
GRE 420 420 343 497
160x160
h-EPI 420 420 362 478
bSSFP 420 420 332 508
GRE 420 420 324 516
192x192
h-EPI 420 420 350 490
bSSFP 420 420 314 526
GRE 420 420 305 535
Table 3.10: R-kc times (ms) for some of the image matrices for the four ac-
quisition orders. Note: The R-kc times for the CE, and EC phase-acquisition
order were different, to ensure imaging in the same window of the heart cycle.
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ihara [1987]. To account for microscopic frequency offsets, the simulations in-
tegrated the field frequency distribution inside each voxel.
Modulation along the frequency-encode direction was calculated by con-
sidering the signal intensity relaxation over the course of one readout line for
the three different sequences using the bandwidths in Table 3.8.
Modulation along the phase-encode direction was calculated by consider-
ing the signal intensity variation for each echo and for each sequence, also us-
ing parameters from Table 3.8*.
3.3.3 Results
Please note that for this chapter of the experimental work some aspects of the
discussion are included with the results. This was necessary to avoid excessive
fragmentation of the text, because of the many separate sub-sections. An over-
all discussion of the simulation findings is still presented as a separate section
afterwards.
The Gibbs data results are mostly shown only for the bSSFP sequence hav-
ing in mind that the dimensions of Gibbs artifacts are related to the image res-
olution rather than the sequence used. Nevertheless, when a comparison is in-
formative, the results are shown for the three sequences. The bSSFP sequence
results for the motion artifacts are for the ECE k-space sampling trajectory un-
less stated otherwise.
3.3.3.1 Gibbs artifacts
Gibbs artifacts are present in all non-filtered magnitude images, with a visible
ringing around the endocardial border. DRAs are caused by the first lobe of
the undershoot in the Gibbs ringing present at subendocardium. In the rest of
this section, we will focus on the signal loss of this region, since this is what
mimics a thin subendocardial real perfusion defect. There is an overshoot in
the blood pool immediately adjacent to the subendocardium; however, this is a
much smaller fraction of the bright blood signal and is not considered further.
*bSSFP sequence was simulated with the classic approach of anα/2 initial pulse described
in Section 2.3.3.
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resolution sequence signal loss % contrast %
128x128
h-EPI -39 -9.6
bSSFP -52 -9.5
GRE -51 -9.5
160x160
h-EPI -38 -9.4
bSSFP -51 -9.4
GRE -51 -9.4
192x192
h-EPI -30 -7.6
bSSFP -42 -7.8
GRE -42 -7.8
Table 3.11: Gibbs SL% and signal loss as a percentage of the contrast be-
tween the myocardial and LV signal (contrast %).
The first results only illustrate some basic aspects of the Gibbs ringing in the
simulated images.
As expected from the theory, Gibbs artifacts scale with pixel size; Figure 3.26
a-c show the magnitude images and the corresponding line profiles, for image
matrices 128x128, 160x160, and 192x192. There was no reason to expect phase
variations other than the alternating polarity of the rings superimposed on the
larger myocardial signal, and phase images were therefore not considered in
this work.
The Gibbs peak signal loss as a percentage of the average myocardial signal
(defined from now on as SL%) and also the signal loss in the DRA as a per-
centage of the contrast between the myocardial and LV signal is shown in Table
3.11, when no filtering is applied. The measured signal loss as a percentage of
contrast between the LV and myocardium was constant at approximately 9%,
as expected from theory. The Gibbs SL% is higher than the one measured in
section 3.1 because the contrast between the LV and the myocardium given by
the SI curves was higher than the one simulated in the gelatin phantom. This
is possibly related to the effect of fresh magnetisation entering the slice due to
blood inflow in the LV, which can increase the signal [Ivancevic et al., 2003],
increasing the contrast in vivo when compared to the “static” phantom.
Figure 3.27 a, c, e shows the SL% vs the k-space filter used, for the h-EPI,
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bSSFP, and GRE sequence respectively. These values are shown for three dif-
ferent resolutions, 128x128, 160x160, 192x192. Note: all the SL% stated in the
Gibbs simulations results are measured with line profiles along the phase-encode
direction (horizontal in the magnitude images) unless stated otherwise; although,
it was assumed that the Gibbs DRAs are isotropic for these resolutions.
There was a slightly smaller signal loss measured on the unfiltered images
at the higher resolution of 192x192. This was due to a different superposition of
endocardial and epicardial Gibbs ringing for each resolution. This effect can
be seen in the line profiles in Figure 3.26. The superposition at the higher
resolution resulted in a slightly lower Gibbs SL%. This was consistent for all
sequences, since this effect depends only on the resolution (myocardial wall
thickness in pixels). Although when using filters, this superposition effect was
also dependent on the filter, and this explains why when using a 0.25 Tukey fil-
ter the Gibbs SL% paradoxically increased slightly for the 192x192 resolution in
all sequences.
Inspection of the basic filtering results in Figure 3.27 a, c, e show that the
Gibbs DRA was reduced with the filtering of larger regions of outer k-space.
Considering the Tukey filtering results, there was a surprisingly slow reduction
of the Gibbs SL% as a function of Tukey filtering strength through r = 0.25, 0.5
and 0.75, with a sudden change to almost no signal loss at r = 1.0. The Ham-
ming filter gave slightly better results than the Hann filter (Tukey 1.0) for the
reduction of the artifact. The higher efficiency of the Hamming filter in nulling
truncation artifacts has been discussed previously by Harris [1978].
Figure 3.28 show the magnitude simulated short-axis images before and af-
ter applying the Hamming filter (found to be the best filter) for the 128x128,
160x160, and 192x192 matrix sizes, and repeated also with a simulated perfu-
sion defect.
Following the results of filtering on the simulated Gibbs DRA, which showed
what filtering was needed to remove the Gibbs DRA, one obvious next ques-
tion was to explore how much that filtering also removes a simulated perfusion
defect. This question was explored initially in Figure 3.27 b, d, f showing the
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Figure 3.27: Gibbs SL% (a) and Gibbs + added-defect SL% (b) for the
128x128, 160x160, and 192x192 matrices as a function of filter type, in the h-
EPI sequence; the same for the bSSFP sequence (c-d) respectively; and for the
GRE sequence (e-f ) respectively.
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Figure 3.28: a) 128x128 unfiltered, b) 128x128 Hamming filtered, c) 128x128
with added defect, unfiltered, d) 128x128 with the added defect, Hamming
filtered. e)-h) similar to a)-d) but for the 160x160 matrix. i)-l) similar to a)-d)
but for the 192x192 matrix.
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resolution sequence signal loss % contrast %
128x128
h-EPI -40 -10
bSSFP -40 -7.4
GRE -40 -7.4
160x160
h-EPI -47 -12
bSSFP -47 -8.7
GRE -47 -8.7
192x192
h-EPI -51 -13
bSSFP -51 -9.4
GRE -51 -9.5
Table 3.12: Gibbs SL% + defect signal loss as a percentage of the myocar-
dial signal and as a percentage of the contrast between the myocardial and LV
signal (contrast %) for the Hamming filtered images.
Gibbs + defect SL% measured from the simulated images with the added de-
fect, as a function of the filter used, for the h-EPI, bSSFP, and GRE sequences
respectively, for the same matrix sizes as Figures a, c, e. As before there was
only a gradual reduction of the Gibbs DRA with increasing Tukey r-value, with
the same abrupt change to virtually no DRA at r=1 (Hann filter). With the Ham-
ming filter, the Gibbs ringing was marginally better nulled, and therefore the
only signal loss measured in these images was from the defect, which was set
to a SL% of 50% the myocardial signal (see Methods). It can be seen that af-
ter filtering the raw-data with the Hamming filter the SL% is measured close to
the 50% for the two higher resolutions of 160x160, and 192x192, however for
the lower resolution of 128x128 the SL% of the defect was shallower than 50%
at approximately 40% for all sequences. This is related to the larger pixels, so
that the defect width is smaller (in pixels) and therefore slightly filtered along
with the Gibbs ringing; see also Table 3.12. Again superposition effects of Gibbs
ringing were visible with the added complexity of having a defect with a differ-
ent signal loss for each sequence (as described in Methods, the signal loss of
the defect is 50% of the myocardial signal). This was responsible for the slightly
different signal loss in the h-EPI sequence at the three resolutions in the non
filtered data (Figure 3.27 b).
Figure 3.29 a-c shows the Gibbs/defect SL% ratio for the h-EPI, bSSFP, and
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resolution sequence
Gibbs DRA defect+DRA defect+Hamming
mm px mm px mm px
128x128
h-EPI 2.8 1.0 9.0 3.1 8.3 2.9
bSSFP 2.8 1.0 8.9 3.1 8.0 2.8
GRE 2.8 1.0 8.9 3.1 8.0 2.9
160x160
h-EPI 2.1 0.9 7.0 3.0 8.6 3.7
bSSFP 2.1 0.9 7.0 3.0 8.2 3.5
GRE 2.1 0.9 7.0 3.0 8.2 3.5
192x192
h-EPI 1.8 1.0 6.8 3.5 8.7 4.5
bSSFP 1.9 1.0 6.6 3.4 8.6 4.5
GRE 1.9 1.0 6.6 3.4 8.6 4.5
Table 3.13: Gibbs DRA, DRA+defect, DRA+defect Hamming filtered width in
mm and real pixel size. Note that the real pixel size is the pixel size without
considering the zero-filling interpolation.
GRE sequence respectively, for the same matrix sizes as Figure 3.27 (128×128,
160×160, and 192×192) as a function of the filter used. For all resolutions as the
filtering weight was increased the contribution of the Gibbs DRA for the total
signal loss decreased in relation to the contribution of the defect, as expected.
The ratio decreased sharply as the defect is reduced by the Tukey r=1.0 (Hann)
and Hamming. h-EPI had a different contrast between the LV and myocardium
showing different ratios, while the similar contrast between the bSSFP and GRE
resulted in very similar values. Figure 3.29 serves to show that a possible loss of
signal in the subendocardium is going to be largely due to a real defect and not
to Gibbs if Hann and especially if Hamming filtering is used. Therefore, for all
further simulation work involving filters, only the Hamming filter was tested.
The measured width of the DRA with no filtering was constant at approxi-
mately one pixel for all the resolutions, as expected from theory, Table 3.13. It
is perhaps useful to remind the reader of the dimensions of the phantom: LV
diameter 31 mm, epicardial diameter 62 mm, myocardial wall thickness 15.5
mm. Due to the nulling of the DRA with the Hamming filter it was not pos-
sible to measure its width with the Hamming filter. The width of the simu-
lated perfusion defect was programmed at 45% of the myocardial thickness,
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Figure 3.29: Gibbs/defect depth ratio for the 128x128, 160x160, and 192x192
matrices as a function of filter type, in the h-EPI (a), bSSFP (b), and GRE (c)
sequence. (The erratic 192x192 no filter point is as previously discussed.)
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i.e. 7.0 mm, and always wider than the Gibbs first lobe. At the lower resolu-
tion of 128x128, the combination of the defect plus the Gibbs ringing resulted
in a width, which was wider than the defect, while for the higher resolutions
of 160x160 and 192x192, the width measured was close to the simulated width.
When using the Hamming filter, the Gibbs ringing was nulled which reduced
slightly the width of the defect for the lower resolution as expected, although
for all three resolutions, the width measured was higher than the input width
(average increase of 1.3 mm), indicating the blurring effect of the filter.
3.3.3.1.1 Filtering and defect width
A further investigation on the visibility of perfusion defects, which may be
compromised by the use of filtering against Gibbs DRA, is shown in the next set
of results.
In figure 3.30 it is shown the SL% as a function of the resolution for 4 differ-
ent defect widths, ranging from 20 % to 80 % of the myocardial wall thickness
for the bSSFP sequence. Table 3.14 shows the defect dimensions in pixels for
each width and for each phase-encode resolution.
Figure 3.30 a shows the defect (with variable width)+Gibbs SL%, and Figure
3.30 b shows the effect of using the Hamming filter. In plot a and more detailed
in Table 3.15 it can be seen that in general as long as the defect was wider than
one pixel, the signal loss was approximately the sum of the defect signal loss
plus the Gibbs contribution, i.e. 50%+ 47% respectively. Again, these values
vary slightly due to different superpositions of Gibbs ringing plus the defect.
Plot b and Table 3.16, show that if a Hamming filter is used to greatly reduce
Gibbs artifacts, then the same filter would not reduce significantly the signal
loss introduced by the real defect (≤ 10 SL% reduction when compared to the
non filtered data), as long as the defect is wider than approximately 2.5 pixels.
However, when a real perfusion defect width is two pixels or less, its visibility
reduction due to filtering cannot be considered negligible. At typical first-pass
image resolution, this is a severe limitation, implying reduced sensitivity to de-
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Figure 3.30: SL% as a function of the resolution for 4 different defect widths
for the bSSFP sequence. a) Without filtering, b) Hamming filtered. The plots
include lower-phase-encode resolutions in a square FOV. These measure-
ments of signal loss and width were done along the phase encode direction.
res.
20%=3.1mm 40%=6.2mm 60%=9.3mm 80%=12.4mm
px px px px
128x96 0.8 1.6 2.4 3.2
128x112 0.9 1.9 2.8 3.8
128x128 1.1 2.1 3.2 4.3
160x112 0.9 1.9 2.8 3.8
160x144 1.2 2.4 3.6 4.8
160x160 1.3 2.7 4.0 5.4
192x128 1.1 2.1 3.2 4.3
192x160 1.3 2.7 4.0 5.4
192x192 1.6 3.2 4.8 6.4
Table 3.14: Simulated defect width in pixels ranging from 20% to 80 % of the
myocardial wall thickness for each resolution matrix along the phase-encode
direction.
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res.
0% 20% 40% 60% 80%
px SL% px SL% px SL% px SL% px SL%
128x96 1.0 -41 1.1 -62 1.4 -94 2.7 -98 3.1 -93
128x112 0.9 -55 1.0 -85 1.3 -97 2.9 -96 3.2 -97
128x128 1.0 -52 1.1 -85 1.5 -97 2.9 -98 3.2 -98
160x112 0.9 -49 1.1 -78 1.4 -98 2.9 -97 3.3 -98
160x144 1.0 -43 1.2 -81 3.1 -100 3.5 -97 4.8 -97
160x160 0.9 -51 1.2 -97 2.9 -98 4.8 -97 5.1 -97
192x128 1.0 -52 1.1 -85 1.5 -97 3.2 -98 3.7 -98
192x160 0.9 -47 1.2 -94 2.9 -98 4.8 -99 5.1 -98
192x192 1.0 -42 1.3 -96 3.2 -94 5.1 -96 6.3 -98
Table 3.15: SL% and width in pixels (px) for each % wall-thickness defect
width and for each matrix size for the bSSFP sequence. Note: signal loss mea-
sured along the phase-encode direction.
res.
20% 40% 60% 80%
px SL% px SL% px SL% px SL%
128x96 0.9 -4.1 1.5 -21 1.9 -39 2.0 -49
128x112 1.3 -5.5 2.1 -28 2.5 -45 2.7 -51
128x128 2.2 -8.7 2.7 -35 3.1 -49 3.3 -51
160x112 1.3 -5.5 2.1 -27 2.5 -45 2.7 -51
160x144 1.9 -12 2.9 -40 3.6 -51 4.0 -52
160x160 2.2 -14 3.0 -44 4.2 -51 4.7 -51
192x128 2.2 -8.7 2.7 -35 3.1 -49 3.3 -51
192x160 2.2 -14 3.0 -44 4.2 -51 4.7 -51
192x192 2.4 -22 4.5 -50 5.2 -52 5.9 -52
Table 3.16: SL% and width in pixels (px) for each % wall-thickness defect
width and for each matrix size for the bSSFP sequence with the Hamming
filter.
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fects that are less than approximately 7 mm thick. This strongly suggests that
inplane filtering by Hamming is inadvisable at current typical spatial resolu-
tions.
3.3.3.1.2 Filtering and defect contrast-to-noise ratio
The effect of Hamming filtering on the visibility of perfusion defects is not
complete without some considerations on image noise; therefore it was also
analysed with realistic noise levels of perfusion images. The magnitude images
without and with noise for the bSSFP sequence are shown in Figure 3.31. Al-
though it is easily seen that the Hamming filter reduces the noise, the earlier
results showed that the filter also weakens the depth of thinner defects. There-
fore the relevant question is: how does filtering affect the contrast-to-noise ra-
tio of a perfusion defect?
The noise of the magnitude images, before and after Hamming filtering, was
measured and is shown in figure 3.32. The noise level is consistently reduced
by almost 2/3, when using the Hamming filter, and not surprisingly this 2/3 re-
duction showed no relation with the pulse sequence or image matrix size used.
The filtering may reduce the contrast of a perfusion defect as shown in fig-
ure 3.30 although at the same time the noise is reduced. Therefore, using the
Hamming filter can possibly maintain or even improve the CNR as long as a
real perfusion defect exceeds some minimal width. For example, for a resolu-
tion of 3.9 mm per pixel (96 phase-encode lines) and a perfusion defect width
of 6 mm (40 % of the simulated width of the myocardial wall), the SL% of the
defect alone was 50%, the contrast to the myocardial signal in the bSSFP se-
quence was therefore 26.7 (A.U.). With the Hamming filter, the SL% reduced
to 21% ≡ 11.2 (A.U.). The noise before and after Hamming filtering was 8.19
and 2.53 respectively (Figure 3.32). Therefore the CNR of the defect increased
from 3.3 (A.U.) to 4.4 (A.U.) with the Hamming filter for this particular example.
The CNR of the defects before and after Hamming filtering were compared for
all resolutions and for all defect widths. This comparison is shown in Tables
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Figure 3.31: a), d), and g) show the magnitude images with Gibbs ringing
and a real perfusion defect with a 40 % myocardial thickness at a 50 SL%. Im-
ages b), e), and h) show the same magnitude images as in a), d), and g) re-
spectively, but with simulated realistic noise levels. Finally images c), f), and
i) show images b), e), and h) after being Hamming filtered.
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Figure 3.32: Noise measured in A.U. for the three sequences with and with-
out Hamming filtering.
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res.
20% 40% 60% 80% all widths
Hamm Hamm Hamm Hamm unfilt
128x96 0.80 4.2 7.6 9.4 4.2
128x112 1.2 5.6 8.9 10 3.5
128x128 1.5 5.8 8.1 8.4 3.0
160x112 1.3 6.1 9.7 11 3.5
160x144 2.2 7.3 9.2 9.3 3.0
160x160 1.8 5.3 6.2 6.2 2.3
192x128 2.0 7.7 11 11 3.7
192x160 2.2 6.4 7.4 7.4 2.7
192x192 2.8 6.0 6.3 6.3 2.2
Table 3.17: CNR values of the myocardial defects for each % wall-thickness
with the Hamming filter and also for the defects of the unfiltered images for
the h-EPI sequence.
res.
20% 40% 60% 80% all widths
Hamm Hamm Hamm Hamm unfilt
128x96 0.87 4.4 8.3 10 3.3
128x112 1.0 5.0 8.2 9.2 2.7
128x128 1.5 6.0 8.4 8.8 2.8
160x112 1.0 5.0 8.3 9.3 3.0
160x144 1.8 6.2 7.9 7.9 2.9
160x160 2.2 6.9 8.0 8.0 2.7
192x128 1.6 6.4 9.2 9.5 3.3
192x160 2.5 7.7 9.0 9.0 3.0
192x192 2.5 5.8 6.0 6.0 2.5
Table 3.18: CNR values of the myocardial defects for each % wall-thickness
with the Hamming filter and also for the defects of the unfiltered images for
the bSSFP sequence.
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res.
20% 40% 60% 80% all widths
Hamm Hamm Hamm Hamm unfilt
128x96 0.88 4.4 8.4 10 3.4
128x112 1.0 5.2 8.5 9.5 2.9
128x128 1.2 4.8 6.8 7.1 2.7
160x112 1.2 5.9 9.7 11 3.0
160x144 1.9 6.5 8.3 8.4 3.3
160x160 2.0 6.4 7.5 7.5 2.8
192x128 1.8 7.2 10 10 3.4
192x160 2.3 7.0 8.2 8.2 3.0
192x192 3.2 7.4 7.7 7.6 2.6
Table 3.19: CNR values of the myocardial defects for each % wall-thickness
with the Hamming filter and also for the defects of the unfiltered images for
the GRE sequence.
3.17-3.19 for the h-EPI, bSSFP, and GRE sequences respectively.
In general the CNR of the defect increases with the Hamming filtering, when
compared to the non filtered data, for defect widths ≥ 40% of the myocardial
wall thickness. For these defect thicknesses, the Hamming filter can possibly
enhance the sensitivity for detection of a real perfusion defect while simulta-
neously improving specificity by reducing Gibbs artifacts.
3.3.3.2 Motion artifacts
Most of the motion artifact results include Gibbs artifacts since no filtering was
used in the motion simulations, with the exception of the final section where
the effect of Hamming filtering was tested.
Figure 3.33 shows the simulations for the h-EPI sequence, at three different
resolutions and for the three different cardiac phases (R-kc times) as described
in Methods. The same resolutions and R-kc times are shown in Figures 3.34,
and 3.35 for the bSSFP and GRE sequences respectively.
For the bSSFP and GRE sequences, the visual appearance of the motion ar-
tifacts was very similar. This similarity would be expected because in these re-
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Figure 3.33: Motion simulations for the h-EPI sequence: a)-c) 128x128 ma-
trix with R-kc times: 120, 310, and 410 ms. d)-f) the same as a)-c) but for a
160x160 matrix. g)-i) the same as a)-c) but for a 192x192 matrix.
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Figure 3.34: Motion simulations for the bSSFP sequence: a)-c) 128x128 ma-
trix with R-kc times: 120, 310, and 410 ms. d)-f) the same as a)-c) but for a
160x160 matrix. g)-i) the same as a)-c) but for a 192x192 matrix.
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Figure 3.35: Motion simulations for the GRE sequence: a)-c) 128x128 matrix
with R-kc times: 120, 310, and 410 ms. d)-f) the same as a)-c) but for a 160x160
matrix. g)-i) the same as a)-c) but for a 192x192 matrix.
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sults the sequences had identical phase-encode orders and similar image ac-
quisition time; furthermore, the simulations took no account of possible bSSFP
sensitivity to motion-induced phase shifts [Bieri and Scheffler, 2005] or through-
plane motion effects on bSSFP signal stabilisation. In both sequences, at 120
and 410 ms, there was a near-circumferential DRA in the subendocardium,
coupled with a blurred border in the phase and diagonal directions. This DRA
tended to be weaker along the frequency-encode direction with no blurring.
The motion-induced DRA was not strong for the 310 ms R-kc when its appear-
ance was more similar to the Gibbs results than at the other two R-kc times,
although it was slightly darker.
A different DRA appearance was visible for the h-EPI sequence in Figure
3.33 as would be expected because of the different phase-encode acquisition
order (interleaved centric order). The lower resolution image at end-systole
had a similar appearance to the Gibbs simulations, while cardiac motion at R-
kc times 120ms and 410ms appeared to reduce Gibbs DRA. This may be as-
cribed to the blurring of the sharp subendocardial border. As the resolution in-
creased, the Gibbs artifacts again were seen to decrease in scale drastically and
motion artifacts became visible in the form of ghosting of the bright LV blood
pool in the phase-encode direction. These artifacts were no longer a dark rim in
the subendocardial region but were more distributed along the phase-encode
through the myocardium. More measurements of all these artifacts are pre-
sented in Subsection 3.3.3.2.4.
3.3.3.2.1 PSF analytical analysis for the ECE phase acquisition order
Before moving further, it is perhaps useful to stop here in order to determine
the role of Gibbs and motion artifacts separately in the DRAs shown in Fig-
ures 3.33-3.35. The radial motion effects can be analysed in terms of the 2D
PSFs of motion and Gibbs convolved with a simulated short-axis magnitude
image. The subendocardial effects of the radial motion in the simulated short-
axis images were approximated to a bulk motion along the frequency-encode
direction for the edge perpendicular to the same direction or motion along the
phase-encode direction for an edge perpendicular to the phase-encode, Figure
3.36.
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Figure 3.36: Short-axis magnitude image indicating the direction of the fre-
quency and phase-encode bulk motion. The coloured rectangles indicate the
edges that are going to be analysed in the following results (red for the bulk
motion along the frequency-encode direction, and green for a bulk motion
along the phase-encode direction).
The 2D motion PSF in k-space for a bulk motion was calculated for the ECE
and for the h-EPI phase-encode acquisition orders by using equation (2.22).
The motion PSFs were convolved with a simulated short-axis image after be-
ing Fourier transformed into the image space* in order to analytically study the
effects of motion.
The numerical simulations of Gibbs alone have been simulated and shown
in the previous section, analytically Gibbs can also be simulated by convolving
the Gibbs PSF (given in equation (2.38)) with the short-axis image.
The short-axis image (Figure 3.36) input to convolution was created directly
in the magnitude space; therefore, it contains no Gibbs truncation artifacts.
The SI values for the short-axis image were chosen to be identical to the
bSSFP and h-EPI magnitude images for the ECE and h-EPI acquisition orders
respectively. This enabled the comparison of these analytical results with the
previous simulated results.
The analysis was made for the following example: matrix size 192x192; R-kc
time of 120 ms (peak radial velocity ≈ 30 mm/s; this velocity was considered
constant in this analysis.). The protocol (FOV, parallel imaging with R=2, TR,
*The PSFs shown in the following figures are all in the image space after FT.
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Figure 3.37: Figure showing from left to right, the zoomed Gibbs PSF, the
zoomed short-axis magnitude image convolved with the PSF, the correspond-
ing unzoomed images, and the line profiles across the centre of the short-axis
along the frequency and phase-encode direction respectively. The red rectan-
gle in the unzoomed images represent the zoom region.
etc) was kept identical to the simulations of the bSSFP and h-EPI cases.
The Gibbs PSF convolution with the simulated short-axis image is shown
in Figure 3.37 for the bSSFP signal contrast only. The obtained Gibbs under-
shoot of the line profiles was similar to the SL% measured in the previous sec-
tion (8.6% and 10% of the contrast between the LV and myocardium along the
phase and frequency-encode direction). The Gibbs artifacts are similar along
the frequency and phase-encode direction as expected, although small differ-
ences exist due to the fact that no k-space based interpolation is used (this topic
is discussed further in section 3.2).
It must be emphasised that for a contracting short-axis image, the motion
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PSF is obviously spatially variant but this simple bulk motion model is used for
each section of the endocardial border.
Motion effects alone were analysed starting with the effects of contraction
and expansion in the border perpendicular to the phase encode direction by
convolving the 2D PSF of a constant velocity (30 mm/s) displacement along
the phase-encode direction. The motion PSF (magnitude and phase) and the
convolved short-axis are shown in Figure 3.38 and 3.39 for the h-EPI and ECE
phase-encode acquisition orders respectively.
Note that the PSF for the ECE order was calculated with a 1 mm resolution,
the sequential ordering allowed a sub-pixel resolution. For the h-EPI, because
of the non continuous phase-encode order, the PSF was calculated with a 1
pixel (1.9 mm for the 370x370 mm FOV) resolution, therefore showing a lower
resolution. The convoluted short-axis h-EPI images were then slightly enlarged
(bicubic interpolation) to the same size as the ECE one for further analysis.
For the h-EPI acquisition order, the motion along the phase-encode direc-
tion creates ringing and ghosting of the bright LV along the same direction. No
artifacts are seen along the frequency-encode direction. For the ECE acquisi-
tion order, the motion artifacts from a phase-encode displacement can be seen
to also create ringing all around the phase-encode and diagonal directions.
This ringing is responsible for the blurring of the endocardial border along the
same direction. The ringing frequency increased away from the discontinuity,
as expected from theory (section 2.5.1). The ringing for the ECE order is worse
when compared with the h-EPI order with a worse signal loss in the blurred
subendocardial border. No significant DRAs are produced in the subendocar-
dial region with the h-EPI acquisition order. Note that the relevant edges are
moving in the same direction, simulating at the same time a contraction and
dilation.
The effects of the PSF were not surprising when zooming in at the cen-
tre, Figure 3.38 and 3.39. For the h-EPI case (Figure 3.38) the magnitude PSF
showed sidelobes along the phase-encode with a lower brightness, responsible
for the ghosting. The phase PSF shows rapid phase oscillations in the same po-
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Figure 3.38: Figure showing from left to right: the phase-encode motion
PSF (magnitude and phase respectively) for the h-EPI acquisition order and
the convolution of the PSF with the short-axis image with an arrow indicating
the bulk motion direction. The PSF images on the bottom show the zoomed
central region demarcated by the blue dashed rectangle. The phase PSF image
is also thresholded to the magnitude image, i.e. the phase values were nulled
(grey) for the corresponding magnitude points with< 10% of the peak magni-
tude. The coloured green rectangle shows the relevant borders to the motion
analysis. (Phase-encode direction horizontal).
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Figure 3.39: Figure showing from left to right: the phase-encode motion
PSF (magnitude and phase respectively) for the ECE acquisition order and the
convolution of the PSF with the short-axis image with an arrow indicating the
bulk motion direction. The PSF images on the bottom show the zoomed cen-
tral region demarcated by the blue dashed rectangle. The phase PSF image
is also thresholded to the magnitude image, i.e. the phase values were nulled
(grey) for the corresponding magnitude points with< 10% of the peak magni-
tude. The coloured green rectangle shows the relevant borders to the motion
analysis. (Phase-encode direction horizontal).
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sitions as the sidelobes, therefore ringing and ghosting of the image edges are
expected along the phase-encode and diagonal directions. For the ECE acqui-
sition order (Figure 3.39), the magnitude PSF appears to be spread out along
the phase-encode also coupled with quick phase oscillations in the phase PSF.
These phase oscillations increased away from the centre. Again ringing is there-
fore expected in the image edges along the phase and diagonal directions with
increasing frequency. It must be emphasised that the anti-phase sidelobes are
crucial to produce myocardial DRAs from bright blood.
A similar analysis was made for a bulk motion along the frequency-encode
direction using the same constant velocity of 30 mm/s, Figure 3.40-3.41.
In the h-EPI acquisition order, the effects of a bulk displacement in the
frequency-encode direction again created ghosting of the bright LV along the
phase-encode direction but only for the edges with a diagonal orientation. Some
less significant ringing was observed along the frequency-encode direction.
For the ECE acquisition order, ringing with an increasing frequency away
from the edge was again seen; also only visible in the diagonal regions of the
disk. The edges along the phase and frequency-encode direction were not blurred
or had any ringing (apart from the intersection of the ringing coming from the
diagonal directions in the LV blood pool). These effects are again expected from
theory covered in section 2.5.1.
It seems perhaps paradoxical that although the border perpendicular to the
frequency-encode direction was moving during image acquisition, it contains
no motion artifacts. Storey et al. [2002] calculated the analytical formula for
the PSF in the image-space for motion along the frequency-encode direction
for the ECE acquisition order (Figure 3.41) and obtained an expression that de-
pended on the product of the position in the frequency and phase encode di-
rections; therefore, it was concluded that tissue boundaries would only have
artifacts if having components in both the phase and frequency-encode direc-
tions as shown in these results. It is also obvious from the phase PSF from Fig-
ure 3.41; the phase PSF only oscillates from negative to positive in the diagonal
directions.
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Figure 3.40: Figure showing from left to right: the frequency-encode mo-
tion PSF (magnitude and phase respectively) for the h-EPI acquisition order
and the convolution of the PSF with the short-axis image with an arrow in-
dicating the bulk motion direction. The PSF images on the bottom show the
zoomed central region demarcated by the blue dashed rectangle. The phase
PSF image is also thresholded to the magnitude image, i.e. the phase values
were nulled (grey) for the corresponding magnitude points with < 10% of the
peak magnitude. The coloured red rectangle shows the relevant borders to
the motion analysis. (Phase-encode direction horizontal).
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Figure 3.41: Figure showing from left to right: the frequency-encode mo-
tion PSF (magnitude and phase respectively) for the ECE acquisition order
and the convolution of the PSF with the short-axis image with an arrow indi-
cating the bulk motion direction. The PSF images show the zoomed central
region demarcated by the blue dashed rectangle. The phase PSF image is also
thresholded to the magnitude image, i.e. the phase values were nulled (grey)
for the corresponding magnitude points with < 10% of the peak magnitude.
The coloured red rectangle shows the relevant borders to the motion analysis.
(Phase-encode direction horizontal).
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Figure 3.42: Line profiles of the short-axis convoluted with the motion PSFs
for the h-EPI acquisition order. Left: line profile along the phase-encode di-
rection for a bulk motion along the same direction. Right: line profile along
the frequency-encode direction for a bulk motion along the same direction.
The arrows on top indicate the direction of the motion.
Sidelobes were again visible along the phase-encode direction but with a
spread along the frequency-encode when zooming in on the centre of the PSFs
for the h-EPI acquisition order (Figure 3.40). This was again coupled with rapid
phase oscillations visible in the phase PSF. The end result was a similar ghost-
ing effect but only along the diagonal components of the bright LV blood pool
edges, coupled with minor ringing along the frequency-encode direction.
For the ECE acquisition order (Figure 3.41) a spread PSF was visible along
the phase-and frequency-encode direction with a squared shape. Inside the
square, magnitude radial oscillations were seen. This blurred PSF was coupled
with quick phase oscillations along the diagonal directions, responsible for the
visible diagonal ringing close to the short-axis edges.
Line profiles along the frequency and phase-encode direction crossing the
centre of the motion convoluted short-axis images are shown in Figures 3.42
and 3.43 for the h-EPI and ECE acquisition orders respectively.
In the line profiles for the h-EPI acquisition order no significant signal loss
in the subendocardium (where DRAs commonly appear) was seen; although
some of the LV ghosting in the LV blood pool can be seen in the line profiles.
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Figure 3.43: Line profiles of the short-axis convoluted with the motion PSFs
for the ECE acquisition order. Left: line profile along the phase-encode direc-
tion for a bulk motion along the same direction. Right: line profile along the
frequency-encode direction for a bulk motion along the same direction. The
arrows on top indicate the direction of the motion.
This may be due mainly to its shorter imaging time.
For the ECE acquisition order, motion along the phase-encode direction
created highly visible ringing along the phase-encode direction. The first mo-
tion ringing undershoot in the border was darker than the Gibbs undershoot at
approximately 24% the contrast between the LV and myocardium signal. For
the motion along the frequency-encode direction, the line profile showed ring-
ing that also originated from the diagonal motion artifacts.
All line profiles shown in Figures 3.42 and 3.43 were approximately symmet-
rical (there are some differences due to different pixel averaging), indicating
that the motion artifacts were not dependent on the direction of the velocity,
i.e. the same artifacts are expected from a contraction or expansion at the same
velocity.
3.3.3.2.2 Combined discussion of PSF theory and simulated image results
In the ECE acquisition order, the motion PSFs are not dependent on the pixel
size, therefore the motion artifacts ringing is the same for all resolutions as long
as the TR does not change. In figures 3.34-3.35 the distance of the motion-DRA
into the myocardium appeared similar for all three resolutions. The visibility
is thus highly dependent on the pixel size, with different sizes averaging the
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ringing differently. This effect is similar in some ways to the Gibbs dependency
on the border position inside a pixel (section 3.2).
The motion artifacts for the h-EPI order do depend on the resolution. As it
can be seen in Figure 3.33, the LV ghosting position does change with resolu-
tion, being more close to the LV centre for the higher matrix size of 192x192.
3.3.3.2.3 Combined Gibbs and motion
To finish this analysis, the effects of Gibbs and motion were combined and a
comparison was made between the analytical results and the numerically sim-
ulated ones. From the previous PSF analysis it is now possible to analyse the
contribution of motion and Gibbs separately. A radial contraction of the simu-
lated short-axis image (from the numerical simulations) can be approximated
to the effects of convolving the short axis image (from the analytical analysis)
with the PSF of a bulk motion (along the phase-encode direction for the edge
perpendicular to this direction, and for a motion along the frequency-encode
direction for the edge perpendicular to this direction), followed by the PSF of
Gibbs. This comparison is shown in Figures 3.44-3.45 for the h-EPI and ECE
acquisition orders respectively.
In Figure 3.44, the numerical simulations and analytical analysis yielded
similar results. The magnitude images showed the same LV ghosting along the
phase-encode direction. From the PSF analysis, it is now known that the LV
ghosting originated from motion along both the frequency and phase-encode
directions. No significant subendocardial undershoot was produced indicat-
ing that Gibbs artifacts were reduced by the h-EPI motion artifacts. This effect
can be seen for example on the magnitude image with motion along the phase-
encode (Figure 3.44); the edge perpendicular to the phase-encode direction did
not have any visible Gibbs ringing. The same effect was seen in the edge per-
pendicular to the frequency-encode direction. Therefore in a radial contrac-
tion/expansion all edges will have reduced Gibbs ringing due to motion arti-
facts.
One interesting phenomenon for the h-EPI is visible in both the numeri-
cally simulated and analytical calculated images (Figure 3.44): the LV ghosting
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Figure 3.44: h-EPI acquisition order. From left to right; Top row: Numerical
simulated short-axis image with motion and Gibbs artifacts, analytical anal-
ysis short-axis image with motion in the phase-encode direction and Gibbs,
analytical analysis short-axis image with motion in the frequency-encode di-
rection and Gibbs. Middle row: Line profiles along the phase-encode direc-
tion for the correspondent images on the top row. Bottom row: Line profiles
along the frequency-encode direction for the correspondent images on the
top row. The coloured lines show the direction of the line profiles.
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Figure 3.45: ECE acquisition order. From left to right; Top row: Numerical
simulated short-axis image with motion and Gibbs artifacts, analytical anal-
ysis short-axis image with motion in the phase-encode direction and Gibbs,
analytical analysis short-axis image with motion in the frequency-encode di-
rection and Gibbs. Middle row: Line profiles along the phase-encode direc-
tion for the correspondent images on the top row. Bottom row: Line profiles
along the frequency-encode direction for the correspondent images on the
top row. The coloured lines show the direction of the line profiles.
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creates an overshoot of signal in the LV while when superimposed in the my-
ocardium the effect is reversed, i.e. it creates an undershoot of the signal. Al-
though no DRA was seen, this undershoot can potentially create a DRA in the
subendocardium for higher resolutions when the LV ghosting becomes closer
to the subendocardial border. This is attributed to the anti-phase sidelobes of
the PSF (Figure 3.38).
For the ECE phase-acquisition order (Figure 3.45), similar to the results for
the h-EPI order, the combined effects of motion and Gibbs were similar in the
border of both numerical simulation, and the corresponding edge in the ana-
lytical approach. The ringing visible along the frequency-encode direction was
mainly created by Gibbs with a small addition of motion ringing in the first lobe
(both undershoot and overshoot). The ringing along the phase-encode direc-
tion and diagonal regions was a mixture of both Gibbs and motion artifacts,
with the latter being more dominant. The loss in sharpness along the phase-
encode direction was evident in the line profiles along the same direction. The
motion DRAs will therefore be slightly deeper into the mid-wall with a blurred
endocardial border in the phase-encode direction; in vivo this would perhaps
tend to make the motion DRA appear deeper into the myocardium than does
the Gibbs DRA. This effect is speculated to be the origin of a deeper DRA seen
in vivo in Figure 2.32 (Section 2.7).
In this analysis, the radial motion was approximated to a basic bulk mo-
tion at constant velocity, nevertheless the simulated line profiles exhibit simi-
lar ringing and undershoots in the subendocardial border and LV. This analysis
was a theoretical foundation that helped understanding the role of motion and
Gibbs separately.
3.3.3.2.4 Measurements of DRAs from simulated motion images
The PSF analytical description is now finished and we resume the numeri-
cal simulated motion results with the measurement of the SL% of the motion
artifacts. Figures 3.46-3.48 show the measurements (from Figures 3.33-3.35)
for the DRA’s SL% and width, for the h-EPI, bSSFP, and GRE sequences respec-
tively. The measurements are displayed for the phase (plots a-b) and frequency-
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Figure 3.46: Motion simulation results for the h-EPI sequence: a)-b) the per-
centage of signal loss and the width of the DRAs respectively in a line profile
along the phase-encode direction with R-kc times: 120, 310, and 410 ms. c)-d)
similar to a)-b) but for line profiles along the frequency-encode direction.
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Figure 3.47: Motion simulation results for the bSSFP sequence: a)-b) the
percentage of signal loss and the width of the DRAs respectively in a line pro-
file along the phase-encode direction with R-kc times: 120, 310, and 410 ms.
c)-d) similar to a)-b) but for line profiles along the frequency-encode direc-
tion.
encode direction (plots c-d).
phase-encode direction
For the h-EPI (plot 3.46 a) in the phase-encode direction, as the resolution
increases the DRAs SL% decreased during contracting and dilating stages. At
end-systole the SL% is more constant. From the PSF analysis, we concluded
that motion artifacts do not produce DRAs and reduce Gibbs SL% for the h-EPI
sequence. These results agree, showing that when motion is an important fac-
tor (R-kc times of 120, and 410 ms) the SL% in the subendocardial is reduced.
The DRA depth measurement is made in the proximity of the subendocardial
border, since this is where DRAs usually appear. The h-EPI did not exhibit in-
creased motion-related DRA with imaging time in this location. However from
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Figure 3.48: Motion simulation results for the GRE sequence: a)-b) the per-
centage of signal loss and the width of the DRAs respectively in a line profile
along the phase-encode direction with R-kc times: 120, 310, and 410 ms. c)-d)
similar to a)-b) but for line profiles along the frequency-encode direction.
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Figure 3.33 clearly the dark band across the myocardium in the phase-encode
direction (with elliptical shape and minor axis = LV diameter) became stronger
with increasing resolution.
For the bSSFP and GRE sequences (plots 3.47 a, and 3.48 a) an increase in
the resolution was generally associated with an increased severity of the DRA in
the phase-encode direction. Storey et al. [2002] showed that for the bSSFP and
GRE phase-encode acquisition orders, the amplitude of the motion artifacts
depended on the signal contrast only. Therefore the increase of SL% as resolu-
tion increases must be attributed to changes in the complex superposition of
Gibbs and motion ringing in both borders (endocardial and epicardial). The
difference in SL% between different R-kc times can also be in part attributed to
different myocardial wall thickness with subsequent ringing superpositions.
frequency-encode direction
For the h-EPI in the frequency-encode direction (plots 3.46 c), the DRA SL%
improved with resolution (worse signal losses for the R-kc time of 310 ms). For
bSSFP and GRE in the frequency-encode direction (plots 3.47 c, and 3.48 c), the
SL% improved as resolution increased as well.
This similarity between the results of the three sequences for the SL% along
the frequency-encode direction is expected due to the fact that motion arti-
facts appear mainly along the phase and diagonal directions. Nevertheless,
from the PSF analysis it was shown that for both acquisition orders (ECE, h-
EPI), in the case of a circular disk, motion artifacts (ringing and blurring) were
seen even along the exact frequency-encode direction. An interaction between
Gibbs and motion artifacts can possibly explain the decrease with resolution.
The inevitable mixture of Gibbs and motion artifacts in these measurements
again makes it difficult to draw conclusions.
For the h-EPI sequence (Figure 3.46) the width of the DRA at the lower res-
olutions is similar to the one measured in the motion simulations for the GRE
and bSSFP sequences in both directions; although, as resolution increases, dur-
ing peak-systole and peak-diastole, the signal loss approaches zero and the
width becomes non-significant (this explains the non-significant peak seen for
the R-kc time of 410 ms). Notice that in both directions the width is approxi-
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mately constant at one pixel for all resolutions as expected from Gibbs artifacts
alone.
The DRA’s width is similar for both the bSSFP and GRE sequences (plots 3.47
b, d and 3.48 b, d) as expected. In the phase-encode direction it ranges from 4
to 2 mm, while in the frequency-encode direction it ranges from 3 to 1 mm.
Along the frequency-encode direction, where Gibbs artifacts are dominant, it is
easily seen that the width of the artifacts scales with the frequency-encode res-
olution as expected, although the width for the higher resolution of 192 is a bit
smaller than one pixel (width expected from Gibbs alone). From theory, along
the phase-encode direction the width of the motion artifacts should be con-
stant although, again, there is the added complexity of interaction with Gibbs
ringing.
In general, the motion simulations indicate that when the motion artifacts
are less severe (310 ms R-kc time and h-EPI lower resolution images), the DRA’s
peak signal loss and width is close to the values obtained in the Gibbs simu-
lations. For all other cases the signal loss and width diverge from these values
due to a complex interaction (both constructively and destructively) between
Gibbs and motion. Figures 3.34 and 3.35 show that motion artifacts, for the
bSSFP and GRE sequences, are localised mainly in the phase-encode and diag-
onal directions of the subendocardium and manifest as ringing with a blurred
endocardial border. For the h-EPI sequence, Figure 3.33, no significant sub-
endocardial DRAs are visible, instead a ghosting of the bright LV blood pool is
visible, located in the phase-encode direction.
3.3.3.2.5 Stress/rest motion differences
To evaluate the sensitivity of the motion artifacts to possible myocardial ve-
locity differences between stress and rest, the motion simulations were repeated
with the radial speeds decreased by 20 %, i.e. at the measured velocities given
by Jung et al. [2006] at rest, Figure 3.24. A comparison of the signal loss and
width of the artifacts between rest and stress during diastolic filling (the most
rapid motion) is shown in figure 3.49 a-d for the bSSFP and h-EPI sequence.
The magnitude images at rest and stress are also shown during diastolic filling
for both sequences, figure 3.49 e-h.
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As expected, the effects of motion at rest in both sequences were similar to
the respective stress results. Along the frequency-encode direction there was a
strong similarity for the width of the two sequences at rest and at stress due to
weak motion artifacts along this direction. Along the same direction, the SL%
was worse, in general, at rest for both sequences when compared to at stress.
In the phase-encode direction, from the theory of motion artifacts, wider
DRAs would be expected with a similar SL% at stress when compared to rest
for the bSSFP sequence. These results were somewhat different from the ob-
served ones possibly due to the complex mixture of Gibbs and motion artifacts,
although as expected for h-EPI, the SL% was worse at rest along the same di-
rection because motion artifacts were weaker (which tend to reduce Gibbs ar-
tifacts in the h-EPI acquisition order) and therefore Gibbs ringing was more
prominent.
In conclusion, motion artifacts coupled with Gibbs are not very different at
rest when compared to the same results at stress (increase of 20% in the veloc-
ity) for both acquisition orders.
3.3.3.2.6 Motion comparison of phase-encode acquisition orders
Different phase-encode acquisition orders were also compared in the bSSFP
sequence, to examine how these affect the “inter-view” motion artifacts. As
described in methods (section 3.3.2) the bSSFP simulation was used simply for
strong blood/myocardial contrast. No modelling of the probable eddy current
effects due to different phase-encode orderings [Bieri et al., 2005] on the bSSFP
steady-state was included in this work.
The magnitude images are shown in Figure 3.50 for the 192x192 resolution
at three different cardiac phases and for four different phase-encode orders.
The respective R-kc times are shown in Table 3.10.
The 226 ms R-kc time (i.e. imaging during peak systole) with the EC tra-
jectory showed very prominent motion artifacts, with deeper signal loss which
was also wider than the corresponding ECE trajectory. At 526 ms (i.e. imaging
during peak diastole) the EC trajectory did not show any DRA apart from some
Gibbs ringing in the frequency-encode direction, which was the direction least
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Figure 3.49: Motion simulation results for the bSSFP sequence and h-EPI
sequence at rest and stress during diastolic filling: a)-b) the percentage of
signal loss and the width of the DRAs respectively in a line profile along the
phase-encode direction. c)-d) similar to a)-b) but for line profiles along the
frequency-encode direction. e)-f) bSSFP at stress and rest respectively. g)-h)
h-EPI at stress and rest respectively. All magnitude images shown at image
matrix size of 192x192. Note that for the h-EPI some signal loss values were
close to zero and therefore the width measured was non-significant (for ex-
ample the peak seen at stress for the width at a resolution of 192x160 along
the frequency-encode direction).
252 Simulations of the dark rim artifact for perfusion protocols
affected by motion artifacts. However, the endocardial layer was more blurred
and contained a bright ring. The CE trajectory showed similar results to the EC
but with systole and diastole R-kc times switched, which was expected since
the acquisition of k-space data during a contraction with a centre-edge trajec-
tory is the same as an edge-centre trajectory during expansion and vice-versa.
The motion artifacts were similar at end diastole for the three k-space trajecto-
ries, apart from some ghosting of the bright LV blood pool in the phase-encode
direction for both the EC and CE trajectories.
The dark sideband occurred on the trailing edge of the motion for EC and on
the leading edge of the motion for CE. Therefore a DRA is expected into the my-
ocardium during contraction for EC and into the myocardium during dilation
for CE. An EC-ECE-CE acquisition order for three slices during an R-R interval
would be the best order for sharing one saturation recovery, unfortunately, the
worst choice regarding motion artifacts in the myocardium!
As stated in the methods section: ECE, EC, and CE acquisition orders did
not share the same R-kc times, although they share the same interval of veloc-
ities from plot a in Figure 3.25. It is assumed that the differences in the motion
artifacts seen in Figure 3.50 are mainly due to different acquisition orders and
only partly due to different R-kc times.
When using an h-EPI style phase-encode acquisition order*, the artifacts
were similar to the h-EPI motion results showing the same LV ghosting in the
phase-encode direction as expected, although because the time of acquisition
was longer with the bSSFP sequence, the LV ghosting was worse and the visu-
alisation of regions of the myocardial wall in the phase-encode direction were
severely affected. These results suggest that some other phase-encode orders
may exist which are optimal for minimal subendocardial motion-DRA, but this
PhD had no time to investigate this interesting possibility.
3.3.3.2.7 Effect of Hamming filtering on motion artifacts with a perfusion
defect
*The reader should be remembered that the h-EPI trajectory is not a CE trajectory, but
an interleaved centric acquisition tailored for perfusion imaging [Ding et al., 1998] (bottom of
Figure 2.21)
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Figure 3.50: Motion simulation images for the bSSFP sequence at a resolu-
tion of 192x192. a)-c) edge-centre-edge trajectory with R-kc times: 120, 310,
and 410 ms. d)-f) edge-centre trajectory with R-kc times: 226, 416, and 526
ms. g)-i) centre-edge trajectory with R-kc times: 14, 204, and 314 ms. j)-l)
h-EPI trajectory with R-kc times: 120, 310, and 410 ms.
254 Simulations of the dark rim artifact for perfusion protocols
Figure 3.51: h-EPI: a)magnitude image for the motion simulations at R-kc
120 ms for the 128x128 matrix size. b) image a Hamming filtered. c) the same
magnitude image as a but with an added perfusion defect. d) image c Ham-
ming filtered. Images e)-h) similar to a-d but for the 310 ms R-kc time. Images
i)-l) similar to a-d but for the 410 ms R-kc time.
This section aimed to investigate whether Hamming filtering improves the
visibility of perfusion defects with motion and Gibbs artifacts.
Figures 3.51 to 3.53 show the motion magnitude images for a 128x128 matrix
size, at the three usual R-kc times, with and without the real defect, before and
after Hamming filtering for the h-EPI, bSSFP, and GRE sequence respectively.
The Hamming filter reduced considerably the combination of motion and
Gibbs artifacts at a resolution of 128x128 for all sequences while keeping the
defect visible. It can also be seen in some images that the ringing from the
artifacts reduced the width of the real defect when not filtered (for example:
image k for the GRE and bSSFP sequences). The same images filtered (image l)
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Figure 3.52: bSSFP: a)magnitude image for the motion simulations at R-
kc 120 ms for the 128x128 matrix size. b) image a Hamming filtered. c) the
same magnitude image as a but with an added perfusion defect. d) image c
Hamming filtered. Images e)-h) similar to a-d but for the 310 ms R-kc time.
Images i)-l) similar to a-d but for the 410 ms R-kc time.
had a considerable increase in the visible width of a real defect.
Figures 3.54-3.56 show the SL% and the width (the width measured is only
valid when the SL% is significant, i.e. not close to zero) of DRA in the subendo-
cardial layer for the magnitude images with the Hamming filter.
It was shown above that for the h-EPI, motion artifacts did not produce
DRAs in the subendocardial border, therefore the only SL% measured in this
area originated from Gibbs artifacts. It was then not surprising that after apply-
ing the Hamming filter, the SL% measured in both the frequency and phase-
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Figure 3.53: GRE: a)magnitude image for the motion simulations at R-kc
120 ms for the 128x128 matrix size. b) image a Hamming filtered. c) the same
magnitude image as a but with an added perfusion defect. d) image c Ham-
ming filtered. Images e)-h) similar to a-d but for the 310 ms R-kc time. Images
i)-l) similar to a-d but for the 410 ms R-kc time.
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Figure 3.54: Motion simulation results for the h-EPI sequence with the
Hamming filter (no defect): a) the signal loss as a percentage of the average
myocardial signal as a function of matrix size along the phase-encode direc-
tion. b) the signal loss as a percentage of the average myocardial signal as a
function of matrix size along the frequency-encode direction. All plots show
the measurements for the three R-kc times: 120, 310, and 410 ms.
Figure 3.55: Motion simulation results for the bSSFP sequence with the
Hamming filter (no defect): a) the signal loss as a percentage of the average
myocardial signal as a function of matrix size along the phase-encode direc-
tion. b) the width of the DRAs in a line profile along the phase-encode direc-
tion as a function of the image matrix. c) the signal loss as a percentage of the
average myocardial signal as a function of matrix size along the frequency-
encode direction. All plots show the measurements for the three R-kc times:
120, 310, and 410 ms.
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Figure 3.56: Motion simulation results for the GRE sequence with the Ham-
ming filter (no defect): a) the signal loss as a percentage of the average my-
ocardial signal as a function of matrix size along the phase-encode direction.
b) the width of the DRAs in a line profile along the phase-encode direction as
a function of the image matrix. c) the signal loss as a percentage of the aver-
age myocardial signal as a function of matrix size along the frequency-encode
direction. All plots show the measurements for the three R-kc times: 120, 310,
and 410 ms.
encode direction was highly reduced, Figure 3.54.
As expected in the bSSFP and GRE sequences, Figures 3.55-3.56, the SL%
was almost nulled with the Hamming filter along the frequency-encode direc-
tion since along this direction there was mainly Gibbs artifacts (plot c). Along
the phase-encode direction the DRAs were caused by a mixture of Gibbs and
motion artifacts. When the phase-encode resolution was low, the resulting ar-
tifacts were approximately one pixel wide and the Hamming filter reduced the
SL%. However, as the phase-encode resolution increased the mixture of Gibbs
and motion artifacts became wider than one pixel, reducing the effects of the
Hamming filter (plot a). Another visible effect of the filtering was the increase
in width of the DRAs (when compared to the non filtered data in Figures 3.47-
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Figure 3.57: Frequency-encode signal modulation for the myocardium (a),
and the LV (b). The initial magnetisation was normalised to M0 = 1.
3.48), due to the inherent blurring of the filtering process (plot b).
3.3.3.3 T1/T2* filtering
3.3.3.3.1 kx-modulation
Starting with the analysis of the T2* signal decay along the frequency-encode
direction (kx-modulation) during signal acquisition of an echo; Figure 3.57 shows
the kx-modulation for the three sequences in the myocardium and LV, for a res-
olution of 128 pixels in the frequency-encode direction. The h-EPI sequence
shows the four echoes of one echo-train (EPI factor 4). The echoes shown cor-
respond to the acquisition of the central phase-encode line.
The effect of this decay over kx is to blur the final image along the frequency-
encode direction. Table 3.20 shows the FWHM of a point source (FWHM = 1
pixel before filtering) after being modulated by the filters shown in Figure 3.57
for three spatial resolutions.
Figure 3.58 shows the FWHM values, given by the kx-modulation, as a func-
tion of the concentration of Gd-DTPA (from one tenth to one and a half times
the full expected Gd concentration at the peak of the first-pass bolus for the
myocardium (1.5 mmol L−1) and LV (12.5 mmol L−1) respectively.
It can be seen from both Table 3.20 and Figure 3.58 that the effects of a kx-
modulation in the raw-data were negligible, with a minimal blurring of less
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sequence resolution
FWHM (pixels)
myocardium LV
h-EPI
128×128 1.03 1.02
160×160 1.02 1.03
192×192 1.02 1.03
bSSFP
128×128 1.00 1.01
160×160 1.00 1.01
192×192 1.00 1.01
GRE
128×128 1.05 1.08
160×160 1.05 1.08
192×192 1.05 1.08
Table 3.20: FWHM in pixels for the kx-modulation for three different spatial
resolutions. The FWHM for the h-EPI is shown for the first echo of the echo-
train (the FWHM varied less than 2% between the four echoes of the echo-
train). For all sequences, the FWHM varied less than 1% between different RF
shots.
Figure 3.58: FWHM as a function of Gd concentration for the kx-
modulation for the myocardium (a), and the LV (b).
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Figure 3.59: Left: kx-modulation as a function of frequency-encode line in
the LV for the bSSFP sequence with a T1 ≈ 8×TR and a T2 ≈ 6×TR (values
used in the bSSFP sequence). Right: Similar to image on the left but for a T1
≈ 400×TR and a T2 ≈ 300×TR. As T1 and T2 increase in relation to TR, the kx-
modulation for the bSSFP becomes less T2* weighted with a complete refocus
at TE, assuming TE = TR/2. In this simulation TE = 1.0ms < TR/2 = 1.1 ms,
thus the centre of the echo (#64) is slightly off the peak of the curve in the plot
shown on the right.
than 10%. The effects did not vary much as the Gd concentration changed,
showing that the kx-modulation effects were negligible throughout the first pass.
There is a noteworthy remark about the bSSFP kx-modulation, for the T1, T2
and TR values used in the bSSFP sequence. In general for the bSSFP sequence
the signal is expected to be T2-weighted with a complete refocus at TE, when
TE= TR/2 and T1 and T2À TR. This is not the case for the simulated protocol,
and the signal was not completely refocused at TE; the point of refocusing was
localised before the centre of the echo (TE), therefore there was a loss of phase
coherence and an additional signal weighting with e−T E/T 2
∗
as with a normal
GRE sequence. This phenomenon is described in more detail by Scheffler and
Lehnhardt [2003], and shown in Figure 3.59. For a normal perfusion protocol
(in a voxel with a frequency distribution around ≈ 100 Hz) there is therefore,
T2* weighting in the bSSFP sequence since T1 and T2 are too low to refocus the
signal at TE=TR/2.
3.3.3.3.2 ky-modulation
Moving into the raw-data modulation along the phase-encode, Figure 3.60
shows the ky-modulation for each sequence for a 128x128 matrix. Figure 3.60 a
shows the modulation for the myocardium, and Figure 3.60 b for the LV cavity.
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Figure 3.60: a) Transverse magnetisation signal in the myocardium as a
function of the phase encode line number for the three sequences. b) sim-
ilar to a) but for the left ventricle. The simulated curves are for an image with
128 phase-encode lines, with only 64 phase-encodes shown because of par-
allel imaging with R = 2. The phase-encode acquisition order of the h-EPI
sequence is not sequential but an interleaved-centric.
Notice that only half the total number of phase-encode lines were plotted, since
parallel imaging with an acceleration factor of 2 was used.
It can be seen in Figure 3.60, that the transverse signals in the LV reached
the steady state approximately after 10 TRs, while the transverse signals in the
myocardium were still approaching the steady state after 64 echoes, of course
neglecting motion.
The broadening of the PSF for each of the ky-modulations was measured
and it is shown in Table 3.21 for three different pixel-matrix sizes for the three
sequences. The highest FWHMs were measured for the GRE in the myocar-
dium, and for the h-EPI in the LV. The signal in Figure 3.60 for the bSSFP in the
LV region was very flat (except for the first 5 echoes), therefore as expected no
broadening of the PSF was measured. In general the FWHM values were greater
for the ky-modulation when compared to the kx-modulation although even the
ky FWHM values (maximum of 25% blur) can still be considered insubstantial.
The broadening of the PSF changes as the concentration of contrast agent
varies during the first-pass perfusion run, especially for the LV. Figure 3.61 a,
and b shows the FWHM (pixels) as a function of the concentration of Gd-DTPA
(ranging from one tenth to one and a half times the expected [Gd] at the peak
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sequence resolution
FWHM (pixels)
myocardium LV
h-EPI
128×128 1.17 1.25
160×160 1.16 1.25
192×192 1.16 1.25
bSSFP
128×128 1.13 1.00
160×160 1.13 1.00
192×192 1.13 1.00
GRE
128×128 1.23 1.07
160×160 1.21 1.06
192×192 1.19 1.05
Table 3.21: FWHM in pixels for the ky-modulation for the three sequences
and for three different resolutions.
Figure 3.61: The FWHM values as a function of the concentration of Gd-
DTPA (from one tenth to 1.5 the expected [Gd] at the peak of the first-pass
bolus for the myocardium (a) and LV (b) respectively.
of the first-pass bolus) for the myocardium and LV respectively.
From these results we can see that the FWHM of the PSF for the h-EPI were
fairly constant for different Gd concentrations because of its more distributed
phase-encode coverage as a function of time; the PSF distortion effect is (rather
as for motion) more distributed over the phase-encode FOV. On the other hand,
reducing the concentration of Gd increases the PSF width by the increased T1
and T2 for the GRE and bSSFP sequences. This occurs because the variation in
signal strength over ky with longer T1 and T2 is more prominent.
Noteworthy is the fact that PSF FWHM in the LV for the bSSFP reaches a
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minimum at approximately the assumed Gd concentration at peak.
The PSF in the image space (magnitude and phase) for the ky-modulation
in the LV for the three sequences is shown in Figure 3.62 for the 128x128 matrix
(64 phase-encode lines after parallel imaging with R=2).
As expected the base of the magnitude PSF was slightly broadened in the
GRE and h-EPI sequences. In the h-EPI, the magnitude PSF was also slightly
distorted by its phase-encode acquisition order, presenting sidelobes although
with a greatly reduced intensity when compared to the main peak intensity.
Because the broadening of the point source is minimal, the convolution of
the image with these PSFs would not contain any signal loss created by intra-
voxel dephasing, therefore it is safe to say that no DRAs are created by T1/T2
filtering, only a minimal blur. In fact, this blurring will reduce the sharpness of
edges, and possibly, slightly reduce Gibbs ringing.
3.3.4 Overall discussion of simulation results
Please note that many aspects of the discussion were included with the results
above. The following section is a general overview of the findings.
Both Gibbs and motion simulations can produce dark rim artifacts mimick-
ing real perfusion defects, during the first pass of contrast agent, since artifacts
arising from the sharp endocardial border can occur in the subendocardium.
In the Gibbs artifacts simulations, the measured Gibbs signal loss caused
by the first undershoot of the artifacts ringing in the myocardial was approx-
imately 9% of the signal jump between the LV blood pool and the myocardial
wall, as expected from theory (equivalent to a signal loss of approximately 48%
for the bSSFP and GRE sequences, and 36% for the h-EPI sequence, when com-
pared to the average myocardial signal). Another theoretically confirmed mea-
surement was the width of the artifact at one pixel, independent of the resolu-
tion, i.e. Gibbs artifacts scaled with resolution as long as the edge maintained
its one pixel sharpness.
The Hamming filter was marginally better at reducing the Gibbs artifact
when compared to the Hann filter. The filtering effect in the magnitude im-
age was to partially average a pixel with its surrounding neighbour pixels, can-
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Figure 3.62: PSF in the image space (Phase and magnitude superimposed
in the same plot) for the ky-modulation in the LV.
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celling out the Gibbs ringing, although if a true defect width was approximately
two and half or less pixels wide, its visibility would be also greatly reduced. Fil-
tering of perfusion images acquired at around 2.5 mm in-plane resolution is
therefore not advisable for defects with widths smaller than approximately 6
mm. However, even if the image contrast of a perfusion defect is slightly re-
duced by the Hamming filter, when considering the simultaneous reduction
of image noise by the Hamming filter, the defect’s visibility can potentially in-
crease due to the increase of its CNR. There appears to be no published inves-
tigation of this possibility in perfusion imaging, alongside the potential use of
slightly weaker Tukey filters.
The visibility of Gibbs DRA is also dependent on the sequence, in the sense
that an artifact to noise ratio must be considered, i.e. the higher SNR of bSSFP
makes the fixed 9% overshoot artifact easier to detect when compared with GRE
or h-EPI sequences.
Inclusion of Gibbs in the motion simulations was inevitable and this made
interpretation of “motion” DRA measurements difficult, justifying the analyti-
cal PSF work where Gibbs and motion could be analysed separately. Gibbs ring-
ing interacted both destructively and constructively with motion ringing, and
the resulting artifacts were shown by the motion simulation results. The su-
perposition of Gibbs and motion ringing varies for different spatial-resolutions
since both depend differently on it.
From the theory an edge moving in the phase-encode direction will poten-
tially show motion artifacts along the phase encoding direction, decreasing in
strength for edges more parallel to the same direction, vanishing exactly only
in the rare event of a length of in vivo endocardial border lying exactly parallel
to the phase-encode direction. If an edge is moving in the frequency-encode
direction then most edges will again potentially show motion artifacts. How-
ever, for the low velocity of myocardial motion intraview distortion may be
neglected and in this case edges perpendicular to either the frequency or the
phase-encode direction are free from frequency-encode motion artifacts. The
former is counterintuitive, and it is perhaps easier to understand by the 2D PSF
analysis shown above in the motion results section. For the endocardial bor-
der contraction/dilation motion, no subendocardial edge would therefore be
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expected to be free from motion artifacts except exactly perpendicular to the
frequency-encode direction. This was confirmed by the motion simulations.
The only artifact visible in that particular myocardial segment will therefore be
Gibbs ringing.
Motion artifacts were visible for the acquisitions during systole and diastole;
during end systole, motion of the endocardial walls was reduced and so was the
visibility of motion artifacts. However, it must be recognised that this particular
end-systolic timing cannot realistically be ‘aimed’ at in vivo, especially with the
small modifications of cardiac timings likely under stress. Myocardial signal
losses of up to 80% were measured for the GRE and bSSFP sequences, in the
phase encode direction. Motion artifacts were also very dependent on the k-
space trajectory used. Centre-edges and edges-centre trajectories were tested
with the bSSFP, and although some of these trajectories at some R-kc times did
not exhibit DRAs, the subendocardial motion blur would likely render thin per-
fusion defects invisible, especially at the lower resolutions.
The h-EPI sequence generally did not exhibit motion DRAs, only ghosting
of the bright LV blood pool as resolution increased, and it was therefore the
most robust sequence in avoiding DRAs caused by motion. The LV-ghosting
position seemed to be dependent on the spatial-resolution. There are two fac-
tors that made the h-EPI less prone to motion artifacts: the shorter imaging
time, and its more “distributed” ky-coverage as a function of time. Gibbs arti-
facts were reduced due to motion blurring of the endocardial border, although
the same blurring was not enough to render thin true defects in the subendo-
cardium invisible (again assisted by the shorter imaging time). To separate the
two improving factors mentioned above, the h-EPI phase-acquisition order was
tested with the bSSFP sequence, and due to the longer time of acquisition the
LV ghosting in the myocardial wall became a bigger problem than with the h-
EPI sequence, and could obscure the visualisation of a real perfusion defect.
Therefore it appears that the shorter imaging time of the h-EPI was at least as
important as its altered k-space coverage in reducing subendocardial motion-
induced DRAs.
The motion artifacts analysed analytically by the 2D motion PSFs showed
that these artifacts in the simplistic model of a short-axis image did not depend
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on the direction of motion, i.e. motion artifacts caused by contraction were the
same as caused by expansion at the same radial velocity.
It was also shown that motion artifacts could be highly reduced when us-
ing the Hamming filter, especially at the lower resolutions where the motion
artifacts have a width of approximately one pixel. Motion artifacts were also
shown to interact destructively with a perfusion defect in some cases; the use
of the Hamming filter increases the defects visibility, especially in these cases,
but with the limitation that the perfusion defect must be wider than two and a
half pixels to avoid being smoothed by the filter.
The effects of T1 and T2 relaxation during acquisition were measured for
the three sequence protocols and found to be negligible in producing DRAs,
although some blurring was introduced by ky-modulation along the phase-
encode direction (maximum of 25% increase in the FWHM of a point source),
especially in the h-EPI sequence at the bright LV blood pool.
The effects of kx and ky-modulation with the use of parallel imaging, es-
pecially image unwrapping algorithms such as TSENSE, were considered but
assumed negligible.
One possible exacerbating phenomenon is the superposition of Gibbs and/or
motion ringing originating from two close edges, most commonly in the sep-
tum during arrival of a contrast agent bolus when both the left and right ventri-
cle are brighter than the myocardium.
The possible effect of fresh magnetisation entering the slice due to blood
inflow in the LV can increase the signal up to two fold [Ivancevic et al., 2003],
which would increase the LV/myocardial signal and subsequently the visibility
of Gibbs and motion artifacts.
Through-plane motion of the heart was not considered in the simulations.
In purely geometrical terms, for a short-axis slice the typical basal motion down
towards the apex would tend to have the effect of slightly decreasing the ap-
parent in plane contraction during systole and similarly decreasing apparent
dilation during filling.
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3.3.5 Conclusion
It was shown that both motion and Gibbs truncation can produce dark rim ar-
tifacts in the subendocardium. It was also shown that filtering can be used to
reduce Gibbs and motion ringing.
Filtering was also shown to reduce noise and potentially increase the visibil-
ity of a perfusion defect, but only if a real perfusion defect is at least two and a
half pixels wide. This condition is not achieved with current standard perfusion
protocols.
T1 and T2* relaxation was also shown to be negligible in producing any
DRAs, although ky-modulation can reduce slightly the image resolution in the
final image, especially for the GRE and h-EPI sequences at peak contrast agent
concentration.
The h-EPI sequence was shown to be the most robust to motion artifacts,
not only due to a faster readout, but also due to the k-space trajectory used
(neglecting off-resonance effects). A higher resolution h-EPI sequence cou-
pled with a Hamming filter post-processing may potentially avoid DRAs with-
out missing genuine defects i.e. can potentially provide higher imaging reso-
lution for improved sensitivity, without loss of specificity. However, it must be
recognised that other factors affect the choice of pulse sequence, for example,
limited SNR in h-EPI, the lower reliability of the centre-out h-EPI path for high
resolution imaging in the presence of B0 field distortion. When considering all
factors there is not a clear optimum protocol for perfusion which might explain
the variability of perfusion protocols between different centres.
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CHAPTER 4
Measurement of myocardial frequency offsets
during first pass of a gadolinium-based contrast
agent in perfusion studies
The contents of this chapter were published in the Journal: Magnetic Reso-
nance in Medicine; Ferreira et al. [2008] (page 450).
4.1 Introduction
DRAs appear to be related with the increase of blood signal in the LV due to the
arrival of the CA. The exact origins of the DRA are unclear and one of the spec-
ulated possible origins for the DRA is susceptibility [Arai, 2000, Fenchel et al.,
2004, Schreiber et al., 2002] (section 2.5.2). More recently Weber et al. [2007]
made a comparison between the three sequences mentioned in section 2.3 (h-
EPI, bSSFP, GRE) in first-pass perfusion studies. Several DRAs were scored in in-
vivo data, and the authors suggested susceptibility as a dominant factor for the
occurrence of DRAs based on two observations: the DRAs’ scores were similar
with TSENSE and without, which would not happen if the mechanism behind
them was cardiac motion; and variability of the artifacts when keeping spatial
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resolution constant, which eliminates Gibbs artifacts from the equation*.
In this chapter we are going to concentrate on the assessment of suscepti-
bility artifacts during first-pass. A method was developed and used to measure
the in vivo field distortions caused by the first pass of a CA in a typical perfusion
setup, and determine how these distortions may depend on cardiac long-axis
orientation with respect to the main field (B0). The in vivo data was compared
to phantom work and numerical simulations. To the best of our knowledge
there has been no previous similar work published.
*The authors were not considering the sub-pixel variability of Gibbs artifacts discussed in
section 3.2
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4.2 Methods
4.2.1 In vivo studies
Seventeen patients agreed to become subjects of this study after signing an
informed consent. Gd-DTPA contrast agent (0.5 mol/L) (Magnevist-Schering,
Germany), with a dose of 0.1 mmol kg−1 of body weight was injected at a rate
of 5 mL s−1 followed by 10 mL of a saline flush at the same rate. Images were
acquired in three short-axis slices for forty R-R intervals, during the first pass of
CA with the patients holding their breath at end-expiration for sufficient time
to cover the first-pass. The study was performed using a 1.5 T scanner (Avanto;
Siemens) with anterior/posterior phased array cardiac coils. A spoiled-GRE se-
quence was used with magnitude and phase reconstructions. The protocol pa-
rameters are displayed in table 4.1.
It may be helpful to point out that no perfusion analysis was made with
this data since this is not a T1-weighted perfusion oriented sequence, and the
relatively long TE for FLASH was chosen to enhance sensitivity to small B0 field
distortions.
Each receiver coil channel’s images were saved separately, and phase cor-
rection (which uses a strongly filtered image to remove slow variations in phase
across the FOV) was disabled in image reconstruction. Slice order was always
apical→mid→ basal.
Single-shot frequency-offset maps were calculated using MATLAB where
the phase image of each coil for the first frame (before CA) was subtracted
parameter value
TR (ms) 3.8
TE (ms) 2.38
base resolution (pixels) 192
voxel size (mm) 1.8×1.8×10 to 2.2×2.2×10
flip angle (deg) 12
bandwidth (Hz pixel−1) 744
GRAPPA R=1.7
Table 4.1: Sequence protocol for the in vivo studies.
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from each subsequent frame’s corresponding phase images, before magnitude-
weighted phase combination. The first frame, known hereafter as the reference
frame, was chosen to be that before contrast arrival to the Right Ventricle (RV)
but with the patient at a stable breath-hold position. It is important to stress
that the images obtained in each cycle were not complete as field-maps, be-
cause this method measured only the phase difference between the reference
cycle and each following heart cycle. Each image was therefore a map of the
additional B0 distortion caused by the arrival of the CA. At a TE = 2.38 ms, the
range ±pi in each phase difference image corresponded to a frequency differ-
ence of ±210 Hz, which at 1.5 T was ±3.3 ppm.
Four ROIs were drawn using CMRtools software (Cardiovascular Imaging
Solutions, London, UK) positioned toward the inner half of the wall in the in-
ferior, anterior, septal, and lateral segments of the myocardium, Figure 4.1 a.
The ROIs shape was drawn manually and carefully placed so as not to include
signal from the LV blood pool. Each ROI had an area around 50 mm2 and re-
mained static throughout the forty frames, thus making the frequency offset
measured on that ROI valid until the patient started to breathe and/or move.
The mean frequency-offset within each ROI was recorded as a function of time,
Figure 4.1 b. The frame where the temporal peak value (positive or negative) of
the mean frequency offset for each ROI was recorded (indicated by arrows on
Figure 4.1 b). This frame where the temporal peak occurred was also used to
extract the spatial peak value (positive or negative) inside each ROI using line
profiles taken diametrically across the short-axis, Figure 4.1 c. Each line profile
was an average formed by using a 3 pixel wide line. Another ROI was drawn in
the mid slice in the LV blood pool in order to track any frequency offset in this
area as well. While the mean-ROI values gave an overview of the field distor-
tion as a function of time, the peak frequency offsets were determined by the
line profile results, and these are the values stated in the results section.
To assess the error in the mean ROI value and line profiles, the temporal
standard deviation of the mean signal in each ROI was also measured during
3-5 frames prior to contrast arrival in the RV or during recirculation, since the
arrival of highly concentrated contrast agent in the RV cavity distorted the field
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Figure 4.1: a) The four ROIs used (Anterior: 1; Inferior: 2; Septal: 3; Lat-
eral: 4). The in plane component of B0 is shown. b) Mean frequency offset
measured for each ROI for each heart cycle for a typical patient. The arrows
represent the time of peak i.e. first pass of CA in the LV. c) Line profiles for the
cardiac cycle pointed by the arrow in b). The ends of each line profile are in
the epicardium. The line profiles are also colour coded and represented in a.
in the septal region due to its closeness.
The ROI data was recorded together with the patient’s short-axis plane ori-
entation. The normal of the plane (given by CMRTools) was used to calculate
the angle between the long-axis of the heart and the direction of the main mag-
netic field (this angle is defined hereafter as θ)
4.2.2 Phantom work
The phantom described in detail in section 3.1 and shown in Figure 3.3, was
also used in the phantom work of this chapter. This phantom was built to
model the myocardial wall and the LV, with similar T1, T2, and susceptibilities
to the ones encountered during first pass of the CA.
For this work the first-pass at rest was modelled estimating a peak Gd con-
centration of 7.5 mmol L−1 in the blood pool, i.e. a lower peak concentration
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than the one estimated at adenosine stress in section 3.1 (12.5 mmol L−1). The
cylinder was filled therefore with water doped with a 7.5 mmol L−1 concen-
tration of Gadolinium. A time series of T1-weighted images showed negligible
dissolving of the gelatine within 30 minutes, Figure 3.4, which allowed these
models to be used quickly for these experiments.
Magnetic susceptibility was modelled taking into consideration that approx-
imately 30 mmol L−1 CA concentration cancels water diamagnetism, and the
diamagnetism of fully oxygenated blood without CA is similar to water [Mulk-
ern et al., 2005, Spees et al., 2001] (see Appendix C).
The gelatin being diamagnetic forms a reasonable magnetic field model of
the myocardium before Gd arrival.
The cylinder axis was oriented at several angles to the main field B0 (θ),
simulating in vivo conditions, as it is well known that tissue geometry alters B0
distortion [Schreiber et al., 2002].
Note that there is no dynamic first-pass of CA in the phantom; only a fixed
concentration of Gd. Therefore, it was not possible to use the phase subtraction
method used in vivo; the phantom was scanned with a field-mapping sequence
instead.
A cross section ("short-axis" slice) field map of the phantom was imaged
with a GRE field-mapping sequence, using a whole-body receiver coil and the
same 1.5 T scanner. The protocol is shown in table 4.2. This protocol had∆TE=
1.19 ms with a corresponding B0 sensitivity of±pi=±420 Hz. All the scans were
acquired using the same scanner reference frequency in order to consistently
compare all measurements. Frequency differences in the field maps were ex-
tracted using line profiles acquired with MATLAB, where all line profiles were
normalised to the mean value obtained in the LV blood pool.
In order to evaluate the field-distortion effects on bSSFP imaging, the phan-
tom was also imaged, in a typical in vivo orientation (θ = 60◦), with an added
positive/negative frequency offset simulating other sources of field distortion
encountered in in vivo hearts [Reeder et al., 1998]. These frequency offsets were
added artificially by offsetting the resonance frequency in the scanner console
before the scan. The sequence protocol is shown in table 4.3. The same 1.5 T
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parameter value
TR (ms) 450
TEs (ms) 3.04, 4.23
base resolution (pixels) 160
voxel size (mm) 1.9×1.9×10
flip angle (deg) 90
bandwidth (Hz pixel−1) 1000
GRAPPA R=1.7
Table 4.2: Sequence protocol for the phantom work (GRE field-mapping).
parameter value
TR (ms) 2.5
TEs (ms) 1.23
TI (ms) 95
base resolution (pixels) 128
voxel size (mm) 2.25×2.25×8
flip angle (deg) 70
bandwidth (Hz pixel−1) 1490
GRAPPA R=1.7
Table 4.3: Sequence protocol for the phantom work with the bSSFP se-
quence.
scanner was used.
4.2.3 Numerical Simulations
The in vivo measurements showed the phase difference introduced by the ar-
rival of the CA within the LV chamber. This situation was also simulated numer-
ically using MATLAB approximating the LV and myocardial wall as a superposi-
tion* of two concentric and infinitely long circular cylinders. The superposition
was built assuming the same concentration of Gd-DTPA in the LV cavity as in
the phantom model i.e. 7.5 mmol L−1.
Magnetostatic equations for this kind of geometry are well established, [Ogawa
et al., 1993] (see appendix 4.A in the end of this chapter).
*The superposition principle states that the net magnetic field in any point is the sum of
the individual magnetic fields.
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The peak frequency offsets when the LV cavity was filled with a solution of
Gd-DTPA were measured in a similar fashion to the in vivo and phantom data
by using line profiles.
Two other doses of contrast agent were simulated: 0.15 mmol kg−1 and 0.05
mmol kg−1 of body weight, assuming a peak bolus LV CA concentration of 11.25
mmol L−1 and 3.75 mmol L−1 respectively and using a θ = 80◦, in order to visu-
alise frequency offsets at different doses of CA.
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4.3 Results
4.3.1 in vivo studies
Twelve patients (mean age 44) managed a stable breath-hold starting from the
reference cycle until the end of the first pass of CA with a stable electrocardio-
gram, completing the frequency-offsets mapping measurements successfully.
The first-pass of contrast agent in the LV blood pool distorted the field ma-
inly in the myocardial wall, Figure 4.2. The maximum frequency offset of each
ROI was observed during the first pass of the contrast agent in the left ventric-
ular cavity (Figure 4.2 b). The magnitude images, although not optimised for
contrast enhancement, showed a change in contrast indicating the arrival of
CA at the same time the peak frequency-offsets were measured (Figure 4.2 d). It
should be pointed out that the magnitude SI curves may also contain T2* signal
loss due their long TE, competing with signal enhancement due to T1 shorten-
ing; nevertheless a change in image contrast was visible as the CA arrived. Fre-
quency offsets were sometimes visible in the myocardium during the first-pass
in the RV, especially in the septal ROI due to its proximity, but the focus of this
study was on the LV first-pass because it is at this stage of the first-pass that the
DRA artifact commonly appears.
The pattern of distortion was the same for every patient, with inferior-anterior
regions having a higher field, and septal-lateral regions having a lower field; the
transition between a higher and a lower field were located in the diagonal re-
gions of the myocardial wall.
The myocardial peak frequency offsets registered for each slice and for each
patient are shown in Figures 4.3-4.5, plotted against the angle θ. The greatest
frequency offsets occurred at the largest angles, but this was non-significant.
While the greatest value found was 85 Hz, taking an average of the largest dis-
tortions found in each of the 33 % of patients with cardiac angles bigger than
65◦, gave a value of 68 Hz.
A negative frequency offset was also observed in the LV blood pool. Again,
the greater negative frequency offsets were found at the greater angles, although
with a lower amplitude than in the subendocardium. The maximum mean-ROI
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Figure 4.2: Three stages of frequency offset for the first pass of Gd-DTPA in
the heart for one volunteer (a, b, c) showing phase difference and magnitude
images. From a) to c) we have the end of first-pass of contrast agent in the RV,
the first-pass in the LV, and during myocardial perfusion. d) frequency off-
sets for a septal ROI, and SI curves for the RV and LV in the magnitude images
with a grey shade marking the timing of the images on the top for the frames
a, b, and c. During the first pass in the LV all patients showed an increase of
B0 in the inferior and anterior myocardial segments (brighter regions) and a
decreasing of B0 in the septal and lateral segments (darker regions) (An ex-
ample of a magnitude and phase image throughout first-pass is shown in the
attached CD). The arrow represents the direction of the in-plane component
of the main magnetic field.
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angle (deg) frequency difference:
along the field. (Hz)
frequency difference:
across the field. (Hz)
50 80 -30
70 150 -20
Table 4.4: Phantom: Frequency difference (frequency subendocardium -
frequency LV) in the subendocardial layer for both along the field and across
the field at two angles: θ = 50◦ and θ = 70◦.
distortion for each patient in the mid slice is shown in Figure 4.6 and ranged
from -2 Hz to -45 Hz, with an average for the 33 % of patients with angles greater
than 65◦ of -23 Hz.
4.3.2 Phantom work
The distortion pattern obtained in the phantom data was similar to the one
obtained in vivo with negative distortions across the direction of B0 (darker re-
gions) and positive distortions located along the B0 direction (brighter regions)
(Figure 4.7 a, b, c, d, e) for the angles 10◦, 25◦, 50◦, 70◦, and 90◦ respectively.
(Note: The numerical simulations (f-j) in this Figure are discussed in the next
section.)
Figure 4.7 also shows the line profiles across the field (a’, b’, c’, d’, e’) and
along the field (a”, b”, c”, d”, e”).
The frequency difference between the LV cavity and the subendocardium
increased with angle in the direction along the field and decreased across the
field. The frequency difference obtained between the LV cavity and the myocar-
dial wall is shown in table 4.4 for two angles in the range recorded in vivo [50◦,
70◦].
282 Results
Figure 4.3: Peak frequency offsets for each patient in the basal slice plotted
against the angle between B0 and the LV long-axis. The error bars are the
temporal standard deviation of the signal in each ROI: a) positive (inferior,
anterior). b) negative (septal, lateral).
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Figure 4.4: Peak frequency offsets for each patient in the mid slice plotted
against the angle between B0 and the LV long-axis. The error bars are the
temporal standard deviation of the signal in each ROI: c) positive (inferior,
anterior). d) negative (septal, lateral).
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Figure 4.5: Peak frequency offsets for each patient in the apical slice plotted
against the angle between B0 and the LV long-axis. The error bars are the
temporal standard deviation of the signal in each ROI: e) positive (inferior,
anterior). f) negative (septal, lateral).
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Figure 4.6: Peak frequency offsets measured in the LV cavity versus the angle
between B0 and the long axis of the LV for each patient in the mid slice. The
error bars are the temporal standard deviation of the signal in the ROI.
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4.3.3 Numerical Simulations
The numerically simulated phase offset data is shown next to the phantom for
the same orientations in relation to the main magnetic field, Figure 4.7 (f, g, h,
i, j) with line profiles across the field and along the field for the angles 10◦, 25◦,
50◦, 70◦, and 90◦ respectively. These line profiles, show the absolute frequency
offset value obtained i.e. they are not normalised to the LV cavity. This makes
it possible to quantify both the subendocardium regions and LV cavity sepa-
rately as in the in vivo case but also compare the relative frequency difference
between the LV blood pool and the subendocardium as in the phantom data.
The distortion pattern is similar to both in vivo and phantom data, with
positive distortions along the field, and negative distortions across the field.
Frequency offsets are bigger than the ones obtained in vivo or in the phantom.
We can see that as the angle increases, the frequency offset in the subendocar-
dium increases, from ≈ 0 Hz at 10◦ to ≈±120 Hz at 90◦.
The LV cavity frequency offset also decreases, changing from positive to
negative values as the angle increases, from ≈ 90 Hz at 10◦ to ≈ −50 Hz at 90◦.
When combined with the behaviour of the subendocardium regions, we have a
similar effect to the one recorded in the phantom, in that the frequency dif-
ference between the LV - subendocardial layer increases along the field and
slightly decreases across the field as the angle increases. Across the field, the
frequency difference (frequency at LV - frequency at subendocardium) is 95 Hz
at 10◦ and 75Hz at 90◦; along the field, the respective frequency difference is 88
Hz at 10◦ and 171Hz at 90◦.
The numerical simulations give us an angle of 55◦ for a null frequency offset
in the LV, which agrees approximately with the in vivo data.
The subendocardial frequency offsets recorded from the numerical simula-
tions are shown in table 4.5 for two angles in the range of angles recorded in
vivo [50◦,70◦].
To assess agreement between in vivo, phantom and simulations results, line
profiles for along and across the field are shown in Figure 4.8 comparing a pa-
tient, a numerical simulated image, and a phantom scan. Although the region
of distortion was transmural, the numerical simulation data seem to suggest
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angle (deg) subendocardial
region (Hz)
LV cavity (Hz) frequency dif-
ference: along
the field. (Hz)
frequency
difference:
across the
field. (Hz)
50 ±73 +11 -61 83
70 ±109 −31 -140 78
Table 4.5: Numerical simulations: Frequency offsets for both the subendo-
cardial wall and the LV cavity in relation to B0 and frequency difference be-
tween the LV cavity and the subendocardial layer.
a larger frequency offset located in the subendocardium region. This is some-
what visible in vivo as well, although with spatial resolution limitations.
The effects of using different doses of contrast agent on the frequency offset
are presented next. Figure 4.9 shows numerical simulations of the field distor-
tions at three different doses 0.05, 0.10, and 0.15 mmol kg−1, at an orientation
of 80◦, assuming that the peak bolus concentration of Gd-DTPA in the LV is 3.75
mmol L−1, 7.50 mmol L−1 and 11.25 mmol L−1 respectively. As the peak con-
centration, which is related to dose, increases, the frequency offsets increase in
a linear fashion as would be expected. This can also be seen from the equations
given in appendix 4.A.
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Figure 4.8: Line profiles taken diametrically across the short-axis, crossing
the LV cavity and subendocardium: inferior-anterior (a,c,e) and septal-lateral
(b,d,f ); for a typical patient (3-pixel average) (a,b), a phantom (c,d) and a nu-
merical simulation (e,f ). Phantom and numerical simulation data at 80◦, and
patient at 76◦ between the long axis and the B0 field. The frequency difference
in the phantom data is normalised to the LV cavity.
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Figure 4.9: Numerical simulation line profiles (along (a, c, e) and across (b,
d, f ) the field) at an 80◦ orientation for three different CA doses, 0.05 (a, b),
0.10 (c, d), and 0.15 mmol / Kg−1 (e, f ), assuming a Gd-DTPA concentration in
the LV of 3.75 mmol L−1, 7.50 mmol L−1 and 11.25 mmol L−1 respectively.
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4.4 Discussion and Conclusions
This study represents the first in vivo quantification of B0-distortion during the
first-pass in a typical myocardial-perfusion setup using realistic CA concentra-
tions corresponding to typical perfusion CA doses and injection rates.
The relevant field distortion is localised in some regions of the subendocar-
dium and it is due to a difference in susceptibility between the LV and myocar-
dium during CA first-pass in the LV chamber. Even when CA perfuses into the
myocardium, it does not approach the peak LV concentration.
In vivo field distortions caused by the peak CA in the LV chamber agreed
with simulations. Simulations showed higher frequency offsets but neverthe-
less the same distortion patterns were observed. All measurements showed
that field distortions occurred mainly in the myocardial wall (stronger in the
subendocardium), with its peak during the maximum concentration of Gd-
DTPA in the LV, i.e. during first-pass in the LV cavity before Gd arrival into the
myocardium itself.
The pattern of field distortion was also consistent in different patients, with
a positive distortion i.e. raising the local field for the inferior-anterior regions
of the myocardial wall and a negative distortion i.e. lowering the field for the
septal-lateral regions. These anatomical regions, although in double oblique
slices, correlate with their orientation to the main field B0, with anterior/inferior
being more along the field, and septal/lateral more across the field; therefore
the in vivo data agrees well with both numerical and phantom simulations.
One numerically-predicted property was stronger field distortions in the
myocardial wall and LV blood pool for more horizontal hearts (for the in-vivo
angle range); this agreed well with both phantom data and volunteers’ data,
with the exceptions of the apical slice where the reduced blood pool volume
probably reduces the CA susceptibility effect. From the numerical simulation,
equations (4.3)-(4.4) (see appendix 4.A), frequency offsets in the myocardial
wall are dependent on the orientation of the axis in relation to the external field
by a sin2(θ) factor.
The numerical simulation also helped to explain why the peak frequency
offsets happen at the LV first-pass; the reason is that it is at this stage that the
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biggest susceptibility difference happens between the LV cavity and the myo-
cardium wall. Subsequent washout of the LV blood pool reduces this difference,
dropping the frequency offset measured. The concentration of CA in the myo-
cardium is sufficiently small that its effect is relatively negligible. Furthermore,
B0 field distortion within the LV chamber itself was shown to be smaller than
that in the myocardium, again consistent with numerical models (for the in-
vivo angle range).
The scatter in the patients’ data may be explained by a range of physiologi-
cal factors affecting first-pass concentrations of Gd-DTPA in the LV blood pool,
for example cardiac function [Elkington et al., 2005a].
We now estimate the likely signal loss caused by field-distortion in the sub-
endocardium for a gradient-echo sequence as follows. From all the in vivo
data acquired, the maximum field distortion was 85 Hz in the subendocar-
dial region. If we couple this value with the maximum LV distortion obtained
(−45 Hz), we have a frequency difference of 130 Hz. Assuming a worst-case
50% of the signal from each of the subendocardium and the LV, the intra-voxel
phase difference for a perfusion sequence with a TE of 1.2 ms is 0.98 rad (φ =
130×2pi×1.2·10−3). The total signal in that voxel will be a vector sum of the two
isochromats; assuming an equal weight, the signal loss due to the phase differ-
ence will therefore be of approximately 25%. Using a more optimistic/averaged
scenario, intra-voxel dephasing would yield a signal loss of 15% for the more
horizontal hearts in pixels straddling the subendocardium border.
Considering a 3 mm pixel located solely in the subendocardium, the same
TE of 1.2 ms, and a slope of 5 Hz mm−1 as shown by the in vivo line profile
in Figure 4.8, the intravoxel dephasing inside that pixel has a maximum phase
range of 0.11 rad in the radial direction. This intravoxel dephasing leads to a
negligible loss of signal of less than 1% (SINC(φ/2), considering an uniform
phase range).
Taking this estimate further for the bSSFP type of sequences, we estimate
the potential for field-distortion frequency-offset related signal loss in these as
follows: A bSSFP sequence yields signal drops in regions where frequency off-
sets accumulate a phase offset of ±pi in the time between RF pulses [Scheffler
and Hennig, 2003]. With a TR of 2.5 ms, this occurs at frequency offsets of±200
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Figure 4.10: Balanced-SSFP images of the phantom at 60◦ orientation (an-
gle between the long axis of the heart and the main magnetic field. a) at res-
onance frequency, b) added frequency offset of −150 Hz, c) added frequency
offset of +100 Hz. The white arrows point out to the regions of the subendo-
cardium with signal loss. The image is slightly darker on the left side due to a
inhomogeneous coil sensitivity. There is also a visible Gibbs DRA all around
the phantom’s subendocardial layer.
Hz from the resonance frequency. This offset is bigger than the one measured at
first pass of CA alone, but when other field distortion sources are added, such
as those typically occurring around the myocardium into the lungs, a signal
loss may occur in the subendocardial regions where the frequency offsets were
measured. The work done by Reeder et al. [1998] measured field distortions at
1.5 T in short axis slices of the heart on five male volunteers without any con-
trast agent. Their results showed that the biggest field inhomogeneities consis-
tently occurred adjacent to the inferior vein region (between the inferior and
lateral regions) with a difference to the surrounding myocardium of 70 to 100
Hz. Adding this field inhomogeneity to the biggest frequency offsets obtained
in vivo during CA first-pass bolus transit through the LV blood pool, the total
frequency offset comes close to the 200 Hz needed to cause dark-band artifacts
in a bSSFP perfusion sequence (with TR = 2.5 ms). This is shown in Figure 4.10,
where the phantom was imaged with a balanced-SSFP sequence with a TR of
2.5 ms. A baseline “offset” before CA arrival of -150 Hz or +100 Hz caused sig-
nal loss in the subendocardium in the regions where the signal was distorted
negatively or positively respectively by the CA (white arrows).
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For a centre-out hybrid-EPI perfusion sequence, the frequency offset caused
by a field distortion could create a splitting of the point-spread-function along
the phase-encode direction [Mugler and Brookeman, 1996]. This would affect
mainly the regions of the subendocardium where the peak distortions were
measured. For an h-EPI sequence with an EPI factor of 4, centric acquisition or-
der [Ding et al., 1998], an echo-spacing of 0.8 ms, and a phase FOV of 370 mm,
a field distortions of 85 Hz would suffer a shift of 1.57 mm in both directions of
the phase-encode direction. This shift, although less than one pixel for a typical
perfusion protocol is in effect doubled by the splitting. When combined with
other sources of frequency offsets and also considering the double-peak PSF
can cause serious artifacts and blurring; one example of this effect is shown in
Figure 3.11.
A noteworthy observation is the location of the field distortions. The peaks
are situated along and across the inplane component of the main field, with
a higher frequency difference between the LV cavity and the subendocardium
along the field. A possible DRA caused by CA first-pass field distortions would
usually be located in particular regions of the subendocardium. It would not be
circumferential as sometimes observed in previous perfusion studies [Fenchel
et al., 2004], and especially observed with the bSSFP sequence type. With an
added frequency offset in a bSSFP sequence, the artifacts would be expected in
specifically opposite directions and would probably never be circumferential.
Since the polarity of a static B0 frequency offset is usually unknown in vivo, it
cannot be predicted whether this effect might occur along the anterior/inferior
or septal/lateral direction. However, as a complicating factor it should also be
remembered this will all occur superimposed upon Gibbs and motion sources
of DRA.
The frequency offsets are dependent on the dose used, although the stan-
dard perfusion protocol used in many centres is a dose of 0.10 mmol kg−1, other
sites suggests a lower dose of up to 0.05 mmol kg−1 of body weight to prevent
non-linear contrast enhancement [Jerosch-Herold et al., 1998, Utz et al., 2007];
a wide range of different doses ranging from 0.05 mmol kg−1 to 0.15 mmol kg−1
have been trialed [Giang et al., 2004, Wolff et al., 2004]. The numerical simu-
lation results using different doses showed that the frequency offsets increased
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linearly with the dose given. Therefore, a lower dose than 0.1 mmol kg−1 would
almost certainly be insignificant in terms of causing any susceptibility artifacts.
Desirable though 3T may be for higher SNR, the susceptibility consequences
at 0.1 mmol kg−1 would correspond to those at 0.2 mmol kg−1 on a 1.5 T field.
Therefore frequency offsets would become more problematic.
Patients with a lower cardiac function also potentially lower the field-distortion
when compared to healthy volunteers, because of the less compact bolus likely
in this situation. Thus, if DRA were to be caused by frequency distortions, it
would be perhaps more likely to occur in patients with normal cardiac function,
which would tend again to increase the rate of false positives, as with Gibbs and
motion.
In conclusion, the numerically simulated and phantom work data agreed
well with the in vivo field distortions caused by the first pass of a CA. Dur-
ing the first-pass, B0 distortion occurs mainly in the subendocardium, and the
same pattern is always observed in conventional magnets with supine patients
(inferior-anterior regions: positive; septal-lateral regions: negative). The my-
ocardial B0 distortion is larger in patients with a more "horizontal" heart i.e. a
greater angle between the long axis of the heart and the direction of the main
field. From these results, we conclude that the field distortions are too weak to
cause DRAs in spoiled GRE sequences at a typical TE due simply to intravoxel
dephasing for a relatively high concentration bolus. However, the effects in
bSSFP and h-EPI perfusion sequences are more complex and when other sources
of off-resonance error are included, significant signal loss can be produced by
the paramagnetism of Gd at the dose given; nevertheless, this signal loss pro-
duced by susceptibility would be localised in specific regions and not with a
circumferential shape as seen often in vivo.
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Figure 4.11: Cylinder schematics.
4.A Field distortion in a cylinder
The field distortion inside and outside an infinite cylinder with a defined mag-
netic susceptibility in an external homogeneous magnetic field is well estab-
lished [Ogawa et al., 1993]. The frequency offset for a given difference in sus-
ceptibility ∆χ between the cylinder (Figure 4.11) and the surrounding is given
by:
Inside the cylinder:
∆ω(θ)= ∆ω
′
3
[
3cos2(θ)−1] (4.1)
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Outside the cylinder:
∆ω(r,θ,φ)=∆ω′ sin2(θ)(a/r )2 cos(2φ) (4.2)
where ∆ω′ = 2piω0∆χ, θ is the angle between the long axis of the cylinder and
the magnetic field direction, and φ and r are the cylindrical coordinates. ω0 is
the angular frequency of B0 and a is the cylinder radius. φ is the angle between
r and the in-plane component of B0.
This model can be adapted to simulate field distortions on the LV and my-
ocardial wall approximating it to a superposition of two infinitely long cylin-
ders. Each region can be defined with a magnetic susceptibility similar to the
one encountered in the heart during first pass, therefore simulating the phase
distortions caused by the arrival of the paramagnetic CA into the LV. Frequency
offsets in this setup are given by the following equations:
In the blood pool:
∆ω(θ)= ∆ω
′
1
3
[
3cos2(θ)−1]+ ∆ω′2
3
[
3cos2(θ)−1] (4.3)
In the myocardium:
∆ω(θ)=∆ω′1 sin2(θ)(a/r )2 cos(2φ)+
∆ω′2
3
[
3cos2(θ)−1] (4.4)
Magnetic permeabilities of each region are: myocardium χm = χ1e +χ2i ; left
ventricle cavity χv =χ1i +χ2i .
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CHAPTER 5
Zonal single-shot spin-echo EPI sequence with
TSENSE
5.1 Aim
The aim of this chapter was to develop an ultra-fast but robust sequence suit-
able for first-pass myocardial perfusion imaging, and assess its in vivo perfor-
mance.
Spin-echo single-shot* EPI has been used before in MPI [Edelman et al.,
1994, Panting et al., 2001]. However, single-shot EPI is well known to be sen-
sitive to off-resonance errors [Farzaneh et al., 1990] and to motion causing dis-
tortion and myocardial signal loss [Duerk and Simonetti, 1991]. These factors
limit its performance in the heart to stationary cardiac phases and require care-
ful attention to B0 shimming, probably making it unsuitable for perfusion de-
spite encouraging early reports using this method. As reviewed in section 2.5.2
and chapter 4 several factors may distort B0 in cardiac work, although there
have been recent improvements in field-mapping for cardiac shimming [Kell-
*Single shot is defined in this text as a sequence that only require two (spin-echo) RF pulses
per image acquisition. Sometimes single-shot is used to describe any perfusion sequence that
acquires a whole image in one heartbeat.
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man et al., 2009].
EPI can be made more robust to motion and off-resonance errors by using
a shorter EPI echo train, which was the main principle behind the work of this
chapter. The echo-train length was reduced in two ways: by using a 2D spatial
excitation enabling the use of a reduced phase FOV, and parallel imaging with
an acceleration factor of 2. The short-echo train also minimises motion-related
perfusion DRAs [Storey et al., 2002] by an ultra-fast image acquisition time.
5.2 Methods
Sequence programming was entirely done by using IDEA (Integrated Devel-
opment Environment for Applications) software provided by Siemens. This
software provides a platform for programming (C++) and simulating pulse se-
quences using a standalone computer. The compiled sequences can then be
exported and used in the appropriate Siemens’ scanners.
Note that the methods section includes some early results used to optimise
various details of the sequence, and these should not be confused with those of
the results section later on regarding its in vivo performance.
5.2.1 Sequence structure
The first step was to modify the software program code as no ready-made se-
quence could support this work. A Siemens single-shot EPI sequence source
code was available, but due to the complexity of that software, it was decided
early on to use a basic tutorial gradient-echo sequence from a Siemens pulse
sequence programming course as the starting point.
The first modifications included changing the sequence loop, associated
conventionally with the phase-encode steps, into a loop of repetitive readout
gradients of alternating polarity interspersed with the phase “blips” of MBEST
EPI [Howseman et al., 1988]. This entire loop was run after a single RF exci-
tation and refocusing pulse in order to construct a single-shot spin-echo EPI
sequence (Figure 5.1). The RF excitation and refocusing pulses had flip angles
of 90◦ and 180◦ respectively.
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The spin-echo served three main purposes: First, to improve image qual-
ity and reduce loss of signal due to field inhomogeneities, the sequence effec-
tive TE* was equal to the TE of the spin-echo. The sequence was therefore
T2-weighted instead of T2∗-weighted. Second, the spin-echo spatial selectiv-
ity could help with zone-selection as explained later. Third, it may also have
helped with the suppression of blood signal as also explained later.
The prephasing gradients in the phase and readout direction were placed in
between the excitation and the refocusing pulse. This is a common technique
in single shot EPI sequences with a T Eeffective = T Espin−echo and with a sequen-
tial Cartesian k-space acquisition because there is always unused time between
the two RF pulses.
*The effective TE is the TE when the central k-space phase-encode line is acquired, and it
will be defined simply as TE from now on.
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Figure 5.1: Spin-echo single-shot EPI sequence: main structure. The slice
selection gradient of the refocussing pulse was perpendicular to that of the
excitation pulse (see page 303). Please note, the slice selection gradient for
the refocussing pulse is invisible due to its low maximum amplitude.
5.2.1.1 Crusher gradients and spoilers
Crusher gradients are used with refocusing pulses in order to dephase possible
unwanted signal pathways that come from regions of transverse magnetisation
due to imperfect refocusing or at the edges of spatially selective refocusing.
The right crusher aims to eliminate the unwanted pathways by dephasing
the spins through the slice. A left crusher is needed to counteract this dephas-
ing in the wanted spin echo signal. The best axis for the crusher gradients is
usually the slice selection axis, since typically the voxels have their largest di-
mension along this direction. In our case though, the crusher gradients were
sometimes positioned in the phase-encode axis due to the perpendicular refo-
cussing pulse.
Methods 303
Spoilers were used at the end of the sequence in order to reduce spurious
signals that can interfere with the desired signal from subsequent measure-
ments. The transverse magnetisation was eliminated in the same way as the
unwanted signals from the refocusing pulse by dephasing the spins. Figure 5.2
shows the effects of not having either crusher gradients or spoiler gradients in a
rapid three slice image acquisition of a homogeneous water phantom, with no
delays between the slices.
Figure 5.2: Demonstration of the importance of using both spoilers and
crusher gradients. The three slices are parallel with a slice gap of 20 mm. The
same slice position is used in the three cases.
5.2.1.2 2D spatial excitation
Two methods of achieving the zone selection were assessed: A perpendicular
refocussing pulse and a 2DRF pulse.
5.2.1.2.1 Perpendicular refocussing pulse
Two perpendicular RF pulses can be used to create a 2D spatial excitation.
This technique could be used in this sequence because it was a spin-echo se-
quence. Crucially for the perfusion application in particular, there was a satu-
ration recovery pulse prior to each slice excitation. This effectively “reset” the
effects of the perpendicular refocusing of the previous slices, and enabled this
method for multi-slice imaging, with the predictable complication of possible
stimulated echo effects.
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The excitation RF pulse was slice-selective as is conventional while the refo-
cussing pulse had its “slice” selection gradient moved into the phase-encoding
direction, becoming a “zone” selection gradient. The strength of the zone se-
lection gradient of the refocussing pulse was linked to the phase-encode FOV
instead of the usual slice thickness, thereby refocussing spins only in the se-
lected phase FOV.
Equation 5.1, shows the dependency of the slice selection gradient magni-
tude Gz on the slice thickness ∆z. ∆ f is the bandwidth of frequencies of the RF
pulse, and γ is the Larmor constant. Replacing the slice thickness by a much
greater phase FOV will therefore reduce the amplitude of the zone selection
gradient. This can be seen in Figure 5.1 with an invisible (because of the low
maximum amplitude) zone selection gradient on the phase-encode axis. The
weakness of this gradient can be expected to make the zone selection some-
what sensitive to off-resonance effects. From Equation (5.1), the strength for
a typical bandwidth of 1.56 kHz and a zone width of 156 mm would be 0.235
mT/m i.e. 10.0 Hz/mm. A 1 ppm off-resonance error would cause a local dis-
tortion offset of the zone selective RF along the phase-encode direction by ≈ 6
mm.
Gz = ∆ f
γ∆z
(5.1)
To improve the potential problem of stimulated echoes, the RF pulses could
be also obliquely orientated (as described in section 2.9.1.1). In order to avoid
the refocussing pulse from overlapping the neighbour slices, the refocusing
pulse must be orientated at an angle θ to the slice direction, Figure 5.3. Considering
a slice thickness (ST) of 10 mm, a slice gap (SG) of 6 mm, and an ROI along the
phase-encode direction of 150 mm, the minimum angle is θ = 86◦. It can also be
shown that the minimum FOV in the phase-encode direction is FOVminimum =
ROI × (1+ STSG )= 400 mm [Symms et al., 2000].
To avoid potential wraparound and SNR loss with an oblique RF pulse setup,
the phase FOV in this example has to be more than twice as big as the ROI,
therefore, the gain in imaging time is small, and oblique pulses were not used.
The reference scans for phase correction and parallel imaging did not con-
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Figure 5.3: Oblique pulse setup from a perspective perpendicular to the im-
age plane (not scaled). The dark grey square represents the ROI (short-axis
LV+myocardial wall), the light grey region represents the additional region
along the phase-encode FOV that must be imaged to prevent wrap-around
into the ROI of any potential stimulated echoes. ST: slice thickness; SG: slice
gap; ROI: region of interest.
tain a saturation recovery pulse prior to data acquisition, complicating the pos-
sible use of the perpendicular 90-180 zonal selection. Also due to concerns
about the likely generation of stimulated echoes by the repeated application of
perpendicular 90-180s*, that approach was discontinued and all further work
used 2D selective RF pulse excitations with slice-selective 180s unless stated
otherwise.
5.2.1.2.2 2DRF pulse
A 2DRF pulse technique was also assessed, in which the 2DRF pulse was used
as the 90◦ excitation pulse. When using a 2DRF excitation pulse, the refocusing
180◦ pulse was used with a conventional slice selection gradient. The 2DRF
pulse code was written by Siemens, but it required in-house modifications as
explained later. This pulse had several advantages when compared to the per-
pendicular RF approach. It did not rely on the use of saturation pulses to permit
multislice imaging and avoided the possible stimulated echo problem of that
*Even when using saturation pulses prior to each slice, stimulated echoes are still possible
to show due to non-spoiled echo-pathways and imperfect saturation pulse profile.
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approach. As a disadvantage, 2DRF pulses required more time and required
careful timing adjustment (between gradient axes and also to the RF transmit)
[Alley et al., 1997] in order to avoid distortions of the 2D RF profile as described
further below.
The 2DRF pulse’s k-space coverage trajectory was a blipped EPI path, and
the excitation profile was rectangular. The desired excitation profile and cor-
responding weighting function are depicted in Figure 5.4. The cross sectional
dimensions of the excitation volume were defined by the phase-encode exci-
tation gradient (Y direction), and the frequency-encode excitation gradient (Z
direction)*, Figure 5.5. The applied B1 field was specified by the two gradients
and by the excitation profile, equation (2.47). The RF pulse with an EPI path
can be regarded as consisting of a mixture of a slow and a fast pulse along the
excite-phase-encode and excite-frequency-encode axes respectively.
Figure 5.4: Left: The excitation profile of the 2DRF pulse. Right: The corre-
sponding weighting function in k-space (2D sinc function).
A 2DRF pulse needs to be optimised for a good compromise between excita-
tion profile sharpness, RF pulse duration, and gradient amplitude. The quality
of the 2DRF pulse was first tested with a GRE† sequence (where the excitation
*Both Z and Y direction are defined as for the conventional directions of a transversal slice
orientation. Please note: the frequency and phase-encode excite directions applies here to the
RF transmit process.
†The correct alignment of the 2DRF pulse gradients with the RF pulse could not be tested
with the zonal-EPI sequence, since it would be difficult to separate the effects of the EPI readout
k-space path from the 2DRF EPI transmit k-space path.
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Figure 5.5: 2DRF pulse used depicting the B1 field, and the blipped EPI gra-
dient scheme in the phase-encode direction and in the slice direction (of the
main sequence). Note that the triangular waveform was impracticably sensi-
tive to timing errors as explained later in this Section.
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pulse was replaced by the 2DRF pulse) in a phantom: big container filled with
gelatin (35×24×41 cm).
The EPI gradient trajectory of the 2DRF pulse is sensitive to eddy currents,
gradient axes anisotropy, and field distortions, in a similar way as a normal EPI
readout. Part of this sensitivity can be approximated to small time errors be-
tween the B1 and the gradients. These unintentional time shifts distort the
weighting function (sinc function, right of figure 5.4) in a way that odd lines
shift to one side, and even lines shift to the other side in the transmit frequency-
encode direction. This comes from the fact that adjacent phase-encode lines of
the 2DRF k-space path are played jointly with alternate signs on the transmit
path’s frequency-encode gradient. As a result we have additional side lobe exci-
tations at half the “excite” phase-encode FOV, exactly analogous to the Nyquist
FOV/2 ghost of single-shot EPI (Figure 5.6).
Side lobes tended to be more prominent when the imaging plane was oblique
or off-isocentre, due to the increasing phase errors due to eddy currents and
anisotropic gradient delays.
The alignment of the weighting function (sinc function) with the gradient
waveforms was optimised, by imaging a uniform part of the phantom with a
2DRF pulse slab perpendicular to the imaging slice (Top right Figure 5.6). To
avoid misleading results, a uniform phantom was used, with a uniform receiver
coil response. The uniform phantom sufficiently filled the excite FOV to show
N/2 sidebands.
The raw data of these perpendicular images gives us a “bird’s eye” view of
the sinc function (Bottom of Figure 5.6). It is easily seen that the sinc function is
distorted, with time errors between odd and even phase-encode steps (arrows).
After synchronising the B1 waveform with the gradients in the 2DRF pulse code,
the sinc function was aligned, suppressing the side lobe excitations (Figure 5.7).
Additional side lobes (named as Exc-FOV aliasing side lobes, to avoid confu-
sion with the side lobes mentioned above) can potentially be seen with a 2DRF
pulse. These side lobes are caused by the finite sampling of the 2DRF EPI path
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Figure 5.6: Top left: sidelobe excitations (white arrows) are easily seen
around the central excitation on the rectangular phantom; the phase-encode
FOV excite was 140 mm,≈ 1/3 of the phantom length along the phase-encode
direction (vertical). Top right: 2DRF pulse being imaged in a perpendicular
orientation relative to the imaging plane (arrows point out the cross section
of the side lobes). Bottom: weighting function; arrows show the misalign-
ment between odd and even RF subpulses of the 2DRF path (enlarged figure
for better visualisation).
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Figure 5.7: Top left: no visible sidelobe excitations around the central exci-
tation on the rectangular phantom; the phase-encode FOV was the same as
in Figure 5.6. Top right: 2DRF pulse being imaged in a perpendicular orienta-
tion relative to the imaging plane; the side lobes signal is much lower than the
central lobe. Bottom: sinc function given by the raw data of the image shown
in the middle; no misalignment between odd and even RF subpulses of the
2DRF path (excite phase-encoding steps) (enlarged figure for better visualisa-
tion).
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Figure 5.8: Top: Rectangular phantom without Exc-FOV aliasing side lobes
(side lobe distance: 300 mm). Bottom: Rectangular phantom with Exc-FOV
aliasing side lobes (white arrows) (side lobe distance: 200 mm). The 2DRF
pulses are shown on the right of the respective image. 2DRF pulse excite
phase FOV of 140 mm.
along the excite phase-encode direction over the B1 sinc function. A higher
sampling density shifts these side lobes further away from the principal exci-
tation in order to use the 2DRF pulse without wraparound artifacts, although
as a trade-off the duration of the pulse increases. The distance of the Exc-FOV
aliasing side lobes is defined in the 2DRF code, (Figure 5.8).
Decreasing the sampling density of the pulse, for demonstration purposes,
shifted the Exc-FOV aliasing side lobes from 300 mm to 200 mm, exciting the
edge of the phantom and reducing the duration of the 2DRF pulse from 8.5 ms
to 6 ms.
In the zonal sequence the 2DRF pulse excite phase-FOV will be linked to the
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image phase FOV length*. If using a coarsely sampled 2DRF pulse, wraparound
of the Exc-FOV aliasing side lobes will superimpose the wrapped tissue in the
FOV (Figure 5.9). Therefore, all side lobe excitations must be outside the patient
or at least outside the receiver coil response to prevent them from corrupting
the image. A longer 2DRF pulse must be used which is not problematic in a
single shot spin-echo sequence, but limits its use in GRE or bSSFP sequences.
Figure 5.9: Rectangular phantom scanned with the phase FOV linked to the
size of the 2DRF pulse (phase-encode direction vertical). Left: Exc-FOV alias-
ing side lobe distance 300 mm. Right: Exc-FOV aliasing side lobe distance 200
mm. 2DRF pulse excite phase FOV of 140 mm.
In vivo in a double oblique slice with the slice centred in the heart, it was
estimated that a Exc-FOV aliasing side lobe distance of 500 mm would be safe,
even to a more obese patient, avoiding wraparound artifacts in the FOV. This
2DRF pulse setup had a duration of ≈ 14 ms (Figure 5.10).
Even though we can synchronise the B1 in relation to the EPI excitation path
gradients, the optimum setup may change for different slice offset/orientations,
depending on the scanner used. The 2DRF pulse software as supplied by Siemens
used the triangular waveform (Figure 5.10), probably because this was the fastest
possible waveform taking full advantage of the scanner’s fast gradient perfor-
mance. However, this unusual design was highly sensitive to timing errors. One
way to make the weighting function alignment less dependent on the imaging
plane orientation was to flatten the top of the gradient in the Z (excite frequency-
encode) direction. A small modification of the gradients code enabled the more
conventional waveform shown in Figure 5.11. This way, small mis-alignments
*The length of the 2DRF pulse along the phase-encode axis will be 75% of the phase FOV
in order to avoid wraparound from a non-perfect pulse profile near the edges along the phase-
encode direction.)
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Figure 5.10: 2DRF pulse with Exc-FOV aliasing side lobe distance of 500
mm.
Figure 5.11: The slice axis gradient top was flattened to minimise the ef-
fects of a small timing error between B1 and the 2DRF pulse gradients. Before
the gradient modification, the slice axis gradient lobe had a ramp-up-time
of 190 µs, and a total-duration of 380 µs. After the modification, the trape-
zoidal gradient lobe had a ramp-up-time of 80 µs, flat-top-time of 370 µs, and
a total-duration of 530 µs.
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between B1 and gradients did not translate into noticeable distortions in the ex-
cite frequency-encode direction, although the 2DRF pulse duration increased
from 14 to 19 ms.
An example showing the advantage of having trapezoidal gradients is shown
in Figure 5.12. When shifting the image plane away from isocentre in the slice
select direction, the 2DRF pulse with triangular gradients became distorted at
an offset of ≈ 100 mm. The 2DRF pulse with the trapezoidal gradients was
more robust to slice-offsets, therefore its lengthening was justifiable. Because
the zonal single-shot EPI sequence used a spin-echo at the centre of the EPI
echo-train, there was unused time between the excitation RF pulse and the re-
focussing RF pulse. Therefore it was feasible to use a long 2DRF pulse without
a big penalty on the total time of imaging.
5.2.1.2.3 Pulse profiles
The thickness of the RF pulses was measured by running the sequence with
the pulse we want to measure applied perpendicularly to the imaging plane.
This turned out to be an important step for determining the true slice profile,
which often differed from the thickness specified in the pulse sequence code.
The FWHM thickness of the 2DRF pulse was measured at FWHM= 18.1 mm,
although it was programmed for a 15 mm thickness in the code. The final slice
thickness of the spin echo was then narrowed by the refocussing pulse which
had a sharper profile.
The desired thickness of the refocussing pulse was 10 mm, i.e. equal to the
slice thickness of the protocol. It was noticed early on that the FWHM of the
refocussing pulse was roughly half the value defined in the code, and there-
fore the thickness of the refocussing pulse was multiplied by a factor of two
in the code. Later on in the work, the thickness of the refocussing pulse was
more accurately measured and a thickness of FWHM= 12.7 mm was obtained
instead of the desired 10 mm. The 180 slice profile was measured by the com-
bination of the excitation pulse and the refocussing 180◦ pulse, i.e. spin-echo
spatial profile with the slice selection gradient on the refocussing pulse along
the phase-encode direction.
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Figure 5.12: Top two rows: 2DRF pulse with a triangular gradient at 4 differ-
ent slice offsets (isocentre, 50, 80, 100 mm). It is shown the excitation in the
image plane and the respective cross section. At 100 mm from isocentre, the
2DRF pulse distortion is notorious. Bottom two rows: Similar to the top two
rows but for the 2DRF with the trapezoidal gradient.
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Unfortunately this refocussing slice profile of 12.7 mm was erroneously left
uncorrected during all the in vivo scans and therefore all results stated in this
chapter are considering a slice thickness of 12.7 mm instead of the desired 10
mm.
Figure 5.13: The measured slice profiles of the RF pulses used in the zonal-
EPI sequence.
5.2.1.3 Ramp Sampling
Ramp sampling was also used in order to speed up the readout train. This sam-
pling can start just after the blip phase-encode gradient until the next blip, Fig-
ure 5.14. When data is sampled only during the plateau of the readout gradient,
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Figure 5.14: Ramp sampling gradient diagram. The sampling frequency is
lower in the ramps to maintain the same distance between different points
in k-space. The variable lower sampling rate was achieved by software 1D-
regridding (Siemens). Duration of one ADC is 0.44 ms.
its amplitude is given by the following formula [Bernstein et al., 2004]:
Gx = 2pinx
γFOVxTacq
(5.2)
where nx is the number of k-space sampled points in the readout direction,
FOVx is the Field of view in the readout direction, and Tacq is the time of ac-
quisition of all nx points. To achieve the same spatial resolution with ramp
sampling, and with the same Tacq, the area under the sampled part of the read-
out gradient waveform must be the same, thus making its amplitude increase.
In this particular case where the whole gradient is used, apart from the area
covered by the phase-encode blips, and Tacq is the same as before using ramp
sampling, the new gradient amplitude, Gx ′, is given by a quadratic formula:
Gx ′2−Tacq ·SR ·Gx ′+delay2 ·SR2+Gx ·Tacq ·SR= 0 (5.3)
where Gx is the amplitude with no ramp sampling, given by equation (5.2), SR
is the slew rate of the readout gradient ramp, and delay is the total duration of
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the blip phase-encode gradient.
The time spent in the ramp by each readout gradient was twice the ramp
time of the phase-encode blips. Therefore, the spacing of each ADC was re-
duced to half with the ramp sampling.
5.2.1.4 Saturation pulse: BIR-4
T1-weighting was achieved with a saturation recovery BIR-4 pulse (Figure 5.15)
[Kim et al., 2005] (see appendix A), since the flip-angle achieved by conven-
tional square pulses is affected by B0 and B1 variations. The time delay from
saturation to the excitation pulse was 86 ms (identical for all slices).
Figure 5.15: BIR-4 used in detail with the amplitude (top) and phase mod-
ulation (bottom) functions.
5.2.1.5 Fat suppression
For a single-shot EPI sequence chemical shift offset artifacts are large in the
phase-encode direction due to the low phase-encode effective bandwidth. The
chemical shift offset ∆ycs (mm), of lipids compared to water can be calculated
by using equation 2.15. For an echo spacing of 0.57 ms, and a reduced phase
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FOV of 150 mm, the chemical shift offset is ∆ycs ≈ 18 mm. A fat suppres-
sion pulse was therefore added to the sequence before the excitation pulse.
This pulse selectively excites spins with a chemical shift by using a frequency-
selective pulse saturating the protons from lipids, followed by a spoiler gradi-
ent, Figure 5.16.
Figure 5.16: Fat saturation pulse applied just before the excitation pulse
followed by spoiler gradients.
The reduced phase FOV of the zonal-sequence, not only allows a quick ac-
quisition, but also reduces chemical shift artifacts from imperfect-spoiled fat
signals. Figure 5.17 shows a bucket half-filled with water and a bar of lard at
the water surface scanned with: a scout image (bSSFP) (no chemical shift and
almost no signal in the fat), and two zonal-EPI images with two different phase-
encode FOVs. The chemical shift is noticeably bigger for the larger phase FOV.
5.2.1.6 Phase correction
As mentioned in section 2.3.4, echo planar imaging sequences are prone to
have an N/2 artifact.
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Figure 5.17: Demonstration of the chemical shift dependency on the phase
FOV. The fat-saturation RF pulse of the zonal-sequence was turned off for this
demonstration. The fat signal is very weak in the bSSFP but it serves to show
the correct position of the lard. Phase-encode direction vertical.
Phase correction algorithms are provided by most manufacturers. In the
case of Siemens, this is typically based on three non-phase-encoded echoes
acquired before imaging [Bruder et al., 1992].
This method runs a short separate EPI echo train of three echoes. It may be
more accurate to replicate the single shot sequence’s entire readout train (apart
from the phase-encode blips) in a pre-scan for the phase-correction, because
this more closely replicates possible eddy currents and gives more accurate es-
timation of the time difference between odd and even echoes. However, the
Siemens phase correction algorithm was designed to use only three phase cor-
rection echoes. The first and last echoes are averaged and used to correct all the
odd echoes, while the second echo is used to correct all the even echoes. There
was insufficient time to optimise this aspect of phase-correction more fully.
The three acquired echoes were therefore acquired positioned during the
centre of the spin-echo (at T Eeff) at the same time as the most important echoes
of the imaging echo train to minimise spin dephasing (Figure 5.18).
The separate pre-scan for phase-correction was done without saturation re-
covery preparation, thus providing more signal to measure the time differences
of the odd and even echoes. This was important because the zonal sequence
using parallel imaging, with its small number of phase-encode lines, had a low
SNR prior to CA signal enhancement. The zonal sequence acquired a separate
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Figure 5.18: Phase correction reference scan.
phase correction pre-scan for each slice, in the first cardiac cycle. These scans
were ECG triggered to be acquired at the same cardiac phase as the normal im-
age readout.
5.2.1.6.1 Optimisation of phase-correction
Some of the initial volunteer results were included here because they deter-
mined the phase-correction method used for the main study. The sequence
when first tested on volunteers presented phase correction artifacts at some
trigger times and some myocardial locations, visible as lines across the phase
FOV (arrows Figure 5.19 Left). The phase correction method used in these im-
ages was the scanner software’s normal (i.e. default) setting. This approach
corresponded to the pixel-by-pixel (x,ky) method described by Bernstein et al.
[2004] (page 729). (It is understood that all such phase-correction methods cor-
rect entire columns along the phase-encode with the same value and cannot be
optimised for individual pixels along that direction.) Following those initial re-
sults, another phase correction method was assessed (Figure 5.19 Right), which
calculated a linear phase slope by fitting to the phase correction echoes [Ahn
and Cho, 1987]. This was found to be more robust to blood flow and myocar-
322 Methods
Figure 5.19: Phase correction comparison. Left: old method (pixel-by-pixel)
showing phase correction artifacts (arrows). Right: The new method (linear
phase slope) with no artifacts. Both images are the exact same protocol at the
same trigger time.
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dial motion, and was used in all the patient scans described later.
5.2.1.7 GRAPPA vs SENSE
Parallel imaging was also used to shorten the EPI echo train for the reasons
stated earlier, and this section describes how parallel imaging was used.
SENSE and GRAPPA image reconstruction was readily available. The se-
quence was therefore modified to support parallel imaging with R=2, making
use of the scanner’s parallel image reconstruction code. When either GRAPPA
or SENSE were selected, the number of phase-encode lines acquired in the
single-shot echo-train was halved; also an extra reference pre-scan per slice
was introduced, where the coil sensitivities were measured for each slice. The
reference scan was acquired with 24 phase-encode lines.
For all the parallel imaging work, the maximum number of RF coils around
the heart was selected to increase the spatial information in the difference be-
tween channels. In a typical perfusion protocol there are six posterior and six
anterior coils around the heart, each having a separate RF receiver and recon-
struction channel. (On the Siemens VB15 software, this was referred to as ma-
trix coil mode set to “triple” with the user interface showing two posterior and
two anterior coils, which each represent coil clusters of 3 RF channels).
Both GRAPPA and SENSE methods should, in theory, yield similar results. In
practice though, GRAPPA was slightly noisier than SENSE* in the Siemens soft-
ware used, although much more robust to phase-encode FOV aliasing [Blaimer
et al., 2004]. This can be seen in Figure 5.20, where a phantom was imaged by
a 2DRF excitation with a phase-encode dimension slightly exceeding the phase
FOV, triggering aliasing of a small amount of the phantom around the edges
of the FOV in the phase-encode direction. Artifacts at the centre of the phase-
FOV [Griswold et al., 2002] are easily seen with the SENSE algorithm but do not
occur with GRAPPA.
It should be pointed out that phase correction artifacts will occur at a quar-
ter of the phase FOV away when parallel imaging is used with R=2.
*A scan of an homogeneous phantom showed that the SNR with GRAPPA is approximately
10% lower than exactly the same protocol with SENSE.
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Figure 5.20: A phantom imaged with the zonal sequence using SENSE (top)
and GRAPPA (bottom). The SENSE algorithm is sensitive to aliasing in the
phase FOV, displaying artifacts in the centre of the FOV. Phase-encode direc-
tion vertical.
GRAPPA was found to be more robust to image wrap, and in the Siemens
software used it also showed less parallel imaging ghosting. As mentioned pre-
viously, single-shot EPI sequences are prone to blurring, signal losses, and ge-
ometric distortions. Accelerating the image acquisition with parallel imaging
and 2DRF excitation reduces these artifacts, nevertheless some of these fac-
tors, like geometric distortions might become problematic with SENSE, since
the distortion in the MRI images may differ from that in the coil sensitivity
maps [Blaimer et al., 2004]. Furthermore, due to the reduced phase-encode
FOV, which is the direction of parallel imaging, accurate discrimination of the
coil profiles may also be more difficult to obtain than it is over a large phase-
encode FOV. GRAPPA has proven to be less affected by geometric distortions,
due to the k-space based reconstruction of missing lines, proving to be suitable
for single-shot EPI [Blaimer et al., 2004, Heidemann et al., 2001].
One final remark is the fact that coil positioning causes localised noise en-
hancement with parallel imaging; this effect is worse for SENSE than GRAPPA.
GRAPPA being a k-space unwrapping algorithm will propagate the errors in-
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volved in the calculation of the missing lines over the entire FOV in the image
space [Blaimer et al., 2004]. This was considered important for the perfusion
application where SNR was limited, except that GRAPPA did have slightly lower
overall image SNR than SENSE in this software. This type of comparison is
highly software-dependent, so no general conclusions can be drawn from this
section, and it was used only for the sequence optimization for this application.
Despite the slightly lower SNR, GRAPPA was therefore considered more suited
to use with this EPI readout. Unless stated otherwise, all results shown below
were obtained with GRAPPA at R=2.
5.2.1.8 Dark blood preparation
A darker LV blood pool would reduce the image contrast between the LV and the
myocardial wall at the beginning of CA perfusion into the myocardium. Reduc-
ing the contrast would automatically reduce potential subendocardial Gibbs
and motion artifacts, since their visibility is dependent on a sharp signal dis-
continuity. Rapid moving blood can also introduce flow-related phase-encode
ghosting artifacts, which can potentially move blood signal into the myocardial
wall.
The slice-selective spin-echo refocusing pulse was expected to attenuate
the signal of rapid moving blood, but not reliably as explained in this section,
requiring further blood suppression techniques. In the zonal sequence the time
between the excitation and the refocusing pulse was TE/2, so for the excited
blood to completely flow out from the slice between the two pulses, its through-
plane velocity v⊥ must be at least:
v⊥ = 2∆z
TE
(5.4)
Where ∆z is the distance in the slice direction between the beginning of the
2DRF slice profile and the end of the refocus slice profile: ∆z = 15.4 mm. Us-
ing equation 5.4 with a TE of 25 ms gives us a v⊥ = 1.2 m/s. This velocity is
close to the maximum blood flow velocity measured during ventricular filling
(≈ 1.0 ms) [Nakamura et al., 2007]. Note also that the blood flow velocity di-
rection is dependent on the position inside the LV blood pool, and might not
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be exactly perpendicular to the imaging slice, which will reduce the chances
of blood flow nulling. Therefore only incomplete blood signal suppression is
expected by the spin-echo refocusing, and extra dark blood techniques were
assessed to increase the chances of nulling the moving blood: Flow Dephasing
Gradients (FDG), and a Black Blood RF (BBRF) (parallel saturation) pulse.
5.2.1.8.1 Flow dephasing gradients
FDG were tested with the aim of reducing the signal of flowing blood. If there
is flowing blood in the slice, and a pair of identical gradients before and after
the refocussing are applied in the direction of the flow, then pixels containing
a range of different velocities would not be completely refocused by the spin-
echo, as they would contain a range of velocity-related phase-shifts. This effect
is known as intra-voxel phase dispersion. Mathematically this can be described
by the following equations:
The position of the blood x(t ) can be extrapolated by a Taylor series (ignor-
ing higher terms):
x(t )= x0+ v0 t + 1
2
a0 t
2 (5.5)
where x0 is the initial position, v0 is the initial velocity, and a0 is the initial ac-
celeration.
The phase accumulation along the flow direction given by the gradient in
the same direction is:
φ(t )= γ
∫ t
0
G(t ′)x(t ′)dt ′ (5.6)
where G is the gradient amplitude as a function of time, and t=0 is the time of
the RF excitation. Combining equations (5.5), and (5.6), we have:
φ(t )= γ
∫ t
0
G(t ′)
(
x0+ v0 t ′+ 1
2
a0 t
′2
)
dt ′ (5.7)
This equation can be rewritten as a moment expansion:
φ(t )= γm0(t )x0+γm1(t )v0+ γ
2
m2(t )a0 (5.8)
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where the nth gradient moment is given by:
mn(t )=
∫ t
o
G(t ′)t ′ndt ′ (5.9)
The sequence without any extra FDG already contained gradients that were
flow sensitive, mainly in the slice select direction due to the crusher gradients.
The zeroth moment is nulled in all axes at TE (centre of the echo). In contrast
the first moment in the slice selection direction at TE was m1z(TE) =−135 mT
ms2 m−1, i.e. - 36.1 radians s m−1 (Figure 5.21). Considering an average blood
flow with a constant velocity of v = 0.5 m/s along the slice direction, the veloc-
ity phase shift is φ(TE) = 18.0 radians. A voxel containing a range of velocities
would therefore contain a range of phase shifts approaching 5.7pi and therefore
likely to induce a noticeable signal loss of moving spins through the slice.
When the FDG were turned on in all axes (amplitude 30 mT/m), the crusher
gradients were turned off and as expected the zeroth moment did not change,
i.e. null at TE (centre of the echo), although the first moment increased dras-
tically in all axes. At TE the first moment for each axis was: m1X (TE) = −343,
m1Y (TE) = −371, and m1Z (TE) = −466 mT ms2 m−1, resulting in 91.8, 99.2,
and 125 radians s m−1 respectively (Figure 5.22). Considering the same ve-
locity of v = 0.5 m/s, the respective velocity phase shift were φX (TE) = 45.9,
φY (TE) = 49.6, φZ (TE) = 62.5 radians. The phase dispersions were therefore
increased and signal loss of moving spins is expected to be more noticeable.
Adding the FDG in all three axis extended the TE by 7 ms.
The FDG were identical in all the three axes, although the time gap between
the two lobes was higher for the slice-axis. As described later, the FDG were also
tested in the z axis only (Table 5.1).
5.2.1.8.2 Black blood RF pulse
Another technique assessed to suppress the signal of moving blood was to
use an RF pulse with an excitation profile that saturates the surroundings of
the imaged plane, but not the plane itself followed by a dephasing gradient
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parameter value
ramp up time (µs) 340
ramp down time (µs) 340
plateau (µs) 1250
time gap read-axis (ms) 6.87
time gap phase-axis (ms) 6.87
time gap slice-axis (ms) 11.7
amplitude (mT/m) 30
Table 5.1: Flow dephasing gradient parameters.
(Figure 5.23). If the saturated blood flows into the imaging plane before the
Figure 5.23: The time domain (absolute part) of the BBRF pulse.
zone-selective excitation, the blood signal in the image will be greatly reduced.
However, the effectiveness of this type of blood suppression depends on the
spatial profile of the BBRF pulse and this was therefore measured as follows.
(The timing is also important and is discussed later).
The sequence was tested with the slice selection gradient of the BBRF pulse
applied along the frequency-encode direction, in order to visualise its satura-
tion profile across the slice. The dark regions of the phantom show the regions
saturated by the BBRF pulse (Figure 5.24). The bright zone in the middle has a
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Figure 5.24: Left: BBRF pulse imaged on a phantom rotated to run per-
pendicular to the slice, displaying its signal profile across the slice. The inner
black bands are the zones excited by the pulse. Right: the saturation line pro-
file of the BBRF pulse shown on the left (black), and a line profile of the same
phantom imaged identically except without the BBRF pulse (red). The yellow
rectangle shows the area used to obtain the averaged line profile (along the
vertical direction).
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FWHM of 13.5 mm, which is wider than the imaging slice thickness (12.7 mm),
therefore the BBRF pulse does not interfere with the signal inside the slice (not
considering myocardial motion).
From the slice profile measurement, blood close to the edge and up to 19
mm from the edge of the imaging slice is ≥ 50% saturated (both sides). These
measurements were used in conjunction with the timings described next, in
order to estimate the range of blood velocities suppressed by the BBRF pulse.
The BBRF pulse was played between the BIR-4 saturation pulse and the fat
saturation pulse, at a timing controlled by a dialog box in the protocol. The in-
terval of time between the peak of the BBRF pulse and the peak 2DRF excitation
was defined as the BBRF delay. However, for the sequence operation a shorter
delay time was entered as explained by Figure 5.25.
Figure 5.25: The BBRF pulse delay was controlled by inserting a shorter de-
lay between the end of the BBRF pulse and the beginning of the fat saturation
pulse.
The expected signal as a function of through-plane blood flow velocity for
the pulse profile shown in Figure 5.24 is shown in Figure 5.26 for three differ-
ent BBRF delays: {20,60,100} ms as selected for in vivo evaluation. These three
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Figure 5.26: Normalised signal (averaged over the entire slice) as a function
of blood flow velocity for three different black blood pulse delays.
values would be predicted to give a ≥ 50% blood suppression for blood veloci-
ties in the range of [0.6,1.3], [0.2,0.45], [0.1,0.25] m/s respectively (considering
a large T1).
It was recognised in advance that this technique could not be expected to
provide complete signal reduction for the peak bolus Gad, but some partial
suppression at least. In principle, the black blood pulse flip angle could be in-
creased to compensate for faster T1-recovery as the Gd bolus arrives, and even
adjusted automatically using the blood signal in a separate low-resolution ar-
terial input function image; however, the reliability of such complex schemes
would obviously be questionable. Also in order to use a large BBRF delay the
time of inversion would have to accommodate the BBRF pulse between the
BIR-4 and the 2DRF pulse.
5.2.1.9 Protocol parameters dialog box
It was important to acquire comparison images using a range of values for many
new parameters in order to assess their optimum settings. The sequence soft-
ware was modified so that the relevant new protocol parameters could be ad-
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parameter value
TE = TEeff (ms) 22
read FOV (mm) 370
phase FOV (mm) 156
flip angle excitation (deg) 90
flip angle refocussing (deg) 180
flip angle BB pulse (deg) 90
TD (ms) 89
TI (ms) 115
TA (ms) 125
bandwidth (Hz/pixel) 2230
pixel size (mm) 3.1×3.1
slice thickness (mm) 13
slice distance gap (mm) 6
parallel imaging R=2 (GRAPPA)
number measurements 50
slice number 3
Table 5.2: Sequence protocols used in the zonal sequence. TD - is the time
delay between the saturation recovery and the excitation RF pulse. TI - is the
time of inversion defined as the time between the saturation recovery prepa-
ration and the acquisition of the k-space centre line. TA - is the time of acqui-
sition of the whole sequence including the saturation recovery preparation.
The TE value rose from 22 to 30 ms if the motion dephasing gradients were
used in the three axes with a velocity sensitivity gradient zeroth moment of 30
mT ms m−1.
justed without having to edit and recompile the pulse sequence. For example,
this interface allowed us to choose between using dark-blood preparation by
RF pulse or by FDG, and also control the BBRF delay or the amplitude of the
FDG, during the same patient session.
5.2.2 Sequence protocol
The protocol parameters used for the zonal sequence are detailed in Table 5.2.
The phase FOV was intended to be wide enough to cover the left-ventricle of
the heart in a short axis plane without myocardial tissue getting too close to the
edges of the zone, where signal suffered some attenuation due to imperfect RF
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profiles. The phase FOV resulted in the acquisition of 27 phase-encode lines.
Figure 5.27 and 5.28 show the structure of the whole scan for one measure-
ment and one slice and also the image data acquisition part in more detail re-
spectively. The sequence was ECG triggered so that the respective phase cor-
Figure 5.27: Sequence structure including pre-scans (no dark blood tech-
nique is shown in order to keep this diagram simple).
rection pre-scans, the coil sensitivity pre-scans, and the main sequence scans
were acquired in the same phase of the cardiac cycle. A phase correction and
coil sensitivity pre-scans were performed for every slice imaged before running
the T1-weighted perfusion sequence (the pre-scans are done only once) in the
whole measurement.
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Figure 5.28: Main sequence structure (showing the dark blood techniques).
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5.2.3 Volunteer scans
All the studies were performed using a 1.5 T scanner (Avanto; Siemens) with
anterior/posterior phased array cardiac coils.
The typical orientation of the slices is shown in Figure 5.29. The plane ro-
tation shown on the left was chosen so that the slice was all inside the body. In
this way, motion of the heart into the outside of the excited zone due to respi-
ratory motion is minimised. Also important to ensure anterior-posterior coil
separation along the phase-encode axis of the imaging, to improve the perfor-
mance of the parallel imaging.
Figure 5.29: Typical plane orientation of the zonal sequence. Left: short-
axis scout showing the image plane orientation in red with the white arrow
showing the phase-encode direction. Right: 4-chamber scout showing the
three slices along the long axis in the LV.
No specialised main field shimming or frequency tuning was used for the in
vivo studies. The main field shim settings were preset routinely by Siemens ser-
vice engineering. The scanner RF centre-frequency was adjusted by the scan-
ner using the entire volume of the slice.
All in vivo studies in this work were conducted with a consent form signed
by the volunteers. The form has been approved by the Ethics Committee of the
Royal Brompton Hospital / National Heart & Lung Institute.
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5.2.3.1 Preliminary scans in healthy volunteers without contrast agent
Preliminary scans were acquired on five healthy volunteers with no contrast-
agent injected. The zonal sequence protocol used was the one shown in Table
5.2, except because no CA was injected the saturation pulse was turned off and
the number of measurements was reduced to 10. The main purpose of these
preliminary scans was to test the sequence robustness in general and also test
the two different dark blood techniques, mainly to see if it was possible to sup-
press the signal of the blood without losing signal in the myocardium (with of
course the limitation that the blood T1 was always long for these tests).
Each volunteer was scanned as follows:
1. Short-axis and long-axis cines were acquired and used to roughly esti-
mate visually the time of end-systole after the R-wave. This information
was useful to have an idea of the time when the heart was moving fastest
(both through-plane and in-plane) [Staehle et al., 2008].
2. No dark blood preparation, acquiring 5 different ECG trigger delays (from
the R wave to the beginning of the 2DRF pulse): 100, 200, 300, 400, 500 ms.
(Image acquisition was not tested immediately after the R-wave because
when tested in clinical patients with CA, a saturation recovery delay is
necessary for perfusion imaging.)
3. Identical sequence timings to the previous step but with FDG turned on:
φ
v = 91.8, 99.2, and 125 radians s m−1 for the read, phase, and slice axes
respectively.
4. Myocardial loss of signal was observed at some trigger times, which var-
ied slightly from patient to patient. This was attributed to a fast myocar-
dial motion. At these specific trigger times the sequence was repeated
with FDG turned on in the z axis only and with up to three different gra-
dient areas (the original area, 2/3 of the original area, and finally 1/3 of
the original area). The intra-voxel phase dispersion per unit of velocity
was respectively:
• original area: φv = 125 radians s m−1 in the slice axis.
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• 2/3 of the original area: φv = 77.9 radians s m−1 in the slice axis.
• 1/3 of the original area: φv = 40.9 radians s m−1 in the slice axis.
5. Sequence tested with FDG turned off in all axes, and the BBRF pulse
turned on at the same ECG trigger times. Each trigger time was imaged
with three different BBRF delays: 20 ms, 60 ms, 100 ms.
All the data acquired was analysed visually using CMRTools examining the
degree of blood suppression and the reliability of myocardial signal, which would
need to be consistently strong.
5.2.3.2 Clinical volunteers scans with contrast agent
Nine patients booked for late-enhancement studies volunteered to be scanned
with the zonal sequence at rest during the first-pass of contrast agent. Because
a power injector was required, a signed consent was mandatory.
The injection protocol was as much as possible identical to a standard MPI
study. Gadobutrol (Gd-DO3A-butriol) (Gadovist-Bayer, Germany) was the Gd-
based contrast agent used with a concentration of 1.0 mmol/mL. A dose of 0.1
mmol kg−1 of body weight was injected at a rate of 3.5 mL s−1 followed by 10
mL of a saline flush at 5 mL s−1.
Images were acquired in three short-axis slices for fifty R-R intervals, dur-
ing the first pass of CA with the patient holding his breath for as long as pos-
sible. Because of the large number of measurements (50 measurements ≈ 40
seconds) the subjects were asked to do two deep breaths followed by breath-
hold at end-expiration.
The sequence protocol used is shown in Table 5.2, except the sequence had
no dark blood preparation. i.e. FDG and the BBRF pulse were turned off. This
decision is discussed in section 5.3.1.
With saturation recovery preparation (TD= 80 ms) turned on for each slice,
the total time spent acquiring one slice was 130 ms. Therefore, three short-axis
slices could be acquired in 390 ms after the R wave.
The three slices were acquired immediately after the R-wave so that they
were completed, as far as possible, just before the most rapid cardiac motion
(early diastolic-filling). The slice order was always apical→mid→ basal.
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All the data acquired was analysed visually and numerically using CMR-
Tools. The signal in the myocardium for each slice was measured throughout
the 50 measurements using the perfusion analysis tools of CMRTools. The my-
ocardium was first divided into 6 segments per slice (Figure 5.30). The signal in
each segment is the respective mean of all the pixels inside the ROIs.
Figure 5.30: Short-axis segments with the respective numbers (left, basal;
centre, mid; right, apical slice.
Each scan was also imported into MATLAB in order to measure the noise in
each slice. The images were interpolated with a bicubic image based interpo-
lation in order to allow an easier ROI manual segmentation. After image inter-
polation, the first frame was subtracted from the following frames before con-
trast arrival in the heart (typically the subsequent 6 frames), following a noise
measurement method, that is appropriate for images with structured noise, by
Sijbers et al. [1998]. The resulting subtraction images removed the stationary
signal and contained only noise. This method was only valid if the patient held
their breath and with good ECG triggering, in order to prevent changes in the
position of the myocardium from frame to frame. An ROI was defined con-
taining the whole of the myocardial wall for each slice. The standard deviation
inside these ROIs was measured for the frames containing only noise. The stan-
dard deviation of each slice was averaged over all the pre-contrast subtraction
time frames (Figure 5.31). Note that the myocardial SNR measurement was af-
fected by surface coil response, GRAPPA reconstruction, and BIR-4 homogene-
ity, since different areas of the myocardium would possibly contain different
SNRs.
The myocardial signal enhancement was evaluated as follows, aiming for an
Methods 341
Figure 5.31: An example of the subtracted frames for one slice in one of the
volunteers. Left: the 6 subsequent frames that were subtracted from the first
one. In each frame, it is shown the ROI containing the subtracted myocardial
wall; the pixels outside the myocardium were greyed out. Right: an histogram
of the pixel values inside the myocardium for the respective frame; these val-
ues were used to calculate the standard deviation.
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assessment of the maximum likely contrast-to-noise ratio between a defect and
normal myocardium. The pre-contrast myocardial signal intensity was aver-
aged from four frames prior to contrast arrival in the LV (typically around frame
# 5). The peak myocardial signal intensity was also averaged from four frames
around peak enhancement (typically around frame # 30). The pre-contrast sig-
nal was subtracted from the peak myocardial signal intensity to obtain the con-
trast enhancement in the myocardium. This value coupled with the noise value
was used to calculate the myocardial CNR:
CNR= myocardial contrast enhacement
noise
(5.10)
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5.3 Results
Please note that some aspects of discussion are included with the results of
each test; an overall discussion is presented in a later section.
5.3.1 Preliminary scans in volunteers without contrast agent
The enumerated items below show the results of the corresponding numbered
items in the methods section (page 338).
1. Table 5.3 shows the approximate end-systole time after the R-wave for
each of the volunteers.
Volunteer time (ms)
I 363
II 391
III 424
IV 521
V 440
Table 5.3: End-systole time.
2. Zonal sequence with no dark blood preparation (FDG and BBRF turned
off) for the five volunteers (Figures 5.32-5.36):
Figure 5.32: ECG trigger times (TT): 100, 200, 300, 400, 500 ms. Volunteer I
(End-systolic time 363 ms).
344 Results
Figure 5.33: Volunteer II (End-systolic time 391 ms).
Figure 5.34: Volunteer III (End-systolic time 424 ms).
Figure 5.35: Volunteer IV (End-systolic time 521 ms).
Figure 5.36: Volunteer V (End-systolic time 440 ms).
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The images showed, as expected, a bright LV blood pool, with some re-
gions of signal loss around the edges of the LV, which would be consis-
tent with signal loss due to velocity sensitivity of the spin-echo sequence
(spin-echo refocussing pulse plus crusher gradients working as FDG).
Myocardial signal loss was not visible in most images, however a few cases
did showed localised myocardial signal loss. Volunteer I showed myocar-
dial signal loss coupled with phase correction errors* at frame TT 300 ms.
Two additional frames also showed myocardial signal loss most likely due
to the sequence velocity sensitivity: volunteer II at TT 400 ms and Volun-
teer V at TT 100 ms.
Significantly, no ghosting artifacts from the moving blood were observed
in the myocardial wall. This robustness regarding phase-encode distor-
tion is probably due to the shorter EPI echo train. While the investiga-
tion of blood suppression techniques continued, it became apparent that
zonal EPI might not require them.
3. FDG turned on in all 3 axes (φv = 91.8, 99.2, and 125 radians s m−1 for the
read, phase, and slice axes respectively) (Figures 5.37-5.41):
Figure 5.37: ECG trigger times (TT): 100, 200, 300, 400, 500 ms. Volunteer I
(End-systolic time 363 ms).
*The phase correction method was changed to the more robust algorithm during this stage
of volunteer scans with no contrast agent, i.e. before the image acquisition of the clinical vol-
unteers with contrast agent.
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Figure 5.38: Volunteer II (End-systolic time 391 ms).
Figure 5.39: Volunteer III (End-systolic time 424 ms).
Figure 5.40: Volunteer IV (End-systolic time 521 ms).
Figure 5.41: Volunteer V (End-systolic time 440 ms).
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The signal in the LV blood pool was successfully darkened with the added
FDG, but this approach was concluded to be impractical since the my-
ocardial signal was also darkened, and in some frames, the whole of the
myocardial wall disappeared. This happened mainly at the trigger times
close to early-diastole (Table 5.3), i.e. during LV refilling when the my-
ocardial wall was moving fast [Staehle et al., 2008]. This finding was sup-
ported by the stronger myocardial signal shown in point 2. Therefore,
signal loss was likely to be caused by the additional FDG.
4. The FDG in the slice axis only, with up to three different gradient areas, at
the trigger times with the most severe signal losses in the results of point
3 is shown in Figures 5.42-5.46:
Figure 5.42: TT = 300, and 400 ms, phase-dispersion of φv = 77.9 radians s
m−1 (left), φv = 40.9 radians s m−1 (right). Volunteer I (End-systolic time 363
ms).
Figure 5.43: TT = 300, and 400 ms, phase-dispersion of φv = 125 radians
s m−1 (left), φv = 77.9 radians s m−1 (centre),
φ
v = 40.9 radians s m−1 (right).
Volunteer II (End-systolic time 391 ms).
The myocardial wall signal was still dephased, especially close to the time
of ventricular filling for volunteers I, II, and III, even for the lowest intra-
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Figure 5.44: TT = 300, and 400 ms, phase-dispersion of φv = 125 radians
s m−1 (left), φv = 77.9 radians s m−1 (centre),
φ
v = 40.9 radians s m−1 (right).
Volunteer III (End-systolic time 424 ms).
Figure 5.45: TT = 500 ms, phase-dispersion of φv = 125 radians s m−1 (left),
φ
v = 77.9 radians s m−1 (centre),
φ
v = 40.9 radians s m−1 (right). Volunteer IV
(End-systolic time 521 ms).
Figure 5.46: TT = 300, and 400 ms, phase-dispersion of φv = 125 radians
s m−1 (left), φv = 77.9 radians s m−1 (centre),
φ
v = 40.9 radians s m−1 (right).
Volunteer V (End-systolic time 440 ms).
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voxel phase-dispersion per unit of velocity. Using FDG only in the slice
axis did not prevent the loss of myocardial signal, as expected the my-
ocardial wall was moving fast in both through-plane and in-plane direc-
tions. Using FDG in the slice-axis only was therefore not reliable for MPI,
even when using a reduced area due to the possibility of losing myocar-
dial signal.
5. Figures 5.47 to 5.61 in the next pages, show the volunteer results for when
the BBRF pulse was used instead of the FDG.
Because no saturation pulse was used prior to the black blood pulse in the
volunteers, the interval of time between the R-wave (ECG trigger) and the
the acquisition of the centre of k-space varied slightly for different black
blood delays in order to accommodate the delay and the BBRF pulse,
therefore the trigger times varied slightly for each delay. BBRF delay: 20
ms (trigger times: 160, 260, 360, 460, 560 ms); 60 ms (trigger times: 195,
295, 395, 495, 595 ms); 100 ms (trigger times: 232, 332, 432, 532, 632 ms).
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Figure 5.47: ECG trigger times (TT): 100, 200, 300, 400, 500 ms. BBRF pulse
delay = 20 ms. Volunteer I (End-systolic time 363 ms).
Figure 5.48: BBRF pulse delay = 60 ms. Volunteer I (End-systolic time 363
ms).
Figure 5.49: BBRF pulse delay = 100 ms. Volunteer I (End-systolic time 363
ms).
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Figure 5.50: BBRF pulse delay = 20 ms. Volunteer II (End-systolic time 391
ms).
Figure 5.51: BBRF pulse delay = 60 ms. Volunteer II (End-systolic time 391
ms).
Figure 5.52: BBRF pulse delay = 100 ms. Volunteer II (End-systolic time 391
ms).
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Figure 5.53: BBRF pulse delay = 20 ms. Volunteer III (End-systolic time 424
ms).
Figure 5.54: BBRF pulse delay = 60 ms. Volunteer III (End-systolic time 424
ms).
Figure 5.55: BBRF pulse delay = 100 ms. Volunteer III (End-systolic time 424
ms).
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Figure 5.56: BBRF pulse delay = 20 ms. Volunteer IV (End-systolic time 521
ms).
Figure 5.57: BBRF pulse delay = 60 ms. Volunteer IV (End-systolic time 521
ms).
Figure 5.58: BBRF pulse delay = 100 ms. Volunteer IV (End-systolic time 521
ms).
354 Results
Figure 5.59: BBRF pulse delay = 20 ms. Volunteer V (End-systolic time 440
ms).
Figure 5.60: BBRF pulse delay = 60 ms. Volunteer V (End-systolic time 440
ms).
Figure 5.61: BBRF pulse delay = 100 ms. Volunteer V (End-systolic time 440
ms).
The results were moderately consistent from patient to patient. The BBRF
pulse was less reliable than the FDG in nulling the blood signal in the LV
blood pool; nevertheless, the BBRF pulse still reduced the signal consid-
erably, especially when the pulse was played 100 ms before the zonal ex-
citation. From Figure 5.26, we can conclude that most of the blood flow
had a lower velocity component in the through-plane direction than 0.5
m/s.
During the early part of the cardiac cycle, it was evident that blood around
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the edge of the LV chamber was slightly less likely to be suppressed, prob-
ably consistent with its lower through-plane velocity. However, during di-
astolic filling there was, in some volunteers, a more reliable suppression.
Unfortunately, the same black blood pulse timing also reduced the my-
ocardial wall signal, especially at trigger time 532 ms, i.e. during peak
filling.
From Figure 5.26, the black blood delay would need to be higher than
60 ms. However, the short T1 during Gad first-pass would render this
approach virtually ineffective.
Interestingly, the black blood pulse and the extra FDG methods tended to
null different types of flow, namely, the fastest moving blood and regions of
greatest intravoxel velocity shear respectively. Although it might seem therefore
sensible to attempt both simultaneously, the myocardial signal loss (and for
the BBRF approach likely failure due to short blood T1), ruled out further work
on blood suppression. Recalling the absence of blood phase-encode artifacts
noted in point 2 (page 343), it was decided to use the zonal-sequence with no
extra black blood techniques, decreasing the risks of losing myocardial signal
which would render this sequence useless for myocardial perfusion analysis.
Both black blood techniques would be more likely to lose myocardial signal
with a patient at stress; furthermore, avoiding peak filling might be more prob-
lematic. It was therefore concluded that both methods of black blood prepara-
tion were not safe to use for myocardial perfusion imaging.
5.3.2 Scans in clinical volunteers
From the nine patient volunteers, two were excluded due to reduced cardiac
function, with subsequent late and dispersed arrival of the contrast agent in
the myocardium. Cardiac function measurements in the other seven volun-
teers were reported to be within the normal limits, and with no other relevant
heart conditions. Table 5.4 shows the end-systolic time for each subject. The
following Figures 5.62 to 5.68, show example images from each of the seven vol-
unteers for the three slices (apical, mid, basal): before arrival of contrast in the
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heart (indicated in the figure caption “pre”), peak contrast agent concentration
in the LV (figure caption “lv”) and at peak myocardium signal (figure caption
“myo”). In the bottom it is also shown a full FOV image. (a video showing the
50 measurements throughout first-pass is included in the attached CD for each
volunteer and for each slice (note: only the 6 volunteers that managed to hold
their breath throughout first pass are shown)).
No obvious myocardial signal loss was visible in any of the volunteers. One
of the volunteers (Volunteer F) did not manage to hold their breath throughout
the first-pass, which complicated the myocardial segmentation, and therefore
was not included in the analysis of the CNR. The signal intensity curves for the
remaining 6 volunteers are shown in Figures 5.69 to 5.74. The corresponding
noise and CNR values are shown in Table 5.5.
Clinical volunteer time (ms)
A 381
B 313
C 324
D 340
E 304
F 397
G 360
Table 5.4: End-systole time for the clinical volunteers.
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Volunteer
apical mid basal
noise CNR noise CNR noise CNR
A 4.8 13 4.0 14 4.2 14
B 3.6 8.6 3.7 7.6 3.6 8.1
C 4.9 8.8 4.2 8.9 3.9 8.7
D 3.5 15 4.1 12 3.8 11
E 3.8 10 4.1 8.0 4.3 7.5
G 3.5 12 3.2 9.2 3.1 7.7
Table 5.5: Clinical volunteers noise and CNR values.
The SI curves showed consistently lower contrast in the myocardial seg-
ments lying further away from the surface coil (segments: 4,5,10,11,16,17), in
common with all cardiac MRI sequences.
It is apparent that some of the SI curves had higher variability of signal in-
tensity in the apical slice, for example subjects A, C, E, and G. This was due
to the myocardial wall being less perpendicular to the slice close to the apex,
which is also a problem in conventional perfusion imaging, although ampli-
fied here by the larger slice thickness. The signal at the edge of the wall was
therefore blurred and introduced partial volume effects with bright signal from
the LV appearing superimposed upon the subendocardial wall signal, render-
ing the CNR value inaccurate. For example, in Figure 5.75 for one volunteer,
when the contrast agent arrives in the LV, some of its bright signal appeared
within the subendocardial wall in the apical slice. This effect was also some-
times seen in the mid slice but with minor consequences.
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Figure 5.62: Perfusion scan for subject A.
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Figure 5.63: Perfusion scan for subject B.
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Figure 5.64: Perfusion scan for subject C.
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Figure 5.65: Perfusion scan for subject D.
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Figure 5.66: Perfusion scan for subject E.
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Figure 5.67: Perfusion scan for subject F.
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Figure 5.68: Perfusion scan for subject G.
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Figure 5.69: SI curve for volunteer A in each slice.
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Figure 5.70: SI curve for volunteer B in each slice.
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Figure 5.71: SI curve for volunteer C in each slice.
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Figure 5.72: SI curve for volunteer D in each slice.
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Figure 5.73: SI curve for volunteer E in each slice.
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Figure 5.74: SI curve for volunteer G in each slice.
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Figure 5.75: Partial volume effects in the apical slice. This slice was acquired
112 ms after the R-wave.
5.4 Discussion
The periods when the blood flows rapidly are at beginning of systole during 30
ms to 200 ms after the R-wave, and at beginning of diastole approximately 350-
450 ms after the R-wave. Together with blood flow, these are also the cardiac
phases when the myocardial wall is moving rapidly, which can cause signal loss
in the myocardium particularly if black blood techniques are used. In an at-
tempt to minimise this, imaging was aimed for the 300 ms time window after
the R-wave.
It was found that the onset of ventricular filling varied slightly in time for
different volunteers (Tables 5.3, 5.4). A higher variability is expected in patients
suffering from arrhythmia. Peak diastole should also happen slightly earlier in
the cardiac cycle when the patient is infused with adenosine. All these factors
would make it detrimental to use black blood preparation techniques in stress
perfusions. Additionally the short T1 of Gd bolus enhancement would likely
render the BBRF pulse approach ineffective. It was therefore decided to assess
the zonal sequence in clinical volunteers without any.
Both blood flow and myocardial wall motion have components in-plane
and through-plane in a typical short-axis image. Kilner et al. [2000] measured
blood flow trajectories using a phase-velocity mapping technique. It was found
that inflow from the mitral valve into the left ventricle creates recirculating flow
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paths beneath the valve. Part of this recirculating flow is directed towards the
semilunar valve. It was also found that both during diastole and systole there
is an in-plane (in a short-axis image orientation) component of the flow. The
measured flow velocities of the blood were around 0.5 m s−1. Nakamura et al.
[2007] using a similar technique measured a higher left-ventricular blood flow
of up to 1 m s−1 during mid-diastole.
During the cardiac cycle, the heart contracts and expands also in all direc-
tions [Staehle et al., 2008] (longitudinal peak velocity ≈ 0.1 m s−1; radial peak
velocity ≈ 0.04 m s−1). These studies’ results correlate with the results seen
when using black blood techniques, where it was found that both blood flow
and myocardial wall motion happens in all three dimensions, complicating
these techniques.
It is clear from the segmental-signal curves that there is sometimes a notice-
able variation across the myocardium attributed to a variable coil sensitivity.
The CNR values stated for each patient are therefore an average CNR.
Ignoring the apical slice due to partial volume artifacts, the CNR’s inter-slice
(mid-basal) variability was small. Inter-patient variability can be attributed to
changes of the coils’ sensitivity, and variability of the 2DRF pulse robustness
with slice offset*. Averaging all the CNRs obtained from the mid and basal slice,
we have a mean value of 9.7. The CNR values obtained by a similar method
in Lyne et al. [2007] are shown in Table 5.6. The pixel size and slice thickness
of Lyne’s work is different from the one used in the zonal sequence, therefore
for a CNR comparison the CNR reported by Lyne et al. [2007] has to be scaled,
considering that the CNR is given by:
CNR= SNRpeak−SNRpre (5.11)
where SNRpeak is the SNR at peak enhacement, and SNRpre is the SNR before
Gd. The CNR therefore scales with [McRobbie et al., 2007]:
CNR∝ FOVx
Nx
FOVy
Ny
∆z
√
Ny
BW
(5.12)
*The 2DRF pulse was used with the trapezoidal gradients in all of the clinical volunteer
scans, nevertheless there was still some loss of SNR when offsetting the slice from isocentre.
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where FOVx and FOVy are the FOV in the frequency and phase-encode direc-
tion respectively, Nx and Ny are the number of points in the matrix along the
frequency and phase-encode direction respectively, ∆z is the slice thickness,
and BW the readout bandwidth per pixel.
Lyne’s protocol has a smaller pixel size (average 2.9 mm in both frequency
and phase direction) and a slice thickness of 8 mm. Ny ≈ 96, and the bandwidth
was BW = 1960 Hz px−1. Scaling the h-EPI CNR obtained by Lyne et al. [2007]
to the zonal sequence protocol (shown on table 5.2) yields a CNR of 9.9. The
CNR obtained with the zonal-sequence is thus very similar to the one obtained
in Lyne’s work for the h-EPI sequence. The CNR values measured with the zonal
sequence were obtained at rest, while in Lyne et al. [2007] they were obtained
at stress, which potentially yielded a more concentrated bolus of the contrast
agent and therefore a higher contrast enhancement.
sequence CNR R time per slice data acquisition time
GRE 10.85 1.6 152 ms 142 ms
bSSFP 13.16 2 147 ms 114 ms
h-EPI 7.85 2 146 ms 69 ms
zonal-EPI 9.7 2 125 ms 15ms
Table 5.6: CNR values and imaging time obtained by Lyne et al. [2007], and
the zonal-EPI sequence.
In the zonal-EPI experiments the slice thickness used was FWHM = 12.7 mm
and larger than the originally planned slice thickness of 10 mm. 10 mm is larger
than the more conventional 8 mm or thinner for first-pass perfusion imaging.
The reason for initially choosing a higher slice thickness was to compensate
the reduced SNR resulting from the small number of phase-encode lines ac-
quired. However, it is now apparent that the slice thickness could be reduced
to a more conventional 8 mm reducing partial volume effects while keeping the
CNR comparable to the one obtained with the h-EPI sequence.
The zonal-EPI data acquisition time (echo train-length ≈ 15 ms) is much
lower than the h-EPI, making this sequence potentially more robust to motion
artifacts, with its ultra-fast readout improving the clarity of myocardial imaging,
possibly without compromising its sensitivity to detecting perfusion defects.
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(Unfortunately, no patients were available for this purpose).
Gibbs artifacts were also reduced due to the reduced signal in the LV blood
pool. The complex flow seen in the blood pool reduced the chances of bright
blood signal next to the subendocardial wall. We consider next the case when
the signal in the blood pool next to the subendocardial border is completely
nulled, then the opposite ringing of a typical perfusion image can happen; i.e.
there is a bright overshoot of the line signal profile when going from the LV
blood pool to the myocardial wall. In this case the first lobe in the subendocar-
dial wall would be positively enhanced, i.e. a “bright rim artifact”, while the sec-
ond pixel in the myocardial wall would be the one affected by a weak negative
lobe. Nevertheless, the signal jump from a dark LV blood pool to the myocar-
dium is smaller than the jump from a bright LV (more than double the bright-
ness in the myocardium for typical protocols) to the myocardium, and there-
fore Gibbs effects in the myocardium would be less visible than with bright
blood. An example (Figure 5.76) shows a darker signal in the mid-wall region
of the myocardium. Before image interpolation, the myocardial wall thickness
is approximately three pixels wide, and in this case, we have a superposition of
two negative lobes resulting from Gibbs ringing of both edges of the myocardial
wall in the middle pixel.
Figure 5.76: Left: Example showing faint “bright rim artifacts” and mid-wall
darker band due to Gibbs ringing (see text). Right: The line profile down the
yellow rectangle on the left, after image interpolation.
In this work, a saturation recovery was used for each slice, but using a single
saturation recovery pulse for all of the slices [Nagel et al., 2003] would increase
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dramatically the number of slices possible per cardiac cycle. This would com-
plicate image analysis (different image contrast for each slice), but the rapid
imaging time of the zonal-sequence would reduce the contrast difference.
The scrambled signal in the LV makes this sequence unable to accurately
measure the arterial input function. But if a semi-quantitative or fully quan-
titative analysis is desired, a dual-sequence technique [Gatehouse et al., 2004]
with a more conventional sequence can be added, to acquire a lower spatial-
resolution image with a shorter saturation recovery-time prior to the zonal se-
quence.
The small phase-encode FOV of the zonal sequence was potentially a con-
cern for the performance of parallel imaging; however this concern seems to
have been unwarranted.
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5.5 Conclusion
The short EPI echo train of the zonal sequence with parallel imaging was robust
with respect to B0-related, cardiac-motion and blood flow distortion artifacts,
without requiring special attention to main field quality or the cardiac timing.
This work also concludes that blood-suppression techniques beyond the
inherent velocity-sensitivity of the sequence were unnecessary due to the short
EPI echo-train’s robustness with respect to blood flow. Furthermore, these tech-
niques risked loss of myocardial signal during the most rapid phase of cardiac
motion.
Early results in clinical volunteers showed promising results with a data ac-
quisition time of≈ 15 ms while achieving a CNR, which is likely to be compara-
ble to the conventional h-EPI perfusion sequence.
CHAPTER 6
Conclusions and future work
Chapter 3 and 4 are the first in-depth study of several different mechanisms
behind DRAs in the heart during peak Gd-bolus in the LV. DRAs are mostly a
varying mixture of Gibbs and motion and therefore there is a conflict; min-
imising Gibbs requires a higher image resolution and therefore more motion
artifacts, and vice-versa. Susceptibility artifacts are unlikely to produce DRAs
in GRE sequences and in fast well-tuned bSSFP sequences, although centric h-
EPI sequences were shown to be susceptible to frequency offsets with localised
DRAs along the phase-encode direction. All these different mechanisms corre-
late with the peak contrast agent concentration in the LV. It was also shown that
the DRAs are certainly not a T1/T2* filtering effect across ky or kx.
The Gibbs visibility dependency on the edge position inside a pixel, in the
absence of zero-filled pre-FFT interpolation, was shown in vivo. Endocardial
border position variability between frames and between patients complicates
clinical reporting. This variability is highly reduced if zero-filling pre-FFT in-
terpolation is used. Although well known in some other MRI topics, this was
demonstrated for the first time in perfusion studies.
It was shown that motion artifacts for an edge-centre-edge phase-encode
acquisition order (commonly used with GRE and bSSFP sequences) will tend to
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be darker and wider than Gibbs artifacts. h-EPI sequences with an interleaved
centric phase-encode acquisition order will not exhibit motion DRAs due to
the more distributed ky-coverage and the shorter imaging time, only ghosting
of the bright LV blood pool along the phase-encode direction. Unfortunately
this same phase-acquisition order exacerbates the splitting of the image along
the phase-encode direction in the presence of frequency-offsets, which can po-
tentially create severe DRAs and ghosting.
It was also shown that the Hamming filter is very effective at reducing Gibbs
artifacts, although with high spatial-resolution costs. Furthermore, it was con-
cluded that Hamming filtering is not advisable at current typical perfusion spatial-
resolutions since the visibility of thin real perfusion defects is highly compro-
mised.
There seems to be no published work on optimising filtering for myocar-
dial perfusion (for example, using a Tukey filter slightly weaker than the Hann
filter). Future work could include the assessment of Tukey filters on the raw-
data of perfusion studies. Further work will also examine any possible effects
of myocardial rotation and realistic through-plane myocardial motion. Respi-
ratory motion can reach around 30 mm/s leading to similar motion artifacts as
myocardial motion and should perhaps be considered.
In Chapter 4, a method to quantify the additional in vivo B0 distortion caused
by the first-pass of strong paramagnetic Gd in a typical perfusion setup is de-
scribed. It was shown that the field distortion occurred in a fixed pattern: rais-
ing the local field for the inferior-anterior regions and lowering the local field
for the septal-lateral regions of the myocardial wall. The field distortions were
stronger for hearts with a long axis more perpendicular to the main field direc-
tion. The peak field distortion occurs at the peak Gd concentration in the LV,
because this is when the difference in susceptibility between the LV and my-
ocardial wall is higher. The measured field distortions alone are not enough
to cause a DRA although when added to other nearby sources of field distor-
tion (lung-air interfaces, veins) the total frequency-offset can possibly create
noticeable signal loss due to intra-voxel signal dephasing, bSSFP dark band ar-
tifacts, and h-EPI frequency offsets artifacts. Although if so, the artifacts will be
localised in particular regions of the myocardium and not circumferential as
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sometimes observed. These results will obviously be dependent on CA dose or
field strength; 3 T fields possibly being problematic.
The work from chapter 5 described the development of an ultra-fast but ro-
bust sequence suitable for first-pass myocardial perfusion imaging, and its in
vivo performance assessment. The sequence was a multi-slice single-shot spin-
echo EPI sequence accelerated by a reduced phase-encode FOV (zonal excita-
tion), and parallel imaging with R=2. A shorter echo-train makes it more robust
to off-resonance artifacts and motion DRAs. Two different extra black blood
preparation techniques were assessed in volunteers with no contrast agent (flow
dephasing gradients, and black blood RF) but found to be detrimental in terms
of losing myocardial signal. Additionally the black blood pulse would likely be
ineffective at peak CA concentration due to the shorter T1 of blood. There were
no visible rapid moving blood artifacts; therefore, it was decided to use the se-
quence without any extra dark blood techniques. Parallel imaging performance
was good considering the small phase-encode FOV.
When tested in clinical volunteers with CA at rest, the sequence yielded a
good CNR, which is expected to be similar to the perfusion h-EPI sequence
when at stress with a similar slice thickness, but importantly, with a much shorter
acquisition time.
Future work planned includes testing this sequence at stress in patients
with CAD and with improved SNR on a 3T scanner and multi-channel (32 or
more) array coils. In the meantime, it is planned to assess the zonal-EPI se-
quence at rest in clinical volunteers with a single saturation-recovery pulse per
heart cycle, followed by the acquisition of 4 or 5 slices. Possibly, it could also be
assessed with its own inherent T1 weighting, running the sequence as a real-
time multislice cine zonal-EPI sequence.
Unfortunately, our understanding of DRAs, following this work, did not re-
sult in a robust solution, but neither was that expected due to their conflict-
ing properties. It has however, underlined how the different mechanism can
contribute and how their artifacts can be combined to add to their complexity.
The systematic studies of simulations and measurements also illustrate how
the appearance of DRAs is affected by many factors. It is not possible to point
out a finger at a single contribution to these artifacts but that many factors are
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normally involved. However, it is still possible to work on minimising the con-
tributing factors. High spatial-resolution imaging coupled with faster parallel
imaging techniques such as k-t SENSE and k-t BLAST plus zonal-EPI, or other
that were not thought of yet open up new promising solutions that can poten-
tially minimise DRAs, although the intolerance to respiratory motion of some
of these techniques requires work in order to be used clinically.
APPENDIX A
Adiabatic RF pulses: BIR-4
An uniform saturation pulse is important for MPI, and for quantification it is
essential. BIR (B1 Independent Rotation) pulses, are a class of adiabatic pulses
that produce an uniform excitation, refocusing or inversion. The most popular
pulse from this class is the BIR-4 pulse.
In a conventional RF pulse, the flip angle is given by:
θ = γ
∫ T
0
B1(t )dt (A.1)
An inhomogeneous B1 field will therefore introduce different angles in different
spatial locations. Adiabatic pulses can be used to produce a uniform excitation,
refocusing or inversion. This type of RF pulse does not obey equation A.1, as the
flip angle is given by the variation of amplitude and phase during the adiabatic
pulse. Another difference is that in excitation when the adiabatic pulse ends,
the magnetisation vector points in the same direction as B1 field, while in non-
adiabatic pulses it points perpendicular to B1.
Adiabatic pulses follow the adiabatic passage principle: the magnetisation
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vector of a spin system follows the direction of the effective magnetic field*, if
the direction of the effective magnetic field does not change much during one
period of precession of the magnetisation about the effective field [Bernstein
et al., 2004]. The adiabatic principle can be satisfied by using a low RF modula-
tion frequency ξ (i.e. the offset from ω= γB0), and a strong effective field.
A magnetisation collinear with the applied effective field will remain collinear
throughout the pulse. A magnetisation perpendicular to the effective field will
precess about the effective field in a plane normal to it during the pulse dura-
tion. Consider, for example, the following RF pulse with an amplitude A(t ) and
frequency wr f (t )(can be converted to phase) modulation:{
A(t )=Bx,0 sinξt
ωr f (t )=ω−γBz,0 cosξt
(A.2)
The amplitude |~Beff| and direction ψ of the effective field are given respec-
tively by:
|~Beff| =
√
(Bx,0 sinξt )2+ (Bz,0 cosξt )2 (A.3)
ψ= arctan
(
Bx,0 sinξt
Bz,0 cosξt
)
(A.4)
where x is an axis in the transversal plane, and z is the longitudinal axis.
If the initial magnetisation is along the z axis at t = 0, then ψ ≈ 0. If a low
*We can describe the time evolution of the magnetisation vector under the influence of an
external magnetic field the Bloch equations (ignoring relaxation and molecular self-diffusion
coefficient):
d ~M
d t
= γ~M ×~B
considering a static B0 and an RF B1 field:
d ~M
d t
= γ~M × (xˆB1(t )cosωRFt − yˆB1(t )sinωRFt + zˆB0)
where ωRF is the carrier frequency.
In the rotating reference frame:(
d ~M
d t
)
ROT
= γ~M × [B1(t )(xˆ cos(ωRF−ω0)t − yˆ sin(ωRF−ω0)t)+ zˆ (B0−ω0/γ)]
the magnetic field in the square brackets is known as the effective field, ~BRF.
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frequency modulation is applied ξ, then the adiabatic passage principle is sat-
isfied and the magnetisation vector will follow ~Beff. At t =pi/(2ξ), ~Beff completes
its rotation into the x axis. If the pulse is terminated at this instance, a 90◦ adia-
batic excitation is achieved. This method is robust to B1 inhomogeneities, since
two different positions with different B1 fields would still rotate 90◦ each.
A potential problem for this method occurs if some component of the mag-
netisation is in the transversal plane and not aligned with the initial applied
effective field. In this case, the transversal component would dephase the mag-
netisation. Also adiabatic pulses as described so far are restricted to 90◦ in order
to be insensitive to field B1 inhomogeneities.
BIR (B1 Independent Rotation) pulses are a class of adiabatic pulses that
can overcome these limitations [Garwood and Ke, 1991, Ugurbil and Garwood,
1987]. The most popular pulse from this class is the BIR-4 pulse, composed
of multiple modulation segments. The modulation functions are hyperbolic
tangents and tangents, and are symmetric in relation to the centre of the pulse.
Amplitude modulation:
A(t )=

B1 tanh[λ (1−4t/T )] (06 t < T /4)
B1 tanh[λ (4t/T −1)] (T /46 t < T /2)
B1 tanh[λ (3−4t/T )] (T /26 t < 3T /4)
B1 tanh[λ (4t/T −3)] (3T /46 t 6 T )
(A.5)
where B1 is the peak amplitude of the B1 field. The pulse width is T , λ and β
are dimensionless constants.
Frequency modulation:
ωrf(t )=

ω− tan(4βt/T )tanβ (06 t < T /4)
ω− tan[β(4t/T−2)]tanβ (T /46 t < 3T /4)
ω− tan[β(4t/T−4)]tanβ (3T /46 t 6 T )
(A.6)
In the scanner it is usually used the phase modulation instead of the fre-
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Figure A.1: Amplitude, frequency and phase modulation functions of a typ-
ical BIR-4 RF pulse. λ= 10, β= arctan(10).
quency modulation. This can be calculated by the following equation:
∆φrf(t )=
∫ t
0
∆ωrf(t
′)dt ′ (A.7)
therefore, using equations A.6 and A.7, the phase modulation functions of a
BIR-4 pulse are given by:
φ(t )=

∫ t
0
[
ω−ωrf
(
t ′
)]
dt ′ (06 t < T /4)∫ t
0
[
ω−ωrf
(
t ′
)]
dt ′+∆φ1 (T /46 t < 3T /4)∫ t
0
[
ω−ωrf
(
t ′
)]
dt ′+∆φ2 (3T /46 t 6 T )
(A.8)
where ∆φ1 ∆φ2 are the phase offsets at t = T /4 and t = 3T /4. Usually ∆φ1=-
∆φ2. The flip angle, θ of the BIR-4 pulse determines these phase offsets:{
∆φ1 =pi+θ/2
∆φ2 =−pi−θ/2
(A.9)
These modulation functions are depicted on Figure A.1.
APPENDIX B
Parallel Imaging
In this section there is a theoretical description of the parallel imaging tech-
niques relevant to this work.
The main idea behind parallel imaging is scan time reduction by skipping
phase-encode lines, i.e. increasing δky . The resolution is not compromised; the
penalty is the reduction of the FOV in the phase-encode direction and conse-
quently wrapping the object’s image, in cases where the object is bigger than
the reduced FOV. The reduction factor is given by R, known as the acceleration
factor in parallel imaging and it is obviously related to δky .
Mathematically this can be explained by starting with equation (B.1). The
image I (r) and the object O(r) are related by the sampling function S(k):
I (r)= F T (S (k))∗O (r)= PSF(r)∗O (r) (B.1)
where r is the position vector in the space domain, k the respective position
vector in the k-space domain, and * is the convolution operator of the object
with the PSF.
Let’s consider a simple and discrete sampling function: Cartesian. We can
define the sampling function as a Dirac comb in the phase direction. The Fourier
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Figure B.1: Nyquist-Shannon sampling theorem: By reducing the sampling
density of the k-space (increasing R) the FOV is reduced and the object is
wrapped, i.e. the object’s frequencies might be aliased, superimposing dif-
ferent voxels V0 and V1. The dashed squares represent the object’s replicas.
transform of the sampling function is also a comb function* and is equal to the
PSF. Performing a convolution of the PSF with the object will therefore give us
an infinite repetition of it in the phase direction. Reducing the sampling den-
sity reduces the distance between replicas. If the FOV is reduced to a certain
amount, the replicas superimpose in the FOV, creating the well-known aliasing
problem. This is the basis of the Nyquist-Shannon sampling theorem and it is
depicted in Figure B.1.
When reducing the FOV some voxels of the resulting image will contain
superimpositions, e.g. V0 and V1 from Figure B.1. If L is the original FOV in
the phase-encode direction, the superimposition happens where a voxel is dis-
placed by an integer multiple of L/R. If the object size is smaller than the orig-
inal FOV (unlikely in a cardiac perfusion application), then the number of su-
perimpositions, Np , in each voxel of a single coil image is Np ≤R including the
non aliased one.
The following subsections describe some mathematical approaches to solve
*Property of the comb function. Its Fourier transform is also a comb function with recipro-
cal spacing:
combT (x)
 comb1/T (k)
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Figure B.2: Schematics of parallel imaging SENSE technique, where on the
top left there is a k-space sampled with an acceleration factor of two. The
aliased imaged that results from the undersampling is then corrected using
the sensitivity map for each coil.
the problem of unwrapping the aliased voxels. This description is left at a basic
level showing only an overall view of different methods, an in-depth technical
description is out of the scope of this thesis.
B.1 SENSE
Using multiple coils with each one having a separate channel, and estimating
the coil sensitivities, makes it possible to unwrap the aliased image, Figure B.2.
This is the basis of SENSE (SENSitivity Encoding). The sensitivity of a coil is the
spatial dependence of the B1 for that coil, and an accurate estimate is crucial
for the unwrapping of the final image.
The sensitivity map for each coil can be obtained using different techniques.
Pruessmann et al. [1999] describe a method where the coil sensitivities are ob-
tained with a separate acquisition (pre-scan). It acquires a full FOV conven-
tional image with each coil. Each image is then divided by a body coil image in
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order to find the coil’s B1. The resulting images are refined by using a low pass
filter and a smoothing filter in order to remove the noise.
Another method known as m-SENSE (developed by Siemens, Medical So-
lutions, Erlangen, Germany) takes advantage of the fact that generally the sen-
sitivity has a slow variation in space. It acquires the centre of k-space for each
coil, and with these centre lines it is possible to build a low resolution sensitivity-
map. This avoids the problem of patient motion between the pre-scan and the
parallel imaging scans. It slightly increases the parallel imaging time of scan,
but it does not require an additional body coil scan.
Mathematically this can be described by the following. An image I ′j (x, y)
received using coil j can be described by the following equation:
I ′j (x, y)=C j (x, y)I (x, y) (B.2)
where C is the coil sensitivity, and I is the unaliased image matrix. Both C and
I are described by complex numbers. When aliasing occurs, equation (B.2) can
be modified to contain all the superpositions of each pixel:
I ′j (x, y)=
Np−1∑
n=0
C j (x, y +nL/R)I (y +nL/R) , j = 0,1,2, . . . , Nc −1 (B.3)
where Nc is the number of coils.
Equation (B.3) can be transformed into its matrix form:
I ′[Nc×1] =C[Nc×Np ]I[Np×1] (B.4)
where both I ′ and C are known for each coil and for each pixel.
The system given in (B.4) can be inverted, provided that Nc ≥ Np , since we
have Nc equations for Np unknowns, and hence obtain I .
The complex values of the magnetisation can then be estimated by using
the pseudoinverse general solution:
I =C−1I ′ , Nc =Np (B.5)
I =
[(
C †ψ−1C
)−1
C †ψ−1
]
I ′ , Nc >Np (B.6)
SENSE 389
Equation (B.6) contains the noise correlation matrix ψ[Nc×Nc ]. This matrix is
derived from the following:
σ2j is the noise variance from coil j given by:
σ2j = E(x∗j x j )−E(x∗j )E(x j )
where x j is a complex random variable that gives us the noise from coil j, and E
is the expectation operator of a random variable. The noise correlation matrix
is defined:
ψ j k = E(x∗j xk )−E(x∗j )E(xk )
The diagonal elements of the ψ are therefore the noise variance of each coil.
The off-diagonal elements represent the noise cross correlation between coil j
and coil k.
The off-diagonal matrix elements are usually negligible when the coils are
well decoupled, and the coils noise variance are nearly equal to one another
[Bernstein et al., 2004], simplifying equation (B.6) to:
I =
[(
C †C
)−1
C †
]
I ′ , Nc >Np (B.7)
Unwrapping the image comes with a magnification of noise, usually spa-
tially variant, due to the combination of data from several coils. The decreasing
factor in the SNR is given by two elements, the acceleration factor R, and the
geometry factor g :
SNRSENSE = SNRnormal
g
p
R
(B.8)
The geometry factor is a function of both the sensitivity of the coils and the
noise correlation matrix, and it varies for each pixel i [Pruessmann et al., 1999]:
gi =
√[(
C †ψ−1C
)−1]
i i
[
C †ψ−1C
]
i i i = 1,2, . . . , Np (B.9)
The noise magnification is dependent on the sensitivity map difference from
each coil. The sensitivity difference in every aliased pixel is related to the coil
positions on the body. The bigger the separation between coils along the phase-
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encode direction, the less noise magnification. The separation factor is thus
accounted for the geometric factor, which ranges from 1.5 to 2 for Np = 2, obvi-
ously being 1 for Np = 1.
Any error in the coil profile will introduce ghosting in the final image, for
Np = 2 this is located 1/2 FOV away. It also must be noticed that the finally
reconstructed phase-encode FOV should not contain wrapped-around tissue,
because that breaks one of the assumptions inherent to SENSE reconstruction
[Goldfarb, 2004].
B.2 SMASH, g-SMASH & GRAPPA
Alternative algorithms exist that in effect unwrap the image in k-space, before
transforming the data into the image space. One of these algorithms is known
as SMASH (Simultaneous Acquisition of Spatial Harmonics). In SMASH the
data is unwrapped in k-space while keeping the coils sensitivity data in the im-
age domain.
Underlying the SMASH and many other k-space parallel imaging algorithms
is the property that the phase-encode gradient applies a sinusoidal phase mod-
ulation across the object being imaged. This modulation encodes the data spa-
tially. The objective of SMASH is to linearly combine the coil sensitivities in
a way that it approximates the sinusoidal (complex exponential) modulations.
The mathematical formalism is described in [Sodickson and Manning, 1997],
and summarised here.
The k-space signal S(kx ,ky ) for coil j is given by:
S j (kx ,ky )=
∫ ∫
C j (x, y)M(x, y)e
(−i 2pikx x)e(−i 2piky y) dx dy (B.10)
where M is the spin density, and C j is the coil sensitivity of coil j . For an accel-
eration factor of R and for a measured phase encode line ky , SMASH synthe-
sises the following k-space signals:
S(kx ,ky +m∆ky )=
∫ ∫
M(x, y)e(−i 2pikx x)e(−i 2piky y)e(−i 2pim∆ky y) dx dy (B.11)
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where m = 0 · · ·R − 1. Hence the fact that these signals are no longer coil de-
pendent. As stated above, the complex exponentials e−i 2pim∆ky y are going to be
created as combinations of the coils’ sensitivities:
Nc−1∑
j=0
a j ,mC j (x, y)= e−i 2pim∆ky y m = 0 · · ·R−1 (B.12)
Combining equation (B.11) with equation (B.12), we have:
S(kx ,ky +m∆ky )=
Nc−1∑
j=0
a j ,p
∫ ∫
C j (x, y)M(x, y)e
(−i 2pikx x)e(−i 2piky y) dx dy
=
Nc−1∑
j=0
a j ,mS j (kx ,ky ) m = 0 · · ·R−1
(B.13)
The phase-encode lines that are not measured are therefore synthesised in
k-space by a combination of the measured k-space lines from each individual
coil. As an example, S(kx ,ky ) is measured, therefore m = 0 which makes equa-
tion (B.12) a scaled sum of all the coils sensitivities. For the next line S(kx ,ky +
∆ky ), a exponential e i 2pi∆ky y = e i 2pi∆
y
FOVy = cos(2pi∆ yFOVy )+i sin(2pi∆
y
FOVy
) has to
be approximated somehow by the coil sensitivities using equation (B.12). This
requirement serves to show an inherent difficulty of SMASH. In many cases it
is not possible to achieve good results due to the coil geometry of the problem.
One method of alleviating the problem is to synthesise the missing lines
with the lowest harmonic possible, since lower harmonics are easier to obtain.
This is done by synthesising a missing line, using the closest measured line. For
example, for R=3 we measure phase encode lines, S(kx ,ki ), for i = 0,3,6 . . .; syn-
thesising line i = 2 is easier using the first negative harmonic of the measured
line i = 3 then the second positive harmonic of the measured line i = 0.
In order to overcome some limitations of SMASH, the g-SMASH (generalised-
SMASH) algorithm was created, [Bydder et al., 2002]. In this case, we reverse
equation (B.12) into:
C j (x, y)=
+q∑
m=−p
a j ,m e
−i 2pim∆k y (B.14)
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i.e. the sensitivity of each coil is a linear combination of spatial harmonics,
where a j ,m is the mth complex Fourier coefficient for coil j , and the interval
−p . . . q can range from the total number of phase-encode lines, to a smaller
subset relaxing the required computationally power. Equation (B.14) can be
seen as a Fourier transform, if using the full range of phase-encode lines.
Using the hybrid space S(x,ky ), we can represent equation (B.10) as:
S j (x,ky )=
∫
C j (x, y)M(x, y)e
−i 2piky y dy
=
+q∑
m=−p
a j ,m
∫
M(x, y)e(−i 2piky y)e(−i 2pim∆k y) dy
=
+q∑
m=−p
a j ,mS(x,ky +m∆k)
(B.15)
In a similar way to SENSE, equation (B.15) can be written in matrix form:
S j (x,ky )[Nc×1] = a[Nc×(p+q+1)]S(x,ky +m∆k)[(p+q+1)×1] (B.16)
the objective is to obtain the intrinsic MR signal S(x,ky+m∆k) by matrix inver-
sion and using the measured coil modulated signal S j (x,ky ). There is an over-
lap of matrix S, i.e. successive points along ky will have many points in common
between S(x,ky−p∆k) and S(x,ky+q∆k). Therefore, the system’s solution can
be determined after matrix inversion.
The last algorithm described that shares its foundations with SMASH is GRAPPA
(Generalised Auto Calibrating Partially Parallel Acquisition), [Griswold et al.,
2002]. In SMASH the missing data is calculated once the coil weights relating
the coil sensitivities to the spatial harmonics have been obtained. The GRAPPA
algorithm is somewhat different; reference lines are acquired, known as calibra-
tion signal scans, and just like in SENSE these reference lines can be acquired
together with the image readout or by a separate scan. The calibration scans
are normally placed in the centre of k-space, and are used to derive the set of
linear weights n j ,m . This method of acquiring calibration scans is also used by
a technique called AUTO-SMASH [Jakob et al., 1998].
The GRAPPA algorithm calculates the full image for each coil prior to their
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combination into the final image. The missing lines of each coil image are
acquired by applying multiple blockwise reconstructions where multiple lines
from all coils are fit to the calibration scan lines. Each coil unwrapped image
is this way obtained and can in the end be combined to the other unwrapped
coil images by a sum of squares. For a line ky +m∆ky , this can be expressed
mathematically as:
SC Sj (kx ,ky +m∆ky )=
Nc−1∑
j=0
n j ,mS j (kx ,ky ) (B.17)
where j is an index that counts through the multiple coils, SC Sj is the calibra-
tion scan of coil j , n j ,m is the linear weights used in the reconstruction and
S j (kx ,ky ) is the measured signal in coil j . One major difference between AUTO-
SMASH and GRAPPA is that in the latter the component coil signals S j (kx ,ky )
are fit to a single component coil SC Sj (kx ,ky+m∆ky ). Therefore in GRAPPA each
uncombined single coil images is derived resulting in an improved SNR when
compared to AUTO-SMASH [Blaimer et al., 2004].
B.3 Temporal filtering: UNFOLD
Either SENSE or GRAPPA can also be used combined with a temporal filter-
ing technique, then usually known as TSENSE and TGRAPPA respectively. The
temporal filter technique is known as UNFOLD and stands for UNaliasing by
Fourier-encoding the Overlaps using the temporaL Dimension [Madore et al.,
1999]. It labels the aliased components by using the time component in the
k-t space. Combining UNFOLD with parallel imaging techniques enables the
relaxation of some of the stringent requirements of the latter, such as the coil
sensitivity estimation.
The basis of UNFOLD is the Shift Theorem*; if there is a linear shift of k0 in
the sampling function, a phase shift of 2pik0x is applied to the PSF in equation
(B.1). As a result all the object replicas at x =±nL, where n is a multiple integer,
*Shift theorem:
F T (S(k+k0))= e i2pik0x F T (S(k)) .
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Figure B.3: Temporal fre-
quency spectrum, showing the
DC component (unaliased com-
ponent) and the aliased compo-
nent at the Nyquist frequency
(half the sampled frequency).
The striped boxes show the zones
removed using a temporal filter.
Figure B.4: In the presence of
motion the peaks from Figure B.3
become gaussian curves.
will suffer increasing phase shifts of 2±pik0nL except the central one.
Madore et al. [1999] proposed a method to easily label the aliased compo-
nents by introducing a shift in the sampling function of half a line distance in
every other image of a series of images. Considering again the superimposed
voxels V0 and V1 in Figure B.1, the result is that V0 remains unchanged, while
the aliased voxel oscillates from V1 to V1e ipi =−V1 during the series.
If we now represent the voxel containing the superposition as a function
of time and Fourier transform it, we have a temporal frequency spectrum with
three peaks, Figure B.3. The DC term, which is basically the mean between
V0+V1 and V0−V1, i.e. the V0 signal, and symmetrically around the DC peak
there are two more peaks corresponding to the shifting V1 signal at the Nyquist
frequency (half the sampling frequency). Using this method, it is therefore pos-
sible to separate and resolve the aliasing for each pixel.
When we are in the presence of motion, e.g. cardiac imaging, the peaks are
in fact Gaussian curves, the more dynamic a pixel is the bigger the half-width
at half-height of the curve, Figure B.4. A problem arises when both the V0 and
V1 are highly dynamic and their spectra overlap.
One solution presented by Madore et al. [1999] is to force the superposi-
tion of highly dynamic voxels with low dynamic ones. The overlap between
k-t BLAST & k-t SENSE 395
the Gaussian curves is this way prevented prevented and easily separated with
UNFOLD. This technique requires that the size of the reduced FOV to be at least
of the same size as the highly dynamic part of the original FOV, e.g. the heart,
while the breathing motion can be considered the less dynamic part. Giving
most of the temporal bandwidth to the dynamic points increases its temporal
resolution in relation to the less dynamic, as is often the required case. One
disadvantage of this technique is the requirement that the dynamic area of the
FOV has to be known a priori.
Another author, Tsao [2002], presents an alternative approach to UNFOLD,
using a sheared grid pattern of the sampling grid in the k-t space. This method
shifts the aliased components from the non-aliased ones automatically at the
sampling without the need to use a temporal frequency spectrum. As a trade-
off, the acceleration factor cannot be higher than two, in order to avoid over-
lapping.
Just like parallel imaging techniques, UNFOLD also decreases the final SNR:
SNRUNFOLD = SNRnormal
√
BW2∫
BW2
F 2(ω)dω
V2
p
τ2
V1
p
τ1
(B.18)
where V and τ represents the volume of a voxel and the time spent acquiring
one time frame respectively. The 1 and 2 indexes refers to a normal acquisition
and an UNFOLD acquisition respectively with the same temporal resolution.
BW2 represents the temporal bandwidth required to resolve both the dynamic
and the less dynamic peaks, and F (ω) is the temporal filter used, [Madore et al.,
1999]. The square root term in equation (B.18) refers to the temporal filter effect
in the SNR, while the second term is the more common SNR formula used in
MRI concerning the volume of the voxel and the time of acquisition. Equation
(B.18) is only valid if most image parameters (e.g. TR, TE...) do not change,
excluding the time of acquisition obviously.
B.4 k-t BLAST & k-t SENSE
k-t BLAST (Broad-use Linear Acquisition Speed-up technique) and k-t SENSE
[Tsao et al., 2003] are also methods of exploiting correlations in both k-space
396 k-t BLAST & k-t SENSE
Figure B.5: A) Sparsely sampled k-t space, ky axis represents the phase-
encode line and t the time axis. B) Three voxels which will be aliased in po-
sition p2 due to R=3 in the y-f space. y represents the phase-encode line in
the image space and f the frequency. C) The training stage and the sparsely
sampled data in the k-t space.
and time. Both methods are based on the premise that the raw-data in dynamic
imaging exhibits correlations in k-space and in time. This way data collection
can be highly accelerated when compared to the normal data acquisition meth-
ods, where a full image is acquired at every time frame (many voxels do not
change or change in a predictable way throughout the measurements). How-
ever it does not tolerate large-scale motion such as respiratory motion.
To describe these methods it is perhaps better to start with a diagram of the
k-t space and the resulting aliasing for a 2D acquisition with R = 3, Figure B.5
A-B.
In order to solve the aliased signal palias, k-t BLAST and k-t SENSE estimate
the magnitude signals (mi i = 1,2,3) of the aliased voxels and present a solu-
tion that minimises the following weighted norm [Tsao et al., 2003]:√
p1
m1
2
+ p2
m2
2
+ p3
m3
2
(B.19)
The solution is given by:
p=M(1M)+palias (B.20)
where p is the vector containing all three different aliased signals, M is a diag-
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onal matrix with the estimated magnitude signals (m1,m2,m3), and the sub-
script (+) indicates a Moore-Penrose pseudoinverse.
An overview of the k-t BLAST/SENSE reconstruction is described: The data
in the k-t space is inverse fourier transformed in the frequency-encode direc-
tion and the missing phase-encode data is zero filled. The resulting data is
then inverse fourier transformed again in the phase-encode and time direction
yielding the y-f space. Derivations from equation (B.20) are then used to solve
the aliased voxels. A fourier transform in the frequency direction of the solved
y-f space is finally done resulting in the y-t space, i.e. the reconstructed frames
in the image space.
The difference between k-t BLAST and k-t SENSE is that the later incorpo-
rates multiple coils sensitivity. With k-t SENSE data reconstruction is therefore
more accurate due to the incorporation of multiple observations.
k-t BLAST/SENSE requires the estimation of the magnitude signals. This
is done by two parameters: a baseline signal and an estimate from the devi-
ation from baseline. The baseline signal estimate is derived directly from the
sparsely sampled data, while the later is obtained from a low resolution fully
sampled pre-scan known as the training stage, Figure B.5 C. In order to obtain
an accurate estimate of the deviation from baseline the training stage period
must cover all the motion/changes that will happen in the acquisition stage. A
detailed explanation of the processing steps to derive both parameters is given
by Tsao et al. [2003].
Although MPI data is not purely periodic due to the contrast arrival, Plein
et al. [2007] demonstrated the feasibility of k-t SENSE in MPI, by using a fully
sampled central k-space with 11 lines as the training data throughout the ac-
quisition, while the outer k-space is sampled with an acceleration factor R=5,
giving an overall acceleration of 3.8. A similar image quality and SI curves were
measured when compared to SENSE with R=2, although there was a reduction
of the dark-rim artifact score and an increase in SNR. One limitation of this
method was its high sensitivity to respiratory motion, which causes registra-
tion errors in the reconstruction.
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APPENDIX C
Blood susceptibility
Almost all the oxygen in the blood is bound to haemoglobin. The haemoglo-
bin contained in blood can have different magnetic susceptibilities, depending
on its oxygen-binding state. The presence of oxygen bound to the haemoglo-
bin changes the chemical bonds between the iron atom, and the haemoglobin.
When it is not carrying oxygen, the haemoglobin contains purely ionic bonds
leaving it with unpaired electrons and causing the blood to be paramagnetic*,
while oxygenated blood contains mostly covalent bonds between iron and hae-
moglobin, leaving the oxyhaemoglobin with no unpaired electrons and there-
fore with diamagnetic properties [Zborowski et al., 2003].
To calculate the susceptibility† of blood, let’s start with the susceptibility of
the red blood cells, χRBC . The susceptibility is a weighted sum of susceptibili-
ties:
χRBC =−9.25×10−6+ (1−Y )×3.31×10−6 (C.1)
*The paramagnetic and diamagnetic properties here are relative, i.e. considered relative to
the susceptibility of pure water. The absolute magnetic susceptibility of blood is always dia-
magnetic.
†Unless stated otherwise susceptibility is the volume susceptibility, i.e. magnetic suscepti-
bility per mL.
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where the first term is the diamagnetic contribution of water and haemoglobin
(Hb), and Y is the fraction of oxygenated blood [Spees et al., 2001].
With equation (C.1) we can obtain the magnetic susceptibility of oxygenated
and deoxygenated red blood cells (RBC).
Fully oxygenated RBC −9.25×10−6
Fully deoxygenated RBC −5.94×10−6
Table C.1: Magnetic susceptibilities of RBC fully oxygenated, and fully de-
oxygenated.
The difference in susceptibilities between the two extremes is ∆χ = 3.31×
10−6.
The magnetic susceptibilities of the whole blood can be calculated by using
equation (C.2):
χbl ood =Hct ·χRBC + (1−Hct ) ·χpl asma (C.2)
where Hct is the haematocrit* (table (C.2)), andχpl asma is the magnetic suscep-
tibility of the plasma. Using the value χpl asma = −9.07×10−6, given by [Spees
et al., 2001], and using an average Hct of 0.44, we have table C.3.
Males [0.42,0.52]
Females [0.36,0.48]
Table C.2: Typical haematocrit values in humans.
Fully oxygenated blood −9.15×10−6
Fully deoxygenated blood −7.68×10−6
Table C.3: Magnetic susceptibilities of blood: fully oxygenated, and fully
deoxygenated.
A normal adult’s artery blood is almost fully oxygenated, but venous blood is
not normally fully deoxygenated. Typical oxygen levels are shown in table C.4.
*Proportion of blood volume that is occupied by the RBC.
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During exercise the oxygen consumption raises, reducing the oxygen saturation
of venous blood. Bearing this in mind, a realistic susceptibility of blood is given
in table C.5.
Hemoglobin saturation percentage
rest
arterial blood 96%
venous blood 76%
exercise
arterial blood 95%
venous blood 44%
Table C.4: Hemoglobin saturation percentages for both rest and during ex-
ercise.
arterial blood −9.12×10−6
venous blood −8.46×10−6
Table C.5: Magnetic susceptibilities of blood: arterial and venous blood at
rest.
We can finally calculate the relative magnetic susceptibility of blood by sub-
tracting its susceptibility to the susceptibility of pure water,χH2O =−9.04×10−6.
The results are displayed in table C.6, showing a negative relative susceptibility
for arterial blood and positive for venous blood; therefore, the first is diamag-
netic and the second is paramagnetic when compared to water (and most other
tissues, such as the myocardium).
arterial blood −0.08×10−6
venous blood 0.59×10−6
Table C.6: Relative magnetic susceptibilities of blood: arterial and venous
blood.
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Abstract
In less than two decades, first-pass perfusion cardiovascular magnetic resonance (CMR) has
undergone a wide range of changes with the development and availability of improved hardware,
software, and contrast agents, in concert with a better understanding of the mechanisms of
contrast enhancement. The following review provides a perspective of the historical development
of first-pass CMR, the developments in pulse sequence design and contrast agents, the relevant
animal models used in early preclinical studies, the mechanism of artifacts, the differences between
1.5T and 3T scanning, and the relevant clinical applications and protocols. This comprehensive
overview includes a summary of the past clinical performance of first-pass perfusion CMR and
current clinical applications using state-of-the-art methodologies.
Introduction
The clinical assessment of myocardial perfusion plays a
central role in the diagnosis, management, and prognosis
of ischemic heart disease patients. Whereas X-ray angiog-
raphy demonstrates the patency of the coronary arteries,
perfusion imaging detects the downstream microvascular
blood flow within the myocardium. Single photon emis-
sion computed tomographic (SPECT) imaging of myocar-
dial perfusion with 201TI or 99mTc-labeled agents is an
established clinical standard [1-4], but has relatively poor
spatial resolution, suffers from soft tissue attenuation arti-
facts, is not quantitative, and delivers a significant dose of
ionizing radiation[1]. Positron emission tomography
(PET) overcomes some of the limitations of SPECT; how-
ever, availability is restricted to sites with a cyclotron for
supplying short-half-life radiotracers. Echocardiography-
based perfusion is another technique but has limited
acoustic windows, low spatial resolution, and concerns
exist about contrast agent administration.
Myocardial perfusion imaging by first-pass contrast-
enhanced cardiovascular magnetic resonance (CMR) was
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introduced in 1990, when Atkinson et al. first used inver-
sion-recovery gradient-echo imaging after injection of a
bolus of Gd-DTPA to observe contrast agent transit
through the cardiac chambers and myocardium[5]. Subse-
quently, the technique has undergone continuous techni-
cal development, experimental validation, and clinical
evaluation. Technical developments have occurred in the
areas of MR hardware (gradient systems, magnetic field
strength, radiofrequency coil arrays), pulse sequence
design, new contrast agents, and perfusion analysis meth-
ods. Evaluation has included preclinical imaging in ani-
mal models of ischemic heart disease, as well as clinical
studies. While the earliest CMR studies had limitations,
such as poor slice coverage and low temporal resolution,
recent clinical studies show that CMR now compares quite
favorably to SPECT and PET [6-8].
In this article, technical issues related to pulse sequences,
contrast agents, and analysis methods are discussed. Both
visual interpretation of images and quantitative analysis
methods are described. A review of preclinical and clinical
evaluation studies is also provided. In addition, practical
clinical matters such as safety, patient monitoring, and
proper training of personnel are covered. The article also
addresses some remaining unanswered questions: Will a
field strength of 3T be advantageous compared to 1.5T?
Given the expense in time and effort, is quantitative anal-
ysis better? Will we eventually understand and resolve the
confounding dark rim artifact?
Contrast agents
There are two major classes of contrast agents used for
first-pass perfusion imaging. The extravascular, extracellu-
lar class of agents were the first agents approved for clini-
cal use. Due to the small size of these agents, they rapidly
diffuse from the vascular space to the extravascular space.
While a wide range of agents have been used, including
manganese, gadolinium, and dysprosium, gadolinium-
based agents are the only clinically approved agents, albeit
primarily for brain and body imaging.
Due to its seven unpaired electrons, gadolinium is one of
the most effective paramagnetic agents[9]. However, due
to the extreme toxicity of free gadolinium, gadolinium is
always chelated. Paramagnetic contrast agents alter the
local magnetic field and thereby enhance the relaxation
rate of water protons in close proximity to the contrast
agent. Thus, intravenous delivery of low doses of para-
magnetic agents results in enhanced signal in T1-weighted
images in the tissues that are perfused. For low doses of
paramagnetic agents, an approximately linear relation-
ship between the image intensity and contrast agent con-
centration exists[10]. For cardiovascular imaging, the
dosage is often not kept low enough for this linearity
assumption to apply. However, the dosage is sufficient
low such that T2 and T2* effects do not predominate
throughout the scan. Thus, perfused tissue appears
brighter during the first pass of the gadolinium-based con-
trast agent[5]. While extravascular, extracellular contrast
agents are excluded from the intracellular space, water can
exchange between the intravascular and extracellular and
intracellular spaces. Thus, the effective concentration of
contrast agent in the tissue will be lower than the "true"
intravascular and extracellular concentrations.
The second major class of first-pass perfusion agents,
which are also primarily gadolinium-based, are the intra-
vascular agents. Diffusion from the vascular space is
inhibited by the large size of these agents. Their large size
also effectively decreases tumbling rates, resulting in a
higher relaxivity than the extravascular, extracellular
agents. One intravascular agent, trisodium- [2-(R)-[(4,4-
diphenylcyclohexyl) phosphono oxymethyl]-diethylene-
triaminepentaacetato) (aquo) gadolinium (III) (Vasovist,
Schering AG) is currently approved for use in Europe. This
agent reversibly binds to albumin in the plasma, effec-
tively resulting in a macromolecular, intravascular MR
contrast agent. While intravascular gadolinium-based
contrast agents were initially developed for MR angiogra-
phy, several groups have identified advantages of these
agents for first-pass perfusion imaging [11-14].
Animal cardiovascular disease models for perfusion 
imaging
To test new contrast agents and validate new imaging
sequences, phantoms and animal models of human cardi-
ovascular disease are often employed. First-pass perfusion
imaging of the heart using contrast agents on clinical scan-
ners has only been performed in larger animals, e.g., dogs,
sheep, and pigs, due to their lower heart rates and larger
cardiac size than murine models.
When considering animal models for human cardiovascu-
lar disease, one of the biggest concerns is whether the
degree of collateral circulation mimics man. Maxwell et al.
demonstrated that dogs and cats possess the greatest cor-
onary collateral flow after acute ischemia, with pigs pos-
sessing the least, and rats, rabbits, and sheep intermediate
between dogs and pigs[15]. There are also gradients in
perfusion across the heart wall, such that the high subepi-
cardial flow in dogs leads to non-transmural, subendocar-
dial infarcts with acute coronary occlusion, whereas pigs
typically have lower epicardial flow and develop transmu-
ral infarctions[16]. On the other hand, rats typically
develop non-transmural infarcts that do not extend to the
subendocardium. The largest determinant of whether tis-
sue is reversibly or irreversibly damaged is the duration of
occlusion. The earliest studies of contrast-enhanced, first-
pass perfusion imaging examined acute infarction animal
models that were either reperfused or permanently
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occluded. Subsequently, animal models of perfusion
abnormalities without infarction have relied on models
that either limit epicardial artery blood flow or study the
effects of short-term coronary artery occlusion followed
by reperfusion [14,17,18]. Another approach is to study
perfusion pathways that develop with collateral vessel for-
mation in acute angina. Extensive studies in swine, who
lack native collaterals, have used an ameroid occluder,
placed around coronary artery branches [19]. Thus, ani-
mal models may provide a platform for validation of per-
fusion image pulse sequences and analysis techniques,
but the limitations of these models must be understood
for translation to the clinical realm.
Pulse sequences
The imaging pulse sequence is critical in determining the
image contrast, spatial resolution, and coverage and influ-
ences the potential for quantification and/or the presence
of artifacts. This section reviews the basics; a more com-
prehensive review of perfusion imaging sequences was
recently published by Kellman and Arai [20]. The basic
requirements of a first-pass myocardial perfusion imaging
pulse sequence are to provide: 1) strong T1 contrast; 2)
coverage of relevant myocardial segments; and 3) ade-
quate spatial resolution. Figure 1 contains a schematic of
a typical first-pass imaging sequence.
To provide T1 contrast, inversion recovery (IR) was the
first contrast preparation to be used, but was limited to
one or a few slices and proved sensitive to heart rate vari-
ation. Saturation recovery (SR) has emerged as the current
standard because contrast is theoretically independent of
the magnetization "history," e.g., heart rate and previous
acquisitions, and a higher numbers of slices (such as six to
eight) can be provided with interleaved acquisitions. SR is
typically implemented using a non-selective 90 degree
radiofrequency (RF) excitation followed by a gradient
crusher. This approach can be sensitive to variations in the
transmitted RF field[21], which has recently led to the use
of pulse trains, composite RF pulses, and B1-insensitive
rotation pulses (e.g., BIR-4), that provide more uniform
saturation in practice, albeit with increased RF heating.
Coverage of relevant myocardial segments is achieved
using an interleaved acquisition of arbitrarily oriented
slices. In Figure 1, six slices are acquired with a temporal
resolution of 2 R-R intervals. This could, for example,
include six short-axis slices or four short-axis slices plus
two-chamber and four-chamber long-axis slices. Note that
the slices have different cardiac phases, but each slice is
acquired repeatedly at the same cardiac phase. Slices
obtained during systole have the advantage of increased
myocardial thickness (i.e., more pixels across the wall),
while those obtained during the relatively stable cardiac
phases (e.g. mid-diastole and end-systole) have the
advantage of reduced motion artifacts. When the patient's
heart rate is elevated, the number of slices per R-R may
need to be reduced. With the goal of identifying large-ves-
Typical first-pass perfusion pulse sequenceFigure 1
Typical first-pass perfusion pulse sequence. (A) Acquisitions are cardiac gated using ECG signals. Multiple slices are acquired 
consecutively (shown: 6 slices every 2 R-R intervals). This is repeated continuously during the first-pass and washout of the 
contrast agent. (B) T1 contrast is generated using a saturation pulse (dark gray) followed by fast imaging of each slice (light 
gray) using gradient echo, gradient echo-planar, or steady state free precession acquisitions. Image contrast is primarily deter-
mined by the saturation recovery time, labeled TSR.
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sel CAD, three to six slices are routinely used. With the
goal of characterizing the extent of disease, there have
been recent attempts at providing contiguous whole-heart
coverage (similar to what SPECT and PET provide) using
either a large number of 2D slices or native 3D encoding
[22].
In multislice perfusion imaging, the slice thickness is typ-
ically 5 to 10 mm, and in-plane resolution is typically 1.5
to 3 mm. Depending on the resolution, field-of-view
(FOV), and use of acceleration, image acquisition of each
slice can take on the order of 50 – 200 ms. This requires
an ultra-fast acquisition, usually based on gradient echo
(GRE), gradient echo-planar (GRE-EPI)[23,24], or bal-
anced steady-state free precession (SSFP). Parallel imaging
[25-27] is also widely used as a means for accelerating
image acquisition. SSFP provides a higher signal-to-noise
ratio compared to GRE, but can suffer from off-resonance
artifacts that limit the repetition time (TR). GRE is the
basis of today's most robust protocols at 1.5T and 3T,
while SSFP has produced promising results at 1.5T [28].
Perfusion quantification is an active area of investigation
(see "Image Analysis" section) that can require a modified
acquisition. For example, measurements of regional myo-
cardial blood flow (in ml/g/min) can be made using time-
intensity curve deconvolution with a measured arterial
input function (AIF), usually from the left ventricular cav-
ity or ascending aorta[29,30]. Measurement of the true
AIF is affected by short T1s and T2* effects[31] that occur
with high contrast agent concentrations during bolus con-
trast agent passage in the blood pool. This has led to two
imaging strategies: 1) the "dual-bolus" method[32,33],
which involves AIF measurement during a separate low-
dose injection (1/10th or 1/20th the dose) prior to the full-
dose injection used for the measurement of myocardial
enhancement and 2) the "dual-sequence" method [34-
36], which replaces one of the imaging slices with an AIF
measurement slice that employs an acquisition that
avoids the saturation and T2* effects at high concentra-
tions.
Artifacts
Several artifacts can occur in first-pass perfusion imaging
that must be recognized in order to correctly interpret the
images qualitatively. The most prominent and trouble-
some artifact is the dark rim artifact (DRA). Recognizing
the causes of the DRA and other artifacts can aid in adjust-
ing the imaging parameters to minimize the consequences
of the artifacts.
The dark rim artifact
In some perfusion scans, a transient dark rim artifact is vis-
ible in the subendocardial layer, which can mimic a
hypoperfused area. An experienced observer can differen-
tiate between the DRA and a real perfusion defect by the
transient behaviour of the DRA. DRAs normally last for a
few heart beats, and vary temporally as the contrast bolus
passes through the left ventricle blood pool, while a real
perfusion defect tends to be visible for a longer duration
of the imaging (Figure 2) [37]. However, a mild perfusion
defect which "fills in" quickly is often difficult to identify
in the presence of artifact. Another property of this artifact
is that the signal intensity drops below the baseline signal,
i.e., below the signal before the contrast arrival [38,39].
Although a visual assessment can be used to identify an
artifact, a semi-quantitative or quantitative analysis can
become complex and erroneously estimate blood flow
when DRAs are present. Therefore, DRAs should be
avoided whenever possible.
Usually the perfusion sequence is acquired at rest and
stress. The DRA may be altered by faster cardiac motion
and a more concentrated Gd bolus due to increased car-
diac function at stress, leading to increased left ventricular
(LV) blood pool signal and more artifact at the margin of
the blood pool. However, the rest scan should not be
taken as a guarantee against DRA. The effect of residual
contrast agent in the second perfusion series should also
be considered.
Several possible causes have been suggested for DRAs. Di
Bella et al [40]. and others have suggested the possibility
of the artifact being produced largely by Gibbs ringing in
the phase encode direction (direction with the lowest res-
olution) at the blood-myocardial interface. A Fourier
transform of a finite signal has inherent difficulty in rep-
resenting a discontinuity; therefore, it will not reconstruct
sharp edges perfectly and will always have at least a 9%
(arising from the Wilbraham-Gibbs constant) signal vari-
ation (undershoot and overshoot) near the edge. A DRA
caused by Gibbs ringing would be dependent on the con-
trast between the LV and the myocardium; this could be
the reason that the intensity of the artifact varies tempo-
rally with the contrast between the blood pool and the
myocardium, (Figure 3 and Additional file 1). This expla-
nation is consistent with the higher concentration of the
contrast agent in the heart with stress, increasing the
Gibbs ringing at the endocardial border. The same effect is
expected from a higher injection rate of the contrast agent.
Balanced SSFP sequences are the most likely to suffer from
Gibbs because they produce a higher signal intensity dif-
ference between the blood pool and myocardium. If the
spatial resolution is sufficiently low, Gibbs ringing could
be severe enough to affect the entire interventricular sep-
tum, particularly during diastole. An obvious solution to
avoid Gibbs ringing is to increase resolution, sampling
larger regions of k-space. However, due to time con-
straints in cardiac imaging, this may not be possible. Par-
allel imaging can be used to increase resolution without
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increasing the duration of each image, but as a trade-off
the signal-to-noise ratio (SNR) decreases. Another option
to reduce Gibbs ringing is to filter the k-space with a win-
dow function, with the trade-off of lowering spatial reso-
lution.
The work done by Arai,[37] Fenchel et al.,[41] and Sch-
reiber et al. [39] attributes magnetic susceptibility, associ-
ated with the concentration of Gd-DTPA in the bolus, as a
possible cause for the DRA. Increased distortions in the
magnetic field around boundaries may cause dephasing
in individual voxels and possible signal misregistration
due to alterations in the Larmor frequency. Albert et
al.[42] studied the mechanism of bulk magnetic suscepti-
bility induced by a contrast agent bolus injection. This
study showed that, in an approximation to an infinitely
long right cylinder (resembling the LV blood pool and the
myocardial wall), the magnetic field of the surroundings
of the cylinder is distorted with the passage of a paramag-
netic substance inside the cylinder. This effect is also
dependent on the orientation of the cylinder in relation to
the main magnetic field, B0. Thus, the susceptibility
change is dependent on the heart orientation in relation
to B0, which will vary from patient to patient. A change of
magnetic susceptibility, caused by the arrival of the Gd in
the LV blood pool, in the DRA region was measured by
Schreiber et al.[39] Gibbs ringing was dismissed due to
the particular orientation of the artifact. The artifact was in
fact only visible when using a b-SSFP sequence, due to its
susceptibility sensitivity that can be avoided by decreasing
TR. The use of a high dose of contrast agent will also more
likely contribute to field distortion. The increase in the Gd
concentration at stress is therefore more likely to produce
a susceptibility artifact.
Banding artifacts at tissue boundaries may occur when the
object moves between the acquisitions of different phase
encode lines and could be another possible origin of the
Comparison between a dark rim artifact (DRA, top) and a real perfusion defect (bottom) from two different patientsFigure 2
Comparison between a dark rim artifact (DRA, top) and a real perfusion defect (bottom) from two different patients. From left 
to right are shown the contrast arrival to the left ventricle, the myocardium, and finally recirculation. A DRA artifact usually 
lasts for a few heartbeats while a real defect tends to be more persistent.
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DRA [43]. Parallel imaging can reduce the artifact width
by a factor equal to the square root of the acceleration
parameter. This study also showed that the direction of
the artifact is in the phase encode direction if the motion
is in that direction, or is oblique to the frequency encode
direction in case of motion in the latter direction. Simula-
tions of the intensity profile of a tissue boundary, mod-
eled as a step function, showed that when sequential
ordering of k-space data acquisition is used the oscilla-
tions occur in the brighter parts of the image, independent
of the motion direction; sequential ordering was preferred
to a centric ordering due to lower artifact amplitude [43].
Motion will result in oscillations in the pixel values along
the borders of different tissues with different intensities,
making it a good contender for a cause of DRA. Again, this
artifact correlates with the brightness difference between
blood and myocardium. A likely increase of motion arti-
facts is expected during stress, as discussed above.
Another possible origin for DRA is the non-uniform raw
k-space data weighting in the phase-encode direction, i.e.,
signal variations during the acquisition [20]. Distortions
in the point spread function along the phase-encode
direction result, due to data acquisition prior to reaching
the steady state. A dependency on T1, the time delay
between the readout and the saturation pulse, the
sequence used, and the flip angle will occur. Because the
LV blood pool and the myocardium have different T1s, a
DRA can be formed in the boundary between them. A pos-
sible way to minimize this artifact is to use an optimized
transition to equilibrium like the one used by Hennig et
al. [44].
Partial volume effects may also produce a DRA at the bor-
der between the LV blood pool and the endocardium.
Using an inversion recovery preparation at certain inver-
sion delays, the phases of both tissues can be opposite,
resulting in signal cancellation at this boundary. How-
ever, this artifact would be expected to appear around the
entire border [20,40]. A larger partial volume artifact
might appear in the apical slice, where the myocardial
wall might not be perpendicular to the imaging plane,
Simulation of a short axis line profileFig re 3
Simulation of a short axis line profile. Comparison between a high and a low contrast (between the LV blood and the myocar-
dium) line profile. Signal oscillations are higher for the high contrast image, as expected from the Gibbs truncation theory. (See 
Additional file 1.)
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with the presence of myocardial wall and the LV blood
pool in the same voxel.
The most frequently used pulse sequences for myocardial
perfusion studies have been studied to determine which
are most prone to DRA. Elkington et al.[45] compared a
hybrid-echoplanar imaging sequence with spoiled GRE in
patients with CAD and found no significant difference in
artifact scoring between the two. Wang et al.[28] com-
pared a b-SSFP sequence with spoiled GRE and segmented
EPI in volunteers with no clinical history of CAD. The
study found a higher DRA score for the bSSFP sequence
when compared to the other two sequences. A similar
study using healthy subjects found a higher score for DRA
when using a b-SSFP sequence, this time compared to
spoiled GRE [41].
Recently, Klem et al. described a method for diagnosis of
coronary artery disease (CAD) where adenosine-stress and
rest perfusion cardiovascular magnetic resonance (CMR)
are combined with late gadolinium enhancement (LGE)
CMR [46]. This method particularly implies that per-
fusion defects detected both at rest and stress combined
with no detection of infarcted areas on the late gadolin-
ium enhancement should be interpreted as an DRA.
Other artifacts
Although DRAs represent the most serious artifact in myo-
cardial perfusion imaging, several other types of artifacts
may also occur. Semiquantitative and quantitative analy-
ses of myocardial perfusion studies assume a perfect mag-
netisation preparation; qualitative analysis will also
improve with a complete saturation. Saturation pulses
are, in general, not perfect, due to B0 and B1 field inho-
mogeneities, leaving regional magnetisation residues that
alter the apparent T1 relaxation times and eventually lead
to errors in quantifying perfusion in those areas. Kim et
al[21] evaluated favourably the use of a B1 Insensitive
Rotation (BIR-4) saturation pulse to account for the field
distortions. This RF pulse is effective in producing a com-
plete saturation at 1.5T. High field strengths will, very
likely, make it even more useful, but with additional spe-
cific absorption rate (SAR) concerns.
A common artifact seen in perfusion studies is wrap arti-
fact, where one part of the anatomy might be encoded in
the same position as another, creating signal interference.
Several solutions exist, such as in-plane rotation of the
phase/frequency encode direction or increasing the phase-
encode field of view. Parallel imaging techniques can also
produce artifacts, particularly spatially variant noise,
which is related to the position of the coils on the patient,
and aliasing due to errors in the sensitivity estimation of
the coils. Chemical shifts and N/2 artifacts can also be
problematic for GRE-EPI sequences. Therefore these
sequences usually incorporate fat suppression pulses and
phase correction reference scans, respectively.
1.5T vs. 3T issues
Whole body 3T scanners are increasing in availability,
prompting comparison between 1.5T and 3T for CMR.
Higher field strengths have the advantage of higher SNR,
but there are also a number of possible disadvantages that
could lead to artifacts in perfusion imaging. Firstly, both
the B0 and B1 field inhomogeneities are increased and
greater care has to be taken to reduce the impact of these.
Secondly, the T1 is increased and this, coupled with a
shorter T2*, could lead to a reduced signal and perfusion
contrast. The relaxivity of the commonly used Gd-DTPA is
3.7 mmol/L/s at 3T versus 4.1 mmol/L/s at 1.5T; therefore,
the T1 shortening effect of the contrast agent is reduced at
3T. Nevertheless, precontrast T1 is higher for higher fields,
making the difference of T1 before and after contrast
larger for high fields and enabling an overall better con-
trast to noise ratio (CNR) for myocardial enhancement
[36,47]. However, increases in SAR at 3T can significantly
limit any possible SNR gains.
An SNR increase of 109% was obtained by Gutberlet et al.
using a T1-weighted segmented EPI with an echo train
length of 4 at 3T when compared to 1.5T [48]. Araoz et al.
obtained an SNR of 82 ± 26 and 25 ± 8 for 3T and 1.5T,
respectively, at peak myocardial enhancement using an
interleaved notched saturation recovery gradient echo
pulse sequence with an echo train of 4 [49]. At clinical
doses of contrast agent, i.e., 0.1 mmol/kg, the SNR
increased in the myocardium, but the LV blood pool SNR
was similar between 3T and 1.5T, suggesting that an
increase in the Gd concentration creates T2* signal loss
that negates the increased signal at higher field strengths.
Hinton et al., using a cine true FISP sequence, compared
functional and morphological cardiac evaluations at 3T
and at 1.5T [50]. The CNR at 3T, using a much smaller flip
angle in order to avoid SAR limitations, was similar to the
one obtained in the 1.5T scans. Susceptibility artifacts
were also increased using the b-SSFP sequence. In order to
avoid the potential banding artifact, a short TR and per-
patient shimming is advised [51]. ECG triggering was
acceptable at both field strengths, based on no increased
motion artifacts in the images when comparing 1.5T to
3T.
SNR increase comes with the penalty of an increase in the
artifact-to-noise ratio (ANR). Artifacts that were already
present at 1.5T become more prominent at 3T, such as
errors in parallel imaging and a deficient crusher gradient
[51]. An increase of CNR in the endocardial boundary
would tend to make Gibbs ringing and motion artifacts
more visible, but the high SNR enables faster imaging and
reduced motion artifact. Chemical shift artifacts also
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increase at 3T, but can be alleviated by increasing the
bandwidth with an SNR penalty.
Another current problem with high-field systems is the
fact that imaging parameters, RF pulse profiles, and RF
coil designs have been extensively optimized at 1.5T
whereas 3T optimization is now only being per-
formed[51,52] As 3T scanners gain a wider market share,
this concern will most likely disappear. With an opti-
mized system, the values of increased SNR and CNR can
be utilized, making high-field systems a contender for car-
diovascular MRI.
Imaging protocols & indications
Imaging indications
Currently, the two major clinical indications for use of MR
perfusion imaging are: 1) the detection and sizing of
microvascular obstruction in patients after acute myocar-
dial infarction, and 2) the detection of ischemia in
patients with suspected coronary artery disease. In both
cases, perfusion imaging pulse sequences will likely be
used in combination with other pulse sequences, such as
segmented k-space cine sequences to allow assessment of
myocardial function, and inversion recovery sequences to
allow assessment of myocardial viability. However, since
the clinical objectives of CMR in these two groups of
patients are different, most investigators will use different
study protocols for each type of patient. Also, the image
parameters for each group of patients will likely differ to
accommodate for the different requirements in these two
clinical situations.
Evaluation of patients with acute myocardial infarction
In patients with acute MI, the main purpose of myocardial
perfusion imaging is the precise estimation of the size of
microvascular obstruction (no-reflow area),[53] if
present. A typical protocol, which might be used for
assessment of microvascular obstruction in patients with
acute MI, is illustrated in Figure 4. Resting perfusion imag-
ing is performed during bolus injection (3–4 ml/min) of
a low dose (0.05–0.1 mmol/kg) of Gd chelate. Since the
purpose of this resting perfusion study is accurate sizing of
the area of microvascular obstruction/no-reflow, one
must increase the spatial coverage and compromise tem-
poral resolution. Since the perfusion defects due to micro-
vascular obstruction fill in relatively slowly, temporal
resolution is less important than for stress perfusion stud-
ies. Typically, dynamic imaging with full coverage of the
entire heart, e. g., 8–10 short axis slices, is performed with
a repetition rate every 2 or 3 heart beats. After the comple-
tion of the rest perfusion study, additional contrast can be
infused for a total dose of 0.15–0.2 mmol/kg for subse-
quent LGE CMR images for infarct sizing. These LGE
images are acquired 10–20 minutes after the contrast
injection, with inversion recovery gradient pulse
sequences. An alternative approach is to just obtain single
shot LGE images to visualize microvascular obstruction.
However, the time between first-pass perfusion sequence
and LGE images can be used to acquire functional SSFP
cine images. Since image contrast in SSFP is determined
by the T2/T1 ratio of the tissue, SSFP image quality is often
not significantly impaired.
Evaluation of patients with suspected coronary artery disease
Suspected coronary artery disease can be most dramati-
cally demonstrated during stress-induced ischemia on MR
perfusion imaging performed during maximal coronary
vasodilation. Vasodilatation can be induced by infusion
of either dipyridamole or adenosine. Both agents act
through stimulation of A2 receptors in the microvascula-
ture. Adenosine is the direct agonist of this receptor. On
the other hand, dipyridamole is a pro-drug, whose liver
metabolite exerts its effect by an indirect mechanism on
the endothelium – blocking the cellular reuptake of ade-
nosine and inhibition of adenosine deaminase in
endothelial cells, which leads to increased extracellular
concentrations of adenosine. The stimulation of the A2
receptors relaxes the resistive arterioles, which normally
autoregulate myocardial perfusion relative to coronary
perfusion pressure. In normal non-ischemic myocardium,
this results in maximal hyperemic vasodilation with an
increase of myocardial perfusion without changes in myo-
cardial blood volume [54]. In myocardium subtended by
a signficant epicardial coronary stenosis, the magnitude of
the perfusion increase during vasodilation is compro-
mised compared to normal myocardium, because of the
drop of coronary perfusion pressure downstream of the
Typical protocol for assessing extent of microvascular obstruction with rest first-pass perfusion imagingFigure 4
Typical protocol for assessing extent of microvascular 
obstruction with rest first-pass perfusion imaging. An alter-
nate method of imaging microvascular obstruction is single 
shot late gadolinium enhancement.
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coronary stenosis [54]. This pressure drop results in capil-
lary closure, reduced perfusion, and reduced blood vol-
ume during hyperemia, which all translates into a slower
arrival and lower contrast agent concentration in the
ischemic as compared to normal myocardium. Thus, the
ischemic regions demonstrate reduced signal intensity rel-
ative to the normal myocardium on T1-weighted images
during vasodilation and appear as a perfusion defect [54].
Two different protocols are currently used for the infusion
of dipyridamole. The low-dose injection protocol consists
of an infusion of a total dose of 0.56 mg/kg dipyridamole
in 4 minutes, with imaging started immediately after com-
pletion of the 4 minute infusion. The high-dose injection
protocol adds a second injection of 0.28 mg/kg dypyrida-
mole for 2 minutes duration, commencing at 8 minutes
after the beginning of the first injection. Thus, a total dose
of 0.84 mg/kg dipyridamole is administrated in this high-
dose dipyridamole infusion protocol. Imaging is initiated
at the end of the second infusion, i.e., 10 minutes after the
beginning of the first dipyridamole infusion. The advan-
tage of the high-dose dipyridamole infusion protocol is a
more intense, longer lasting and more predictive vasodil-
atation response than that obtained by the low-dose pro-
tocol.
For the adenosine infusion protocol, adenosine is injected
at a rate of 0.14 mg/kg/min, typically for 3–6 minutes for
a total dose of 0.48 to 0.84 mg/kg, with imaging during
the terminal portion of the adenosine infusion. Adenos-
ine and contrast are administered via separate IVs to avoid
large bolus drug delivery that increases risk of heart block.
The adenosine infusion can be stopped when the contrast
is completed. Both dipyridamole and adenosine can cause
similar side effects, which may include light flushing,
mild chest discomfort, and headache. Patients with signif-
icant coronary artery disease may experience angina pec-
toris. More serious side effects include atrioventricular
(A) Typical first-pass perfusion protocol for adenosine stress perfusion CMRFigure 5
(A) Typical first-pass perfusion protocol for adenosine stress perfusion CMR. (B) Typical first- pass perfusion protocol for dipy-
ridamole stress perfusion imaging.
(a)
(b)
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(AV) conduction block, bronchospasm or cerebral hypop-
erfusion with potential neurological symptoms in the
presence of significant carotid stenosis.
The advantage of dipyridamole over adenosine is the
lower cost and longer duration of vasodilation with a half-
life of ~30 minutes versus < 10 seconds for adenosine,
which gives a longer time period for performing the per-
fusion imaging. This longer half-life of dipyridamole can
be associated with a longer duration of potential side
effects that are not as self-limiting as adenosine. On the
other hand, the short half-life of adenosine may give less
time to respond to potential side effects. Because of the
potential side effects, patients need to be monitored
before, during, and after stress protocols, and equipment
and qualified personnel for life support and resuscitation
needs to be available. Since the vasodilating effects of
both dipyridamole and adenosine can be abolished by
ingestion of xanthine inhibitors, patients should with-
hold caffeinated beverages and theophylline for 24 hours
prior to imaging [55]. Dipyridamole and adenosine are
contraindicated in patients with severe conduction altera-
tions, obstructive pulmonary disease (COPD and asthma)
and severe carotid stenosis. Neither drug should be
administered to pregnant women.
After induction of vasodilation by either adenosine or
dipyridamole, first-pass perfusion imaging is performed
during intravenous bolus injection of a gadolinium-based
contrast agent. The objective of the test is the detection of
perfusion defects in the ischemic area. Due to the extravas-
cular distribution of most clinically approved contrast
agents, such perfusion defects persist very briefly after
bolus injection, before disappearing due to redistribution
into the extravascular space. Hence, stress MR perfusion
imaging requires very rapid image acquisitions. The focus
of the pulse sequence will thus be maximal temporal res-
olution, at the cost of left ventricular coverage and spatial
resolution. The best available perfusion sequences typi-
cally allow 3–4 short and/or long-axis slices to be
acquired in a dynamic mode with a temporal repetition
rate of every heart beat.
Typical MR stress perfusion protocols are illustrated in
Figure 5. Most protocols consist of stress and rest per-
fusion studies, to allow distinction of perfusion defects
from ischemia versus image artifacts. The optimal order of
rest and stress perfusion test may be different for adenos-
ine versus dipyridamole protocols. Due to the short half-
life of adenosine, it may be better to perform the stress
study first so that the stress perfusion measurement is not
contaminated by residual gadolinium injected at rest.
Indeed, if resting perfusion is performed first, there is a
potential risk that Gd might accumulate in infarcted areas
and mask the inducible ischemic areas in a subsequent
stress test. However, in the case of dipyridamole, it may be
better to first perform the resting study and then the stress
study, since the long-lasting vasodilatory effect of dipyri-
damole can persist and delay the rest study by more than
15 minutes. Thus, adenosine may be the preferred vasodi-
lator for MR perfusion studies.
Staffing and technical components required for patient 
stress testing
Patient safety during myocardial perfusion assessment
requires appropriate staffing and technical considera-
tions. The three types of staff typically involved in per-
forming a stress CMR examination include technologist,
nurse, and physician. The nurse and physician should be
certified in basic and advanced cardiac life support with
experience in anticipating, recognizing, and managing
cardiac events that may occur secondary to or independ-
ently of pharmaceutical-induced effects. This is facilitated
by having MR-compatible monitoring equipment in the
scanner room with an additional display outside the
room if needed. The minimum monitoring needs include
continuous electrocardiographic display and heart rate
measurement as well as periodic blood pressure record-
ing. Capabilities for noninvasive oximetry are often help-
ful, particularly for the patient with obstructive lung
disease of uncertain severity undergoing stress with
vasodilators that may produce bronchoconstrictive
effects. Weight-based vasodilator doses for stress are typi-
cally prepared by the pharmacy staff and delivered to the
MR lab at the start of the procedure. In the MR lab area,
there is also a point-of-care automated medication storage
unit accessible by the clinical staff that is stocked with
medications such as aminophylline, metoprolol, and
lidocaine that may be needed for acute reversal or therapy
of complications. In instances requiring defibrillation or
resuscitation, there should be a plan in place that clearly
delineates individual responsibilities when a patient
needs to be brought out of the scanner room. One indi-
vidual is typically responsible for patient transferal,
another goes to get the resuscitation equipment or "crash
cart", and the physician is responsible for directing appro-
priate inteventions. Such events may trigger the arrival of
many individuals, who arrive to help with resuscitation
but may not be facile with principles of MR safety. Thus,
vigilance by the MR staff is required.
Pre- and post-procedure patient assessment
Prior to the exam, the nurse typically screens the patient
for clinical history that would preclude administration of
adenosine or dipyridamole. This is done in conjunction
with screening for MR contraindications, such as presence
of ferromagnetic foreign body, aneurysm clip, intraorbital
metal, or non-MR compatible implant. As noted earlier, a
history of obstructive airway disease or conduction abnor-
malities should prompt the discussion of whether adeno-
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sine or dipyridamole stress testing is appropriate. A
baseline electrocardiogram (ECG) is acquired prior to the
MRI examination.
After the exam, the patient is returned to the preparatory/
recover area outside the scanner room where the nurse
repeats a 12-lead ECG. The yield of this tracing is fairly
low, given the rarity of ST changes due to adenosine. How-
ever, ischemic ECG changes resulting from adenosine por-
tend a high likelihood of significant obstructive coronary
artery disease. A post-procedure blood pressure measure-
ment should also be documented, particularly if there was
any significant blood pressure deviation during the exam.
Image analysis
Qualitative interpretation
Qualitative interpretation of perfusion CMR images
remains the mainstay of clinical reporting in 2007. Fur-
thermore, stress perfusion interpretation almost always
requires concomitant acquisition and interpretation of
LGE images. A step-wise algorithm that begins with review
of LGE images, followed by stress and rest perfusion
images works well for overall classification of presence or
absence of epicardial coronary disease in most cases [46].
After carefully identifying the presence and extent of inf-
arct scar on LGE imaging, the interpreting physician can
better determine whether perfusion defects match regions
of scar vs. those that extend beyond the scar. In the
absence of scar or artifact (see below), uniform myocar-
dial enhancement throughout the myocardium in all
slices at rest and with vasodilator stress indicates absence
of ischemia. With LGE in a region and corresponding
defect on stress perfusion images, the interpretation of
"fixed defect, no ischemia" is appropriate. When a region
demonstrates stress perfusion abnormality that normal-
izes at rest without LGE, the interpretation of "positive for
ischemia" follows, barring artifact (Figure 6). A region of
perfusion abnormality with stress that corresponds to the
scar on LGE but subtends a greater myocardial extent war-
rants description as "infarct with peri-infarct ischemia."
Clinically, this is helpful to the referring physician when
judging whether or not to revascularize a chronically
occluded vessel (Figure 7). Viable myocardium based on
transmural extent of scar along with extent of ischemia
may help guide assessment of the need for and likely
response to revascularization in such cases [56]. Finally,
some patients undergoing stress CMR may have circum-
ferential subendocardial ischemia. Angiography may be
required to classify diffuse subendocardial perfusion
abnormality with vasodilator stress as multivessel or left
mainstem coronary artery disease versus microvascular
disease, as has been described in patients with syndrome
X [57].
Myocardial perfusion CMR was performed in a 43 year-old female to evaluate exertional chest pressureFigure 6
Myocardial perfusion CMR was performed in a 43 year-old female to evaluate exertional chest pressure. Perfusion images 
obtained during intravenous infusion of adenosine (A) demonstrate severe hypoenhancement of the septum, anterior wall, and 
apex that is not present on resting perfusion imaging (B). Late gadolinium enhancement acquisitions are negative for hyperen-
hancement (C); together, these findings suggest severe myocardial ischemia in the distribution of the left anterior descending 
coronary artery without infarction. (D) Invasive coronary angiography confirms high-grade serial stenoses in the left anterior 
descending coronary artery. (See Additional file 2.)
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Quantification and validation
Image analysis for quantitative MRI perfusion studies
In analyzing first-pass contrast enhancement images for
quantitative assessment of cardiac perfusion, we need to
be able to position a region of interest (ROI) within the
wall, in order to follow the dynamic changes in MRI signal
intensity. While in principle this is straightforward, there
are some relevant issues that may need to be considered.
First, we need to position the ROI carefully, so as to avoid
contaminating the wall signal with signal from the adja-
cent blood. Another potential problem with ROI posi-
tioning can arise if there are premature ventricular beats,
leading to variability of the size of the ventricular cavity
and thus the position of the wall. Also, since patients are
often unable to hold their breath for the full duration of
the sequence of dynamic enhancement images, interac-
tively repositioning of the ROI on sequential images may
be needed to track a consistent portion of the heart wall.
First-pass myocardial perfusion CMR was performed in a 75 year-old male with a history of bypass surgery seeking a second opinion regarding intervention for bypas graft dis aseigure 7
First-pass myocardial perfusion CMR was performed in a 75 year-old male with a history of bypass surgery seeking a second 
opinion regarding intervention for bypass graft disease. Perfusion images obtained during intravenous infusion of adenosine (A) 
demonstrates diffuse subendocardial perfusion abnormality not present on resting perfusion imaging (B). Late gadolinium 
enhancement acquisitions (C) show a small region of enhancement involving the lateral wall. Together, these findings suggested 
prior infarct with ischemia. His symptoms were controlled with optimization of anti-anginal medical therapies. (See Additional 
file 3.)
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One frequent method of segmentation is the 17-segment
model proposed by the American Heart Association, cor-
responding to the typical blood flow distributions of the
coronary arteries [58]. The epicardial and endocardial
borders of the heart are defined, and then the resulting
annular regions are divided into suitable septal and free
wall segments. As the subendocardial portion of the heart
wall is most vulnerable to ischemia, it can be useful to fur-
ther subdivide the segmental ROIs into endocardial and
epicardial halves.
As there is no absolute scale of image intensity in MR, and
there are many potential sources of variability of the
image intensity, an approach to standardize and repro-
ducibly quantify dynamic intensity changes is needed.
One approach is to acquire additional calibration images,
whose intensities must also be measured. For example,
acquiring a "proton density" image at the same location
can be used both to provide an "absolute" intensity scale
and to correct for shading due to the use of local surface
coils [59,60]. A separate noise image can also be acquired
for estimating possible noise bias in low intensity images
(as may be seen prior to the arrival of the contrast bolus
in the T1-weighted images).
In any attempt at quantitative analysis of dynamic first-
pass perfusion images, we need to be able to account for
the effect of potential variations in the rate, amount, and
timing of the delivery of the contrast agent in the blood
(the arterial input function) on the resulting enhance-
ment of the heart wall. One way to estimate the arterial
input function (AIF) is to position an ROI within the left
ventricular cavity, while minimizing contamination due
to volume averaging, and follow the sequential signal
changes in the blood.
Quantification of CMR perfusion
There are many potential problems associated with the
determination of contrast concentrations from serial MR
intensity measurements. First, the relationship between
contrast concentration and signal is nonlinear, and also
depends in a nonlinear way on the imaging parameters,
such as the time between the saturation pulse that pro-
duces the T1 weighting and the image data acquisition.
This nonlinearity can be particularly problematic when
the concentration of contrast agent is high, as during the
peak enhancement phase, as the response of the signal
intensity may be effectively saturated, leading to a ten-
dency to underestimate the concentration. Regional varia-
tions in the RF excitation field (B1) and the main
magnetic field of the MR system (B0) can produce a corre-
sponding variation of the amount of residual magnetiza-
tion left after the nominal saturation pulse, with a
resulting uncertainty of the amount of the contrast agent-
induced signal increase [21]. Finally, there may be some
uncertainty as to whether it is reasonable to assume that
all the water in the tissue is equally exposed to the contrast
agent ("fast exchange" condition) [61].
Assuming that we can determine the time course of the
contrast agent concentrations in the arterial blood and the
myocardium, calculation of the corresponding perfusion
blood flow and related parameters can then be done. A
hypothetical instantaneous bolus input ("impulse") of
contrast agent at the tissue arteriolar level would produce
a corresponding transient increase in the tissue concentra-
tion that would depend on the blood flow into the tissue,
and would last for at least the duration of the transit of the
labeled blood through the tissue. The mean transit time
(MTT) of an instantaneous bolus is given by the ratio of
the fractional blood volume of the tissue and the flow. As
conventional contrast agents can diffuse from the vascular
space into the extravascular space (but not into normal
cells), the observed transit will be longer than the nomi-
nal vascular MTT. Obviously, any delay or prolongation of
the delivery of the contrast agent to the tissue will be
directly reflected in the observed tissue response, effec-
tively being combined ("convolved") with the ideal
impulse response, and will also need to be accounted for.
A variety of approaches have been proposed to approxi-
mately correct the observed tissue enhancement for the
effects of the AIF. These include calculating various
parameters of the observed tissue enhancement curves,
such as the time of arrival of the contrast agent, the time
of the peak enhancement, and the slope of the enhance-
ment curve, and correcting them by subtracting or scaling
by the corresponding AIF parameters. The presence of
noise in the data and other experimental limitations can
lead to problems in reliably defining these parameters in
practice. Furthermore, these empirical estimates don't
allow a full calculation of the tissue transit effects or
extravascular exchange of the contrast agent. A potentially
better approach is to approximately mathematically undo
("deconvolve") the effects of the AIF from the observed
tissue response, in order to estimate the corresponding
underlying MTT and calculate the blood flow; a variety of
approaches have been proposed for carrying out such cal-
culations [29,62,63].
In light of the numerous obstacles outlined above, no
quantitative perfusion analysis technique has gained
widespread clinical use at this time. However, in research
endeavors and in some clinical settings, one may use a rel-
ative index of myocardial perfusion reserve [7,57,64,65].
For example, using semiautomatic delineation of endo-
cardial and epicardial left ventricular borders throughout
the phases of first-pass perfusion, with respiratory motion
correction as needed, rest and stress myocardial perfusion
slopes may be derived using Fermi-fitting of signal inten-
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sity versus time and normalized to the LV blood pool
slope as well as heart rate [57]. A Myocardial Perfusion
Reserve Index (MPRI) is then the ratio of stress to rest nor-
malized myocardial perfusion slopes.
Clinical interpretation of first-pass CMR perfusion
Cardiovascular MR perfusion imaging with rest and stress
acquisitions also helps answer a variety of clinical ques-
tions in the subacute or chronic setting. For example, the
patient with atypical chest pain in whom ischemic heart
disease is suspected may undergo rest/stress CMR per-
fusion imaging with LGE to define the presence or
absence of flow-limiting coronary artery disease as the
cause of symptoms. This is particularly helpful if there is
known coronary artery disease and prior infarction. The
superiority of CMR to delineate infarct scar becomes criti-
cal in providing this information in addition to extent of
ischemia [66]. In patients identified as having anatomic
lesions of uncertain hemodynamic significance by angiog-
raphy, CMR with rest/stress perfusion may be helpful to
define the angiographic lesion(s) producing impaired
myocardial blood flow under stress conditions.
Rest perfusion CMR in acute MI patients
Detection of microvascular obstruction can assist in the
distinction of chronic from acute infarcts, since microvas-
cular obstruction occurs exclusively in acute myocardial
infarction and disappears progressively over time [67].
The presence of microvascular obstruction in an infarcted
area can be a marker of non-viable tissue in which func-
tion rarely recovers [68-72]. More importantly the pres-
ence of microvascular obstruction has been shown to have
negative prognostic value in patients with acute infarcts
[67,73,74]. Patients who had infarcts with microvascular
obstruction were found to have significantly more events,
such as death and hospitalization for heart failure, and
increased adverse remodeling [73-75].
Stress perfusion CMR in patients with suspected coronary 
artery disease
Diagnosis of coronary artery disease in with stable chest pain
The results of nine studies of 618 patients, which reported
diagnostic accuracy on per-patient basis for detection of
coronary artery disease versus detection of invasive coro-
nary angiography, are summarized in Table 1. Overall, in
these studies, perfusion CMR had high sensitivity (89%),
specificity (81%), and accuracy (86%) for detection of sig-
nificant (> 75% diameter stenosis) coronary artery disease
on a per-patient basis. Similarly high accuracy was
reported in other single-center studies[64,76,77] on a seg-
mental basis alone.
At present, two multicenter studies have examined the
influence of contrast agent dose on diagnostic accuracy.
[78,79] Most studies have examined the diagnostic accu-
racy for detection of anatomical coronary artery stenosis
(defined either as > 50% or > 75% luminal diameter
reduction). The limitation of this approach is that func-
tional severity of a coronary stenosis may vary and depend
on parameters other than lumen diameter. Two studies
[7,80] compared flow reserve by CMR versus PET, the
non-invasive gold-standard at present, and demonstrated
a high correlation and diagnostic accuracy. In another
study, Rieber et al.[81] compared the diagnostic accuracy
of perfusion CMR versus angiographically measured frac-
tional flow reserve and reported good diagnostic accuracy
of perfusion CMR to this invasive gold-standard.
A few studies have compared diagnostic accuracy of CMR
versus other techniques for detection of coronary artery
disease. Ishida et al.[82] showed a higher diagnostic accu-
racy of perfusion CMR than SPECT for detection of signif-
icant CAD. Similarly, Sakuma at al.[8] observed a similar
higher diagnostic accuracy for CMR than for 201Tl SPECT.
Paetch et al.[83] reported similarly high sensitivity, specif-
icity, and accuracy compared to dobutamine stress MR for
detection of coronary artery disease.
Table 1: Diagnostic accuracy of perfusion MR for assessment of coronary artery disease
Author Remarks # of patients Prevalence of CAD Sensitivity (%) Specificity (%) Accuracy (%)
Schwitter et al. [7] upslope 57 65% 86% 85% 86%
Nagel et al. [90] upslope 84 51% 88% 90% 89%
Ishida et al. [82] 104 74% 90% 85% 88%
Wolff et al. [78] low dose group 26 54% 93% 75% 85%
Giang et al. [79] group 2 and 3 44 64% 93% 75% 86%
Paetsch et al. [83] upslope 79 67% 91% 62% 81%
Plein et al. [91] upslope 92 64% 88% 82% 86%
Sakuma et al. [8] visual 40 53% 81% 68% 75%
Klem et al. [46] visual: perfusion and late 
enhancement
92 40% 89% 87% 88%
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Patients with chest pain with suspected unstable coronary artery 
disease presenting to the emergency room
In a study of 135 patients, who presented to the emer-
gency department with chest pain, but without acute myo-
cardial infarction, Ingkanisorn et al.[84] reported that an
abnormal adenosine perfusion CMR exam had a 100%
sensitivity and 93% specificity for predicting future
events, such as coronary artery disease, new MI, or death.
This suggests that perfusion CMR could have a potential
role in selecting patients with high risk in the emergency
department.
Perfusion CMR in other diseases
Panting et al.[57] employed perfusion CMR to elucidate
the cause of chest pain in patients without significant cor-
onary artery disease or Syndrome X. A reduced flow
reserve was shown in the subendocardium, but not in the
subepicardium in these patients, suggesting a potential
ischemic origin for Syndrome X. A study by Vermeltfoort
et al.[85] did not confirm this finding, but a more recent
study by Lanza et al. was confirmative and showed Dop-
pler derived coronary flow abnormalities in the abnormal
regions identified by perfusion CMR [86]. In addition,
abnormalities in subendocardial perfusion have been
recently reported in patients with repaired aortic coarcta-
tion, a population that suffers early death due to myocar-
dial ischemia [87].
Prognostic value of stress perfusion CMR
Finally, perfusion CMR has also been shown to have pre-
dictive value in patients with coronary artery disease.
Indeed, Jahnke et al.79 evaluated the prognostic value of
this technique in 533 patients with chest pain or dyspnea
and suspected coronary artery disease in comparison to
dobutamine stress MR. Over a median follow-up of 2.3
years, ischemia by perfusion CMR was found to be the sin-
gle best predictor of cardiac death or nonfatal myocardial
infarctions and was superior to ischemia on dobutamine
stress CMR. Presence of a normal perfusion test was pre-
dictive of 99% chance of a 3 year event-free survival.
LGE/stress/rest perfusion vs. other approaches
It should be remembered that clinicians have choices
among several modalities when deciding whether or not
to refer individual patients for perfusion CMR examina-
tion, particularly stress perfusion imaging. The value
added by LGE imaging comes from its proven reliability in
delineating extent of infarcted myocardium[56] as well as
its superior ability to detect myocardial disease due to
other nonischemic cardiomyopathies [88]. Incorporating
other measurements, such as presence of significant valvu-
lar disease and velocity-encoded data to assess diastolic
function[89]1, allows a brief, single CMR exam to provide
comprehensive assessment for etiologies of cardiovascular
signs and symptoms that might otherwise require multi-
ple testing and, therefore, less cost-effective healthcare.
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Measurement of Myocardial Frequency Offsets During
First Pass of a Gadolinium-Based Contrast Agent in
Perfusion Studies
Pedro Ferreira,1* Peter Gatehouse,2 Chiara Bucciarelli-Ducci,1,2 Ricardo Wage,2 and
David Firmin1,2
MRI of myocardial perfusion observed with an extracellular
contrast agent has proven valuable for the detection of coro-
nary artery disease. During contrast enhancement transient
dark rim artifacts are sometimes visible, complicating diagno-
sis and quantiﬁcation. In this work a quantiﬁcation of the fre-
quency offsets caused solely by the ﬁrst pass of Gd-DTPA in a
typical perfusion setup was made in vivo and compared with
both phantom work and numerical simulations data. The results
show that numerically simulated and phantom data agree well
with in vivo frequency offsets. During the ﬁrst pass main ﬁeld
distortion occurs mainly in the subendocardium, and the same
pattern is always observed: positive for posterior/anterior re-
gions, negative for septal/lateral regions (from 69 to 85 Hz).
The larger myocardial frequency offsets were measured for
patients with greater angles between the long axis of the heart
and the direction of the main ﬁeld. From these results it would
appear that the frequency offsets are too weak to cause dark
rim artifacts due simply to intravoxel dephasing in a typical
perfusion sequence. However, when added to other sources of
off-resonance it can cause dark rims in particular regions of the
myocardium wall in balanced-SSFP sequences. Magn Reson
Med 60:860–870, 2008. © 2008 Wiley-Liss, Inc.
Key words: myocardial perfusion; susceptibility; gadolinium;
artifacts
Myocardial Perfusion studies using MRI have in recent
years improved in terms of resolution and coverage, pro-
viding a valid alternative to nuclear medicine in the de-
tection of coronary artery disease (1–4).
However, myocardial perfusion images are often af-
fected by artifacts that complicate the diagnosis. The most
common artifact is the dark rim artifact (DRA), which
appears in the subendocardium during the ﬁrst left-ven-
tricular pass of the contrast agent (CA) mimicking an un-
derperfused region. An experienced observer can detect a
DRA due to its transient behavior, typically lasting for a
few heartbeats, while a real perfusion defect is visible for
longer. The signal drop is also commonly below the signal
before contrast arrival (5). DRA is visible during stress-
induced scans but also, although less frequently, during
rest scans. This type of artifact appears to be related to the
increase of blood signal in the left ventricle (LV) due to the
arrival of the CA.
The exact origins of the DRA are unclear and several
causes have been suggested: motion artifacts (6), Gibbs
truncation (7), nonuniform k-space weighting (8), and sus-
ceptibility associated with the concentration of the con-
trast agent (9–11).
In this work a method has been developed and used to
measure the in vivo ﬁeld distortions caused by the ﬁrst
pass of a CA in a typical perfusion setup, and determine
how these distortions may depend on cardiac long-axis
orientation with respect to the B0 (amplitude of main mag-
netic ﬁeld). The in vivo data were compared to phantom
work and numerical simulations. Field distortion effects
were examined in a general perfusion setup where other
possible ﬁeld distortion sources were considered. To the
best of our knowledge there has been no previous similar
work published.
MATERIALS AND METHODS
In Vivo Studies
Seventeen patients agreed to become subjects of this study
after signing an informed consent. Gd-DTPA (gadolinium
complex with diethylenetriamine pentaacetic acid) con-
trast agent (Magnevist-Schering, Germany) at a dose of
0.1 mmol kg1 of body weight was injected at a rate of 5 mL
s1 followed by 10 mL of a saline ﬂush at the same rate.
Images were acquired in three short-axis slices for 40 R-R
intervals during the ﬁrst pass of CA with the patients
holding their breath at end-expiration for a sufﬁcient time
to cover the ﬁrst pass of CA. The study was performed
using a 1.5 T scanner (Avanto; Siemens, Erlangen, Ger-
many) with anterior/posterior phased array cardiac coils.
A FLASH (fast low angle shot) sequence was used with
magnitude and phase reconstructions: TR (time of repeti-
tion) / TE (time of echo) of 3.8/2.38 ms; base resolution 192
pixels; pixel size 1.8 1.8 10 mm to 2.2 2.2 10 mm;
ﬂip angle 12°; bandwidth 744 Hz pixel1; GRAPPA (gen-
eralized autocalibrating partially parallel acquisitions),
R 1.7. It is helpful to point out that no perfusion analysis
was made with these data, since this is not a T1-weighted
perfusion oriented sequence, the relatively long TE for
FLASH was chosen to enhance sensitivity to small B0 ﬁeld
distortions.
Each receiver coil channel’s images were saved sepa-
rately and phase correction was disabled in image recon-
struction. Slice order was always apical 3 mid 3 septal.
Single-shot frequency-offset maps were calculated using
MatLab (MathWorks, Natick, MA) where the phase image
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of each coil for the ﬁrst frame (before CA) was subtracted
from each subsequent frame’s corresponding phase im-
ages, before magnitude-weighted phase combination. The
ﬁrst frame was chosen to be that before contrast arrival to
the right ventricle (RV) but with the patient at a stable
breath-hold position. It is important to stress that the im-
ages obtained in each cycle were not ﬁeld maps. This
method relied on the phase difference between the refer-
ence cycle and each following heart cycle. Each image was
therefore a map of the additional B0 distortion caused by
the arrival of the CA. At a TE  2.38 ms, the range  in
each phase difference image corresponded to a frequency
difference of 210 Hz, which at 1.5 T was 3.3 ppm.
Four regions of interest (ROIs) were drawn using CMR-
tools software (Cardiovascular Imaging Solutions, London,
UK) weighted toward the inner half of the wall and posi-
tioned in the posterior, anterior, septal, and lateral regions
of the myocardium (Fig. 1a). The ROIs shape was drawn
manually and carefully placed so as not to step into the LV
blood pool. Each ROI had an area around 50 mm2 and
remained static throughout the 40 frames, thus making the
frequency offset measured on that ROI valid until the
patient started to breath and/or move. The mean frequen-
cy-offset within each ROI was recorded as a function of
time (Fig. 1b). The frame where the temporal peak value
(positive or negative) of the mean frequency offset for each
ROI was recorded (indicated by arrows in Fig. 1b). This
frame where the temporal peak occurred was also used to
extract the spatial peak value (positive or negative) inside
each ROI using line proﬁles taken diametrically across the
short axis (Fig. 1c). Each line proﬁle was an average
formed by using a 3-pixel-wide line for the proﬁle. An-
other ROI was drawn in the mid-slice in the LV blood pool
in order to track any frequency offset in this area as well.
While the mean ROI values gave an overview of the ﬁeld
distortion as a function of time, the peak frequency offsets
were determined by the line proﬁle results, and these are
the values stated in the Results section.
To assess the error in the mean ROI value and line
proﬁles the temporal standard deviation of the mean signal
in each ROI was also measured during 3–5 frames prior to
contrast arrival in the RV or during recirculation, since the
arrival of highly concentrated contrast agent in the RV
cavity distorted the ﬁeld in the septal region due to its
closeness.
The ROI data were recorded together with the patient’s
short-axis plane orientation. The normal of the plane was
used to calculate the angle between the long-axis of the
heart and the direction of the main magnetic ﬁeld.
Phantom Work
A phantom was speciﬁcally built to model the myocardial
wall and the LV, with similar susceptibilities to the ones
encountered during the ﬁrst pass of the CA.
The ﬁrst pass was modeled estimating 1.5% of Gd-DTPA
(100%  0.5 molL1) in the blood pool (12). Magnetic
FIG. 1. a: The four ROIs used (Anterior: 1; Posterior: 2; Septal: 3; Lateral: 4). The in-plane component of B0 is shown. b: Mean frequency
offset measured for each ROI for each heart cycle for a typical patient. The arrows represent the time of peak, i.e., ﬁrst pass of CA. c: Line
proﬁles for the cardiac cycle pointed by the arrow in (b).
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susceptibility was modeled taking into consideration that
6% CA concentration cancels water diamagnetism, and
the diamagnetism of fully oxygenated blood without CA is
similar to water (13,14).
The phantom was built using gelatin (Hartley’s Straw-
berry Jelly, Spalding, UK), and its dimensions are depicted
in Fig. 2. It consisted of a hollow cylinder (made with 50%
gelatin, 50% water) simulating the myocardium.
The cylinder was ﬁlled with water doped with 1.5%
Gd-DTPA to simulate the blood pool with contrast agent in
the left ventricle during ﬁrst pass. A time series of T1
(longitudinal relaxation time)-weighted images (results
not shown) showed negligible dissolving of the gelatin
within 30 min, which allowed these models to be used
quickly for these experiments.
The cylinder axis was oriented at several angles to the
main ﬁeld B0, simulating in vivo conditions, as it is well
known that tissue geometry alters B0 distortion (11). A
cross-section (“short-axis” slice) ﬁeld map of the phantom
was imaged with a GRE (gradient recalled echo) ﬁeld-
mapping sequence, and using a whole-body receiver coil:
TR 450 ms; TEs 3.04 and 4.23 ms; base resolution 160;
voxel size 1.9  1.9  10 mm; ﬂip angle 90°; bandwidth
1 kHz pixel1; using also the same 1.5 T scanner. TE 
1.19 ms with a corresponding B0 sensitivity of  
420 Hz. All the scans were acquired using the same
scanner reference frequency in order to consistently com-
pare all measurements. Frequency differences in the ﬁeld
maps were extracted using line proﬁles acquired with
MatLab, where all line proﬁles are normalized to the mean
value obtained in the LV blood pool.
The phantom was also imaged, in a typical in vivo
orientation (60°), with an added positive/negative fre-
quency offset simulating other sources of ﬁeld distortion
encountered in in vivo hearts (15). The sequence used was
a balanced steady-state free precession (b-SSFP) perfusion
sequence: TR 2.5 ms; TE 1.23 ms; saturation recovery with
a TI of 95 ms; base resolution 128; voxel size 2.25 2.25
8 mm; ﬂip angle 70°; bandwidth 1490 Hz pixel1; using
also the same 1.5 T scanner.
Numerical Simulations
What is measured in vivo is the phase difference intro-
duced by the arrival of the CA. This same offset was
simulated numerically using MatLab approximating the
LV and myocardial wall to a superposition of two concen-
tric and inﬁnitely long circular cylinders. The superposi-
tion was built assuming the same concentration of Gd-
DTPA as in the phantom model, i.e., 1.5% Gd-DTPA,
which is inside the interval estimated at the injection rate
used in vivo, 5 mL s1 (12). Magnetostatic equations for
this kind of geometry are well established (16) (Appendix).
The same superposition weight was given to each cylin-
der, i.e., 1  2  0.5.
The peak frequency offsets for when the LV cavity was
ﬁlled with a solution of Gd-DTPA were measured in a
similar fashion as the in vivo and phantom data by using
line proﬁles.
Two other doses of contrast agent were simulated:
0.15 mmol kg1 and 0.05 mmol kg1 of body weight, as-
suming an LV CA concentration of 2.1% and 0.7%, respec-
tively, for an 80° angle orientation in order to visualize
frequency offsets at different doses of CA.
RESULTS
In Vivo Studies
Twelve patients (mean age 44) managed to breath-hold
until the end of the ﬁrst pass of CA with a stable electro-
cardiogram, completing the measurements successfully.
The ﬁrst-pass of contrast agent in the LV blood pool
distorted the ﬁeld mainly in the myocardial wall (Fig. 3).
The maximum frequency offset of each ROI was observed
during the ﬁrst pass of the CA in the LV cavity (Fig. 3b).
The magnitude images, although not T1-weighted and op-
timized for contrast enhancement with Gd-DTPA, show a
change in contrast indicating the arrival of CA at the same
time the peak frequency-offsets were measured (Fig. 3d). It
should be pointed out that the magnitude signal intensity
(SI) curves are rather complicated because of T2* (effective
transverse relaxation time) signal loss due to long TE,
competing with signal enhancing due to T1 shortening,
nevertheless a change in contrast is visible. Frequency
offsets with a lower magnitude were sometimes visible
during the ﬁrst pass in the RV, especially in the septal ROI
due to its proximity, but the focus of this study was on the
LV ﬁrst pass, not because of the higher magnitude but
because it is in this stage that the DRA artifact commonly
appears.
FIG. 2. The schematics of the phantom used. Shown is the angle 	
between the long axis and the direction of the main magnetic ﬁeld,
and the cylindrical coordinates on the bottom, used in the numerical
simulation equations (Appendix).
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The pattern of distortion was the same for every patient,
with posterior–anterior regions having a higher ﬁeld, and
septal–lateral regions having a lower ﬁeld; the transition
between a higher and a lower ﬁeld were located in the
diagonal regions of the myocardial wall.
The myocardial peak frequency offsets registered for
each slice and for each patient is shown in Fig. 4, plotted
against the angle (	) between B0 and the long axis of the
LV. The greatest frequency offsets occurred at the largest
angles. While the greatest value found was 85 Hz, taking
an average of the largest distortions found in each of the
33% of patients with cardiac angles bigger than 65° gave a
value of 68 Hz.
A negative frequency offset was also observed in the LV
blood pool. Again, the greater negative frequency offsets
were found at the greater angles, although with a lower
amplitude than in the subendocardium. The maximum
mean-ROI distortion for each patient in the mid-slice is
shown in Fig. 5 and ranged from2 Hz to45 Hz, with an
average for the 33% of patients with angles greater than
65° of 23 Hz.
Phantom Work
The distortion pattern obtained in the phantom data is
similar to that obtained in vivo with negative distortions
FIG. 3. Three stages of frequency offset for the ﬁrst pass of Gd-DTPA in the heart for one volunteer (a–c) showing phase difference and
magnitude images. From (a–c) we have the end of the ﬁrst pass of contrast agent in the RV, the ﬁrst pass in the LV, and during myocardial
perfusion. d: frequency offsets for a septal ROI, and SI curves for the RV and LV in the magnitude images with a gray shade marking the
timing of the images on the top for frames (a–c). During the ﬁrst pass in the LV all patients showed an increase of B0 in the posterior and
anterior myocardial segments (brighter regions) and a decreasing of B0 in the septal and lateral segments (darker regions). The SI curves
of the magnitude image are rather complex since they are affected by T2* signal loss due to its long TE; nevertheless, a change of contrast
is present, indicating the arrival of the CA.
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across the direction of B0 (darker regions) and positive
distortions located along the B0 direction (brighter regions)
(Fig. 6a–e).
Figure 6 also shows the line proﬁles across the ﬁeld
(a
–e
) and along the ﬁeld (a–e) for the angles 10°, 25°,
50°, 70°, and 90°, respectively.
The frequency difference between the LV cavity and the
subendocardium increases with angle in the direction
along the ﬁeld and decreases across the ﬁeld. In the range
of angles recorded in vivo (50°, 70°), the frequency differ-
ence between the LV cavity and the myocardial wall is: 50°
along the ﬁeld (80 Hz), across the ﬁeld (30 Hz); 70°
along the ﬁeld (150 Hz), across the ﬁeld (20 Hz). These
results are summarized in Table 1.
FIG. 4. Peak frequency offsets
positive (posterior, anterior) (a,c,e),
negative (septal, lateral) (b,d,f) for
each patient in each slice (basal:
a,b; mid: c,d; apical: e,f), plotted
against the angle between B0 and
the LV long-axis. The error bars are
the temporal standard deviation of
the signal in each ROI.
FIG. 5. Peak frequency offsets measured in the LV cavity versus the
angle between B0 and the long axis of the LV for each patient in the
mid-slice. The error bars are the temporal standard deviation of the
signal in the ROI.
FIG. 6. Phantom and numerical simulation images at a range of
angles: phantom/simulation: (a/f) 10°; (b/g) 25°; (c/h) 50°; (d/i) 70°;
(e/j) 90°. Line proﬁles for the respective images are given on the
right: across the ﬁeld (a/f, b/g, c/h, d/i, e/j; along the ﬁeld
a/f, b/g, c/h, d/i, e/j). All images are at 1.5% Gd-DTPA
concentration in the LV cavity and 0% in the myocardium, and with
the same frequency range of 420Hz. The orientation of the in-
plane component of the main ﬁeld is vertical for all images.
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The phantom when imaged with a b-SSFP sequence
with a shift in frequency of 150 Hz or 100 Hz showed
signal loss in the regions where the ﬁeld maps yielded
negative and positive frequency offsets, respectively (Fig.
7). Signal loss is expected in regions with frequency offsets
of 200 Hz for the b-SSFP sequence used (17).
Numerical Simulations
The numerical simulated phase offset data are shown next
to the phantom for the same orientations in relation to the
main magnetic ﬁeld (Fig. 6f–j). Figure 6 also shows the line
proﬁles across the ﬁeld (f
–j
) and along the ﬁeld (f–j) for
the angles 10°, 25°, 50°, 70°, and 90°, respectively. These
line proﬁles show the absolute frequency offset value ob-
tained, i.e., they are not normalized to the LV cavity. This
makes it possible to quantify both the subendocardium
regions and LV cavity separately, as in the in vivo case, but
also compare the relative frequency difference between the
LV blood pool and the subendocardium, as in the phantom
data.
The distortion pattern is identical to both in vivo and
phantom data, with positive distortions along the ﬁeld and
negative distortions across the ﬁeld. Frequency offsets are
similar to the ones obtained in vivo, although smaller
when compared to the phantom data. We can see that as
the angle increases the frequency offset in the subendocar-
dium increases, from 0 Hz at 10° to 60 Hz at 90°.
The LV cavity frequency offset also decreases toward
negative values as the angle increases, from 46 Hz at 10° to
23 Hz at 90°. When combined with the behavior of the
subendocardium regions, we have a similar effect to the
one recorded in the phantom, the frequency difference
between the LV-subendocardium border increases along
the ﬁeld and decreases across the ﬁeld as the angle in-
creases. For across/along the ﬁeld the frequency difference
is 46/46 Hz at 10° and 37/83 Hz at 90°.
The numerical simulations give us an angle of 55° for a
null frequency offset in the LV, which agrees well with the
in vivo data.
In the range of angles recorded in vivo (50°, 70°), the
subendocardial frequency offsets recorded are: 50°
(35 Hz); 70° (52 Hz). In the LV the frequency offsets
recorded are: 50° (6 Hz); 70° (14 Hz). These results are
summarized in Table 2.
Line proﬁles for along and across the ﬁeld are shown in
Fig. 8 for a patient, a numerical simulated image, and a
phantom scan. Phantom and numerical data are at 80°
orientation and the patient is at 76°. Although the region of
distortion was transmural, the numerical simulation data
seem to suggest a larger frequency offset located in the
subendocardium region. This is somewhat visible in vivo
as well, although with spatial resolution limitations.
Figure 9 shows three different doses 0.05, 0.10, and
0.15 mmol kg1 numerically simulated at an orientation of
80°, assuming that the concentration of Gd-DTPA in the
LV is 0.7%, 1.5%, and 2.1%, respectively. As the dose
increases the frequency offsets increase in a linear fashion.
This can be shown from the numerical equations given in
the Appendix.
DISCUSSION AND CONCLUSIONS
This study represents the ﬁrst in vivo quantiﬁcation of
B0-distortion during the ﬁrst pass in a typical myocardial-
perfusion setup using realistic perfusion injection rate and
doses of CA.
In vivo ﬁeld distortions agreed well with numerical
simulations. Phantom work shows higher frequency off-
sets; the authors speculate that this is due to small mag-
netic susceptibility differences between water and gelatin;
nevertheless, the same distortion patterns were observed.
All measurements showed that ﬁeld distortions occurred
mainly in the myocardial wall, with its peak during the
maximum concentration of Gd-DTPA in the LV, i.e., dur-
ing ﬁrst pass in the LV cavity before Gd arrival into the
myocardium itself. The pattern of ﬁeld distortion was also
consistent in different patients, with a higher ﬁeld for the
posterior–anterior regions of the myocardial wall and a
lower ﬁeld for the septal–lateral regions. These anatomical
regions, although in double oblique slices, correlate with
their orientation to the main ﬁeld B0, with anterior/poste-
rior being more along the ﬁeld and septal/lateral more
across the ﬁeld; therefore, the in vivo data agree well with
both numerical and phantom simulations.
One numerically predicted property was the higher ﬁeld
distortions in both the myocardial wall and LV blood pool
for more horizontal hearts; this agrees well with both
phantom data and volunteers’ data, with the exceptions of
the apical slice where the reduced blood pool volume
reduces the CA susceptibility effect. From the numerical
simulation, Eqs. [1, 2] (see Appendix), frequency offsets in
the myocardial wall are dependent on the orientation of
the axis in relation to the external ﬁeld by a sin2(	) factor.
FIG. 7. Balanced-SSFP images of the phantom at 60° orientation
(angle between the long axis of the heart and the main magnetic
ﬁeld; (a) at resonance frequency, (b) added frequency offset of
150 Hz, (c) added frequency offset of100 Hz. An overall dark rim
in the subendocardium is caused by Gibbs truncation, with subse-
quent signal loss areas in (b) and (c) due to the added frequency
offsets.
Table 1
Phantom Data
Angle (deg)
Frequency difference:
along the ﬁeld. (Hz)
Frequency difference:
across the ﬁeld. (Hz)
50 80 30
70 150 20
Frequency difference (frequency subendocardium – frequency LV)
in the subendocardial border for both along the ﬁeld and across the
ﬁeld, for 1.5% concentration of Gd-DTPA in the LV cavity and 0% in
the myocardium.
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The numerical simulation also helps understanding
why the peak frequency offsets happen at the LV ﬁrst pass:
the reason is that it is at this stage that the biggest suscep-
tibility difference happens between the LV cavity and the
myocardium wall. Subsequent washout of the LV blood
pool associated with myocardial perfusion reduces this
difference, dropping the frequency offset measured.
Furthermore, B0 ﬁeld distortion within the LV chamber
itself was shown to be smaller than that in the myocar-
dium, again consistent with numerical models.
The scatter in the patients’ data may be explained by a
range of physiological factors affecting ﬁrst pass concen-
trations of Gd-DTPA in the LV blood pool, for example,
cardiac function (12).
From all the in vivo data acquired the maximum ﬁeld
distortion was 85 Hz in the subendocardial region. If we
couple this value with the maximum LV distortion ob-
tained (45 Hz) and assuming a worst-case 50% partial
volume between the subendocardium and the LV, the in-
travoxel phase difference for a perfusion sequence with a
TE of 1.2 ms would yield a signal loss of 25%. Using a
more optimistic/averaged scenario, intravoxel dephasing
would yield a signal loss of 15% for the more horizontal
hearts in pixels straddling the subendocardium border.
For the same TE, a 3 mm pixel located solely in the
subendocardium would experience a maximum phase
range of 0.11 rad in the radial direction across it, leading to
negligible loss of signal (1%) based on a ﬁeld-distortion
Table 2
Numerical Simulations
Angle (deg)
Subendocardial
region (Hz)
LV cavity (Hz)
Frequency difference:
along the ﬁeld (Hz)
Frequency difference:
across the ﬁeld (Hz)
50 35 6 29 41
70 52 14 66 38
Frequency offsets for both the subendocardial wall and the LV cavity in relation to B0 and frequency difference between the LV cavity and
the subendocardial layer.
FIG. 8. Line proﬁles taken diamet-
rically across the short axis, cross-
ing the LV cavity and subendocar-
dium: posterior–anterior (a,c,e) and
septal–lateral (b,d,f); for a typical
patient (3-pixel average) (a,b), a
phantom (c,d), and a numerical
simulation (e,f). Phantom and nu-
merical simulation data at 80° and
the patient at 76° between the long
axis and the B0 ﬁeld. The frequency
difference in the phantom data is
normalized to the LV cavity.
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slope of 5 Hz mm1 as shown by the in vivo line proﬁle in
Fig. 7.
A balanced-SSFP perfusion sequence yields signal
drops in regions where frequency offsets are (17). With
a TR of 2.5 ms, this occurs at frequency offsets of 200 Hz
from the resonance frequency. This offset is bigger than the
one measured at ﬁrst pass of CA alone, but when other
ﬁeld distortion sources are added a signal loss can occur in
the subendocardial regions where the frequency offsets
were measured. The work done by Reeder et al. (15) mea-
sured ﬁeld distortions on short axis slice of the heart on
ﬁve male volunteers without any contrast agent. The re-
sults show that the biggest ﬁeld inhomogeneities consis-
tently occurred adjacent to the posterior vein region (be-
tween the posterior and lateral regions) with a difference
to the surrounding myocardium of 70–100 Hz. Adding this
ﬁeld inhomogeneity to the biggest frequency offsets ob-
tained in vivo, the total frequency offset comes close to the
one needed to cause dark rims in a b-SSFP perfusion
sequence. This is shown in Fig. 7, where a phantom was
imaged with a b-SSFP sequence with a TR of 2.5 ms. An
added offset of –150 Hz or 100 Hz yielded signal loss in
the subendocardium in the regions where the signal is
distorted negatively or positively respectively by the CA.
On a center-out hybrid-EPI perfusion sequence (18) the
frequency offset caused by a ﬁeld distortion could create a
splitting of the point-spread-function along the phase-en-
code direction. This would affect mainly the regions of the
subendocardium where the peak distortions were mea-
sured. For a hybrid-EPI with an EPI factor of 4, an echo-
spacing of 0.9 ms, and a phase FOV of 280 mm the ﬁeld
distortions measured in this work alone are not enough to
cause any serious spatial misregistration unless the EPI
factor increases by a factor of four.
A noteworthy observation is the location of the ﬁeld
distortions. The peaks are situated along and across the
ﬁeld components, with a higher frequency difference be-
tween the LV cavity and the subendocardium along the
ﬁeld. A possible DRA caused by CA ﬁrst-pass ﬁeld distor-
tions would usually be located in particular regions of the
subendocardium and not circumferential, as was some-
times observed in previous perfusion studies (10). With an
added frequency offset in a b-SFFP sequence, the artifacts
would be expected in speciﬁcally opposite directions and
would probably never be circumferential. Since the polar-
ity of a static B0 frequency offset is usually unknown in
vivo, it cannot be predicted whether this effect might
occur anterior/posterior or septal/lateral. It should also be
FIG. 9. Numerical simulation line
proﬁles along (a,c,e) and across
(b,d,f) the ﬁeld at an 80° orienta-
tion for three different CA doses,
0.05 (a,b), 0.10 (c,d), and
0.15 mmol/Kg1 (e,f), assuming a
Gd-DTPA concentration in the LV
of 0.7%, 1.5%, and 2.1%, re-
spectively.
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remembered this will all occur superimposed upon Gibbs
and motion sourced of DRA.
The frequency offsets are dependent on the dose used,
although the standard perfusion protocol used here was a
dose of 0.10 mmol kg1, other sites suggests a lower dose of
up to 0.05 mmol kg1 of body weight to prevent nonlinear
contrast enhancement (19); different doses ranging from
0.05 mmol kg1 to 0.15 mmol kg1 have been tried (20,21).
A numerical simulation using different doses shows that
the frequency offsets increase linearly with the dose given.
Therefore, a lower dose is insigniﬁcant in terms of causing
any susceptibility artifacts.
Patients with a lower cardiac function also potentially
lower the ﬁeld distortion when compared to healthy vol-
unteers. Thus, if DRA were to be caused by frequency
distortions, it would be perhaps more likely to occur in
patients with normal cardiac function, which would tend
to increase the rate of false-positives.
In conclusion, the numerically simulated and phantom
work data agree well with the in vivo ﬁeld distortions
caused by the ﬁrst pass of a CA. During the ﬁrst pass, B0
distortion occurs mainly in the subendocardium, and the
same pattern is always observed (posterior–anterior re-
gions: positive; septal–lateral regions: negative). The myo-
cardial B0 distortion is larger in patients with a more
“horizontal” heart, i.e., a greater angle between the long
axis of the heart and the direction of the main ﬁeld. From
these results we conclude that the ﬁeld distortions are too
weak to cause DRAs due simply to intravoxel dephasing at
a 5 mL s1 antecubitally injected dose of 0.1 mmol kg1 of
body weight or less. However, the effects in b-SSFP and
h-EPI perfusion sequences are more complex, and when
other sources of off-resonance error are considered a dark
rim can be produced by the paramagnetism of Gd in SSFP
at the dose given; nevertheless, signal loss artifacts pro-
duced by susceptibility would be localized in speciﬁc
regions and not with a circumferential shape, as seen often
in vivo.
APPENDIX
The ﬁeld distortion inside and outside an inﬁnite cylinder
with a deﬁned magnetic susceptibility in an external ho-
mogeneous magnetic ﬁeld is well established (16). The
frequency offset for a given difference in susceptibility 
between the cylinder and the surrounding is given by:
Inside the cylinder:
	 


3
3cos2	 1
Outside the cylinder:
r,	,  
sin2	a/r2 cos2
Where 
  20, 	 is the angle between the long axis
of the cylinder and the magnetic ﬁeld direction, and  and
r are the cylindrical coordinates (Fig. 2). 0 is the angular
frequency of B0 and a is the cylinder radius.
This model can be adapted to simulate ﬁeld distortions
on the LV and myocardial wall approximating it to a
superposition of two inﬁnitely long cylinders. Each region
can be deﬁned with a magnetic susceptibility similar to the
one encountered in the heart during ﬁrst pass, therefore
simulating the phase distortions caused by the arrival of
the paramagnetic CA into the LV. Frequency offsets in this
setup are given by the following equations:
In the blood pool:
  1
1

3
3cos2	 1 2
2

3
3cos2	 1 [1]
In the myocardium:
r,	,  11
sin2	a/r2cos2
 2
2

3
3cos2	 1 [2]
where i, i  1,2 are the weights of the superposition.
Magnetic permeabilities of each region are: myocardium
m  1e  2i; left ventricle cavity v  1i  2i.
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Abstract
Background: Gibbs ringing has been shown as a possible source of dark rim artifacts in myocardial
perfusion studies. This type of artifact is usually described as transient, lasting a few heart beats, and
localised in random segments of the myocardial wall. Dark rim artifacts are known to be
unpredictably variable. This article aims to illustrate that a sub-pixel shift, i.e. a small displacement
of the pixels with respect to the endocardial border, can result in different Gibbs ringing and hence
different artifacts. Therefore a hypothesis for one cause of dark rim artifact variability is given based
on the sub-pixel position of the endocardial border. This article also demonstrates the
consequences for Gibbs artifacts when two different methods of image interpolation are applied
(post-FFT interpolation, and pre-FFT zero-filling).
Results: Sub-pixel shifting of in vivo perfusion studies was shown to change the appearance of Gibbs
artifacts. This effect was visible in the original uninterpolated images, and in the post-FFT
interpolated images. The same shifted data interpolated by pre-FFT zero-filling exhibited much less
variability in the Gibbs artifact. The in vivo findings were confirmed by phantom imaging and
numerical simulations.
Conclusion: Unless pre-FFT zero-filling interpolation is performed, Gibbs artifacts are very
dependent on the position of the subendocardial wall within the pixel. By introducing sub-pixel
shifts relative to the endocardial border, some of the variability of the dark rim artifacts in different
myocardial segments, in different patients and from frame to frame during first-pass perfusion due
to cardiac and respiratory motion can be explained. Image interpolation by zero-filling can be used
to minimize this dependency.
Background
Myocardial perfusion imaging with magnetic resonance,
combined with other Cardiovascular Magnetic Resonance
scans such as Late Gadolinium Enhancement, is develop-
ing into an alternative to nuclear medicine [1-5]. There is
however a well-known dark rim artifact (DRA) that com-
plicates diagnosis and quantification. There have been
several possible mechanisms described in literature that
can explain DRAs including cardiac motion during image
acquisition [6], Gibbs ringing in the subendocardial bor-
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der due to a finite resolution [7], non-uniform k-space
weighting resulting in point spread function distortion
[1]. Recently main field distortion during first-pass was
measured and shown likely to be insufficient to cause sus-
ceptibility artifacts in typical 1.5 T perfusion protocols [8].
In this work we are going to focus only in the contribution
that Gibbs artifact makes to DRAs in perfusion studies.
Cardiac motion tends to cause artifacts more toward mid-
wall in the myocardium [6], and non-uniform k-space
weighting point-spread function distortion [1] was
assumed negligible for the perfusion setup used in this
study.
The Gibbs ringing artifact (also known as truncation arti-
fact) is present at bright borders such as the endocardial
border during the first-pass and it manifests as signal
intensity oscillations with distance from the border. As a
rule of thumb, Gibbs ringing becomes a noticeable prob-
lem when the border is so sharp that its width is equal or
smaller than the true pixel size in the direction across the
border. The Gibbs oscillation nearest to the border has an
amplitude of 9% of the intensity change across the border
(i.e. 9% undershoot and 9% overshoot) which is inde-
pendent of image resolution. Although 9% might seem
relatively small, it results in an 18% variation in the sub-
endocardium for a typical blood/myocardium signal ratio
of 3/1 during LV (Left Ventricle) first-pass, and this can be
very noticeable. Gibbs ringing is therefore important in
generating DRAs, and it is exactly during early contrast
enhancement (i.e. while the LV blood is still much
brighter than the myocardium) that mild perfusion
defects are diagnosed. DRAs are commonly described as
transient lasting a few heart beats [9,10]. Some of this
transient behaviour can be explained by the DRA becom-
ing visible only when the LV is much brighter than the
myocardium, i.e. the DRA is a ringing artifact into the
myocardium from the sharp edge. Therefore DRAs are of
great importance because they can obscure underlying
short-lived mild perfusion defects in the subendocardium
and it is therefore clinically important to fully understand
their properties.
This article illustrates a source of DRA variability based on
the sub-pixel position of the endocardial border. The exact
position of the endocardial border with respect to a pixel
will determine the amount of Gibbs artifacts visible near
that border, i.e. by introducing a relative shift of the pixels
by a distance smaller than the pixel size (sub-pixel shifts)
the amount of visible Gibbs ringing can be affected. This
is illustrated in Figure 1, on the left it is shown a simplified
signal profile that could be found across a short axis of the
heart, crossing the centre of the LV blood pool and the
myocardial wall on both sides (red line). The sharp step of
the line profile corresponds to the endocardial border on
each side. Because of the limited spatial resolution of a
typical perfusion image acquisition, the signal around
these edges would actually be corrupted with Gibbs arti-
facts (blue line). Figure 1 shows how different pixel posi-
tions would result in the oscillating signal being displayed
very differently. This occurs because each pixel displays
the sum of the signal within its finite size (orange and
green represent different pixel positions and the respective
pixel values obtained). Gibbs ringing is much more prom-
inent for the orange pixel position than for the green pixel
position. (This illustration is over-simplified neglecting
Pixel position and Gibbs ringingFigure 1
Pixel position and Gibbs ringing. A simulated short axis signal profile across the myocardium and LV (red). The sharp edge 
in the profile represents the signal contrast between the myocardium and the LV. The signal around these edges is going to be 
corrupted with Gibbs artifacts (blue line). Different pixel positions would measure the oscillating signal differently, since each 
pixel has a finite size, integrating the signal inside its corresponding position. Orange and green represent different pixel posi-
tions and the respective signal profile measured. Gibbs ringing is much more visible in the orange pixel position that on the 
green pixel position. This figure does not consider any image interpolation effects.
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any point-spread function to make the fundamental
point).
The appearance of the magnitude image is commonly
improved by increasing the matrix size. This can be
achieved by zero-filling the raw-data or by interpolating in
the image space. Zero-filling (pre FFT (Fast Fourier Trans-
form) interpolation) is widely used, and it has been
reported to reduce partial volume artifacts and increase
the resolution in the diagonal direction [11,12]. Image
display programs also usually interpolate data in the
image space (post FFT interpolation). This article will also
demonstrate the effects on the Gibbs artifacts caused by
interpolating the original image; mainly the difference
between pre and post FFT interpolation.
The objective of this article is to illustrate the effect on
Gibbs artifacts of introducing sub-pixel shifts in the con-
text of myocardial perfusion imaging. To the best of our
knowledge this has not been published before in the con-
text of myocardial perfusion.
Methods
Phantom imaging
For a practical example of the effect which will be exam-
ined in the context of perfusion imaging, we made the fol-
lowing initial demonstration. Images were acquired with
a 8 mm slice perpendicular to a flat boundary between a
solution of Gd-DTPA and undiluted gelatine with a signal
ratio of approximately 3/1 (which is similar to typical per-
fusion first-pass images when normal myocardium begins
to enhance after the LV bolus peak). The sequence used
was a balanced Steady State Free Precession: TR (time of
repetition)/TE (echo time) of 1.6/1 ms; base resolution
128 × 128 pixels; pixel size 3 × 3 mm; flip angle 70°;
bandwidth 890 Hz pixel-1. The image plane was slightly
rotated with respect to the phantom's edge so that the
edge was slightly misaligned in relation to the pixel orien-
tation. This aimed to test the effect of varying border posi-
tion in relation to pixels in the vertical direction, as a
function of position across the image. The uninterpolated
image was compared with the two approaches to interpo-
lation described in the Introduction: 1) the phantom
image was interpolated in MATLAB (Mathworks, Natick,
USA-MA) using a bicubic interpolation in the image space
by a factor of two in each direction; 2) the same raw data
of the image was zero-filled by a factor of two in each
direction before FFT.
Simulated data
A short-axis image of the heart with an epicardial diameter
of 65 mm and an endocardial diameter of 35 mm was
simulated numerically using MATLAB. The LV/myocar-
dium signal ratio was 3/1. The magnitude image was
reconstructed from a finite 128 × 128 raw-data matrix, as
would be obtained in practical MR imaging, and therefore
is inherently corrupted with Gibbs artifacts. Sub pixel
shifts were introduced by applying a linear phase slope
across the simulated raw-data, which corresponds to a
translation of the object being imaged. Reconstruction
was repeated with appropriate phase slopes to introduce
shifts of half a pixel horizontally and then vertically, in
order to simulate the effects of a small sub-pixel shift in
the subendocardium. A magnitude image with a lower
image contrast with a ratio of 4/3 between the LV and the
myocardium was also simulated, representing the normal
heart after the bolus transit. No filtering was applied dur-
ing any reconstruction.
All of the uninterpolated simulated magnitude images
described above were also compared against two methods
of interpolation, in a similar fashion to the phantom data:
1) image-based interpolation by a factor of 2 along each
direction in the image space using bicubic interpolation
(MATLAB), and 2) zero-filling of the raw-data by a factor
of 2 along each direction before FFT.
Patient images
By retrospective processing of patient data, sub-pixel shifts
were also introduced into the raw-data of three patients
who had clinical stress perfusion studies, where a DRA
was visible. All the in vivo raw-data used was anonymised;
totally anonymised data does not come under the juris-
diction of the UK Data Protection Act, and therefore con-
sent for the anonymous use of patient data is not legally
required in the UK. The perfusion sequence was a hybrid
echo planar imaging (h-EPI) sequence with an EPI factor
of 4; TR (time of repetition)/TE (time of first echo) of 5.1/
1.02 ms; base resolution 128 pixels; pixel size 2.8 × 2.8
mm; slice thickness 8 mm; flip angle 30°; bandwidth
1860 Hz pixel-1; TI (time of inversion) of 90 ms using a
non-selective BIR-4 saturation pulse, TSENSE with an
acceleration factor of 2. Perfusion was imaged for three
slices (order: basal, mid, apical) each heartbeat, at the first
pass of Gd-DTPA at a dose of 0.1 mmol/Kg of body weight
at an injection rate of 3 mL/s (1 M contrast agent). Images
were acquired in the short-axis plane for fifty R-R inter-
vals, with the patient holding their breath for as long as
possible. Maximal hyperaemia was induced by a continu-
ous intravenous infusion of adenosine at a rate of 140 μg/
kg/min and stress perfusion images acquired after 4 min-
utes of adenosine infusion.
The in-vivo sub-pixel shifts applied had a step of 1/8th of a
pixel ranging from 0.125 to 0.875 of a pixel length. The
unprocessed raw-data was transferred and an appropriate
phase slope introduced using MATLAB before reconstruct-
ing the data back on the scanner using the same image
reconstruction settings as the original images. The scan-
ner's image reconstruction was also repeated with a zero-
filling interpolation by a factor of two. The final non-
interpolated magnitude images were also interpolated in
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the image space using MATLAB with a bicubic interpola-
tion by a factor of two. The original and shifted magnitude
images were compared visually.
The myocardial segments pointed out as DRAs were not in
territories where a real perfusion defect was reported clin-
ically. Specifically all the DRAs considered were transient
in nature lasting only a few heart beats during first-pass
and correlated with the LV bright blood signal.
The Gibbs artifact signal loss was measured as a percent-
age of the average myocardial signal in all experiments.
These values were measured with a 3 pixel wide line pro-
file perpendicular to the endocardial border in the myo-
cardial segment being considered.
Results
Figure 2a–c shows the phantom edge results: uninterpo-
lated image, the image interpolated in the image space,
and the zero-filled interpolated image respectively. It can
be seen, in image a, and b that the near-horizontal edge
generates Gibbs artifacts at some locations along the hor-
izontal direction (solid arrows) but not at others (dashed
arrows). The artifact is seen in the single-pixel layer imme-
diately adjacent to the bright region (simulated LV
blood), to which layer all of the following descriptions
will refer. The locations indicated by the solid arrows cor-
respond to the situation shown in orange in Figure 1,
while the locations of the dashed arrows correspond to
the green case also shown in Figure 1. The maximum
measured signal loss on the uninterpolated image (Fig 2a)
was 14%. On Figure 2c, following zero filling interpola-
tion, the artifact's variability with the edge position is less
visible and this would be expected to be further reduced if
more zero filling was used.
The simulated images are displayed in Figure 3. Image a
shows Gibbs artifacts in the subendocardial layer in the
anterior, septal, inferior and lateral regions. In Figure 3b,
the heart has been given a half-pixel shift in the horizontal
direction in relation to the original position given in a,
and this results in a reduction of the Gibbs artifacts for the
septal, and lateral segments (arrows), i.e. the regions with
vertical edges. In Figure 3c the heart has been given a half-
pixel shift in the vertical direction with a reduction of the
Gibbs artifacts for the inferior and anterior segments
(arrows), i.e. the regions with horizontal edges. However,
note that at some nearby positions around the circumfer-
ence, towards the diagonal regions of the subendocar-
dium in image b-c, there are sometimes increases of the
Gibbs artifacts with the shift; these positions can be seen
to have low-Gibbs offset before the shift. Figure 3d is the
same as Figure 3a except for a much lower contrast ratio
between the LV blood pool and the myocardium, and this
shows less prominent Gibbs artifact as expected. The
measured signal losses were 23% and 6% for 3a and 3d
respectively.
Figure 3e–h show the image based interpolated magni-
tude images of a-d respectively. This interpolation exhibits
exactly the same shifting effects as in Figures 3b and 3c, i.e.
a similar reduction of the artifacts in the regions pointed
out by the arrows, but increased artifact at other locations.
Figure 3i–l show the zero-filled images corresponding to
images a-d respectively. In this subset of images, the arti-
facts appear consistently regardless of the small inplane
shifts of the heart.
Results from the in-vivo sub-pixel shifts are shown in Figures
4, 5 and 6. Figure 4a shows the original uninterpolated
image retrieved from the perfusion scan for one patient, with
an artifact in the septal region as pointed out by the white
arrow. After testing several sub-pixel shifts, Figure 4b shows
the same magnitude image but with a shift of 0.375 pixel
length in the horizontal direction, corresponding to the shift
with the most prominent artifact in the same region. Figure
4c shows a shift of half a pixel compared to image b in the
horizontal direction, showing a reduction of the DRA. The
measured signal loss in the DRA was 21%, 36% and 17% for
a, b and c respectively. Figure 4d–f, and 4g–i show images a-
c interpolated in the image space, and zero-filled pre-FFT
respectively; the effects noted in Figures 4b and 4c are repli-
Phantom imagesFigure 2
Phantom images. A phantom with a near horizontal flat 
edge between undiluted gelatine and a solution of Gd-DTPA, 
corresponding to a signal ratio of 1:3 in the edge boundary. 
a) Phantom image uninterpolated. b) Image a interpolated in 
the image space with a bicubic interpolation. The solid 
arrows point into the regions where Gibbs artifacts are visi-
ble, while the dashed arrows point into the in-between 
regions with no artifact. c) Image a but with zero-filling pre 
FFT interpolation. Figure 2 a (bottom right) shows the meas-
ured peak artifact signal loss in the bottom right corner.
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cated in Figures 4e and 4f with image-based interpolation,
but the variability of Gibbs artifact is highly reduced by zero-
filling interpolation (Figures 4g–i).
Figure 5a shows another in-vivo example where the DRA is
located in the anterior region of the subendocardium. The
shifts (in the vertical direction) shown in Figure 5b and 5c
are 0.875 and 0.375 pixel length respectively. Figure 5b
corresponds to the shift with the most prominent artifact,
and figure 5c the shift with the biggest DRA reduction. The
measured signal loss in the DRA was 47%, 52% and 20%
for a, b and c respectively. Figures 5d–f, and 5g–i show the
post-FFT and pre-FFT interpolations respectively. Post-FFT
interpolation again replicates the uninterpolated
case whereas pre-FFT interpolation greatly reduces the var-
iability.
Figure 6a shows a third example of a perfusion scan, this
time with an artifact in the septal segment, and is an exam-
ple where the original mid-septal endocardial boundary
happened to be in the position with the most prominent
DRAs. Figure 6b corresponds to image a shifted in the hor-
izontal direction by 0.5 of a pixel length, showing a reduc-
tion of the artifact. The measured signal reduction was
24% and 7% for a and b respectively. Figures 6c–d and 6e–
f are the respective post-FFT and pre-FFT interpolations of
figures 6a–b. Post-FFT interpolation shows the same vari-
ability of DRA appearance as the uninterpolated images,
while pre-FFT interpolation highly reduces the variability.
Note that there is a real perfusion defect in the inferior seg-
ment of the myocardium, but we are interested in the
mid-septal segment as marked in Figures 6a and 6b.
See also additional file 1: Animation1 where four consec-
utive frames during first-pass of the contrast agent bolus
are shown alternating between the worst and the best shift
for two artifacts located in the anterior and inferior myo-
cardial segments.
Numerical simulationFigure 3
Numerical simulation. Top: a) numerically simulated short axis image. b) Image a shifted horizontally half a pixel by phase-
shifting the raw-data. c) Image a shifted vertically half a pixel using the same method. d) Image a with lower LV/myocardium sig-
nal ratio. Images e-h are images a-d interpolated in the image space. Images i-l are images a-d zero-filled pre-FFT. Both figure 3 
a, and d also show, in the top right corner, the correspondent measured peak artifact signal loss.
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In-vivo IFigure 4
In-vivo I. a) The original image retrieved from the perfusion scan, with a mild artifact in the septal region as pointed by the 
white arrow. b) The same magnitude image but with a shift of 0.375 pixel length in the horizontal direction, corresponding to 
the shift with the most prominent artifact in the same region. c) A shift of half a pixel compared to image b in the horizontal 
direction, showing a reduction of the DRA. Images d-f, and g-i show images a-c interpolated in the image space, and zero-filled 
pre-FFT respectively. Figure 4 a-c in the bottom, show the measured peak artifact signal loss in the region pointed by the 
arrows.
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In-vivo IIFigure 5
In-vivo II. a) Original perfusion image with a DRA located in the anterior region of the subendocardium. b) Image a shifted 
0.875 pixel length in the vertical direction. c) Image a shifted 0.375 pixel length in the vertical direction (half-pixel difference 
from b). Image b corresponds to the shift with the most prominent artifact, and image c the shift with the biggest DRA reduc-
tion. Images d-f, and g-i show the post-FFT and pre-FFT interpolations of images a-c. Figure 5 a-c in the bottom, also show the 
measured peak artifact signal loss in the region pointed by the arrows.
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All the in-vivo images shown interpolated in image space
exhibit similar Gibbs artifact dependency on the edge
position as shown by the non-interpolated images. This
dependency is highly reduced for the images interpolated
by zero-filling pre-FFT, i.e. the DRAs seem identical before
and after shifting the raw-data.
Discussion
It should be noted that this work focussed on the Gibbs
artifact's contribution to perfusion DRAs and other factors
that contribute to DRAs are not considered here.
This work illustrates that how the exact position of the
endocardial border with respect to the image pixels can
explain some of the variability of the DRA in different
myocardial segments, in different patients and from frame
to frame during first-pass perfusion and how this could be
affected by cardiac and respiratory motion. It should be
understood that the relevant sub-pixel shift is the sub-
pixel remainder of any larger in-plane shift, i.e. if the heart
moves by a length of three and a half pixels then the sub-
pixel shift effects described here are the same as moving by
half a pixel. Although it may be possible to minimise the
Gibbs ringing contribution to a DRA in a particular myo-
cardial segment by introducing a phase slope to the raw-
data and repeating its reconstruction, it may also make
Gibbs ringing contribute more to DRAs in other subendo-
cardial segments (i.e. where the subpixel remainder of
border location in relation to pixels differs). Also
although it may appear that there is perhaps the option to
identify DRAs due to Gibbs by repeating shifted recon-
structions while checking consistent appearance of DRA,
this idea would probably be confounded by partial-vol-
ume effects on true thin defects. For these reasons,
although it might seem possible to devise a tool to evalu-
ate the contribution of Gibbs ringing artifacts by applying
shifted image reconstructions, we doubt whether this
would be worthwhile.
The nature of the Gibbs artifact makes it very sensitive to
sub-pixel shifts, since each oscillation lobe covers the size
of one pixel. Gibbs artifacts scale with the pixel size, there-
fore the spatial frequency of the oscillations increases
exactly with the resolution. Consequently, the sensitivity
to sub-pixel shift applies at any resolution, although at
higher resolution the relative sharpness of endocardial
borders is likely to be reduced and this reduces the artifact.
This is in line with the work done Plein et al., where a high
resolution k-t-SENSE perfusion study was compared with
a standard SENSE perfusion protocol, scoring less dark-
rim artifacts [13].
Reducing the Gibbs artifact can be achieved by filtering
the raw data, reducing the ringing drastically at the price
of reducing the resolution as well, which is a high cost
when considering the typical low resolutions obtained
clinically by most perfusion studies.
In theory each frame of each slice in a perfusion study will
image the heart in the same part of the cardiac cycle, nev-
ertheless small differences in the position of the heart
walls from frame to frame will be very likely, changing the
position of the edge inside an approximate 2.5 × 2.5 mm
pixel. Sub-pixel shifts are therefore a contributor to the
variability of the Gibbs artifacts, in addition to the varia-
ble sharpness of the endocardial border between the LV
blood pool and the myocardium from frame to frame and
also between patients.
In-vivo IIIFigure 6
In-vivo III. a) The original perfusion frame with an artifact in 
the septal region, and is an example where the original 
boundary was exactly at a location with the most prominent 
DRA. b) corresponds to image a shifted in the horizontal 
direction by half a pixel length, showing a reduction of the 
artifact. Figures c-d and e-f are the respective post-FFT and 
pre-FFT interpolations of figures a-b. Figure 6 a, and b in the 
bottom, show the measured peak artifact signal loss in the 
regions pointed by the arrows.
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The appearance of the Gibbs artifact is not only depend-
ent on the LV blood pool/myocardium signal ratio but
also on the myocardial signal-to-noise ratio, i.e. sequences
less affected by random noise, such as b-SSFP, make Gibbs
artifacts easier to be seen. It is also recognized that the
most sensitive time for DRA is shortly after the LV peak,
when contrast agent begins to perfuse normal myocar-
dium but the LV blood is sometimes still extremely bright.
Also, a higher gadolinium concentration or the use of a 3
T field with its associated increase in SNR and CNR would
therefore increase the overall visibility of Gibbs artifacts.
Although a rest scan is sometimes used to determine
DRAs [14-16], it is often associated with a less compact
bolus due to the lower cardiac output, resulting in a
smaller LV/myocardium ratio, which in addition to the
effect of possible sub pixel positional differences, makes
the rest scan potentially unreliable in determining Gibbs-
related DRAs.
This work showed that the DRA variability is reduced by
zero-filling the raw-data before FFT and reconstructing a
larger matrix image, since this technique upsamples (i.e.
places more interpolated pixels on each cycle of) the
Gibbs signal oscillations and thereby reduces the variabil-
ity of Gibbs appearance; a factor higher than 2 in the inter-
polation would make the zero-filled data even less
dependent on the edge position [12,17]. On the other
hand, if interpolation in the image space is used, the sub-
pixel shift variability is the same as the original data. It is
important to point out that zero-filling does not reduce
the artifacts in any way; it only reduces their variability by
reducing their dependency on the endocardial border
position. Nevertheless a less variable artifact may be pref-
erable, especially if quantification methods are used.
A phenomenon of Gibbs ringing interference between
two close edges might also be possible, such as in the sep-
tal segment of the myocardium in-between the right and
left ventricle, where the ringing from both edges interfere
either destructively or constructively, decreasing or
increasing the Gibbs artifacts respectively.
It was difficult to measure the in vivo average signal inten-
sities accurately due to the low resolution and low SNR of
the perfusion frames. Nevertheless the average of the in-
vivo signal loss caused at the artifact regions in the images
with the prominent artifact was 31% of the respective
average myocardial signal.
Motion artifacts are more complicated than Gibbs arti-
facts, in that their signal oscillation wavelength increases
with distance from the sharp edge. Considering a simpli-
fication of a constant motion and a normal Cartesian k-
space filling, the signal oscillations will have a first lobe
width of approximately 2 pixels for a typical perfusion
sequence protocol [6]. Motion artifacts alone are therefore
wider and probably less prone to be affected by sub-pixel
shifts, but motion artifacts may occur in combination
with Gibbs artifacts, since the latter are always present
(assuming no image filtering).
Conclusion
It was shown that the contribution made by Gibbs arti-
facts to DRAs in perfusion studies is very dependent on
the position of the subendocardial wall inside the pixel in
the absence of zero-filled pre-FFT interpolation. Position
variations between patient studies and from frame to
frame in a typical ECG-gated perfusion study can explain
some of the variability often seen in DRAs. This work also
showed that image-based pixel interpolation does not
reduce this source of DRA variability. However, interpola-
tion by zero-filling prior to FFT makes the DRA appear-
ance less variable, i.e. reduces the artifact's ringing
dependency on the position of the subendocardial wall in
relation to image pixels.
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